data_2n19_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n19 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 889' ' ' LYS . 41.1 mmtm . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 50.8 m -106.98 142.63 36.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.44 139.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -105.2 119.51 39.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.868 0.366 . . . . 0.0 110.291 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.08 119.25 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.051 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 896' ' ' VAL . 34.8 ttpt 55.01 5.13 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.842 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.99 24.96 14.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.602 0.761 . . . . 0.0 110.15 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 894' ' ' LYS . 9.7 p -103.18 -27.33 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.64 24.99 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.283 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -122.2 135.16 54.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 27.1 m -103.7 126.03 50.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.714 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -86.68 116.14 24.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.906 0.384 . . . . 0.0 110.675 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.84 145.6 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 10.0 p -67.18 -20.26 65.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.9 m -81.84 2.61 29.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.308 . . . . 0.0 111.714 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.47 7.9 63.01 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.496 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.53 140.1 30.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.503 HG11 ' HB ' ' A' ' 919' ' ' VAL . 4.2 p -117.19 123.17 71.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.282 0.563 . . . . 0.0 109.866 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -101.2 112.23 24.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 917' ' ' LEU . 5.9 p -114.61 117.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.812 0.815 . . . . 0.0 111.046 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.3 tt0 -104.53 143.28 33.25 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.52 166.26 10.91 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.779 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -64.85 -20.45 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.698 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.6 1.3 26.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 111.122 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 92.14 5.5 65.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.289 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.0 m -97.23 153.21 18.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.583 ' C ' HD12 ' A' ' 917' ' ' LEU . 83.1 mt-30 -125.4 153.28 43.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.708 ' HB2' HG11 ' A' ' 909' ' ' VAL . 6.9 mp -134.22 137.78 44.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.69 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.79 120.66 62.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.503 ' HB ' HG11 ' A' ' 907' ' ' VAL . 74.2 t -119.7 132.65 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.72 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -93.48 138.3 31.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.6 127.1 29.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.58 0.229 . . . . 0.0 110.847 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.41 -0.13 82.95 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.693 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.596 HG11 ' H ' ' A' ' 925' ' ' SER . 27.8 t -120.19 140.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.5 t -91.35 -14.83 30.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 111.131 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.596 ' H ' HG11 ' A' ' 923' ' ' VAL . 22.5 p -87.95 114.67 24.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.361 0.6 . . . . 0.0 110.718 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 938' ' ' TYR . 2.4 pp -116.68 162.89 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.819 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 7.2 t -117.47 117.01 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.3 128.63 53.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.795 0.331 . . . . 0.0 110.681 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 31.3 m -114.71 128.91 56.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.512 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.0 m -105.88 138.38 19.62 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.38 -7.41 15.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.681 2.921 . . . . 0.0 113.611 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -78.72 -1.44 34.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.312 0.577 . . . . 0.0 109.791 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 92.62 39.32 5.32 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.577 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -133.66 106.17 7.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.213 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 9.3 t -104.65 126.49 51.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.247 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 20.6 m -117.97 136.4 53.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.593 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.66 127.58 43.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.577 ' HD2' HG13 ' A' ' 926' ' ' ILE . 7.7 t80 -99.2 126.59 45.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.97 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -117.74 169.56 13.29 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.38 -15.61 58.03 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.507 0.653 . . . . 0.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.09 23.38 9.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.045 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -127.55 147.02 50.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -100.69 140.24 35.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.853 0.359 . . . . 0.0 111.084 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.488 ' HG ' HD12 ' A' ' 952' ' ' LEU . 2.3 mm? -93.23 140.1 23.19 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.555 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.433 ' HD2' ' CG1' ' A' ' 948' ' ' ILE . 24.0 Cg_exo -65.52 170.11 11.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.372 2.048 . . . . 0.0 110.596 165.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.88 -52.51 57.24 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 67.1 m-85 -66.04 -33.94 76.94 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 944' ' ' LEU . 23.1 mm -71.19 -43.47 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-O 121.346 0.593 . . . . 0.0 109.827 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -64.38 -38.96 92.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.851 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -61.47 -47.39 85.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.5 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.467 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 12.7 ptpt -70.11 -38.15 75.54 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.488 HD12 ' HG ' ' A' ' 944' ' ' LEU . 37.3 mt -58.03 -30.97 66.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 111.406 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -60.13 -33.8 72.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.55 -24.23 63.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.11 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.427 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 38.5 pttt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.7 m -107.34 155.7 19.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.535 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.6 138.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.319 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -100.22 131.3 46.24 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.012 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.65 HG12 ' SG ' ' A' ' 954' ' ' CYS . 55.3 t -95.18 117.06 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.533 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.448 ' HE2' ' H ' ' A' ' 894' ' ' LYS . 0.7 OUTLIER 51.64 9.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.002 0.921 . . . . 0.0 112.881 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.54 22.37 12.1 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.606 0.763 . . . . 0.0 109.893 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.55 -27.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 109.786 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.1 160.83 25.91 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.382 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.477 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.0 OUTLIER -121.55 136.26 54.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.68 56.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.1 m -114.37 132.77 56.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.83 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.26 123.56 39.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.087 0.47 . . . . 0.0 111.6 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.463 HD22 ' HE3' ' A' ' 908' ' ' TRP . 3.3 mm? -96.84 139.03 33.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.5 t -67.12 -10.67 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 11.1 t -85.99 0.38 53.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.479 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.3 10.09 59.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.437 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.01 141.47 28.59 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.31 122.58 70.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.463 ' HE3' HD22 ' A' ' 902' ' ' LEU . 0.0 OUTLIER -103.74 114.96 29.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.423 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.0 t -110.0 118.42 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.27 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.477 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 51.1 mt-30 -101.67 143.01 32.16 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.827 0.346 . . . . 0.0 110.165 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.537 ' CZ ' ' HE2' ' A' ' 951' ' ' LYS . 0.3 OUTLIER -92.71 151.55 20.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . 0.461 ' N ' ' HD1' ' A' ' 911' ' ' PHE . 28.0 t-20 -58.39 -26.89 63.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.45 2.47 47.63 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.67 5.09 60.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.551 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 65.4 m -83.29 162.45 21.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -132.94 151.41 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.455 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 7.0 mp -124.58 136.64 54.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.436 HG23 ' NE1' ' A' ' 908' ' ' TRP . 27.8 t -111.76 118.27 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.618 HG23 HG22 ' A' ' 926' ' ' ILE . 34.2 t -122.99 131.86 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.902 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 923' ' ' VAL . 34.7 tt0 -94.47 139.03 31.67 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.22 127.41 31.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.063 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 100.16 -5.65 57.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.967 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.627 HG21 ' H ' ' A' ' 925' ' ' SER . 7.7 p -124.88 140.24 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 924' ' ' SER . . . . . 0.943 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 26.4 m -89.13 -5.9 57.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.416 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.627 ' H ' HG21 ' A' ' 923' ' ' VAL . 34.7 m -73.26 117.8 15.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.671 0.272 . . . . 0.0 110.565 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.618 HG22 HG23 ' A' ' 919' ' ' VAL . 1.5 mp -112.58 144.42 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.228 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 15.6 m -119.15 113.79 21.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.627 ' HE1' ' HE1' ' A' ' 938' ' ' TYR . 24.1 p90 -111.39 130.13 55.79 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.981 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 11.4 t -113.1 136.99 52.11 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 4.0 t -122.65 125.62 26.36 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.85 135.97 72.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.944 3.096 . . . . 0.0 113.156 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 65.16 11.44 7.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -118.76 -84.46 0.94 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.303 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 933' ' ' GLY . 6.5 tp-100 169.53 160.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 6.9 t -103.08 128.86 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.461 . . . . 0.0 109.936 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 936' ' ' THR . . . . . 0.611 ' HB ' ' CE1' ' A' ' 928' ' ' TYR . 38.0 m -116.9 136.41 52.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.681 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -116.33 128.06 55.22 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.132 0.491 . . . . 0.0 110.628 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.627 ' HE1' ' HE1' ' A' ' 928' ' ' TYR . 56.1 m-85 -109.88 131.46 55.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.054 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -92.68 179.41 40.06 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.517 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . 0.943 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 24.7 mp0 -63.72 -26.04 68.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.855 0.327 . . . . 0.0 111.294 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -87.23 1.58 52.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.935 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -108.6 142.48 39.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.427 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -76.84 129.85 36.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.629 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 91.2 mt -93.83 134.17 26.67 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.255 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 27.0 Cg_exo -63.78 164.53 21.22 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.015 2.477 . . . . 0.0 112.071 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.61 -62.81 1.27 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.686 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -68.06 -33.03 73.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.391 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.43 -43.88 83.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.121 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -63.28 -43.41 97.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.24 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -59.82 -44.16 94.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.309 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.537 ' HE2' ' CZ ' ' A' ' 911' ' ' PHE . 4.5 mttp -68.41 -43.47 77.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.653 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.409 HD22 HG12 ' A' ' 926' ' ' ILE . 3.9 mm? -64.24 -35.97 82.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.0 110.816 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -61.47 -35.2 76.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.507 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . 0.65 ' SG ' HG12 ' A' ' 893' ' ' VAL . 35.6 t -73.5 -26.68 61.0 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -179.754 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 p -107.38 143.61 35.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.296 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.04 154.96 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.712 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -106.98 130.61 54.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.656 0.265 . . . . 0.0 110.681 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.09 119.08 59.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.458 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.564 ' HB2' HG13 ' A' ' 896' ' ' VAL . 3.2 mmmp? 54.16 7.62 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.86 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.01 22.55 10.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.064 0.546 . . . . 0.0 110.261 -171.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 894' ' ' LYS . 12.8 p -103.69 -27.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . 0.887 ' HA3' ' HE3' ' A' ' 951' ' ' LYS . . . -140.12 158.89 25.99 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.568 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 2.0 m95 -121.93 135.54 54.88 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.026 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.1 m -115.6 124.72 51.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.02 117.18 34.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.261 0.553 . . . . 0.0 110.717 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.72 137.3 33.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.265 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 5.9 m -64.53 -13.24 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.262 0.554 . . . . 0.0 111.189 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 13.5 m -79.93 0.42 31.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 94.47 6.67 60.99 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.629 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.5 137.84 32.05 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -110.53 111.96 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 43.8 t -116.56 116.92 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 46.4 mt-30 -94.04 160.65 14.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.893 0.377 . . . . 0.0 110.5 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.43 ' HD1' ' HZ2' ' A' ' 951' ' ' LYS . 38.3 t80 -104.47 164.48 11.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -60.29 -26.01 66.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.3 0.1 54.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.54 4.8 60.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.707 . . . . 0.0 113.726 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 60.5 p -81.24 162.86 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.571 0.686 . . . . 0.0 109.332 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.736 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.6 OUTLIER -132.51 153.45 50.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 112.318 -177.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 916' ' ' GLN . 5.9 mp -126.92 135.97 51.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 32.8 t -112.39 122.69 67.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.73 137.16 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.127 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 923' ' ' VAL . 77.1 mm-40 -93.39 138.46 31.69 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.64 129.42 40.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.641 0.258 . . . . 0.0 111.062 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.17 -6.84 61.94 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.412 174.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 920' ' ' GLN . 33.5 m -130.14 156.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.393 0.596 . . . . 0.0 110.821 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 4.6 p -91.05 -6.7 53.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.297 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 21.7 m -72.06 128.54 36.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.956 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.88 146.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.529 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 13.0 m -114.01 116.43 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -97.12 127.21 42.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.045 0.45 . . . . 0.0 109.873 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.736 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 17.1 m -114.28 123.63 50.01 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.394 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 930' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 33.8 t -122.91 106.21 34.33 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 37.5 Cg_endo -66.41 -5.74 13.42 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.938 2.425 . . . . 0.0 111.993 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -93.18 -6.81 46.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.43 -66.5 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.638 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 179.74 169.06 1.17 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -169.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 18.2 m -103.23 124.78 49.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 53.5 m -119.66 130.17 54.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -97.85 130.25 44.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.62 127.64 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.024 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.88 172.56 24.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.66 -18.31 64.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.569 0.685 . . . . 0.0 110.721 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.05 2.29 47.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.565 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.87 143.97 26.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -95.95 125.69 40.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.915 0.388 . . . . 0.0 110.472 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.83 133.54 39.27 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.22 -66.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.601 2.201 . . . . 0.0 112.068 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -163.36 -64.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.688 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -59.74 -32.07 70.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.795 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.52 -43.56 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 0.0 110.385 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -64.23 -42.72 96.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.868 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -60.01 -43.78 95.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.219 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.887 ' HE3' ' HA3' ' A' ' 897' ' ' GLY . 23.2 tptm -68.1 -43.29 78.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.261 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.29 -37.74 88.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.883 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.76 -21.38 62.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.397 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.18 -23.07 67.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 110.712 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.771 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.388 0.614 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.6 m -103.2 141.08 36.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.832 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.56 140.55 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 898' ' ' TRP . 36.0 p90 -90.37 125.54 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.066 0.46 . . . . 0.0 110.736 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 894' ' ' LYS . 7.3 p -95.26 123.44 47.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.089 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.516 ' HG2' HG22 ' A' ' 893' ' ' VAL . 33.3 mmtp 57.91 8.29 0.71 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.678 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.99 22.56 11.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.69 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.74 -30.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.827 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.2 163.85 25.34 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.139 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.636 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 2.1 m95 -121.36 134.89 55.13 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.45 129.98 55.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.883 0.373 . . . . 0.0 110.633 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 24.9 m -116.88 126.89 53.67 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.419 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -94.34 116.14 28.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.249 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.7 p -66.4 -15.56 63.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.8 p -85.54 0.55 52.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.739 0.304 . . . . 0.0 111.213 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.21 9.71 60.29 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.235 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.85 139.67 30.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.403 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.84 122.31 68.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.14 0.495 . . . . 0.0 109.735 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.579 ' HE1' ' HG3' ' A' ' 916' ' ' GLN . 8.6 t90 -108.66 113.52 26.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 35.9 t -116.03 115.88 50.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 110.346 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.636 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 23.2 pt20 -105.26 163.22 12.76 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.48 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 23.9 m-85 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -65.45 -17.24 64.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.369 0.604 . . . . 0.0 110.147 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.76 3.33 41.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.725 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.5 6.78 59.55 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.798 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 14.6 m -88.81 158.42 18.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.883 0.342 . . . . 0.0 110.456 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.785 ' HB3' ' HB ' ' A' ' 929' ' ' THR . 50.5 tt0 -132.1 150.91 52.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.073 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.499 HD23 HD12 ' A' ' 926' ' ' ILE . 6.4 mp -137.82 135.88 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 171.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.96 121.59 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.63 HG11 ' HG ' ' A' ' 955' ' ' LEU . 11.6 t -120.04 135.97 58.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.15 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.23 139.41 30.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.84 128.1 35.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.029 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.37 -6.02 83.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.635 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 925' ' ' SER . 24.2 t -107.84 138.05 36.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.721 0.296 . . . . 0.0 110.644 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 38.1 m -91.29 -6.19 53.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.13 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.641 ' H ' HG13 ' A' ' 923' ' ' VAL . 21.5 p -95.44 123.8 39.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.499 HD12 HD23 ' A' ' 917' ' ' LEU . 2.6 pp -116.03 150.16 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.514 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 21.0 m -105.43 116.63 32.27 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -96.81 128.43 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.785 ' HB ' ' HB3' ' A' ' 916' ' ' GLN . 40.1 m -112.39 122.89 49.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.056 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.9 t -123.68 99.29 39.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.49 -12.29 32.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.73 2.287 . . . . 0.0 111.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -86.26 -14.26 44.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.484 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.95 -62.05 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.178 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -173.28 159.27 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.106 0.453 . . . . 0.0 110.513 -167.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 929' ' ' THR . 67.1 p -102.81 125.29 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 169.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 27.2 m -120.59 132.23 55.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.477 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -97.29 129.04 44.63 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.204 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.583 ' HB3' ' CD2' ' A' ' 944' ' ' LEU . 98.4 m-85 -107.17 139.61 41.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . 0.738 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -147.02 -172.73 17.57 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.92 -1.133 . . . . 0.0 112.818 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -26.61 67.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.899 0.48 . . . . 0.0 111.576 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -97.25 7.27 46.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . 0.738 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 5.9 mm-40 -113.13 150.76 31.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 111.031 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -74.52 122.25 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.837 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.583 ' CD2' ' HB3' ' A' ' 938' ' ' TYR . 77.7 mt -98.6 132.3 24.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.354 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 55.4 Cg_endo -84.25 172.36 9.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.618 2.212 . . . . 0.0 111.423 171.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -53.43 -60.93 2.67 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -64.79 -31.3 72.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.696 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.646 ' HB ' ' HD2' ' A' ' 945' ' ' PRO . 45.1 mm -68.78 -41.77 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.41 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.9 -39.12 88.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.7 ' HB3' ' HZ1' ' A' ' 951' ' ' LYS . 5.6 mmmp? -65.43 -42.73 92.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.471 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.39 -36.46 80.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -69.02 -31.5 70.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.96 -25.35 64.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.63 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.0 mm? . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.4 p -107.24 143.83 34.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.844 170.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.33 155.21 14.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.677 0.275 . . . . 0.0 110.319 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -101.84 130.54 48.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.58 120.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.672 ' HB2' HG11 ' A' ' 896' ' ' VAL . 2.9 mptp? 57.36 4.28 0.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.091 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 59.89 22.1 11.09 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.533 0.733 . . . . 0.0 110.47 -170.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 894' ' ' LYS . 12.9 p -105.57 -28.43 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 0.0 109.639 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.05 25.54 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.072 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.741 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 1.2 m95 -122.18 135.76 54.82 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -115.42 131.35 56.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.984 0.421 . . . . 0.0 110.733 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 15.8 m -116.02 130.46 56.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.765 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -94.88 115.31 27.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.657 HD12 ' HE3' ' A' ' 908' ' ' TRP . 86.3 mt -82.28 154.43 25.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -20.41 65.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.24 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.3 m -84.7 0.84 49.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 110.893 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.38 14.56 58.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.475 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . 0.634 ' HB2' HD11 ' A' ' 902' ' ' LEU . . . -90.03 139.14 30.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.626 0.25 . . . . 0.0 110.429 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.44 122.31 55.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.657 ' HE3' HD12 ' A' ' 902' ' ' LEU . 1.6 t-105 -110.75 114.72 28.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.821 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.79 117.7 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 111.071 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.741 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 22.3 pt20 -105.41 161.62 14.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.452 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.516 ' HE1' HD22 ' A' ' 917' ' ' LEU . 43.3 m-85 -121.61 -179.91 4.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.875 0.369 . . . . 0.0 111.515 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.52 -26.86 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.774 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -87.82 1.18 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.234 0.54 . . . . 0.0 111.006 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.52 4.84 87.43 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.495 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.8 t -79.43 151.12 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.535 ' HB3' ' HE1' ' A' ' 908' ' ' TRP . 29.5 mt-30 -133.46 154.92 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.476 -171.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.651 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 0.9 OUTLIER -139.66 136.04 33.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 165.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.6 p -113.28 126.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.148 0.499 . . . . 0.0 110.533 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.43 HG21 HG23 ' A' ' 926' ' ' ILE . 32.7 t -117.29 132.5 66.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.911 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.464 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 83.8 mm-40 -88.15 138.02 31.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.14 125.35 23.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 86.85 -6.06 83.76 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.25 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.632 HG11 ' H ' ' A' ' 925' ' ' SER . 36.4 t -107.56 138.22 34.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 59.8 m -91.44 -6.44 52.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.836 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.632 ' H ' HG11 ' A' ' 923' ' ' VAL . 72.1 p -90.62 114.98 27.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.018 0.437 . . . . 0.0 110.077 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 919' ' ' VAL . 78.6 mt -112.77 146.61 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.045 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.431 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 14.0 m -117.31 115.64 25.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.651 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 52.0 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.126 0.489 . . . . 0.0 110.3 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.522 HG21 HG22 ' A' ' 935' ' ' THR . 24.4 m -113.1 121.99 46.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 930' ' ' SER . . . . . 0.555 ' HB2' ' OD1' ' A' ' 932' ' ' ASN . 7.2 p -122.23 99.05 43.66 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.61 -26.73 80.24 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.61 2.873 . . . . 0.0 112.19 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . 0.555 ' OD1' ' HB2' ' A' ' 930' ' ' SER . 27.4 p-10 -71.63 -2.12 16.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.231 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -154.03 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.763 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -163.64 -175.43 4.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.898 0.38 . . . . 0.0 110.203 -168.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.522 HG22 HG21 ' A' ' 929' ' ' THR . 82.4 p -104.02 133.53 48.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 936' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 928' ' ' TYR . 14.2 t -117.47 140.93 48.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -107.09 130.46 54.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.088 0.471 . . . . 0.0 111.503 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.492 ' CE1' HD22 ' A' ' 944' ' ' LEU . 12.0 t80 -104.57 127.81 52.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.986 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -130.45 174.7 19.6 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -54.62 -27.04 36.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 0.0 111.68 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.02 2.85 53.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.48 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -104.67 141.29 36.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 111.857 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -99.46 123.93 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.069 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.492 HD22 ' CE1' ' A' ' 938' ' ' TYR . 1.5 mm? -79.84 133.23 58.84 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 18.8 Cg_exo -67.35 -66.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.938 2.426 . . . . 0.0 112.931 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -152.62 -74.97 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.271 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 52.5 m-85 -64.18 -29.75 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.493 ' O ' HD11 ' A' ' 952' ' ' LEU . 45.2 mm -68.21 -44.09 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.866 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.47 -39.19 91.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 953' ' ' GLN . 5.6 tp-100 -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.015 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 13.8 ptpt -69.22 -36.75 77.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.996 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 948' ' ' ILE . 4.7 mp -56.95 -31.61 65.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 950' ' ' GLN . 5.7 tp-100 -58.63 -31.04 67.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.165 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 38.1 t -69.41 -20.91 63.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 952' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . 0.405 ' HD3' ' NE2' ' A' ' 901' ' ' GLN . 60.5 mttm . . . . . 0 C--O 1.233 0.215 0 CA-C-O 121.431 0.634 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 16.6 p -106.8 142.9 35.69 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.956 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.85 140.7 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.05 119.4 30.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 109.951 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.56 122.61 50.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 62.14 2.88 0.88 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.524 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.15 22.33 11.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.633 0.773 . . . . 0.0 110.24 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.41 -30.47 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.379 0.609 . . . . 0.0 110.099 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.73 168.33 25.03 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.674 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.563 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.2 OUTLIER -117.1 134.72 54.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -119.51 131.07 55.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.096 0.474 . . . . 0.0 111.334 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 14.9 m -115.41 126.72 54.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.336 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . 0.405 ' NE2' ' HD3' ' A' ' 889' ' ' LYS . 10.6 pt20 -89.82 138.77 31.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.899 0.381 . . . . 0.0 110.264 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.29 142.32 44.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 18.7 p -66.86 -15.01 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 0.0 111.077 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 4.0 m -79.48 0.3 30.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.957 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.8 3.98 65.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.599 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -93.2 141.49 28.37 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.772 HG11 ' HB ' ' A' ' 919' ' ' VAL . 3.4 p -119.05 122.71 69.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.452 0.644 . . . . 0.0 109.428 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 11.5 t-105 -97.71 113.83 25.67 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.351 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 917' ' ' LEU . 3.3 p -114.56 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.596 0.712 . . . . 0.0 110.363 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.563 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 53.0 tt0 -98.68 142.63 30.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.975 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -91.79 151.62 20.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.674 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -64.13 -22.97 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.68 2.18 38.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 96.48 6.55 58.5 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.219 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.2 m -95.47 158.72 15.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.83 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 17.7 pm0 -132.91 154.96 49.91 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.254 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.767 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.3 mp -129.04 139.81 51.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.97 122.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.772 ' HB ' HG11 ' A' ' 907' ' ' VAL . 61.4 t -117.24 132.54 66.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.785 0.326 . . . . 0.0 110.217 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -92.23 139.4 30.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -52.81 128.96 28.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.53 -6.41 63.01 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.962 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 923' ' ' VAL . 14.6 t 61.31 32.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 121.885 0.85 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 15.5 m -72.87 -14.94 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.394 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 22.8 t -173.51 125.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.617 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.592 HG23 HG13 ' A' ' 919' ' ' VAL . 0.2 OUTLIER -125.02 144.16 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.519 ' OG ' ' HG2' ' A' ' 937' ' ' ARG . 10.2 m -118.82 122.04 41.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -96.66 124.08 40.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.875 HG22 ' HB ' ' A' ' 935' ' ' THR . 14.1 m -115.5 122.75 46.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 23.0 p -125.88 102.35 28.45 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.04 -40.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.752 2.968 . . . . 0.0 113.366 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.0 -29.74 71.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.552 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -116.61 -75.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.309 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -163.71 153.4 14.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.658 0.266 . . . . 0.0 111.118 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.875 ' HB ' HG22 ' A' ' 929' ' ' THR . 8.9 t -104.87 125.37 50.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 936' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 927' ' ' SER . 27.2 m -120.07 135.64 54.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.405 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.519 ' HG2' ' OG ' ' A' ' 927' ' ' SER . 40.2 mtp180 -98.11 126.79 43.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.92 140.46 45.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.163 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -106.4 161.68 14.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.404 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -5.76 20.65 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.391 0.615 . . . . 0.0 110.526 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -90.61 2.11 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.84 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 11.8 pt-20 -129.07 170.9 12.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.227 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -80.14 129.9 34.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.467 . . . . 0.0 110.521 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.631 HD22 HG22 ' A' ' 948' ' ' ILE . 32.2 mt -98.05 133.38 23.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.006 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.62 ' HB2' HD12 ' A' ' 948' ' ' ILE . 26.6 Cg_exo -63.74 156.11 59.51 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 111.629 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.89 -53.07 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.62 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . 0.416 ' O ' ' HD2' ' A' ' 951' ' ' LYS . 78.4 m-85 -63.24 -31.3 72.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.573 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.631 HG22 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -67.82 -42.94 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.836 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . 0.502 ' HZ2' ' HB3' ' A' ' 949' ' ' LYS . 3.4 mmmp? -63.31 -39.9 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.125 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.35 -43.77 98.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.599 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.527 ' HE2' ' N ' ' A' ' 951' ' ' LYS . 0.7 OUTLIER -68.34 -40.41 81.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.328 0.585 . . . . 0.0 109.694 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.76 -36.04 77.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -27.44 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.125 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.3 -20.58 63.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.54 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.91 -178.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . 0.515 ' HZ2' ' HB2' ' A' ' 889' ' ' LYS . 10.1 mtmp? . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.2 m -102.34 143.28 32.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.863 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.05 139.11 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -94.3 130.44 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.842 0.353 . . . . 0.0 110.598 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.46 118.79 54.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.0 9.68 0.33 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.415 1.072 . . . . 0.0 112.061 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 59.58 22.85 11.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.307 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.6 t -104.86 -30.42 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.29 159.33 25.66 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.024 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.511 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.3 135.97 54.82 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.64 129.85 53.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.84 0.353 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 43.9 m -107.09 132.89 52.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.116 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -93.6 115.07 27.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.964 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.17 146.43 23.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.9 t -63.82 -14.24 51.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.479 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 6.0 p -86.59 0.37 54.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.104 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.84 13.64 66.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.832 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 955' ' ' LEU . 42.7 t -109.81 123.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 7.1 t-105 -109.42 113.62 26.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 46.4 t -115.28 117.26 55.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 60.5 tt0 -106.52 142.99 35.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.48 160.81 16.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.73 -16.35 63.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.351 0.596 . . . . 0.0 110.127 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -73.9 -1.47 19.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.817 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.72 2.61 89.82 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.104 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.6 m -97.44 151.1 20.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.476 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 1.2 pm0 -133.3 162.45 31.78 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.357 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.23 137.41 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.828 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.433 ' HB ' ' OG ' ' A' ' 927' ' ' SER . 21.2 t -104.67 123.81 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.767 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 30.9 t -117.28 132.77 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.205 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -92.36 138.95 31.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.41 126.84 29.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.006 0.432 . . . . 0.0 111.002 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.53 83.5 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.639 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 925' ' ' SER . 25.3 t -110.17 128.4 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.596 -0.355 . . . . 0.0 110.737 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 32.4 t -89.28 -7.22 55.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.575 ' H ' HG11 ' A' ' 923' ' ' VAL . 23.8 m -90.89 111.97 23.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.673 HD13 HD13 ' A' ' 952' ' ' LEU . 43.1 pt -113.75 165.77 8.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.439 -171.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' A' ' 918' ' ' VAL . 9.1 p -116.97 116.02 26.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.281 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.19 131.07 44.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.758 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.476 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 7.3 m -111.35 124.35 52.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 48.3 t -115.92 127.44 26.77 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.513 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.64 -7.7 7.78 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.21 3.273 . . . . 0.0 112.695 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -54.54 -28.62 46.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.494 0.664 . . . . 0.0 109.572 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 117.07 35.54 1.11 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.327 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.82 140.0 11.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.769 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 7.2 t -104.31 127.31 51.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.273 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 15.0 t -117.92 138.64 52.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.618 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -98.35 130.34 45.01 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.53 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.29 127.41 53.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.8 13.3 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.339 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.0 -25.72 67.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.315 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -94.29 1.55 55.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.24 0.543 . . . . 0.0 110.649 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.8 160.98 16.25 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.034 -0.416 . . . . 0.0 110.974 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -85.31 122.85 30.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.426 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.487 HD22 HG23 ' A' ' 948' ' ' ILE . 82.6 mt -97.43 133.52 23.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.242 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 15.3 Cg_exo -71.21 169.78 19.84 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.092 2.528 . . . . 0.0 112.444 175.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.45 -56.84 16.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -62.2 -32.38 73.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.487 HG23 HD22 ' A' ' 944' ' ' LEU . 47.8 mm -69.91 -43.56 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.919 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -63.53 -44.92 92.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.51 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -61.4 -44.66 96.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.587 ' O ' ' HG ' ' A' ' 955' ' ' LEU . 11.1 mptt -68.98 -40.19 78.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.768 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.673 HD13 HD13 ' A' ' 926' ' ' ILE . 7.8 mp -63.05 -36.75 84.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.937 0.399 . . . . 0.0 110.273 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -70.63 -35.03 72.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.522 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 29.6 p -72.5 -24.63 61.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.795 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 951' ' ' LYS . 92.6 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.226 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 901' ' ' GLN . 3.4 mppt? . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 890' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 15.7 p -98.64 144.36 28.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.952 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . 0.715 ' HB ' ' HB1' ' A' ' 899' ' ' ALA . 60.6 t -126.23 140.25 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.679 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . 0.618 ' HD1' ' HE3' ' A' ' 898' ' ' TRP . 78.0 m-85 -106.6 119.99 40.77 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 894' ' ' LYS . 97.3 t -108.76 117.79 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.428 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.435 ' HD3' HG11 ' A' ' 893' ' ' VAL . 2.0 mptm? 54.12 3.87 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.371 1.068 . . . . 0.0 112.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.82 23.98 12.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.196 0.599 . . . . 0.0 110.12 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.34 -29.75 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.96 158.25 25.12 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.985 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.618 ' HE3' ' HD1' ' A' ' 892' ' ' PHE . 0.5 OUTLIER -121.81 136.43 54.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 891' ' ' VAL . . . -109.61 132.42 54.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' THR . . . . . 0.679 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 8.1 m -101.87 125.84 48.64 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 889' ' ' LYS . 28.2 mm-40 -94.99 116.51 28.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.007 0.432 . . . . 0.0 110.981 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.13 129.04 49.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.888 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.9 t -67.53 -4.61 12.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.384 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 33.5 t -85.71 -0.09 54.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.69 62.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.319 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.65 138.7 31.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 919' ' ' VAL . 44.0 t -112.4 122.97 67.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.679 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 3.1 t-105 -110.27 118.77 37.23 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.1 t -107.21 125.96 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.035 0.445 . . . . 0.0 111.08 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.509 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 76.7 mm-40 -103.46 143.28 32.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.572 173.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.68 167.15 9.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.73 0.3 . . . . 0.0 110.481 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -63.41 -26.43 68.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.75 0.08 55.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.061 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.54 72.34 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.279 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 18.1 m -75.74 153.29 37.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.721 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 47.4 mt-30 -132.03 153.57 50.26 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.058 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.771 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 8.7 mp -130.73 135.36 47.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.141 171.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 927' ' ' SER . 47.4 t -113.34 121.71 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 907' ' ' VAL . 48.2 t -118.08 130.84 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.695 0.284 . . . . 0.0 110.575 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -93.23 139.86 30.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.24 129.52 21.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.072 0.463 . . . . 0.0 111.114 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.16 61.37 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.479 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 923' ' ' VAL . 12.6 t 57.54 34.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.949 0.88 . . . . 0.0 110.317 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.9 m -74.02 -17.53 60.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.34 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 48.3 p -169.64 135.08 1.47 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.343 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.62 144.23 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.575 ' HB3' ' HB ' ' A' ' 918' ' ' VAL . 23.0 t -118.65 117.44 28.96 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -96.76 127.43 42.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.721 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 63.5 m -113.07 121.44 44.6 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.585 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 59.5 p -127.84 103.37 21.52 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.23 -12.4 30.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.265 2.643 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -81.76 -10.51 59.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.042 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -151.68 -68.36 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -171.13 164.57 7.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.214 0.507 . . . . 0.0 111.272 -166.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.645 HG23 HG23 ' A' ' 929' ' ' THR . 39.9 p -104.07 123.85 47.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.7 m -120.47 129.2 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.605 0.241 . . . . 0.0 111.108 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.665 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -98.44 128.56 44.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 110.151 178.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.8 128.0 54.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.384 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.66 166.34 27.72 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.91 -20.54 65.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.0 111.161 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -92.97 2.82 56.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.801 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -96.75 -178.84 4.38 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -100.56 128.42 46.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 945' ' ' PRO . 5.5 tp -92.29 132.74 31.37 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.942 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.752 ' HB2' HD12 ' A' ' 948' ' ' ILE . 37.1 Cg_exo -61.84 152.46 74.5 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.484 2.122 . . . . 0.0 111.435 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -52.99 -64.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.525 0.515 . . . . 0.0 111.922 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -59.91 -32.18 70.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.645 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 945' ' ' PRO . 2.4 mp -69.55 -42.81 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -40.94 97.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.941 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -42.37 93.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.361 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.971 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 4.5 mmpt? -64.94 -43.45 92.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.211 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.44 -36.62 84.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 110.865 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 953' ' ' GLN . 1.0 OUTLIER -66.95 -34.42 77.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.832 177.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.06 -28.78 64.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.164 0.506 . . . . 0.0 109.893 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 951' ' ' LYS . 7.9 mp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.225 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 121.39 0.614 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 43.5 m -106.96 144.81 33.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.676 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . 0.59 ' HB ' ' HB1' ' A' ' 899' ' ' ALA . 88.7 t -114.43 139.56 39.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -106.66 119.97 40.72 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.106 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 895' ' ' ASN . 48.7 t -103.23 120.21 52.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.637 ' HB3' HG13 ' A' ' 896' ' ' VAL . 53.0 tttm 56.98 3.71 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.367 1.042 . . . . 0.0 111.358 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 893' ' ' VAL . 2.7 t30 60.03 23.65 12.83 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.994 0.918 . . . . 0.0 109.787 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 894' ' ' LYS . 13.1 p -104.7 -28.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.225 173.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.77 159.05 24.87 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.841 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.97 136.03 54.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.59 ' HB1' ' HB ' ' A' ' 891' ' ' VAL . . . -107.29 131.69 53.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 4.2 m -115.14 132.86 56.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.71 116.04 25.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.341 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.29 142.24 40.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.648 0.261 . . . . 0.0 110.389 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.7 p -68.14 -8.62 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.697 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 44.6 t -80.95 -0.8 41.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.223 0.535 . . . . 0.0 110.163 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.94 4.42 87.1 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.66 139.33 30.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.813 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.65 122.58 56.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.483 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 6.5 t-105 -100.66 114.11 27.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.008 -176.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 48.4 t -104.04 115.98 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 110.036 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.841 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 37.3 mt-30 -106.17 142.96 34.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.711 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.462 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 44.8 m-85 -97.24 160.1 14.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.86 -25.78 68.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.471 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -86.38 2.18 48.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.354 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 93.79 5.05 63.14 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.361 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 45.5 m -84.33 152.12 24.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.635 0.718 . . . . 0.0 109.274 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.68 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 40.3 mt-30 -132.47 153.38 50.95 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.799 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.623 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 9.7 mp -130.59 136.24 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.13 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 41.5 t -113.12 120.43 63.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 926' ' ' ILE . 42.9 t -119.35 132.02 70.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.27 137.93 31.94 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.55 126.77 28.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.52 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.4 -0.42 83.28 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.258 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.68 HG11 ' H ' ' A' ' 925' ' ' SER . 54.5 t -115.06 138.05 46.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.234 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 3.1 p -91.24 -6.13 53.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.68 ' H ' HG11 ' A' ' 923' ' ' VAL . 39.3 m -90.45 138.74 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.643 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 952' ' ' LEU . 2.9 mp -118.02 146.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.495 -175.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.675 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 16.0 m -110.68 116.29 31.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 936' ' ' THR . 24.2 t80 -96.42 126.24 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.68 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 47.2 m -113.71 122.8 48.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.09 0.471 . . . . 0.0 111.329 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 10.3 p -122.99 120.35 27.55 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.271 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 -2.13 5.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.399 2.732 . . . . 0.0 112.181 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -59.17 -22.86 61.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.41 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.05 0.87 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.109 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -157.77 133.29 9.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.209 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -105.89 126.87 52.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 166.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 936' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 928' ' ' TYR . 4.3 t -118.32 128.74 54.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.391 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -103.24 130.79 50.56 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.403 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -108.91 138.76 44.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.726 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -115.76 156.37 15.68 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.146 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -7.2 26.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.771 0.319 . . . . 0.0 111.855 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.34 0.68 40.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.428 0.632 . . . . 0.0 110.209 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 17.2 pt-20 -132.66 -171.95 2.79 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -95.42 122.4 38.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.975 0.417 . . . . 0.0 109.929 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.22 138.42 45.49 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.788 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.689 ' HG2' HD12 ' A' ' 948' ' ' ILE . 48.4 Cg_exo -57.58 142.2 95.5 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.535 2.156 . . . . 0.0 111.231 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -43.24 -63.3 0.84 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.038 0.836 . . . . 0.0 112.935 -172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -67.89 -28.24 67.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.689 HD12 ' HG2' ' A' ' 945' ' ' PRO . 59.1 mt -69.72 -44.98 78.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.69 -38.12 88.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.075 0.464 . . . . 0.0 109.985 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . 0.588 ' O ' ' HG3' ' A' ' 953' ' ' GLN . 17.2 tm0? -60.16 -42.65 95.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.074 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 1.087 ' HA ' ' HE3' ' A' ' 951' ' ' LYS . 0.0 OUTLIER -69.86 -37.94 76.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.442 0.639 . . . . 0.0 110.003 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.626 HD21 HD12 ' A' ' 926' ' ' ILE . 62.7 tp -57.58 -36.9 72.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 950' ' ' GLN . 4.9 pp0? -69.61 -21.15 63.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.32 -28.04 65.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.023 0.44 . . . . 0.0 109.981 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.288 175.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 31.0 p -108.31 144.77 35.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.228 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.06 140.13 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.08 125.17 47.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' ' 954' ' ' CYS . 23.2 m -109.76 121.18 62.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 120.834 0.35 . . . . 0.0 110.83 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.697 ' HB2' HG11 ' A' ' 896' ' ' VAL . 71.8 mmtt 58.62 -1.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.709 0.804 . . . . 0.0 112.675 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 893' ' ' VAL . 65.2 t30 60.46 22.64 12.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.942 0.877 . . . . 0.0 109.154 -167.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 894' ' ' LYS . 9.9 p -104.09 -24.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.096 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . 0.4 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -140.78 159.75 26.5 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.057 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.719 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.0 OUTLIER -120.82 135.3 55.2 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 173.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.38 131.45 56.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 9.1 m -110.41 125.24 53.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.835 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -82.44 115.93 21.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.878 0.37 . . . . 0.0 110.022 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 906' ' ' ALA . 77.1 mt -90.74 149.79 21.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.079 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 13.2 t -66.91 -15.89 63.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.009 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.0 m -80.13 0.26 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 110.734 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.87 87.71 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.715 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 902' ' ' LEU . . . -91.3 157.54 17.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.341 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.61 123.48 71.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.808 0.337 . . . . 0.0 110.223 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -98.12 113.42 25.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.94 117.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.032 0.444 . . . . 0.0 110.615 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.719 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 8.3 tt0 -94.38 143.13 26.66 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.5 ' HD2' ' H ' ' A' ' 913' ' ' ASP . 25.7 t80 -93.51 148.6 21.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -55.13 -25.45 31.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . 0.5 ' H ' ' HD2' ' A' ' 911' ' ' PHE . 19.8 t70 -86.24 0.35 53.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.49 5.74 60.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.407 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 50.3 m -85.3 164.1 18.2 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -125.01 151.95 44.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.41 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.594 ' CD2' HG23 ' A' ' 919' ' ' VAL . 10.4 tt -141.49 135.0 29.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 51.2 t -115.98 122.57 69.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 122.384 -0.198 . . . . 0.0 111.209 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.594 HG23 ' CD2' ' A' ' 917' ' ' LEU . 76.4 t -120.07 134.27 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.531 0.205 . . . . 0.0 111.037 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -89.81 136.97 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -62.9 126.9 28.89 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.161 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.2 -2.49 85.29 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.672 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 925' ' ' SER . 54.4 t -106.01 137.61 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.754 0.312 . . . . 0.0 110.865 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.5 m -78.26 -15.89 58.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.739 ' H ' HG13 ' A' ' 923' ' ' VAL . 34.1 m -85.61 117.18 24.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -113.24 145.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.113 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 21.5 m -113.63 116.39 29.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -106.09 128.63 54.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 20.2 m -112.51 121.68 45.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.126 0.489 . . . . 0.0 110.886 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 930' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 931' ' ' PRO . 73.5 m -99.77 165.16 15.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.745 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 930' ' ' SER . 72.5 Cg_exo -49.74 156.68 2.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.027 2.485 . . . . 0.0 112.664 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 931' ' ' PRO . 14.6 m120 75.01 5.35 4.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 75.44 50.42 8.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.991 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.05 101.06 9.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -100.59 129.18 46.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.428 0.632 . . . . 0.0 111.103 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 32.0 p -116.88 141.4 48.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.448 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -101.55 126.51 48.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.251 0.548 . . . . 0.0 110.698 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' A' ' 944' ' ' LEU . 90.2 m-85 -109.91 138.22 46.58 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -154.09 -160.31 9.72 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 119.128 -1.51 . . . . 0.0 113.927 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.03 -27.1 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.432 -0.884 . . . . 0.0 112.441 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.46 1.2 56.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.176 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -132.6 -177.15 4.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -99.23 138.18 36.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 948' ' ' ILE . 63.6 mt -95.22 133.1 26.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.472 ' HB2' HD12 ' A' ' 948' ' ' ILE . 18.3 Cg_exo -67.44 154.79 72.76 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.883 2.388 . . . . 0.0 111.044 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.78 -37.52 87.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.46 -33.47 75.95 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.436 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.622 HG23 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -70.98 -39.55 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.994 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . 0.581 ' HE3' ' HB2' ' A' ' 944' ' ' LEU . 33.0 mmtp -56.93 -43.8 81.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.319 0.581 . . . . 0.0 109.714 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.55 -42.32 98.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.341 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 67.3 mmtt -62.51 -43.18 99.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.77 -32.43 72.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.748 0.308 . . . . 0.0 110.498 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.49 -34.84 77.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . 0.518 ' HB3' HG11 ' A' ' 893' ' ' VAL . 59.2 m -70.32 -26.64 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.1 mm? . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.767 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.9 m -104.21 142.46 34.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.89 139.6 40.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.1 127.71 36.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 954' ' ' CYS . 80.7 t -114.14 119.54 61.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm 59.18 7.52 0.89 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.369 1.043 . . . . 0.0 111.194 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.63 20.45 9.07 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.926 0.89 . . . . 0.0 110.758 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 41.6 t -107.2 -29.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.337 0.589 . . . . 0.0 110.364 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.96 163.04 26.32 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.467 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.464 ' CD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -121.41 136.94 54.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -116.36 133.87 55.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.751 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 21.0 m -101.09 125.28 47.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.675 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.45 120.92 37.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.886 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 906' ' ' ALA . 7.4 mp -98.44 144.45 27.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.634 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 15.9 m -67.28 -16.48 64.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.0 p -82.58 0.93 40.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.229 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.86 12.15 62.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.645 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.44 138.4 31.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.16 121.64 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.494 ' CZ2' ' HG2' ' A' ' 916' ' ' GLN . 30.2 t90 -110.63 113.39 25.96 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.17 116.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.756 0.313 . . . . 0.0 110.951 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 898' ' ' TRP . 35.7 tt0 -105.64 142.85 34.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.447 ' HE2' HD13 ' A' ' 917' ' ' LEU . 38.9 m-85 -88.09 160.64 17.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.598 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -63.81 -16.72 61.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.781 0.801 . . . . 0.0 108.865 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.84 -0.25 42.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.14 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.19 5.98 86.82 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.628 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 2.0 p -97.78 153.38 18.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.048 0.424 . . . . 0.0 110.132 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.494 ' HG2' ' CZ2' ' A' ' 908' ' ' TRP . 0.3 OUTLIER -125.78 154.48 42.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.281 -175.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.447 HD13 ' HE2' ' A' ' 911' ' ' PHE . 5.5 mp -127.78 132.83 49.47 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 119.06 60.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.089 170.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 926' ' ' ILE . 7.8 p -124.66 132.83 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.501 170.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.568 ' O ' HG22 ' A' ' 923' ' ' VAL . 25.6 tt0 -94.61 139.86 30.63 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 170.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.03 39.99 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.552 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 105.43 -6.15 41.76 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.083 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 920' ' ' GLN . 8.6 m -102.28 155.43 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.456 0.628 . . . . 0.0 110.426 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.4 p -92.2 -4.85 53.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.841 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 12.9 p -133.54 135.89 44.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.281 0.562 . . . . 0.0 111.763 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 919' ' ' VAL . 4.4 mp -111.42 146.68 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.779 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 20.0 m -108.47 116.76 32.58 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.404 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -96.62 125.38 41.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 934' ' ' GLN . 8.8 t -116.3 135.03 54.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.741 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 20.1 m -103.74 144.28 28.35 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.795 171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.84 -7.72 1.76 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 124.127 3.218 . . . . 0.0 114.493 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -16.96 62.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 99.12 28.69 7.56 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 929' ' ' THR . 43.1 tt0 -104.64 110.32 22.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.758 -174.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.434 HG21 ' HB ' ' A' ' 929' ' ' THR . 18.2 p -103.54 125.52 50.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.61 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 35.5 m -118.21 134.89 54.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -97.79 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 0.0 110.899 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -112.05 134.82 53.37 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.667 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . 0.759 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -153.07 -165.7 13.71 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.968 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.11 -27.28 67.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.791 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -97.69 -0.84 44.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.449 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . 0.759 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 8.7 mm-40 -116.97 109.68 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.05 138.94 46.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.396 0.617 . . . . 0.0 112.008 -169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.586 ' CB ' ' HB3' ' A' ' 949' ' ' LYS . 3.3 mm? -94.11 133.82 26.86 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.531 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.6 -70.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 111.806 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.29 -77.69 0.1 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -56.8 -32.75 66.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.572 ' HB ' HD11 ' A' ' 944' ' ' LEU . 26.4 mm -70.3 -45.11 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.996 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . 0.586 ' HB3' ' CB ' ' A' ' 944' ' ' LEU . 11.8 pttm -66.66 -36.63 83.0 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.568 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.05 -40.8 90.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.912 0.387 . . . . 0.0 110.501 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -66.89 -43.79 82.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 87.4 mt -65.14 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.002 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -61.65 -33.7 74.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.001 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 893' ' ' VAL . 16.7 t -71.47 -24.89 62.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.411 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.446 -177.222 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.2 mttm . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.307 0.575 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 22.9 m -106.8 143.62 34.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.003 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.53 155.38 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.041 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -99.53 130.74 45.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 895' ' ' ASN . 5.9 p -105.39 121.13 57.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.057 0.456 . . . . 0.0 110.27 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.673 ' HB3' HG13 ' A' ' 896' ' ' VAL . 14.4 tmtt? 61.68 -1.44 0.33 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.747 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 893' ' ' VAL . 19.5 t-20 61.3 23.7 13.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.842 0.829 . . . . 0.0 109.409 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' A' ' 894' ' ' LYS . 12.4 p -105.84 -27.89 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -136.01 160.6 24.68 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.812 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.629 ' HB2' ' HG3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.9 136.77 54.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.61 130.38 56.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 32.4 m -115.64 135.83 53.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.981 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -95.03 125.35 39.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.162 0.506 . . . . 0.0 110.118 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.76 146.99 24.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.746 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.4 m -65.13 -20.33 66.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.626 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 0.12 33.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.153 0.502 . . . . 0.0 110.698 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.09 8.88 68.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.444 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.24 148.52 22.87 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.567 ' HB ' HG11 ' A' ' 919' ' ' VAL . 47.4 t -110.37 124.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -104.31 114.56 28.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.06 120.14 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.457 0.646 . . . . 0.0 110.817 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.77 ' HB3' HE22 ' A' ' 916' ' ' GLN . 1.1 pt20 -104.65 143.26 33.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -119.6 157.93 27.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.092 0.472 . . . . 0.0 111.763 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.3 -17.9 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -77.4 1.44 19.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.635 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.62 8.4 84.73 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 5.8 p -98.23 153.47 18.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.768 0.318 . . . . 0.0 111.198 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.77 HE22 ' HB3' ' A' ' 910' ' ' GLN . 12.5 mm100 -122.78 150.88 42.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.983 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.575 HD13 ' C ' ' A' ' 916' ' ' GLN . 7.1 mp -138.69 133.81 32.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.5 p -116.83 123.94 72.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 168.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.59 HG21 HG21 ' A' ' 923' ' ' VAL . 2.2 p -117.86 138.27 49.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -93.48 150.62 20.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -49.81 128.38 18.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . 0.508 ' O ' HG13 ' A' ' 923' ' ' VAL . . . 99.48 -8.35 60.22 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.776 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.59 HG21 HG21 ' A' ' 919' ' ' VAL . 0.8 OUTLIER 58.2 2.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.238 1.415 . . . . 0.0 113.947 172.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 47.4 m -74.76 -5.66 44.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.152 -0.343 . . . . 0.0 111.639 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 1.9 p -142.01 114.79 8.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.962 0.41 . . . . 0.0 111.318 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.551 HG21 ' HB ' ' A' ' 919' ' ' VAL . 0.2 OUTLIER -126.99 145.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.368 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.527 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 20.1 m -118.24 122.46 43.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -97.34 129.96 44.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 34.2 m -111.7 121.87 46.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 25.8 m -97.24 135.47 21.86 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.581 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.03 -13.99 17.33 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 113.205 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.48 -25.79 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 109.667 174.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 106.15 35.53 2.92 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -126.8 116.54 21.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.999 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 36.6 p -105.31 126.46 52.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.3 m -117.79 128.66 55.08 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -98.37 126.58 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 110.358 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -112.52 131.12 55.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.44 170.97 16.9 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.62 -20.63 66.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.299 0.55 . . . . 0.0 110.692 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.17 -0.65 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -108.21 147.83 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -99.93 130.97 46.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 111.13 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.1 133.6 72.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.63 -68.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.562 2.174 . . . . 0.0 111.939 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.94 -70.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.751 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -58.62 -29.67 66.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 25.9 mm -67.61 -43.66 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.77 -39.42 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.271 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.08 -43.18 91.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.743 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 9.7 mmpt? -68.29 -41.58 80.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.54 -34.99 79.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.697 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.86 -25.66 68.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.626 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.0 -23.15 65.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 36.0 tp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.309 0.576 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 10.1 m -106.96 147.55 29.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.928 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.03 139.97 45.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -98.91 131.34 45.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.72 120.77 64.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 58.09 4.63 0.32 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.112 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 59.8 23.12 12.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.136 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 95.2 t -104.8 -31.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.44 158.53 25.49 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.172 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.5 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -123.27 134.96 54.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.29 130.83 53.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.112 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.2 m -115.98 125.73 52.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.39 115.66 21.52 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 906' ' ' ALA . 84.3 mt -86.3 148.3 25.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.372 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 2.4 p -67.37 -9.58 42.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.74 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 14.3 m -87.54 1.14 54.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.92 4.53 82.07 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.146 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 902' ' ' LEU . . . -91.2 152.6 20.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.7 123.71 64.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.498 ' HD1' HG23 ' A' ' 918' ' ' VAL . 38.6 t90 -106.83 112.91 26.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 7.7 p -115.51 118.82 59.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 111.151 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.5 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 46.7 tt0 -102.34 142.47 33.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.931 175.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -112.06 160.05 17.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.694 0.283 . . . . 0.0 110.876 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.38 -17.62 54.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.774 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.82 1.43 12.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.366 0.603 . . . . 0.0 110.654 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.22 4.59 88.06 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.975 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.4 t -99.48 155.58 17.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.557 ' HB2' ' HG1' ' A' ' 929' ' ' THR . 15.4 mp0 -130.74 151.7 50.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.9 HD23 ' HD1' ' A' ' 928' ' ' TYR . 1.5 mt -133.62 136.01 44.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.498 HG23 ' HD1' ' A' ' 908' ' ' TRP . 25.2 t -113.6 119.58 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.603 HG23 HG12 ' A' ' 926' ' ' ILE . 6.7 p -120.14 133.65 66.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 0.0 110.591 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.05 143.98 31.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.42 129.69 22.33 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.587 0.554 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 103.12 -8.13 53.09 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.459 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 923' ' ' VAL . 13.7 t 48.49 44.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.953 0.882 . . . . 0.0 111.279 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 5.7 p -82.72 -23.76 33.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.889 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 63.8 m -162.16 130.53 4.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.256 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.603 HG12 HG23 ' A' ' 919' ' ' VAL . 16.3 mt -119.15 145.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.024 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.6 m -118.01 117.35 28.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.9 ' HD1' HD23 ' A' ' 917' ' ' LEU . 41.8 m-85 -99.02 130.05 45.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.557 ' HG1' ' HB2' ' A' ' 916' ' ' GLN . 22.8 p -112.26 122.3 47.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 0.0 110.733 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 930' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 45.3 m -140.2 109.75 6.97 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.11 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 20.8 Cg_endo -60.99 -16.74 47.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.243 2.629 . . . . 0.0 112.61 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -74.89 -10.17 59.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.25 -68.1 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . 0.691 ' HG2' ' H ' ' A' ' 935' ' ' THR . 29.8 tt0 169.14 -168.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.691 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 10.0 t -105.33 128.85 53.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.94 0.4 . . . . 0.0 110.279 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 936' ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' ' 928' ' ' TYR . 10.0 t -117.02 142.11 47.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.71 128.66 54.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.1 0.476 . . . . 0.0 111.204 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.515 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 53.2 t80 -109.57 128.06 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.114 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -112.37 162.54 12.36 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.69 -5.7 4.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.478 0.639 . . . . 0.0 112.077 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.85 4.65 49.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.425 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . 0.453 ' OE1' ' HD3' ' A' ' 943' ' ' LYS . 6.7 tp10 -122.98 162.2 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 943' ' ' LYS . 0.0 OUTLIER -99.92 138.81 36.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.023 176.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 948' ' ' ILE . 60.7 mt -97.06 140.6 22.18 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.826 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.18 165.37 24.52 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.806 2.337 . . . . 0.0 111.254 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . 0.535 ' O ' ' HG3' ' A' ' 950' ' ' GLN . 58.0 m-20 -53.47 -56.91 12.96 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -61.22 -34.18 74.7 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 944' ' ' LEU . 3.2 mp -69.53 -43.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.69 -40.2 96.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.681 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 946' ' ' ASP . 97.0 mt-30 -61.46 -44.47 97.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.991 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -69.31 -39.91 77.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.292 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.66 -36.79 85.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.331 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -64.58 -24.91 67.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 83.3 m -69.31 -22.29 63.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.437 HD21 HG13 ' A' ' 909' ' ' VAL . 4.1 mm? . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.163 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 49.5 pttt . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.748 0.309 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 39.9 m -91.16 142.89 27.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 34.7 t -125.47 141.41 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -89.1 132.14 34.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.0 121.09 56.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.427 ' HB2' HG12 ' A' ' 896' ' ' VAL . 42.8 mtmt 52.13 11.78 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 59.76 22.47 11.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.438 0.695 . . . . 0.0 110.735 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 894' ' ' LYS . 14.9 p -105.4 -29.06 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.54 162.24 26.16 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.13 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.768 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.3 m95 -118.73 136.09 54.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.91 130.14 54.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.876 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.8 m -117.58 125.31 50.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.253 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -92.0 116.02 28.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.38 152.55 20.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 19.1 p -67.0 -20.06 65.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.538 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 16.2 m -84.88 3.57 37.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 85.2 11.12 76.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.4 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.06 148.91 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.88 122.89 68.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -108.49 113.64 26.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 39.9 t -115.8 117.75 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 110.768 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.768 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 17.7 mp0 -101.71 148.8 24.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.419 ' HE2' HD23 ' A' ' 917' ' ' LEU . 57.2 m-85 -118.52 159.75 22.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.946 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.1 -17.05 63.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.89 1.53 17.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.651 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.97 5.53 87.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.14 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.2 m -97.21 156.87 16.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 79.4 mt-30 -123.15 152.43 41.17 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.731 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 916' ' ' GLN . 10.6 mp -133.96 136.3 44.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 36.4 t -112.52 121.15 64.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.93 138.54 49.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -92.58 137.15 32.61 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.73 127.96 33.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.538 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.47 84.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.456 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 925' ' ' SER . 8.4 t -122.53 146.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 117.334 0.567 . . . . 0.0 110.331 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.0 t -86.06 -6.62 58.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.492 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.518 ' H ' HG11 ' A' ' 923' ' ' VAL . 59.6 p -74.1 121.13 20.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 110.287 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 926' ' ' ILE . 0.2 OUTLIER -124.39 146.91 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.825 -177.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 31.7 m -107.86 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.99 128.32 42.77 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 27.3 m -113.0 122.05 46.47 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.387 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 930' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 20.2 m -102.93 124.04 40.03 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.352 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 31.6 Cg_exo -60.59 -10.99 15.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.568 2.845 . . . . 0.0 113.426 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.91 -15.45 63.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.26 0.553 . . . . 0.0 110.164 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 111.25 44.29 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.866 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -140.58 111.78 7.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.549 0.214 . . . . 0.0 111.098 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 20.8 m -104.59 123.57 47.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 26.5 m -121.75 128.31 51.61 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 0.1 OUTLIER -104.65 128.87 52.83 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.274 176.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -107.86 127.14 53.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.745 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -94.26 167.54 27.72 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.806 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.27 -27.48 67.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.219 0.533 . . . . 0.0 110.609 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.21 1.92 48.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.24 -173.62 2.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -99.14 119.11 37.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 945' ' ' PRO . 13.3 tp -101.67 131.77 22.51 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.452 ' HD2' HD12 ' A' ' 944' ' ' LEU . 19.2 Cg_exo -68.55 153.53 73.46 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.767 2.312 . . . . 0.0 111.993 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.91 -46.44 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.487 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.14 -32.2 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.774 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.42 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 47.4 mm -69.32 -44.03 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 110.013 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -64.69 -44.18 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.16 -43.65 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -38.61 83.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.546 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 83.1 mt -64.01 -36.39 83.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 110.569 175.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -63.13 -23.08 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.867 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.94 -25.27 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 178.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.008 0.432 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 890' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 66.8 m -106.96 144.4 33.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 111.474 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.83 140.0 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.43 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -100.88 124.43 46.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.042 0.449 . . . . 0.0 110.944 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 895' ' ' ASN . 7.0 p -117.07 123.93 72.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.299 -176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 67.63 -7.86 0.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.09 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 893' ' ' VAL . 3.6 m-20 60.51 22.29 12.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.015 0.926 . . . . 0.0 110.089 -168.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.69 -28.65 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.881 171.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . 0.537 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -138.93 158.68 25.27 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.105 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.852 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 0.8 OUTLIER -122.65 136.2 54.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -114.2 130.89 56.62 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.969 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 89.9 m -109.93 124.61 51.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -97.27 115.44 27.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.0 111.224 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.476 HD13 ' HB1' ' A' ' 906' ' ' ALA . 98.0 mt -90.22 130.37 36.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 16.9 m -67.06 -9.29 37.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.088 0.471 . . . . 0.0 111.064 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.4 m -80.68 -0.24 37.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.1 60.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.59 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' A' ' 902' ' ' LEU . . . -91.94 138.71 31.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.66 122.27 69.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.126 0.488 . . . . 0.0 109.844 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -108.4 113.38 26.4 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 955' ' ' LEU . 38.3 t -115.11 118.2 58.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.852 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 11.8 pt20 -103.43 171.32 7.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.798 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -118.44 169.66 9.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -66.19 -17.33 64.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.807 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.66 -0.76 48.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.565 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.2 90.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.017 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 157.6 18.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 910' ' ' GLN . 4.2 pt20 -132.27 154.71 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.583 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 4.6 pp -137.05 137.38 39.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 169.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.16 121.76 65.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.966 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 926' ' ' ILE . 20.5 t -120.73 134.55 63.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.366 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -92.76 139.68 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -58.06 127.12 30.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.93 0.395 . . . . 0.0 111.34 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.48 -6.25 83.35 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.986 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.731 HG11 ' H ' ' A' ' 925' ' ' SER . 46.4 t -99.86 139.56 21.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.996 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.5 p -91.19 -8.37 48.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.404 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.731 ' H ' HG11 ' A' ' 923' ' ' VAL . 14.1 m -93.34 124.84 37.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.472 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.57 HG22 HG21 ' A' ' 919' ' ' VAL . 55.1 mt -114.48 145.8 19.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.675 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 11.0 p -117.67 116.41 26.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.583 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 79.7 t80 -110.96 127.02 55.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.031 0.443 . . . . 0.0 110.17 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.483 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 14.2 m -114.5 121.97 45.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.534 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.5 t -115.91 123.72 30.72 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.317 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.59 -0.97 5.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.349 2.7 . . . . 0.0 112.489 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.62 -6.63 45.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.717 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.05 31.45 4.73 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.122 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -143.69 118.99 10.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.931 0.395 . . . . 0.0 111.828 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 5.5 t -104.57 127.19 52.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 31.8 m -118.59 128.79 54.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 111.393 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -100.55 127.65 46.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.563 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 60.1 t80 -109.1 126.27 53.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.388 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.31 161.11 14.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.78 -4.78 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.986 0.422 . . . . 0.0 112.046 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.76 2.98 56.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.036 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.64 176.03 8.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.05 143.76 29.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.545 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 948' ' ' ILE . 51.6 mt -97.37 147.1 32.48 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.224 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.559 ' HB2' HD13 ' A' ' 948' ' ' ILE . 31.9 Cg_exo -59.23 154.96 42.81 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.454 2.103 . . . . 0.0 110.447 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -57.32 -43.25 83.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -170.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . 0.601 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 85.4 m-85 -68.31 -35.3 77.6 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.324 -176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.644 HG21 HD23 ' A' ' 944' ' ' LEU . 2.5 mp -70.92 -43.36 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 944' ' ' LEU . 18.0 tppt? -63.7 -39.61 94.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -44.55 97.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.777 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 947' ' ' TYR . 13.5 mmmm -65.29 -42.92 92.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 919' ' ' VAL . 3.7 mm? -63.04 -35.71 81.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -69.48 -34.88 74.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.12 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 85.0 m -70.53 -24.72 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.543 HD21 HG23 ' A' ' 909' ' ' VAL . 85.9 mt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.617 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 57.9 p -106.75 141.57 37.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.511 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.7 140.15 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.59 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -106.53 130.51 54.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.962 0.411 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.17 117.94 46.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 45.55 17.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.96 1.412 . . . . 0.0 112.749 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.74 24.38 12.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.4 t -102.09 -30.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.13 157.55 24.95 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.643 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -124.89 136.55 53.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 909' ' ' VAL . . . -124.65 131.78 53.45 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.197 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 17.1 m -105.01 125.54 51.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -85.76 116.66 24.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.23 158.43 23.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.885 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.3 m -66.79 -22.04 66.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.733 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 7.8 t -83.38 0.63 45.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.976 0.417 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.33 4.88 67.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.341 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.07 140.69 29.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 955' ' ' LEU . 36.4 t -106.06 123.55 60.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -102.24 111.96 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.643 HG11 ' HG ' ' A' ' 917' ' ' LEU . 3.2 p -114.51 118.29 58.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.601 0.715 . . . . 0.0 111.119 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 1.013 ' HB3' ' HG2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -106.88 148.02 29.07 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.229 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 951' ' ' LYS . 36.5 m-85 -91.47 175.05 7.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.185 0.517 . . . . 0.0 110.956 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -65.23 -17.39 64.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.698 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.62 -2.44 50.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.37 0.605 . . . . 0.0 111.201 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.01 90.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 63.5 m -95.68 152.29 18.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 1.013 ' HG2' ' HB3' ' A' ' 910' ' ' GLN . 32.0 mt-30 -132.05 154.86 48.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.726 0.298 . . . . 0.0 111.269 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.643 ' HG ' HG11 ' A' ' 909' ' ' VAL . 0.8 OUTLIER -137.83 137.98 38.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.927 0.394 . . . . 0.0 110.003 169.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 15.7 t -104.27 123.39 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.008 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 926' ' ' ILE . 42.5 t -118.21 129.9 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.788 176.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -94.59 139.6 30.98 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.32 127.61 32.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.874 0.369 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.74 83.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.61 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.574 HG11 ' H ' ' A' ' 925' ' ' SER . 30.7 t -115.78 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 122.792 -0.24 . . . . 0.0 110.508 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 35.0 t -91.06 -10.35 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.574 ' H ' HG11 ' A' ' 923' ' ' VAL . 12.5 m -82.61 111.52 18.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.732 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.51 HG23 HD12 ' A' ' 952' ' ' LEU . 40.4 pt -113.3 155.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 0.0 110.918 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 14.4 m -117.49 116.34 26.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.421 ' HE2' ' HE2' ' A' ' 911' ' ' PHE . 39.7 t80 -101.0 124.68 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.0 t -116.31 128.37 55.5 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.065 0.46 . . . . 0.0 110.046 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.2 t -132.88 120.71 16.58 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.43 -12.96 30.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.076 2.518 . . . . 0.0 111.732 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -76.72 -15.87 59.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.097 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.09 -68.38 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . 0.74 ' HG3' ' H ' ' A' ' 935' ' ' THR . 4.0 tp-100 166.1 -164.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.74 ' H ' ' HG3' ' A' ' 934' ' ' GLN . 18.9 m -103.42 127.11 50.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.001 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.6 t -119.06 143.34 47.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.255 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 937' ' ' ARG . 8.1 ptt180 -97.78 135.18 39.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.214 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.477 ' HB3' HD23 ' A' ' 944' ' ' LEU . 76.9 m-85 -110.78 126.88 55.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 170.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -146.21 -170.74 15.05 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.231 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.89 -27.41 68.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.828 0.347 . . . . 0.0 110.832 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.89 1.38 57.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.113 0.483 . . . . 0.0 110.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . 0.599 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 1.3 mp0 -108.07 174.47 5.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.679 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -99.17 124.19 44.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 938' ' ' TYR . 62.5 mt -97.01 131.04 28.47 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.984 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.03 154.67 57.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.903 2.402 . . . . 0.0 111.033 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.26 -48.08 82.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.12 -176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . 0.714 ' O ' ' HD3' ' A' ' 951' ' ' LYS . 44.9 m-85 -66.82 -30.67 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.6 -40.81 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.821 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -63.34 -37.63 88.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.004 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -61.08 -44.63 97.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.047 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.714 ' HD3' ' O ' ' A' ' 947' ' ' TYR . 2.3 mptp? -68.61 -42.96 77.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.313 0.578 . . . . 0.0 109.483 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.51 HD12 HG23 ' A' ' 926' ' ' ILE . 62.1 tp -59.38 -38.34 80.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.605 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.19 -25.59 63.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 71.3 m -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.932 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.444 HD11 HG11 ' A' ' 907' ' ' VAL . 2.8 mm? . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.602 0.239 . . . . 0.0 111.435 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.384 0.611 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 14.5 m -107.52 148.36 29.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.629 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . 0.664 ' HB ' ' HB1' ' A' ' 899' ' ' ALA . 19.8 t -112.93 138.48 42.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -108.58 126.15 52.63 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.02 118.6 59.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.38 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.622 ' HB2' HG13 ' A' ' 896' ' ' VAL . 94.0 mttt 53.49 7.97 0.12 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.31 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.3 23.49 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.627 0.771 . . . . 0.0 109.854 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 894' ' ' LYS . 12.5 p -105.2 -28.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.65 158.14 24.92 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.876 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.467 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 2.9 m95 -122.97 136.53 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.664 ' HB1' ' HB ' ' A' ' 891' ' ' VAL . . . -110.87 130.07 55.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.026 0.441 . . . . 0.0 110.124 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 900' ' ' THR . . . . . 0.751 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 10.1 m -116.99 125.37 51.28 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.758 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.92 117.08 29.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.228 0.537 . . . . 0.0 110.112 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.685 HD22 ' HE3' ' A' ' 908' ' ' TRP . 3.6 mm? -95.56 137.05 35.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.807 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.7 t -63.34 -17.82 62.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 22.7 t -81.81 1.04 36.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.07 11.31 61.55 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.029 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.43 140.63 29.58 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.823 -0.222 . . . . 0.0 110.443 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.698 HG12 HD13 ' A' ' 955' ' ' LEU . 46.7 t -107.59 122.83 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.751 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 1.5 t90 -110.23 115.74 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.452 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 57.5 t -112.41 119.39 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.436 0.636 . . . . 0.0 110.245 173.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.652 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.1 tt0 -104.4 143.33 33.14 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.478 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.52 171.06 9.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.56 -21.04 66.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.25 1.87 49.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.642 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.0 5.35 87.78 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.085 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.5 m -94.63 152.07 18.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.652 ' HG2' ' HG3' ' A' ' 910' ' ' GLN . 51.6 mt-30 -134.5 159.15 42.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.507 HD12 HG23 ' A' ' 926' ' ' ILE . 1.3 pt? -137.91 136.07 36.7 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 169.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 907' ' ' VAL . 7.0 m -114.3 128.08 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.43 . . . . 0.0 111.545 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.93 136.69 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -92.3 140.86 29.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.21 128.5 37.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.32 -6.14 83.6 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.693 HG11 ' H ' ' A' ' 925' ' ' SER . 41.6 t -111.61 134.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.109 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.8 m -91.0 -5.34 55.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.743 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.693 ' H ' HG11 ' A' ' 923' ' ' VAL . 15.0 m -95.43 131.58 41.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.475 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.507 HG23 HD12 ' A' ' 917' ' ' LEU . 3.7 mp -113.15 146.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 15.2 m -115.34 117.1 29.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.614 ' HB2' ' HE1' ' A' ' 938' ' ' TYR . 43.8 t80 -96.24 127.18 42.01 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 8.9 t -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.333 0.587 . . . . 0.0 110.918 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 22.8 t -118.01 111.18 39.1 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.01 144.83 93.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.0 12.62 8.05 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.577 0.548 . . . . 0.0 110.396 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . 0.63 ' O ' ' HG3' ' A' ' 934' ' ' GLN . . . -131.39 -91.46 0.54 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 933' ' ' GLY . 30.0 mt-30 178.01 168.1 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.621 0.768 . . . . 0.0 109.9 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 50.3 m -105.24 126.2 51.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.663 0.268 . . . . 0.0 110.359 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 24.7 m -118.96 128.84 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.414 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.58 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 13.7 ptm180 -99.67 127.4 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.369 0.604 . . . . 0.0 111.278 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.614 ' HE1' ' HB2' ' A' ' 928' ' ' TYR . 26.0 p90 -110.06 138.53 46.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.011 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -90.94 -179.71 43.0 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.615 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.45 -13.01 60.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.813 0.34 . . . . 0.0 111.152 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.83 -0.16 57.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -92.67 141.07 28.88 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.94 -0.475 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -92.99 123.5 36.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.32 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -96.51 135.53 22.34 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 33.9 Cg_exo -61.62 -73.43 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.909 2.406 . . . . 0.0 113.148 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -145.61 -71.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -64.1 -32.77 74.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.667 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 32.5 mm -68.53 -43.06 83.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -64.01 -39.68 94.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.807 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.56 -43.7 96.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 951' ' ' LYS . 2.8 mptp? -67.95 -38.69 83.11 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.208 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 89.2 mt -62.97 -31.74 72.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.159 0.504 . . . . 0.0 110.494 175.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -69.27 -36.42 77.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.5 -11.71 60.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.588 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.698 HD13 HG12 ' A' ' 907' ' ' VAL . 3.1 mm? . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.821 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 11.1 p -106.64 143.92 34.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.944 0.402 . . . . 0.0 110.823 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.17 142.63 41.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.001 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -106.76 129.16 54.68 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.25 121.03 54.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.609 ' HB3' HG13 ' A' ' 896' ' ' VAL . 58.9 tttm 57.8 4.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.136 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.66 24.42 14.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.779 0.799 . . . . 0.0 109.178 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 894' ' ' LYS . 13.9 p -103.71 -28.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.21 158.47 25.34 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.849 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.686 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.7 OUTLIER -121.6 135.43 54.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.4 130.18 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.067 0.46 . . . . 0.0 110.865 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 28.8 m -115.66 132.85 56.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.047 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -94.82 115.79 27.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.33 153.67 19.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -19.11 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.239 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.3 m -85.2 1.03 49.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.715 0.293 . . . . 0.0 111.262 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.73 69.11 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.943 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.35 141.76 28.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.6 122.31 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.415 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 2.0 t-105 -104.01 114.62 29.0 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 48.7 t -112.41 117.29 54.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.265 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.686 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 42.7 mt-30 -103.62 143.51 32.66 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.907 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 152.41 20.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.418 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' A' ' 896' ' ' VAL . 26.7 p30 -65.09 -16.24 63.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.35 2.34 50.63 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.289 -0.257 . . . . 0.0 111.555 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.53 5.81 60.04 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.602 -0.808 . . . . 0.0 114.202 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 14.0 m -96.53 157.93 15.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.749 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.8 OUTLIER -133.2 154.68 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.02 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 917' ' ' LEU . 5.6 mp -123.07 134.85 54.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.495 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.67 118.66 59.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.25 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 955' ' ' LEU . 12.5 p -123.22 144.61 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 906' ' ' ALA . 61.8 tt0 -93.17 139.55 30.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.146 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.99 128.93 38.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 99.24 -4.01 58.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.981 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 925' ' ' SER . 9.9 p -139.69 151.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 117.257 0.529 . . . . 0.0 110.521 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 924' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 940' ' ' GLU . 5.1 p -91.45 -6.74 52.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 923' ' ' VAL . 16.4 p -68.49 108.85 3.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.25 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.05 145.28 25.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.343 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 6.2 p -117.61 122.41 43.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.795 0.331 . . . . 0.0 110.292 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -96.1 127.89 42.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.749 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 20.9 m -113.96 123.39 49.61 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.323 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 930' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 48.0 t -107.35 115.06 60.24 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 23.3 Cg_exo -65.59 2.48 1.57 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.673 2.915 . . . . 0.0 112.861 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.33 -3.48 57.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.55 . . . . 0.0 109.563 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.45 44.28 1.59 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.373 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.29 102.57 2.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 11.9 t -105.43 129.67 53.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.042 0.448 . . . . 0.0 110.57 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 14.8 p -116.93 128.64 55.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.033 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 7.2 ptp85 -107.8 126.89 53.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.552 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.46 139.65 46.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.574 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -109.39 173.1 16.75 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.033 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . 0.407 ' HB2' ' OG ' ' A' ' 924' ' ' SER . 30.5 tt0 -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.83 0.347 . . . . 0.0 111.569 -176.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -95.34 2.22 54.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.322 0.582 . . . . 0.0 110.688 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -91.48 172.32 8.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . 0.704 ' HZ1' ' HB2' ' A' ' 943' ' ' LYS . 0.1 OUTLIER -100.32 130.77 46.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.952 0.406 . . . . 0.0 110.111 178.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -94.84 133.2 26.9 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.866 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 31.4 Cg_exo -59.82 -65.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 0.0 111.683 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -165.68 -64.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.46 -33.59 72.79 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.57 -172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.24 -42.72 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.2 -44.27 92.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.452 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.6 -43.98 96.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.682 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 951' ' ' LYS . 35.4 mmtm -71.15 -38.02 72.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 955' ' ' LEU . 28.0 tp -57.98 -36.56 72.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.858 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.51 -35.09 79.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.885 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 27.8 t -72.1 -25.26 61.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.256 0.55 . . . . 0.0 110.602 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 952' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 t -107.36 143.42 35.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.754 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 35.0 t -126.42 140.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.272 . . . . 0.0 110.565 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -92.07 130.68 37.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 954' ' ' CYS . 14.4 m -111.2 122.26 65.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.972 0.415 . . . . 0.0 111.597 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . 0.71 ' HB3' HG13 ' A' ' 896' ' ' VAL . 39.8 ttmt 60.91 1.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.932 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.08 22.52 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.074 -170.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 894' ' ' LYS . 13.3 p -104.22 -29.19 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.9 160.32 26.17 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.327 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.544 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -120.68 133.79 55.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -125.14 130.66 52.63 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.243 -0.583 . . . . 0.0 112.188 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 52.0 m -115.52 125.65 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.296 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -86.59 124.13 32.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.14 141.7 28.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 3.6 m -66.65 -8.4 27.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 3.0 m -85.49 0.5 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.32 4.21 71.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.68 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.02 142.67 27.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.2 123.18 68.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -107.71 112.55 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 917' ' ' LEU . 6.0 p -116.85 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.748 0.785 . . . . 0.0 110.767 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.544 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 7.6 tt0 -91.91 143.14 26.8 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.857 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . 0.75 ' HD1' ' H ' ' A' ' 913' ' ' ASP . 19.7 t80 -92.66 150.0 20.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.8 -19.72 60.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . 0.75 ' H ' ' HD1' ' A' ' 911' ' ' PHE . 37.9 t70 -79.97 1.1 28.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.188 0.518 . . . . 0.0 111.264 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 91.94 5.71 65.93 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.94 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.7 p -96.05 153.3 17.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -121.83 155.48 35.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.549 0.214 . . . . 0.0 110.555 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.625 ' HB3' HG11 ' A' ' 909' ' ' VAL . 7.9 tt -137.75 131.0 30.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.54 120.8 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.33 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.22 145.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.74 139.33 30.66 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.42 128.68 37.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.811 0.338 . . . . 0.0 111.691 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.02 -6.63 64.19 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.09 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.07 156.36 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 122.511 -0.405 . . . . 0.0 111.1 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 924' ' ' SER . . . . . 0.411 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 42.0 m -90.32 -5.68 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 15.3 t -69.2 112.35 5.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.218 0.532 . . . . 0.0 109.839 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 948' ' ' ILE . 0.0 OUTLIER -120.64 146.61 25.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.897 -174.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 5.8 m -116.15 117.63 30.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -108.02 129.37 55.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 23.6 m -100.44 121.94 42.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 44.6 t -123.02 125.03 26.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -11.92 32.42 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.348 2.032 . . . . 0.0 111.422 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -105.06 -14.5 15.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.916 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -149.33 22.3 1.22 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.458 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . 0.8 ' HG2' ' H ' ' A' ' 935' ' ' THR . 39.3 tt0 68.3 -161.26 0.2 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.051 0.426 . . . . 0.0 109.906 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.8 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 3.3 p -97.29 126.0 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.439 . . . . 0.0 110.972 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 19.9 p -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.851 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -98.95 128.99 45.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.855 0.36 . . . . 0.0 110.369 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . 0.413 ' HB2' HG23 ' A' ' 926' ' ' ILE . 58.4 m-85 -101.84 127.85 48.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.41 141.74 15.67 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.676 -167.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 43.3 tt0 -66.35 -21.88 66.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.533 0.682 . . . . 0.0 109.802 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.18 2.04 37.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.862 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -142.02 -140.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.838 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -100.01 136.26 40.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.706 -169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.96 132.74 22.35 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.836 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.54 155.29 70.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.677 2.251 . . . . 0.0 111.42 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 950' ' ' GLN . 24.8 t70 -60.21 -46.74 88.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.376 -176.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -61.69 -31.81 71.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 111.348 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.601 HG21 HG22 ' A' ' 926' ' ' ILE . 45.3 mm -69.35 -42.56 81.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.44 . . . . 0.0 109.966 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -63.01 -37.24 86.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.104 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 946' ' ' ASP . 81.1 mm-40 -61.11 -44.14 97.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.609 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.63 -43.64 79.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.4 -36.24 83.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.855 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -59.4 -34.18 72.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.261 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 893' ' ' VAL . 61.2 m -69.9 -25.41 63.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.651 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -178.397 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.056 0.455 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 3.8 p -107.08 154.0 21.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.804 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.63 139.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -97.08 130.13 44.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.51 119.46 62.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.629 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 56.37 4.96 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.622 1.201 . . . . 0.0 112.316 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 59.07 23.58 11.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.333 0.653 . . . . 0.0 109.944 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.57 -29.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.78 158.77 25.76 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.448 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 898' ' ' TRP . . . . . 0.455 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 3.6 m95 -121.03 136.0 55.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.49 130.16 52.76 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.104 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 23.9 m -116.62 127.07 54.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.483 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -88.63 117.55 27.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.887 0.375 . . . . 0.0 110.427 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 902' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 908' ' ' TRP . 3.1 mm? -80.21 149.42 30.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.975 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 8.4 t -65.88 -20.28 66.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.446 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 39.9 t -83.95 0.77 46.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 111.041 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.62 6.5 63.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.912 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -85.24 152.34 23.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 907' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 919' ' ' VAL . 45.2 t -112.08 122.92 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.252 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 908' ' ' TRP . . . . . 0.668 ' HB2' HD22 ' A' ' 902' ' ' LEU . 22.6 t90 -110.08 113.68 26.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 909' ' ' VAL . . . . . 0.768 ' HB ' ' HG ' ' A' ' 917' ' ' LEU . 45.7 t -115.2 129.01 72.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 -175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 910' ' ' GLN . . . . . 0.448 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 35.1 mt-30 -98.61 150.05 22.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -108.5 162.25 14.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.475 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.9 -27.77 61.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.347 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.71 1.53 42.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.489 0.662 . . . . 0.0 111.103 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.76 8.19 83.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.065 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.68 165.38 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -0.627 . . . . 0.0 109.519 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 151.99 50.63 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.2 -177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.768 ' HG ' ' HB ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -137.67 134.82 35.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.013 0.435 . . . . 0.0 110.018 173.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 918' ' ' VAL . . . . . 0.599 HG23 ' HD1' ' A' ' 908' ' ' TRP . 42.4 t -114.2 124.3 70.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.157 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 907' ' ' VAL . 14.6 p -118.8 132.55 68.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 110.331 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.04 141.66 28.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.162 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.19 40.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 101.33 6.48 50.89 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.647 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.696 HG23 ' H ' ' A' ' 925' ' ' SER . 8.1 p -149.78 141.14 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 924' ' ' SER . . . . . 0.581 ' HB3' ' HB3' ' A' ' 940' ' ' GLU . 35.1 t -87.1 -5.57 58.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.874 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 925' ' ' SER . . . . . 0.696 ' H ' HG23 ' A' ' 923' ' ' VAL . 19.6 m -82.31 131.16 35.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.3 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.776 HD12 HD13 ' A' ' 952' ' ' LEU . 3.6 mt -120.0 146.43 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.252 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 917' ' ' LEU . 23.3 t -104.35 115.41 30.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 928' ' ' TYR . . . . . 0.569 ' CZ ' HD13 ' A' ' 917' ' ' LEU . 19.7 m-85 -102.12 125.81 48.91 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 929' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.5 t -114.99 123.52 49.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.57 0.7 . . . . 0.0 110.661 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 43.2 t -105.07 106.61 56.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.697 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.66 -39.0 93.6 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.346 2.697 . . . . 0.0 112.932 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -97.0 16.18 20.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.785 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -137.63 -75.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.532 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 175.54 169.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 935' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 29.1 m -104.43 124.51 49.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 11.1 m -121.54 130.0 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.62 128.96 44.73 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.145 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.56 127.44 53.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.803 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.15 169.55 22.89 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.332 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 940' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 924' ' ' SER . 11.7 pt-20 -64.68 -15.93 62.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.449 0.299 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.45 1.61 55.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -100.93 146.43 27.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.339 . . . . 0.0 110.684 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.38 123.38 31.56 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 944' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 948' ' ' ILE . 2.2 mm? -91.43 133.57 31.12 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.407 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -71.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.271 2.647 . . . . 0.0 113.334 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -147.26 -75.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.754 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 948' ' ' ILE . . . . . 0.562 HG22 ' CZ ' ' A' ' 928' ' ' TYR . 4.0 mp -67.72 -42.66 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 949' ' ' LYS . . . . . 0.419 ' HB3' ' HZ1' ' A' ' 949' ' ' LYS . 2.4 ttpm? -63.31 -44.05 96.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.781 175.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -62.25 -42.63 99.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.854 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 951' ' ' LYS . . . . . 0.499 ' O ' HD12 ' A' ' 955' ' ' LEU . 25.5 mmmt -68.81 -40.58 79.49 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.149 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 926' ' ' ILE . 56.5 tp -62.15 -39.65 93.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.847 175.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -73.2 -35.45 66.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.38 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 954' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 31.8 p -71.53 -20.68 62.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.031 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 955' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 951' ' ' LYS . 4.4 mp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 112.246 -0.342 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 97.04 9.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.479 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -156.78 142.43 17.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.237 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -77.74 -65.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.83 133.65 52.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.769 0.318 . . . . 0.0 110.804 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.1 132.08 55.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.845 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 889' ' ' LYS . 41.1 mmtm -93.07 -4.17 52.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 50.8 m -106.98 142.63 36.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.44 139.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -105.2 119.51 39.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.868 0.366 . . . . 0.0 110.291 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.08 119.25 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.051 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 896' ' ' VAL . 34.8 ttpt 55.01 5.13 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.842 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.99 24.96 14.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.602 0.761 . . . . 0.0 110.15 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 894' ' ' LYS . 9.7 p -103.18 -27.33 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.64 24.99 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.283 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -122.2 135.16 54.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 27.1 m -103.7 126.03 50.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.714 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -86.68 116.14 24.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.906 0.384 . . . . 0.0 110.675 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.84 145.6 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 10.0 p -67.18 -20.26 65.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.9 m -81.84 2.61 29.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.308 . . . . 0.0 111.714 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.47 7.9 63.01 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.496 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.53 140.1 30.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.503 HG11 ' HB ' ' A' ' 919' ' ' VAL . 4.2 p -117.19 123.17 71.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.282 0.563 . . . . 0.0 109.866 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -101.2 112.23 24.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 917' ' ' LEU . 5.9 p -114.61 117.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.812 0.815 . . . . 0.0 111.046 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.3 tt0 -104.53 143.28 33.25 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.52 166.26 10.91 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.779 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -64.85 -20.45 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.698 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.6 1.3 26.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 111.122 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 92.14 5.5 65.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.289 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.0 m -97.23 153.21 18.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.583 ' C ' HD12 ' A' ' 917' ' ' LEU . 83.1 mt-30 -125.4 153.28 43.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.708 ' HB2' HG11 ' A' ' 909' ' ' VAL . 6.9 mp -134.22 137.78 44.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.69 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.79 120.66 62.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.503 ' HB ' HG11 ' A' ' 907' ' ' VAL . 74.2 t -119.7 132.65 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.72 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -93.48 138.3 31.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.6 127.1 29.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.58 0.229 . . . . 0.0 110.847 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.41 -0.13 82.95 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.693 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.596 HG11 ' H ' ' A' ' 925' ' ' SER . 27.8 t -120.19 140.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.5 t -91.35 -14.83 30.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 111.131 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.596 ' H ' HG11 ' A' ' 923' ' ' VAL . 22.5 p -87.95 114.67 24.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.361 0.6 . . . . 0.0 110.718 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 938' ' ' TYR . 2.4 pp -116.68 162.89 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.819 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 7.2 t -117.47 117.01 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.3 128.63 53.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.795 0.331 . . . . 0.0 110.681 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 31.3 m -114.71 128.91 56.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.512 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.0 m -105.88 138.38 19.62 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.38 -7.41 15.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.681 2.921 . . . . 0.0 113.611 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -78.72 -1.44 34.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.312 0.577 . . . . 0.0 109.791 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 92.62 39.32 5.32 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.577 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -133.66 106.17 7.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.213 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 9.3 t -104.65 126.49 51.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.247 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 20.6 m -117.97 136.4 53.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.593 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.66 127.58 43.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.577 ' HD2' HG13 ' A' ' 926' ' ' ILE . 7.7 t80 -99.2 126.59 45.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.97 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -117.74 169.56 13.29 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.38 -15.61 58.03 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.507 0.653 . . . . 0.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.09 23.38 9.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.045 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -127.55 147.02 50.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -100.69 140.24 35.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.853 0.359 . . . . 0.0 111.084 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.488 ' HG ' HD12 ' A' ' 952' ' ' LEU . 2.3 mm? -93.23 140.1 23.19 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.555 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.433 ' HD2' ' CG1' ' A' ' 948' ' ' ILE . 24.0 Cg_exo -65.52 170.11 11.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.372 2.048 . . . . 0.0 110.596 165.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.88 -52.51 57.24 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 67.1 m-85 -66.04 -33.94 76.94 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 944' ' ' LEU . 23.1 mm -71.19 -43.47 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-O 121.346 0.593 . . . . 0.0 109.827 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -64.38 -38.96 92.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.851 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -61.47 -47.39 85.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.5 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.467 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 12.7 ptpt -70.11 -38.15 75.54 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.488 HD12 ' HG ' ' A' ' 944' ' ' LEU . 37.3 mt -58.03 -30.97 66.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 111.406 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -60.13 -33.8 72.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.55 -24.23 63.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.11 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -70.32 -15.74 62.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.427 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 14.6 t -58.61 -30.85 67.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.931 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 46.7 p -59.66 -37.59 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 49.4 mt -68.35 -39.31 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.226 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.97 -41.73 96.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.175 0.512 . . . . 0.0 110.208 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.26 -34.73 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.748 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' MET . . . . . 0.834 ' HA ' ' HE2' ' A' ' 961' ' ' MET . 1.5 tpt -64.57 -26.39 68.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.346 . . . . 0.0 110.702 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -84.96 -5.81 59.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 111.008 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 33.1 m -89.18 3.98 50.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.182 0.515 . . . . 0.0 110.082 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . 0.429 ' OD1' ' HD2' ' A' ' 965' ' ' PRO . 47.7 t30 -65.58 127.08 92.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.633 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.429 ' HD2' ' OD1' ' A' ' 964' ' ' ASN . 92.9 Cg_exo -43.64 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.606 2.871 . . . . 0.0 113.605 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 3.3 p -145.83 152.71 48.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.659 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.47 -19.93 54.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.929 2.42 . . . . 0.0 112.579 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.86 -0.43 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.82 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -119.68 144.59 47.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.7 t -75.26 164.4 26.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -72.64 111.98 8.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.48 . . . . 0.0 110.37 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.17 147.69 23.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.395 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.406 HD11 ' HE2' ' A' ' 889' ' ' LYS . 97.3 mt -111.62 134.29 53.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.78 45.55 1.08 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.268 0.556 . . . . 0.0 111.584 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . 0.406 ' HE2' HD11 ' A' ' 887' ' ' LEU . 38.5 pttt -128.47 96.26 4.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.244 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.7 m -107.34 155.7 19.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.535 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.6 138.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.319 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -100.22 131.3 46.24 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.012 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.65 HG12 ' SG ' ' A' ' 954' ' ' CYS . 55.3 t -95.18 117.06 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.533 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.448 ' HE2' ' H ' ' A' ' 894' ' ' LYS . 0.7 OUTLIER 51.64 9.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.002 0.921 . . . . 0.0 112.881 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.54 22.37 12.1 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.606 0.763 . . . . 0.0 109.893 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.55 -27.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 109.786 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.1 160.83 25.91 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.382 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.477 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.0 OUTLIER -121.55 136.26 54.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.68 56.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.1 m -114.37 132.77 56.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.83 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.26 123.56 39.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.087 0.47 . . . . 0.0 111.6 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.463 HD22 ' HE3' ' A' ' 908' ' ' TRP . 3.3 mm? -96.84 139.03 33.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.5 t -67.12 -10.67 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 11.1 t -85.99 0.38 53.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.479 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.3 10.09 59.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.437 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.01 141.47 28.59 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.31 122.58 70.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.463 ' HE3' HD22 ' A' ' 902' ' ' LEU . 0.0 OUTLIER -103.74 114.96 29.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.423 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.0 t -110.0 118.42 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.27 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.477 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 51.1 mt-30 -101.67 143.01 32.16 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.827 0.346 . . . . 0.0 110.165 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.537 ' CZ ' ' HE2' ' A' ' 951' ' ' LYS . 0.3 OUTLIER -92.71 151.55 20.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . 0.461 ' N ' ' HD1' ' A' ' 911' ' ' PHE . 28.0 t-20 -58.39 -26.89 63.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.45 2.47 47.63 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.67 5.09 60.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.551 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 65.4 m -83.29 162.45 21.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -132.94 151.41 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.455 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 7.0 mp -124.58 136.64 54.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.436 HG23 ' NE1' ' A' ' 908' ' ' TRP . 27.8 t -111.76 118.27 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.618 HG23 HG22 ' A' ' 926' ' ' ILE . 34.2 t -122.99 131.86 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.902 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 923' ' ' VAL . 34.7 tt0 -94.47 139.03 31.67 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.22 127.41 31.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.063 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 100.16 -5.65 57.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.967 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.627 HG21 ' H ' ' A' ' 925' ' ' SER . 7.7 p -124.88 140.24 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' SER . . . . . 0.943 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 26.4 m -89.13 -5.9 57.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.416 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.627 ' H ' HG21 ' A' ' 923' ' ' VAL . 34.7 m -73.26 117.8 15.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.671 0.272 . . . . 0.0 110.565 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.618 HG22 HG23 ' A' ' 919' ' ' VAL . 1.5 mp -112.58 144.42 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.228 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 15.6 m -119.15 113.79 21.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.627 ' HE1' ' HE1' ' A' ' 938' ' ' TYR . 24.1 p90 -111.39 130.13 55.79 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.981 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 11.4 t -113.1 136.99 52.11 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 4.0 t -122.65 125.62 26.36 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.85 135.97 72.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.944 3.096 . . . . 0.0 113.156 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 65.16 11.44 7.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -118.76 -84.46 0.94 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.303 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 933' ' ' GLY . 6.5 tp-100 169.53 160.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 6.9 t -103.08 128.86 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.461 . . . . 0.0 109.936 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 936' ' ' THR . . . . . 0.611 ' HB ' ' CE1' ' A' ' 928' ' ' TYR . 38.0 m -116.9 136.41 52.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.681 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -116.33 128.06 55.22 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.132 0.491 . . . . 0.0 110.628 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.627 ' HE1' ' HE1' ' A' ' 928' ' ' TYR . 56.1 m-85 -109.88 131.46 55.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.054 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -92.68 179.41 40.06 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.517 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . 0.943 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 24.7 mp0 -63.72 -26.04 68.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.855 0.327 . . . . 0.0 111.294 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -87.23 1.58 52.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.935 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -108.6 142.48 39.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.427 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -76.84 129.85 36.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.629 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 91.2 mt -93.83 134.17 26.67 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.255 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 27.0 Cg_exo -63.78 164.53 21.22 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.015 2.477 . . . . 0.0 112.071 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.61 -62.81 1.27 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.686 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -68.06 -33.03 73.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.391 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.43 -43.88 83.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.121 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -63.28 -43.41 97.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.24 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -59.82 -44.16 94.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.309 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.537 ' HE2' ' CZ ' ' A' ' 911' ' ' PHE . 4.5 mttp -68.41 -43.47 77.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.653 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.409 HD22 HG12 ' A' ' 926' ' ' ILE . 3.9 mm? -64.24 -35.97 82.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.0 110.816 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -61.47 -35.2 76.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.507 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . 0.65 ' SG ' HG12 ' A' ' 893' ' ' VAL . 35.6 t -73.5 -26.68 61.0 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.21 -20.61 63.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 47.9 t -58.12 -38.86 77.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 109.948 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 17.4 t -65.82 -38.07 87.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.121 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.98 -40.09 80.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.186 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.93 -43.96 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.62 -39.47 88.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 27.4 ttt -69.42 -27.03 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -84.83 -5.82 59.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 28.2 t -93.54 21.42 6.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.502 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 10.1 p30 -77.05 131.02 73.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.922 0.392 . . . . 0.0 110.561 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 1.7 Cg_endo -83.89 150.98 12.68 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.99 2.46 . . . . 0.0 111.905 176.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 40.1 m -136.46 103.88 9.39 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.762 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.86 90.9 0.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.491 2.128 . . . . 0.0 112.445 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -93.94 -0.58 55.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.491 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -89.57 -1.14 57.94 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.241 0.544 . . . . 0.0 109.869 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.54 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 14.2 m -90.74 -6.59 54.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.781 0.291 . . . . 0.0 110.748 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 69.78 2.38 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.213 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 886' ' ' GLN . 15.2 mm-40 -92.85 -10.36 36.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.862 0.363 . . . . 0.0 111.107 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 90.9 mt -124.23 118.42 26.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.11 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.18 114.26 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.201 0.524 . . . . 0.0 110.932 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -121.09 -32.18 3.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.0 173.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 p -107.38 143.61 35.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.296 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.04 154.96 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.712 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -106.98 130.61 54.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.656 0.265 . . . . 0.0 110.681 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.09 119.08 59.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.458 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.564 ' HB2' HG13 ' A' ' 896' ' ' VAL . 3.2 mmmp? 54.16 7.62 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.86 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.01 22.55 10.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.064 0.546 . . . . 0.0 110.261 -171.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 894' ' ' LYS . 12.8 p -103.69 -27.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . 0.887 ' HA3' ' HE3' ' A' ' 951' ' ' LYS . . . -140.12 158.89 25.99 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.568 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 2.0 m95 -121.93 135.54 54.88 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.026 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.1 m -115.6 124.72 51.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.02 117.18 34.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.261 0.553 . . . . 0.0 110.717 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.72 137.3 33.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.265 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 5.9 m -64.53 -13.24 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.262 0.554 . . . . 0.0 111.189 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 13.5 m -79.93 0.42 31.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 94.47 6.67 60.99 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.629 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.5 137.84 32.05 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -110.53 111.96 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 43.8 t -116.56 116.92 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 46.4 mt-30 -94.04 160.65 14.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.893 0.377 . . . . 0.0 110.5 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.43 ' HD1' ' HZ2' ' A' ' 951' ' ' LYS . 38.3 t80 -104.47 164.48 11.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -60.29 -26.01 66.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.3 0.1 54.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.54 4.8 60.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.707 . . . . 0.0 113.726 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 60.5 p -81.24 162.86 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.571 0.686 . . . . 0.0 109.332 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.736 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.6 OUTLIER -132.51 153.45 50.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 112.318 -177.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 916' ' ' GLN . 5.9 mp -126.92 135.97 51.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 32.8 t -112.39 122.69 67.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.73 137.16 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.127 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 923' ' ' VAL . 77.1 mm-40 -93.39 138.46 31.69 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.64 129.42 40.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.641 0.258 . . . . 0.0 111.062 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.17 -6.84 61.94 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.412 174.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 920' ' ' GLN . 33.5 m -130.14 156.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.393 0.596 . . . . 0.0 110.821 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 4.6 p -91.05 -6.7 53.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.297 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 21.7 m -72.06 128.54 36.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.956 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.88 146.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.529 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 13.0 m -114.01 116.43 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -97.12 127.21 42.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.045 0.45 . . . . 0.0 109.873 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.736 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 17.1 m -114.28 123.63 50.01 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.394 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 930' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 33.8 t -122.91 106.21 34.33 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 37.5 Cg_endo -66.41 -5.74 13.42 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.938 2.425 . . . . 0.0 111.993 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -93.18 -6.81 46.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.43 -66.5 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.638 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 179.74 169.06 1.17 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -169.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 18.2 m -103.23 124.78 49.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 53.5 m -119.66 130.17 54.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -97.85 130.25 44.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.62 127.64 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.024 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.88 172.56 24.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.66 -18.31 64.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.569 0.685 . . . . 0.0 110.721 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.05 2.29 47.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.565 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.87 143.97 26.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -95.95 125.69 40.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.915 0.388 . . . . 0.0 110.472 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.83 133.54 39.27 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.22 -66.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.601 2.201 . . . . 0.0 112.068 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -163.36 -64.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.688 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -59.74 -32.07 70.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.795 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.52 -43.56 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 0.0 110.385 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -64.23 -42.72 96.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.868 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -60.01 -43.78 95.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.219 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.887 ' HE3' ' HA3' ' A' ' 897' ' ' GLY . 23.2 tptm -68.1 -43.29 78.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.261 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.29 -37.74 88.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.883 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.76 -21.38 62.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.397 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.18 -23.07 67.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 110.712 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.35 -14.07 62.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.771 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 956' ' ' SER . . . . . 0.495 ' O ' ' HG ' ' A' ' 959' ' ' LEU . 37.3 m -53.64 -35.14 60.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.712 0.291 . . . . 0.0 111.565 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 12.4 m -62.96 -38.25 90.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.044 0.45 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.88 -43.93 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 956' ' ' SER . 4.5 pp -64.18 -34.27 77.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 110.2 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.11 -39.82 94.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.558 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 47.5 ttm -66.01 -27.24 67.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.232 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -80.77 -7.7 59.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.868 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 20.0 m -95.64 0.59 52.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.072 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 65.07 106.46 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.276 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.94 126.15 21.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.036 2.491 . . . . 0.0 112.446 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 9.5 t -102.1 148.48 35.43 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.461 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.55 108.07 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.836 2.358 . . . . 0.0 111.973 172.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -90.4 22.67 3.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.114 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.18 117.38 5.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.419 -179.717 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.3 t -86.11 101.94 13.42 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -108.69 87.28 2.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.203 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -103.56 105.26 15.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.648 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 6.0 tt -100.1 103.26 14.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.909 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.07 -154.91 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.862 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -73.98 -12.81 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.388 0.614 . . . . 0.0 109.36 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.6 m -103.2 141.08 36.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.832 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.56 140.55 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 898' ' ' TRP . 36.0 p90 -90.37 125.54 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.066 0.46 . . . . 0.0 110.736 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 894' ' ' LYS . 7.3 p -95.26 123.44 47.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.089 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.516 ' HG2' HG22 ' A' ' 893' ' ' VAL . 33.3 mmtp 57.91 8.29 0.71 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.678 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.99 22.56 11.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.69 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.74 -30.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.827 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.2 163.85 25.34 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.139 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.636 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 2.1 m95 -121.36 134.89 55.13 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.45 129.98 55.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.883 0.373 . . . . 0.0 110.633 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 24.9 m -116.88 126.89 53.67 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.419 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -94.34 116.14 28.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.249 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.7 p -66.4 -15.56 63.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.8 p -85.54 0.55 52.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.739 0.304 . . . . 0.0 111.213 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.21 9.71 60.29 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.235 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.85 139.67 30.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.403 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.84 122.31 68.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.14 0.495 . . . . 0.0 109.735 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.579 ' HE1' ' HG3' ' A' ' 916' ' ' GLN . 8.6 t90 -108.66 113.52 26.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 35.9 t -116.03 115.88 50.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 110.346 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.636 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 23.2 pt20 -105.26 163.22 12.76 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.48 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 23.9 m-85 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -65.45 -17.24 64.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.369 0.604 . . . . 0.0 110.147 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.76 3.33 41.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.725 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.5 6.78 59.55 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.798 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 14.6 m -88.81 158.42 18.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.883 0.342 . . . . 0.0 110.456 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.785 ' HB3' ' HB ' ' A' ' 929' ' ' THR . 50.5 tt0 -132.1 150.91 52.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.073 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.499 HD23 HD12 ' A' ' 926' ' ' ILE . 6.4 mp -137.82 135.88 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 171.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.96 121.59 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.63 HG11 ' HG ' ' A' ' 955' ' ' LEU . 11.6 t -120.04 135.97 58.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.15 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.23 139.41 30.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.84 128.1 35.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.029 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.37 -6.02 83.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.635 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 925' ' ' SER . 24.2 t -107.84 138.05 36.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.721 0.296 . . . . 0.0 110.644 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 38.1 m -91.29 -6.19 53.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.13 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.641 ' H ' HG13 ' A' ' 923' ' ' VAL . 21.5 p -95.44 123.8 39.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.499 HD12 HD23 ' A' ' 917' ' ' LEU . 2.6 pp -116.03 150.16 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.514 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 21.0 m -105.43 116.63 32.27 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -96.81 128.43 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.785 ' HB ' ' HB3' ' A' ' 916' ' ' GLN . 40.1 m -112.39 122.89 49.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.056 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.9 t -123.68 99.29 39.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.49 -12.29 32.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.73 2.287 . . . . 0.0 111.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -86.26 -14.26 44.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.484 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.95 -62.05 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.178 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -173.28 159.27 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.106 0.453 . . . . 0.0 110.513 -167.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 929' ' ' THR . 67.1 p -102.81 125.29 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 169.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 27.2 m -120.59 132.23 55.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.477 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -97.29 129.04 44.63 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.204 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.583 ' HB3' ' CD2' ' A' ' 944' ' ' LEU . 98.4 m-85 -107.17 139.61 41.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . 0.738 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -147.02 -172.73 17.57 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.92 -1.133 . . . . 0.0 112.818 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -26.61 67.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.899 0.48 . . . . 0.0 111.576 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -97.25 7.27 46.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . 0.738 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 5.9 mm-40 -113.13 150.76 31.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 111.031 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -74.52 122.25 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.837 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.583 ' CD2' ' HB3' ' A' ' 938' ' ' TYR . 77.7 mt -98.6 132.3 24.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.354 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 55.4 Cg_endo -84.25 172.36 9.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.618 2.212 . . . . 0.0 111.423 171.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -53.43 -60.93 2.67 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -64.79 -31.3 72.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.696 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.646 ' HB ' ' HD2' ' A' ' 945' ' ' PRO . 45.1 mm -68.78 -41.77 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.41 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.9 -39.12 88.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.7 ' HB3' ' HZ1' ' A' ' 951' ' ' LYS . 5.6 mmmp? -65.43 -42.73 92.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.471 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.39 -36.46 80.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -69.02 -31.5 70.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.96 -25.35 64.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.63 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.0 mm? -72.48 -15.88 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 78.1 p -59.41 -39.91 84.97 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.412 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 15.8 m -65.84 -39.94 91.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.13 -39.45 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.135 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.02 -44.22 97.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.167 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.344 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 56.0 ttp -70.04 -26.33 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -89.35 -3.88 58.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.557 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 32.3 t -83.08 21.83 1.03 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.446 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.63 123.56 71.69 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 121.18 0.514 . . . . 0.0 110.984 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.81 176.02 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.892 2.395 . . . . 0.0 113.116 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 8.6 t -149.05 138.55 12.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.761 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.65 48.88 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 112.121 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 18.24 2.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -95.74 -1.07 50.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.779 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 17.9 m -114.21 20.62 15.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -84.86 148.36 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.435 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -85.36 -27.67 25.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.0 110.397 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 887' ' ' LEU . 4.0 mm? -122.9 130.44 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.09 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.82 135.31 42.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.052 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.94 -42.92 20.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.4 p -107.24 143.83 34.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.844 170.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.33 155.21 14.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.677 0.275 . . . . 0.0 110.319 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -101.84 130.54 48.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.58 120.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.672 ' HB2' HG11 ' A' ' 896' ' ' VAL . 2.9 mptp? 57.36 4.28 0.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.091 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 59.89 22.1 11.09 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.533 0.733 . . . . 0.0 110.47 -170.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 894' ' ' LYS . 12.9 p -105.57 -28.43 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 0.0 109.639 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.05 25.54 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.072 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.741 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 1.2 m95 -122.18 135.76 54.82 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -115.42 131.35 56.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.984 0.421 . . . . 0.0 110.733 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 15.8 m -116.02 130.46 56.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.765 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -94.88 115.31 27.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.657 HD12 ' HE3' ' A' ' 908' ' ' TRP . 86.3 mt -82.28 154.43 25.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -20.41 65.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.24 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.3 m -84.7 0.84 49.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 110.893 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.38 14.56 58.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.475 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . 0.634 ' HB2' HD11 ' A' ' 902' ' ' LEU . . . -90.03 139.14 30.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.626 0.25 . . . . 0.0 110.429 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.44 122.31 55.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.657 ' HE3' HD12 ' A' ' 902' ' ' LEU . 1.6 t-105 -110.75 114.72 28.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.821 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.79 117.7 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 111.071 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.741 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 22.3 pt20 -105.41 161.62 14.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.452 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.516 ' HE1' HD22 ' A' ' 917' ' ' LEU . 43.3 m-85 -121.61 -179.91 4.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.875 0.369 . . . . 0.0 111.515 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.52 -26.86 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.774 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -87.82 1.18 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.234 0.54 . . . . 0.0 111.006 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.52 4.84 87.43 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.495 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.8 t -79.43 151.12 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.535 ' HB3' ' HE1' ' A' ' 908' ' ' TRP . 29.5 mt-30 -133.46 154.92 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.476 -171.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.651 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 0.9 OUTLIER -139.66 136.04 33.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 165.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.6 p -113.28 126.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.148 0.499 . . . . 0.0 110.533 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.43 HG21 HG23 ' A' ' 926' ' ' ILE . 32.7 t -117.29 132.5 66.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.911 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.464 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 83.8 mm-40 -88.15 138.02 31.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.14 125.35 23.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 86.85 -6.06 83.76 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.25 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.632 HG11 ' H ' ' A' ' 925' ' ' SER . 36.4 t -107.56 138.22 34.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 59.8 m -91.44 -6.44 52.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.836 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.632 ' H ' HG11 ' A' ' 923' ' ' VAL . 72.1 p -90.62 114.98 27.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.018 0.437 . . . . 0.0 110.077 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 919' ' ' VAL . 78.6 mt -112.77 146.61 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.045 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.431 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 14.0 m -117.31 115.64 25.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.651 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 52.0 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.126 0.489 . . . . 0.0 110.3 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.522 HG21 HG22 ' A' ' 935' ' ' THR . 24.4 m -113.1 121.99 46.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 930' ' ' SER . . . . . 0.555 ' HB2' ' OD1' ' A' ' 932' ' ' ASN . 7.2 p -122.23 99.05 43.66 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.61 -26.73 80.24 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.61 2.873 . . . . 0.0 112.19 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . 0.555 ' OD1' ' HB2' ' A' ' 930' ' ' SER . 27.4 p-10 -71.63 -2.12 16.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.231 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -154.03 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.763 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -163.64 -175.43 4.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.898 0.38 . . . . 0.0 110.203 -168.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.522 HG22 HG21 ' A' ' 929' ' ' THR . 82.4 p -104.02 133.53 48.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 936' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 928' ' ' TYR . 14.2 t -117.47 140.93 48.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -107.09 130.46 54.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.088 0.471 . . . . 0.0 111.503 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.492 ' CE1' HD22 ' A' ' 944' ' ' LEU . 12.0 t80 -104.57 127.81 52.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.986 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -130.45 174.7 19.6 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -54.62 -27.04 36.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 0.0 111.68 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.02 2.85 53.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.48 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -104.67 141.29 36.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 111.857 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -99.46 123.93 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.069 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.492 HD22 ' CE1' ' A' ' 938' ' ' TYR . 1.5 mm? -79.84 133.23 58.84 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 18.8 Cg_exo -67.35 -66.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.938 2.426 . . . . 0.0 112.931 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -152.62 -74.97 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.271 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 52.5 m-85 -64.18 -29.75 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.493 ' O ' HD11 ' A' ' 952' ' ' LEU . 45.2 mm -68.21 -44.09 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.866 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.47 -39.19 91.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 953' ' ' GLN . 5.6 tp-100 -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.015 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 13.8 ptpt -69.22 -36.75 77.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.996 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 948' ' ' ILE . 4.7 mp -56.95 -31.61 65.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 950' ' ' GLN . 5.7 tp-100 -58.63 -31.04 67.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.165 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 38.1 t -69.41 -20.91 63.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 952' ' ' LEU . 4.0 mm? -72.15 -19.66 61.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 77.2 p -59.73 -38.84 82.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.0 p -66.08 -39.85 90.37 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 15.1 tt -69.58 -37.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.855 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.86 -38.82 89.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 0.0 110.282 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 960' ' ' LEU . 5.6 tt -63.75 -39.29 93.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.769 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 67.3 mtt -64.6 -26.09 68.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.861 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -85.94 -6.85 58.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.284 0.564 . . . . 0.0 110.25 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 33.7 t -91.18 5.27 49.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.837 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -56.55 124.41 62.22 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.475 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -34.3 104.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.408 3.405 . . . . 0.0 113.987 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.25 128.23 22.04 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.982 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 -24.37 79.23 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.717 2.278 . . . . 0.0 112.586 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -97.11 9.86 40.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.339 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.91 -21.77 17.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.443 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.178 -177.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 20.1 m -96.64 93.59 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.364 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -76.39 97.65 4.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -129.87 163.08 27.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.948 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 9.5 mp 63.25 21.43 12.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 110.559 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.61 165.26 23.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.692 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . 0.405 ' HD3' ' NE2' ' A' ' 901' ' ' GLN . 60.5 mttm -87.66 40.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 110.455 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 16.6 p -106.8 142.9 35.69 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.956 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.85 140.7 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.05 119.4 30.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 109.951 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.56 122.61 50.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 62.14 2.88 0.88 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.524 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.15 22.33 11.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.633 0.773 . . . . 0.0 110.24 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.41 -30.47 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.379 0.609 . . . . 0.0 110.099 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.73 168.33 25.03 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.674 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.563 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.2 OUTLIER -117.1 134.72 54.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -119.51 131.07 55.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.096 0.474 . . . . 0.0 111.334 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 14.9 m -115.41 126.72 54.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.336 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . 0.405 ' NE2' ' HD3' ' A' ' 889' ' ' LYS . 10.6 pt20 -89.82 138.77 31.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.899 0.381 . . . . 0.0 110.264 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.29 142.32 44.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 18.7 p -66.86 -15.01 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 0.0 111.077 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 4.0 m -79.48 0.3 30.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.957 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.8 3.98 65.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.599 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -93.2 141.49 28.37 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.772 HG11 ' HB ' ' A' ' 919' ' ' VAL . 3.4 p -119.05 122.71 69.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.452 0.644 . . . . 0.0 109.428 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 11.5 t-105 -97.71 113.83 25.67 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.351 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 917' ' ' LEU . 3.3 p -114.56 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.596 0.712 . . . . 0.0 110.363 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.563 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 53.0 tt0 -98.68 142.63 30.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.975 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -91.79 151.62 20.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.674 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -64.13 -22.97 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.68 2.18 38.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 96.48 6.55 58.5 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.219 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.2 m -95.47 158.72 15.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.83 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 17.7 pm0 -132.91 154.96 49.91 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.254 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.767 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.3 mp -129.04 139.81 51.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.97 122.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.772 ' HB ' HG11 ' A' ' 907' ' ' VAL . 61.4 t -117.24 132.54 66.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.785 0.326 . . . . 0.0 110.217 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -92.23 139.4 30.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -52.81 128.96 28.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.53 -6.41 63.01 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.962 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 923' ' ' VAL . 14.6 t 61.31 32.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 121.885 0.85 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 15.5 m -72.87 -14.94 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.394 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 22.8 t -173.51 125.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.617 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.592 HG23 HG13 ' A' ' 919' ' ' VAL . 0.2 OUTLIER -125.02 144.16 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.519 ' OG ' ' HG2' ' A' ' 937' ' ' ARG . 10.2 m -118.82 122.04 41.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -96.66 124.08 40.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.875 HG22 ' HB ' ' A' ' 935' ' ' THR . 14.1 m -115.5 122.75 46.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 23.0 p -125.88 102.35 28.45 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.04 -40.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.752 2.968 . . . . 0.0 113.366 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.0 -29.74 71.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.552 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -116.61 -75.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.309 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -163.71 153.4 14.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.658 0.266 . . . . 0.0 111.118 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.875 ' HB ' HG22 ' A' ' 929' ' ' THR . 8.9 t -104.87 125.37 50.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 936' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 927' ' ' SER . 27.2 m -120.07 135.64 54.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.405 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.519 ' HG2' ' OG ' ' A' ' 927' ' ' SER . 40.2 mtp180 -98.11 126.79 43.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.92 140.46 45.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.163 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -106.4 161.68 14.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.404 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -5.76 20.65 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.391 0.615 . . . . 0.0 110.526 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -90.61 2.11 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.84 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 11.8 pt-20 -129.07 170.9 12.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.227 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -80.14 129.9 34.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.467 . . . . 0.0 110.521 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.631 HD22 HG22 ' A' ' 948' ' ' ILE . 32.2 mt -98.05 133.38 23.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.006 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.62 ' HB2' HD12 ' A' ' 948' ' ' ILE . 26.6 Cg_exo -63.74 156.11 59.51 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 111.629 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.89 -53.07 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.62 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . 0.416 ' O ' ' HD2' ' A' ' 951' ' ' LYS . 78.4 m-85 -63.24 -31.3 72.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.573 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.631 HG22 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -67.82 -42.94 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.836 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . 0.502 ' HZ2' ' HB3' ' A' ' 949' ' ' LYS . 3.4 mmmp? -63.31 -39.9 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.125 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.35 -43.77 98.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.599 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.527 ' HE2' ' N ' ' A' ' 951' ' ' LYS . 0.7 OUTLIER -68.34 -40.41 81.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.328 0.585 . . . . 0.0 109.694 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.76 -36.04 77.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -27.44 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.125 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.3 -20.58 63.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.54 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.91 -14.75 63.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.91 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.5 m -57.8 -27.31 63.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 111.281 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 24.4 p -60.41 -37.57 81.28 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.65 -39.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.709 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.1 tt -60.77 -42.9 98.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.14 -40.4 94.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.028 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' MET . . . . . 0.813 ' HA ' ' HE2' ' A' ' 961' ' ' MET . 2.4 tpt -70.52 -26.68 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.592 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -93.6 11.66 28.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.739 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 50.0 m -78.25 11.37 2.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.106 0.479 . . . . 0.0 110.819 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -120.09 82.51 29.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.512 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.68 -13.94 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.646 2.231 . . . . 0.0 111.202 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 30.5 p 49.79 81.0 0.27 Allowed Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.77 0.828 . . . . 0.0 112.482 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 112.75 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.918 2.412 . . . . 0.0 110.819 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -86.23 19.66 2.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.025 0.44 . . . . 0.0 110.349 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 71.32 -0.65 3.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.454 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.818 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 39.3 p -141.2 138.48 33.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 111.102 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -74.36 159.48 32.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.22 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.88 -173.62 3.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.5 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.79 -15.31 59.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.232 0.539 . . . . 0.0 110.045 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.83 179.5 7.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.48 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . 0.515 ' HZ2' ' HB2' ' A' ' 889' ' ' LYS . 10.1 mtmp? -80.45 94.27 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.928 0.394 . . . . 0.0 110.567 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.2 m -102.34 143.28 32.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.863 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.05 139.11 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -94.3 130.44 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.842 0.353 . . . . 0.0 110.598 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.46 118.79 54.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.0 9.68 0.33 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.415 1.072 . . . . 0.0 112.061 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 59.58 22.85 11.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.307 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.6 t -104.86 -30.42 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.29 159.33 25.66 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.024 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.511 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.3 135.97 54.82 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.64 129.85 53.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.84 0.353 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 43.9 m -107.09 132.89 52.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.116 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -93.6 115.07 27.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.964 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.17 146.43 23.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.9 t -63.82 -14.24 51.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.479 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 6.0 p -86.59 0.37 54.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.104 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.84 13.64 66.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.832 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 955' ' ' LEU . 42.7 t -109.81 123.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 7.1 t-105 -109.42 113.62 26.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 46.4 t -115.28 117.26 55.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 60.5 tt0 -106.52 142.99 35.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.48 160.81 16.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.73 -16.35 63.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.351 0.596 . . . . 0.0 110.127 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -73.9 -1.47 19.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.817 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.72 2.61 89.82 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.104 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.6 m -97.44 151.1 20.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.476 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 1.2 pm0 -133.3 162.45 31.78 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.357 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.23 137.41 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.828 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.433 ' HB ' ' OG ' ' A' ' 927' ' ' SER . 21.2 t -104.67 123.81 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.767 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 30.9 t -117.28 132.77 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.205 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -92.36 138.95 31.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.41 126.84 29.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.006 0.432 . . . . 0.0 111.002 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.53 83.5 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.639 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 925' ' ' SER . 25.3 t -110.17 128.4 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.596 -0.355 . . . . 0.0 110.737 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 32.4 t -89.28 -7.22 55.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.575 ' H ' HG11 ' A' ' 923' ' ' VAL . 23.8 m -90.89 111.97 23.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.673 HD13 HD13 ' A' ' 952' ' ' LEU . 43.1 pt -113.75 165.77 8.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.439 -171.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' A' ' 918' ' ' VAL . 9.1 p -116.97 116.02 26.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.281 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.19 131.07 44.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.758 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.476 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 7.3 m -111.35 124.35 52.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 48.3 t -115.92 127.44 26.77 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.513 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.64 -7.7 7.78 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.21 3.273 . . . . 0.0 112.695 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -54.54 -28.62 46.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.494 0.664 . . . . 0.0 109.572 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 117.07 35.54 1.11 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.327 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.82 140.0 11.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.769 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 7.2 t -104.31 127.31 51.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.273 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 15.0 t -117.92 138.64 52.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.618 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -98.35 130.34 45.01 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.53 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.29 127.41 53.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.8 13.3 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.339 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.0 -25.72 67.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.315 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -94.29 1.55 55.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.24 0.543 . . . . 0.0 110.649 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.8 160.98 16.25 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.034 -0.416 . . . . 0.0 110.974 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -85.31 122.85 30.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.426 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.487 HD22 HG23 ' A' ' 948' ' ' ILE . 82.6 mt -97.43 133.52 23.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.242 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 15.3 Cg_exo -71.21 169.78 19.84 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.092 2.528 . . . . 0.0 112.444 175.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.45 -56.84 16.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -62.2 -32.38 73.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.487 HG23 HD22 ' A' ' 944' ' ' LEU . 47.8 mm -69.91 -43.56 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.919 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -63.53 -44.92 92.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.51 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -61.4 -44.66 96.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.587 ' O ' ' HG ' ' A' ' 955' ' ' LEU . 11.1 mptt -68.98 -40.19 78.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.768 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.673 HD13 HD13 ' A' ' 926' ' ' ILE . 7.8 mp -63.05 -36.75 84.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.937 0.399 . . . . 0.0 110.273 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -70.63 -35.03 72.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.522 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 29.6 p -72.5 -24.63 61.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.795 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.63 ' O ' HG22 ' A' ' 958' ' ' ILE . 92.6 mt -71.53 -15.02 62.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.226 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 45.0 t -56.96 -24.1 50.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.74 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.9 p -63.44 -38.22 90.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 955' ' ' LEU . 15.8 tt -69.31 -35.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.51 -43.55 98.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.65 -34.99 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.033 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' MET . . . . . 0.704 ' HA ' ' HG3' ' A' ' 965' ' ' PRO . 15.4 tmm? -67.54 -27.02 66.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 110.288 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -89.01 -7.11 56.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.243 0.544 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 11.4 t -95.13 14.25 22.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.159 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.18 91.0 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.997 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.704 ' HG3' ' HA ' ' A' ' 961' ' ' MET . 6.3 Cg_endo -85.45 95.74 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.796 2.33 . . . . 0.0 111.419 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 29.6 m -134.91 86.44 32.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.009 0.433 . . . . 0.0 111.009 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.57 -7.75 9.62 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.128 2.552 . . . . 0.0 111.098 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.22 23.44 6.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.386 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -51.79 138.4 23.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.445 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 45.4 m80 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.557 -176.079 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 41.9 m -87.96 7.35 31.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.579 0.228 . . . . 0.0 110.86 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 66.82 9.97 7.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.911 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -113.01 86.89 2.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.857 0.36 . . . . 0.0 110.147 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 887' ' ' LEU . 0.9 OUTLIER -81.98 127.07 32.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.691 177.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.9 129.7 38.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.358 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 901' ' ' GLN . 3.4 mppt? 61.29 74.17 0.45 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.088 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' A' ' 887' ' ' LEU . 15.7 p -98.64 144.36 28.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.952 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . 0.715 ' HB ' ' HB1' ' A' ' 899' ' ' ALA . 60.6 t -126.23 140.25 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.679 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . 0.618 ' HD1' ' HE3' ' A' ' 898' ' ' TRP . 78.0 m-85 -106.6 119.99 40.77 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 894' ' ' LYS . 97.3 t -108.76 117.79 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.428 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.435 ' HD3' HG11 ' A' ' 893' ' ' VAL . 2.0 mptm? 54.12 3.87 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.371 1.068 . . . . 0.0 112.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.82 23.98 12.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.196 0.599 . . . . 0.0 110.12 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.34 -29.75 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.96 158.25 25.12 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.985 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.618 ' HE3' ' HD1' ' A' ' 892' ' ' PHE . 0.5 OUTLIER -121.81 136.43 54.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 891' ' ' VAL . . . -109.61 132.42 54.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' THR . . . . . 0.679 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 8.1 m -101.87 125.84 48.64 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 889' ' ' LYS . 28.2 mm-40 -94.99 116.51 28.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.007 0.432 . . . . 0.0 110.981 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.13 129.04 49.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.888 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.9 t -67.53 -4.61 12.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.384 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 33.5 t -85.71 -0.09 54.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.69 62.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.319 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.65 138.7 31.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 919' ' ' VAL . 44.0 t -112.4 122.97 67.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.679 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 3.1 t-105 -110.27 118.77 37.23 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.1 t -107.21 125.96 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.035 0.445 . . . . 0.0 111.08 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.509 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 76.7 mm-40 -103.46 143.28 32.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.572 173.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.68 167.15 9.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.73 0.3 . . . . 0.0 110.481 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -63.41 -26.43 68.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.75 0.08 55.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.061 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.54 72.34 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.279 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 18.1 m -75.74 153.29 37.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.721 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 47.4 mt-30 -132.03 153.57 50.26 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.058 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.771 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 8.7 mp -130.73 135.36 47.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.141 171.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 927' ' ' SER . 47.4 t -113.34 121.71 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 907' ' ' VAL . 48.2 t -118.08 130.84 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.695 0.284 . . . . 0.0 110.575 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -93.23 139.86 30.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.24 129.52 21.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.072 0.463 . . . . 0.0 111.114 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.16 61.37 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.479 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 923' ' ' VAL . 12.6 t 57.54 34.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.949 0.88 . . . . 0.0 110.317 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.9 m -74.02 -17.53 60.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.34 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 48.3 p -169.64 135.08 1.47 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.343 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.62 144.23 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.575 ' HB3' ' HB ' ' A' ' 918' ' ' VAL . 23.0 t -118.65 117.44 28.96 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -96.76 127.43 42.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.721 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 63.5 m -113.07 121.44 44.6 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.585 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 59.5 p -127.84 103.37 21.52 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.23 -12.4 30.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.265 2.643 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -81.76 -10.51 59.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.042 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -151.68 -68.36 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -171.13 164.57 7.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.214 0.507 . . . . 0.0 111.272 -166.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.645 HG23 HG23 ' A' ' 929' ' ' THR . 39.9 p -104.07 123.85 47.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.7 m -120.47 129.2 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.605 0.241 . . . . 0.0 111.108 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.665 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -98.44 128.56 44.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 110.151 178.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.8 128.0 54.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.384 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.66 166.34 27.72 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.91 -20.54 65.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.0 111.161 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -92.97 2.82 56.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.801 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -96.75 -178.84 4.38 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -100.56 128.42 46.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 945' ' ' PRO . 5.5 tp -92.29 132.74 31.37 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.942 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.752 ' HB2' HD12 ' A' ' 948' ' ' ILE . 37.1 Cg_exo -61.84 152.46 74.5 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.484 2.122 . . . . 0.0 111.435 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -52.99 -64.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.525 0.515 . . . . 0.0 111.922 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -59.91 -32.18 70.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.645 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 945' ' ' PRO . 2.4 mp -69.55 -42.81 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -40.94 97.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.941 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -42.37 93.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.361 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.971 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 4.5 mmpt? -64.94 -43.45 92.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.211 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.44 -36.62 84.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 110.865 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 953' ' ' GLN . 1.0 OUTLIER -66.95 -34.42 77.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.832 177.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.06 -28.78 64.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.164 0.506 . . . . 0.0 109.893 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 951' ' ' LYS . 7.9 mp -73.84 -30.99 62.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.225 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 46.1 t -58.58 -39.59 80.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.311 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 28.4 t -66.34 -38.3 87.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 110.009 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.96 -41.21 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.555 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.56 -41.31 97.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.49 -40.03 96.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.548 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 53.9 tpp -70.1 -24.76 63.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.888 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -83.61 -5.84 59.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.487 0.661 . . . . 0.0 110.16 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 10.7 t -87.65 13.96 9.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.479 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 963' ' ' SER . 25.6 m-80 72.98 149.88 0.13 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.791 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.473 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 36.0 Cg_endo -66.31 117.29 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.614 2.209 . . . . 0.0 112.268 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 55.2 m -88.56 104.1 6.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 965' ' ' PRO . 86.5 Cg_endo -85.63 151.78 10.19 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.564 2.176 . . . . 0.0 113.167 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -85.75 0.1 53.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.386 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.28 124.22 22.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.118 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 48.7 m80 . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.124 179.077 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 18.6 p -76.95 153.98 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.37 0.129 . . . . 0.0 110.954 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 61.73 81.4 0.2 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.872 0.732 . . . . 0.0 111.353 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.44 -64.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.645 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 8.0 mp 56.17 56.23 6.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.917 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.45 -166.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -86.35 10.94 13.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.39 0.614 . . . . 0.0 110.157 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 43.5 m -106.96 144.81 33.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.676 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . 0.59 ' HB ' ' HB1' ' A' ' 899' ' ' ALA . 88.7 t -114.43 139.56 39.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -106.66 119.97 40.72 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.106 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 895' ' ' ASN . 48.7 t -103.23 120.21 52.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.637 ' HB3' HG13 ' A' ' 896' ' ' VAL . 53.0 tttm 56.98 3.71 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.367 1.042 . . . . 0.0 111.358 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 893' ' ' VAL . 2.7 t30 60.03 23.65 12.83 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.994 0.918 . . . . 0.0 109.787 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 894' ' ' LYS . 13.1 p -104.7 -28.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.225 173.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.77 159.05 24.87 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.841 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.97 136.03 54.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.59 ' HB1' ' HB ' ' A' ' 891' ' ' VAL . . . -107.29 131.69 53.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 4.2 m -115.14 132.86 56.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.71 116.04 25.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.341 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.29 142.24 40.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.648 0.261 . . . . 0.0 110.389 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.7 p -68.14 -8.62 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.697 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 44.6 t -80.95 -0.8 41.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.223 0.535 . . . . 0.0 110.163 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.94 4.42 87.1 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.66 139.33 30.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.813 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.65 122.58 56.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.483 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 6.5 t-105 -100.66 114.11 27.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.008 -176.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 48.4 t -104.04 115.98 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 110.036 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.841 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 37.3 mt-30 -106.17 142.96 34.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.711 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.462 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 44.8 m-85 -97.24 160.1 14.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.86 -25.78 68.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.471 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -86.38 2.18 48.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.354 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 93.79 5.05 63.14 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.361 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 45.5 m -84.33 152.12 24.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.635 0.718 . . . . 0.0 109.274 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.68 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 40.3 mt-30 -132.47 153.38 50.95 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.799 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.623 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 9.7 mp -130.59 136.24 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.13 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 41.5 t -113.12 120.43 63.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 926' ' ' ILE . 42.9 t -119.35 132.02 70.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -90.27 137.93 31.94 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.55 126.77 28.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.52 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.4 -0.42 83.28 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.258 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.68 HG11 ' H ' ' A' ' 925' ' ' SER . 54.5 t -115.06 138.05 46.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.234 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 3.1 p -91.24 -6.13 53.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.68 ' H ' HG11 ' A' ' 923' ' ' VAL . 39.3 m -90.45 138.74 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.643 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 952' ' ' LEU . 2.9 mp -118.02 146.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.495 -175.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.675 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 16.0 m -110.68 116.29 31.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 936' ' ' THR . 24.2 t80 -96.42 126.24 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.68 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 47.2 m -113.71 122.8 48.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.09 0.471 . . . . 0.0 111.329 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 10.3 p -122.99 120.35 27.55 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.271 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 -2.13 5.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.399 2.732 . . . . 0.0 112.181 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -59.17 -22.86 61.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.41 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.05 0.87 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.109 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -157.77 133.29 9.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.209 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -105.89 126.87 52.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 166.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 936' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 928' ' ' TYR . 4.3 t -118.32 128.74 54.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.391 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -103.24 130.79 50.56 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.403 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -108.91 138.76 44.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.726 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -115.76 156.37 15.68 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.146 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -7.2 26.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.771 0.319 . . . . 0.0 111.855 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.34 0.68 40.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.428 0.632 . . . . 0.0 110.209 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 17.2 pt-20 -132.66 -171.95 2.79 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -95.42 122.4 38.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.975 0.417 . . . . 0.0 109.929 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.22 138.42 45.49 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.788 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.689 ' HG2' HD12 ' A' ' 948' ' ' ILE . 48.4 Cg_exo -57.58 142.2 95.5 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.535 2.156 . . . . 0.0 111.231 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -43.24 -63.3 0.84 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.038 0.836 . . . . 0.0 112.935 -172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -67.89 -28.24 67.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.689 HD12 ' HG2' ' A' ' 945' ' ' PRO . 59.1 mt -69.72 -44.98 78.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.69 -38.12 88.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.075 0.464 . . . . 0.0 109.985 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . 0.588 ' O ' ' HG3' ' A' ' 953' ' ' GLN . 17.2 tm0? -60.16 -42.65 95.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.074 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 1.087 ' HA ' ' HE3' ' A' ' 951' ' ' LYS . 0.0 OUTLIER -69.86 -37.94 76.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.442 0.639 . . . . 0.0 110.003 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.626 HD21 HD12 ' A' ' 926' ' ' ILE . 62.7 tp -57.58 -36.9 72.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 950' ' ' GLN . 4.9 pp0? -69.61 -21.15 63.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.32 -28.04 65.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.023 0.44 . . . . 0.0 109.981 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.98 -31.47 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.288 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 956' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 55.8 m -59.7 -39.02 83.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 961' ' ' MET . 21.9 t -65.69 -38.14 88.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 109.966 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.44 -40.24 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.866 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.39 -39.59 91.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.568 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 956' ' ' SER . 93.5 mt -64.11 -35.02 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.374 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 957' ' ' SER . 93.8 mmm -63.59 -25.51 68.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.282 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.15 -2.65 58.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.145 0.498 . . . . 0.0 110.621 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 42.6 t -94.08 14.51 19.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.084 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . 0.478 ' HB3' ' HD2' ' A' ' 965' ' ' PRO . 44.8 m-80 69.53 170.67 0.11 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.679 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 964' ' ' ASN . 50.5 Cg_exo -54.77 96.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.924 1.749 . . . . 0.0 111.233 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 27.6 m -98.21 115.63 65.72 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.901 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 966' ' ' THR . 8.2 Cg_exo -71.77 102.33 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.492 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.61 0.16 47.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 110.439 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -97.14 165.21 12.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.011 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.3 t -97.15 122.67 40.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -70.45 143.43 51.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.505 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -72.84 132.41 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.93 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.19 -13.13 62.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 888' ' ' LEU . 3.8 mm? -74.38 -10.31 59.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.925 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -94.1 -10.49 33.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.091 0.472 . . . . 0.0 110.393 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 31.0 p -108.31 144.77 35.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.228 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.06 140.13 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.08 125.17 47.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' A' ' 954' ' ' CYS . 23.2 m -109.76 121.18 62.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 120.834 0.35 . . . . 0.0 110.83 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.697 ' HB2' HG11 ' A' ' 896' ' ' VAL . 71.8 mmtt 58.62 -1.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.709 0.804 . . . . 0.0 112.675 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 893' ' ' VAL . 65.2 t30 60.46 22.64 12.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.942 0.877 . . . . 0.0 109.154 -167.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 894' ' ' LYS . 9.9 p -104.09 -24.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.096 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . 0.4 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -140.78 159.75 26.5 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.057 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.719 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.0 OUTLIER -120.82 135.3 55.2 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 173.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.38 131.45 56.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 9.1 m -110.41 125.24 53.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.835 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -82.44 115.93 21.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.878 0.37 . . . . 0.0 110.022 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 906' ' ' ALA . 77.1 mt -90.74 149.79 21.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.079 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 13.2 t -66.91 -15.89 63.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.009 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.0 m -80.13 0.26 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 110.734 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.87 87.71 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.715 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 902' ' ' LEU . . . -91.3 157.54 17.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.341 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.61 123.48 71.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.808 0.337 . . . . 0.0 110.223 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -98.12 113.42 25.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.94 117.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.032 0.444 . . . . 0.0 110.615 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.719 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 8.3 tt0 -94.38 143.13 26.66 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.5 ' HD2' ' H ' ' A' ' 913' ' ' ASP . 25.7 t80 -93.51 148.6 21.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -55.13 -25.45 31.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . 0.5 ' H ' ' HD2' ' A' ' 911' ' ' PHE . 19.8 t70 -86.24 0.35 53.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.49 5.74 60.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.407 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 50.3 m -85.3 164.1 18.2 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -125.01 151.95 44.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.41 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.594 ' CD2' HG23 ' A' ' 919' ' ' VAL . 10.4 tt -141.49 135.0 29.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 51.2 t -115.98 122.57 69.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 122.384 -0.198 . . . . 0.0 111.209 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.594 HG23 ' CD2' ' A' ' 917' ' ' LEU . 76.4 t -120.07 134.27 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.531 0.205 . . . . 0.0 111.037 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -89.81 136.97 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -62.9 126.9 28.89 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.161 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.2 -2.49 85.29 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.672 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 925' ' ' SER . 54.4 t -106.01 137.61 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.754 0.312 . . . . 0.0 110.865 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.5 m -78.26 -15.89 58.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.739 ' H ' HG13 ' A' ' 923' ' ' VAL . 34.1 m -85.61 117.18 24.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -113.24 145.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.113 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 21.5 m -113.63 116.39 29.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -106.09 128.63 54.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 20.2 m -112.51 121.68 45.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.126 0.489 . . . . 0.0 110.886 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 930' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 931' ' ' PRO . 73.5 m -99.77 165.16 15.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.745 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 930' ' ' SER . 72.5 Cg_exo -49.74 156.68 2.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.027 2.485 . . . . 0.0 112.664 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 931' ' ' PRO . 14.6 m120 75.01 5.35 4.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 75.44 50.42 8.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.991 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.05 101.06 9.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -100.59 129.18 46.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.428 0.632 . . . . 0.0 111.103 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 32.0 p -116.88 141.4 48.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.448 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -101.55 126.51 48.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.251 0.548 . . . . 0.0 110.698 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' A' ' 944' ' ' LEU . 90.2 m-85 -109.91 138.22 46.58 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -154.09 -160.31 9.72 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 119.128 -1.51 . . . . 0.0 113.927 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.03 -27.1 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.432 -0.884 . . . . 0.0 112.441 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.46 1.2 56.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.176 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -132.6 -177.15 4.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -99.23 138.18 36.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 948' ' ' ILE . 63.6 mt -95.22 133.1 26.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.472 ' HB2' HD12 ' A' ' 948' ' ' ILE . 18.3 Cg_exo -67.44 154.79 72.76 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.883 2.388 . . . . 0.0 111.044 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.78 -37.52 87.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.46 -33.47 75.95 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.436 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.622 HG23 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -70.98 -39.55 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.994 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . 0.581 ' HE3' ' HB2' ' A' ' 944' ' ' LEU . 33.0 mmtp -56.93 -43.8 81.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.319 0.581 . . . . 0.0 109.714 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.55 -42.32 98.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.341 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 67.3 mmtt -62.51 -43.18 99.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.77 -32.43 72.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.748 0.308 . . . . 0.0 110.498 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.49 -34.84 77.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . 0.518 ' HB3' HG11 ' A' ' 893' ' ' VAL . 59.2 m -70.32 -26.64 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.1 mm? -72.36 -14.5 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.767 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 37.3 m -56.6 -31.22 64.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.4 p -64.09 -40.64 96.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -173.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 955' ' ' LEU . 16.2 tt -70.55 -35.51 61.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.222 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.82 -43.93 97.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.23 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.27 -37.18 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 49.5 tpp -66.56 -28.15 68.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 111.021 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -94.12 3.88 54.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.442 . . . . 0.0 110.999 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 32.7 t -93.67 2.44 56.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.273 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 44.3 t30 69.95 119.36 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.724 0.64 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.37 -25.29 56.42 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.098 2.532 . . . . 0.0 112.816 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 88.1 m -88.42 119.04 70.09 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.67 178.07 3.6 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -87.03 19.33 3.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.366 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 70.15 -53.85 0.63 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.787 0.835 . . . . 0.0 110.818 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 67.7 t60 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.687 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 14.9 m -75.78 -70.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.829 0.347 . . . . 0.0 110.967 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -113.67 178.43 4.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.764 -176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -66.11 129.36 39.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.692 HD21 ' H ' ' A' ' 887' ' ' LEU . 2.3 pt? -76.64 18.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.304 -173.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 888' ' ' LEU . 4.1 mm? -98.3 -23.57 15.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.285 175.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -105.61 -48.0 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.629 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 887' ' ' LEU . 8.9 m -104.21 142.46 34.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.89 139.6 40.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.1 127.71 36.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 954' ' ' CYS . 80.7 t -114.14 119.54 61.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm 59.18 7.52 0.89 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.369 1.043 . . . . 0.0 111.194 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.63 20.45 9.07 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.926 0.89 . . . . 0.0 110.758 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 41.6 t -107.2 -29.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.337 0.589 . . . . 0.0 110.364 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.96 163.04 26.32 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.467 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.464 ' CD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -121.41 136.94 54.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -116.36 133.87 55.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.751 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 21.0 m -101.09 125.28 47.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.675 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.45 120.92 37.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.886 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 906' ' ' ALA . 7.4 mp -98.44 144.45 27.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.634 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 15.9 m -67.28 -16.48 64.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.0 p -82.58 0.93 40.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.229 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.86 12.15 62.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.645 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.44 138.4 31.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.16 121.64 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.494 ' CZ2' ' HG2' ' A' ' 916' ' ' GLN . 30.2 t90 -110.63 113.39 25.96 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.17 116.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.756 0.313 . . . . 0.0 110.951 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 898' ' ' TRP . 35.7 tt0 -105.64 142.85 34.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.447 ' HE2' HD13 ' A' ' 917' ' ' LEU . 38.9 m-85 -88.09 160.64 17.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.598 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -63.81 -16.72 61.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.781 0.801 . . . . 0.0 108.865 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.84 -0.25 42.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.14 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.19 5.98 86.82 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.628 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 2.0 p -97.78 153.38 18.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.048 0.424 . . . . 0.0 110.132 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.494 ' HG2' ' CZ2' ' A' ' 908' ' ' TRP . 0.3 OUTLIER -125.78 154.48 42.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.281 -175.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.447 HD13 ' HE2' ' A' ' 911' ' ' PHE . 5.5 mp -127.78 132.83 49.47 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 119.06 60.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.089 170.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 926' ' ' ILE . 7.8 p -124.66 132.83 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.501 170.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.568 ' O ' HG22 ' A' ' 923' ' ' VAL . 25.6 tt0 -94.61 139.86 30.63 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 170.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.03 39.99 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.552 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 105.43 -6.15 41.76 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.083 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 920' ' ' GLN . 8.6 m -102.28 155.43 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.456 0.628 . . . . 0.0 110.426 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.4 p -92.2 -4.85 53.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.841 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 12.9 p -133.54 135.89 44.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.281 0.562 . . . . 0.0 111.763 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 919' ' ' VAL . 4.4 mp -111.42 146.68 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.779 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 20.0 m -108.47 116.76 32.58 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.404 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -96.62 125.38 41.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 934' ' ' GLN . 8.8 t -116.3 135.03 54.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.741 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 20.1 m -103.74 144.28 28.35 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.795 171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.84 -7.72 1.76 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 124.127 3.218 . . . . 0.0 114.493 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -16.96 62.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 99.12 28.69 7.56 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 929' ' ' THR . 43.1 tt0 -104.64 110.32 22.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.758 -174.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.434 HG21 ' HB ' ' A' ' 929' ' ' THR . 18.2 p -103.54 125.52 50.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.61 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 35.5 m -118.21 134.89 54.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -97.79 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 0.0 110.899 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -112.05 134.82 53.37 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.667 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . 0.759 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -153.07 -165.7 13.71 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.968 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.11 -27.28 67.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.791 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -97.69 -0.84 44.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.449 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . 0.759 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 8.7 mm-40 -116.97 109.68 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.05 138.94 46.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.396 0.617 . . . . 0.0 112.008 -169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.586 ' CB ' ' HB3' ' A' ' 949' ' ' LYS . 3.3 mm? -94.11 133.82 26.86 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.531 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.6 -70.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 111.806 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.29 -77.69 0.1 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -56.8 -32.75 66.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.572 ' HB ' HD11 ' A' ' 944' ' ' LEU . 26.4 mm -70.3 -45.11 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.996 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . 0.586 ' HB3' ' CB ' ' A' ' 944' ' ' LEU . 11.8 pttm -66.66 -36.63 83.0 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.568 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.05 -40.8 90.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.912 0.387 . . . . 0.0 110.501 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -66.89 -43.79 82.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 87.4 mt -65.14 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.002 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -61.65 -33.7 74.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.001 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 893' ' ' VAL . 16.7 t -71.47 -24.89 62.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.411 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.14 -16.55 62.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.446 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 50.2 m -58.62 -23.97 60.02 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.043 0.449 . . . . 0.0 111.287 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 5.9 m -59.38 -34.27 72.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.177 0.513 . . . . 0.0 110.339 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.4 -38.22 80.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.63 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.86 -42.45 97.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.536 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.82 -34.82 78.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.887 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 88.3 mtp -64.96 -25.67 67.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.709 0.29 . . . . 0.0 111.043 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -86.41 -0.45 55.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 110.929 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 23.1 t -91.96 11.75 24.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -73.51 122.52 87.82 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.971 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -90.45 101.81 0.28 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.728 2.285 . . . . 0.0 112.895 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 28.8 m -110.45 101.79 49.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.87 5.66 3.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.983 2.455 . . . . 0.0 113.334 -173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.76 -2.09 57.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.139 0.495 . . . . 0.0 110.281 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.71 132.78 55.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.97 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.608 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 20.3 m -85.69 134.64 33.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.867 0.365 . . . . 0.0 110.675 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -75.13 99.71 4.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.771 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 888' ' ' LEU . 15.4 mm100 -84.31 112.6 20.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 890' ' ' SER . 37.2 tp -91.93 73.85 5.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.362 0.601 . . . . 0.0 110.562 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 886' ' ' GLN . 8.0 mp -121.34 107.33 12.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.669 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.2 mttm 55.89 34.72 24.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.307 0.575 . . . . 0.0 110.79 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.514 ' HB2' HD12 ' A' ' 887' ' ' LEU . 22.9 m -106.8 143.62 34.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.003 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.53 155.38 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.041 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -99.53 130.74 45.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 895' ' ' ASN . 5.9 p -105.39 121.13 57.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.057 0.456 . . . . 0.0 110.27 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.673 ' HB3' HG13 ' A' ' 896' ' ' VAL . 14.4 tmtt? 61.68 -1.44 0.33 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.747 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 893' ' ' VAL . 19.5 t-20 61.3 23.7 13.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.842 0.829 . . . . 0.0 109.409 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' A' ' 894' ' ' LYS . 12.4 p -105.84 -27.89 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -136.01 160.6 24.68 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.812 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.629 ' HB2' ' HG3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.9 136.77 54.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.61 130.38 56.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 32.4 m -115.64 135.83 53.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.981 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -95.03 125.35 39.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.162 0.506 . . . . 0.0 110.118 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.76 146.99 24.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.746 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.4 m -65.13 -20.33 66.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.626 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 0.12 33.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.153 0.502 . . . . 0.0 110.698 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.09 8.88 68.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.444 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.24 148.52 22.87 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.567 ' HB ' HG11 ' A' ' 919' ' ' VAL . 47.4 t -110.37 124.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -104.31 114.56 28.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.06 120.14 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.457 0.646 . . . . 0.0 110.817 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.77 ' HB3' HE22 ' A' ' 916' ' ' GLN . 1.1 pt20 -104.65 143.26 33.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -119.6 157.93 27.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.092 0.472 . . . . 0.0 111.763 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.3 -17.9 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -77.4 1.44 19.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.635 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.62 8.4 84.73 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 5.8 p -98.23 153.47 18.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.768 0.318 . . . . 0.0 111.198 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.77 HE22 ' HB3' ' A' ' 910' ' ' GLN . 12.5 mm100 -122.78 150.88 42.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.983 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.575 HD13 ' C ' ' A' ' 916' ' ' GLN . 7.1 mp -138.69 133.81 32.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.5 p -116.83 123.94 72.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 168.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.59 HG21 HG21 ' A' ' 923' ' ' VAL . 2.2 p -117.86 138.27 49.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -93.48 150.62 20.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -49.81 128.38 18.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . 0.508 ' O ' HG13 ' A' ' 923' ' ' VAL . . . 99.48 -8.35 60.22 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.776 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.59 HG21 HG21 ' A' ' 919' ' ' VAL . 0.8 OUTLIER 58.2 2.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.238 1.415 . . . . 0.0 113.947 172.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 47.4 m -74.76 -5.66 44.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.152 -0.343 . . . . 0.0 111.639 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 1.9 p -142.01 114.79 8.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.962 0.41 . . . . 0.0 111.318 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.551 HG21 ' HB ' ' A' ' 919' ' ' VAL . 0.2 OUTLIER -126.99 145.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.368 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.527 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 20.1 m -118.24 122.46 43.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -97.34 129.96 44.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 34.2 m -111.7 121.87 46.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 25.8 m -97.24 135.47 21.86 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.581 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.03 -13.99 17.33 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 113.205 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.48 -25.79 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 109.667 174.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 106.15 35.53 2.92 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -126.8 116.54 21.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.999 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 36.6 p -105.31 126.46 52.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.3 m -117.79 128.66 55.08 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -98.37 126.58 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 110.358 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -112.52 131.12 55.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.44 170.97 16.9 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.62 -20.63 66.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.299 0.55 . . . . 0.0 110.692 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.17 -0.65 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -108.21 147.83 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -99.93 130.97 46.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 111.13 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.1 133.6 72.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.63 -68.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.562 2.174 . . . . 0.0 111.939 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.94 -70.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.751 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -58.62 -29.67 66.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 25.9 mm -67.61 -43.66 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.77 -39.42 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.271 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.08 -43.18 91.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.743 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 9.7 mmpt? -68.29 -41.58 80.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.54 -34.99 79.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.697 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.86 -25.66 68.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.626 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.0 -23.15 65.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.72 -17.59 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.1 m -58.42 -31.55 67.83 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.651 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 16.4 m -60.7 -36.5 78.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 893' ' ' VAL . 50.6 mm -67.95 -39.4 81.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.047 0.451 . . . . 0.0 109.924 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 63.0 tp -60.85 -43.28 98.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.51 -37.23 84.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 25.7 ttt -66.9 -26.33 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 0.0 110.63 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.82 -5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.32 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 46.6 t -93.89 6.1 49.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 963' ' ' SER . 5.3 m-20 73.76 148.0 0.12 Allowed Pre-proline 0 N--CA 1.469 0.5 0 O-C-N 123.785 0.678 . . . . 0.0 111.276 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.58 99.11 1.03 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.532 2.155 . . . . 0.0 112.711 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 99.3 m -89.23 114.81 61.8 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.87 69.74 6.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.947 2.431 . . . . 0.0 111.176 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -86.15 0.39 53.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.273 0.559 . . . . 0.0 110.78 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -126.87 148.29 50.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 80.8 m80 . . . . . 0 C--N 1.322 -0.624 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.297 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 21.8 t -86.8 -20.23 27.86 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.752 -0.263 . . . . 0.0 111.061 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -84.24 -13.5 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -108.04 107.57 18.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.534 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.434 ' HB3' ' CB ' ' A' ' 890' ' ' SER . 92.0 mt -98.46 108.34 21.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 112.034 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 889' ' ' LYS . 2.9 mm? -109.59 136.35 49.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.362 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 888' ' ' LEU . 4.8 mptp? 69.77 21.73 6.33 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.709 0.631 . . . . 0.0 110.325 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 887' ' ' LEU . 10.1 m -106.96 147.55 29.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.928 -178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.03 139.97 45.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -98.91 131.34 45.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.72 120.77 64.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 58.09 4.63 0.32 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.112 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 59.8 23.12 12.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.136 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 95.2 t -104.8 -31.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.44 158.53 25.49 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.172 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.5 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -123.27 134.96 54.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.29 130.83 53.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.112 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.2 m -115.98 125.73 52.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.39 115.66 21.52 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 906' ' ' ALA . 84.3 mt -86.3 148.3 25.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.372 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 2.4 p -67.37 -9.58 42.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.74 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 14.3 m -87.54 1.14 54.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.92 4.53 82.07 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.146 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 902' ' ' LEU . . . -91.2 152.6 20.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.7 123.71 64.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.498 ' HD1' HG23 ' A' ' 918' ' ' VAL . 38.6 t90 -106.83 112.91 26.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 7.7 p -115.51 118.82 59.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 111.151 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.5 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 46.7 tt0 -102.34 142.47 33.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.931 175.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -112.06 160.05 17.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.694 0.283 . . . . 0.0 110.876 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.38 -17.62 54.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.774 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.82 1.43 12.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.366 0.603 . . . . 0.0 110.654 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.22 4.59 88.06 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.975 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.4 t -99.48 155.58 17.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.557 ' HB2' ' HG1' ' A' ' 929' ' ' THR . 15.4 mp0 -130.74 151.7 50.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.9 HD23 ' HD1' ' A' ' 928' ' ' TYR . 1.5 mt -133.62 136.01 44.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.498 HG23 ' HD1' ' A' ' 908' ' ' TRP . 25.2 t -113.6 119.58 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.603 HG23 HG12 ' A' ' 926' ' ' ILE . 6.7 p -120.14 133.65 66.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 0.0 110.591 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.05 143.98 31.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.42 129.69 22.33 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.587 0.554 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 103.12 -8.13 53.09 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.459 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 923' ' ' VAL . 13.7 t 48.49 44.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.953 0.882 . . . . 0.0 111.279 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 5.7 p -82.72 -23.76 33.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.889 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 63.8 m -162.16 130.53 4.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.256 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.603 HG12 HG23 ' A' ' 919' ' ' VAL . 16.3 mt -119.15 145.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.024 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.6 m -118.01 117.35 28.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.9 ' HD1' HD23 ' A' ' 917' ' ' LEU . 41.8 m-85 -99.02 130.05 45.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.557 ' HG1' ' HB2' ' A' ' 916' ' ' GLN . 22.8 p -112.26 122.3 47.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 0.0 110.733 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 930' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 45.3 m -140.2 109.75 6.97 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.11 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 20.8 Cg_endo -60.99 -16.74 47.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.243 2.629 . . . . 0.0 112.61 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -74.89 -10.17 59.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.25 -68.1 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . 0.691 ' HG2' ' H ' ' A' ' 935' ' ' THR . 29.8 tt0 169.14 -168.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.691 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 10.0 t -105.33 128.85 53.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.94 0.4 . . . . 0.0 110.279 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 936' ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' ' 928' ' ' TYR . 10.0 t -117.02 142.11 47.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.71 128.66 54.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.1 0.476 . . . . 0.0 111.204 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.515 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 53.2 t80 -109.57 128.06 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.114 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -112.37 162.54 12.36 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.69 -5.7 4.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.478 0.639 . . . . 0.0 112.077 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.85 4.65 49.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.425 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . 0.453 ' OE1' ' HD3' ' A' ' 943' ' ' LYS . 6.7 tp10 -122.98 162.2 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 943' ' ' LYS . 0.0 OUTLIER -99.92 138.81 36.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.023 176.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 948' ' ' ILE . 60.7 mt -97.06 140.6 22.18 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.826 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.18 165.37 24.52 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.806 2.337 . . . . 0.0 111.254 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . 0.535 ' O ' ' HG3' ' A' ' 950' ' ' GLN . 58.0 m-20 -53.47 -56.91 12.96 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -61.22 -34.18 74.7 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 944' ' ' LEU . 3.2 mp -69.53 -43.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.69 -40.2 96.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.681 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 946' ' ' ASP . 97.0 mt-30 -61.46 -44.47 97.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.991 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -69.31 -39.91 77.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.292 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.66 -36.79 85.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.331 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -64.58 -24.91 67.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 83.3 m -69.31 -22.29 63.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.635 ' HA ' HD12 ' A' ' 958' ' ' ILE . 4.1 mm? -69.89 -15.97 63.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.163 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 9.0 t -58.14 -36.24 72.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.49 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 23.1 t -65.71 -37.63 86.96 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 955' ' ' LEU . 3.4 mp -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.971 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 59.8 tp -66.72 -39.76 88.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.801 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 46.1 tpp -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.503 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -77.91 -5.89 52.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 14.2 t -88.09 4.19 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 8.9 t30 63.65 89.18 0.11 Allowed Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.549 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.45 123.18 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.778 2.319 . . . . 0.0 112.029 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 26.6 m -119.9 89.07 41.51 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.056 0.455 . . . . 0.0 110.33 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.0 49.02 3.05 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.067 2.511 . . . . 0.0 113.014 -176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.98 0.28 57.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 0.0 110.249 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.94 160.46 39.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.53 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 9.2 m -96.83 -45.42 6.65 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -97.46 -21.71 16.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.527 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -83.71 122.4 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.245 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.96 133.64 36.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.07 123.99 44.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.66 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -82.91 -14.85 53.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.748 0.309 . . . . 0.0 110.98 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 39.9 m -91.16 142.89 27.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 34.7 t -125.47 141.41 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -89.1 132.14 34.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.0 121.09 56.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.427 ' HB2' HG12 ' A' ' 896' ' ' VAL . 42.8 mtmt 52.13 11.78 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 59.76 22.47 11.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.438 0.695 . . . . 0.0 110.735 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 894' ' ' LYS . 14.9 p -105.4 -29.06 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.54 162.24 26.16 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.13 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.768 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.3 m95 -118.73 136.09 54.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.91 130.14 54.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.876 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.8 m -117.58 125.31 50.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.253 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -92.0 116.02 28.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.38 152.55 20.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 19.1 p -67.0 -20.06 65.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.538 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 16.2 m -84.88 3.57 37.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 85.2 11.12 76.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.4 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.06 148.91 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.88 122.89 68.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -108.49 113.64 26.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 39.9 t -115.8 117.75 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 110.768 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.768 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 17.7 mp0 -101.71 148.8 24.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.419 ' HE2' HD23 ' A' ' 917' ' ' LEU . 57.2 m-85 -118.52 159.75 22.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.946 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.1 -17.05 63.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.89 1.53 17.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.651 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.97 5.53 87.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.14 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.2 m -97.21 156.87 16.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 79.4 mt-30 -123.15 152.43 41.17 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.731 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 916' ' ' GLN . 10.6 mp -133.96 136.3 44.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 36.4 t -112.52 121.15 64.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.93 138.54 49.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -92.58 137.15 32.61 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.73 127.96 33.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.538 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.47 84.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.456 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 925' ' ' SER . 8.4 t -122.53 146.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 117.334 0.567 . . . . 0.0 110.331 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.0 t -86.06 -6.62 58.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.492 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.518 ' H ' HG11 ' A' ' 923' ' ' VAL . 59.6 p -74.1 121.13 20.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 110.287 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 926' ' ' ILE . 0.2 OUTLIER -124.39 146.91 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.825 -177.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 31.7 m -107.86 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.99 128.32 42.77 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 27.3 m -113.0 122.05 46.47 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.387 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 930' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 20.2 m -102.93 124.04 40.03 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.352 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 31.6 Cg_exo -60.59 -10.99 15.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.568 2.845 . . . . 0.0 113.426 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.91 -15.45 63.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.26 0.553 . . . . 0.0 110.164 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 111.25 44.29 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.866 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -140.58 111.78 7.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.549 0.214 . . . . 0.0 111.098 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 20.8 m -104.59 123.57 47.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 26.5 m -121.75 128.31 51.61 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 0.1 OUTLIER -104.65 128.87 52.83 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.274 176.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -107.86 127.14 53.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.745 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -94.26 167.54 27.72 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.806 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.27 -27.48 67.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.219 0.533 . . . . 0.0 110.609 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.21 1.92 48.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.24 -173.62 2.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -99.14 119.11 37.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 945' ' ' PRO . 13.3 tp -101.67 131.77 22.51 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.452 ' HD2' HD12 ' A' ' 944' ' ' LEU . 19.2 Cg_exo -68.55 153.53 73.46 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.767 2.312 . . . . 0.0 111.993 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.91 -46.44 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.487 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.14 -32.2 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.774 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.42 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 47.4 mm -69.32 -44.03 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 110.013 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -64.69 -44.18 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.16 -43.65 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -38.61 83.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.546 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 83.1 mt -64.01 -36.39 83.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 110.569 175.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -63.13 -23.08 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.867 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.94 -25.27 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 958' ' ' ILE . 3.8 mm? -71.83 -30.38 65.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 16.4 m -59.22 -24.32 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.943 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 16.4 m -64.78 -39.4 93.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 955' ' ' LEU . 10.9 tp -69.63 -36.46 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.242 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 51.4 tp -62.34 -41.66 98.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.056 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.09 -39.92 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.232 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 23.9 ttt -67.25 -24.34 65.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 110.476 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -89.58 0.23 57.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 7.7 t -78.79 13.88 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.122 0.487 . . . . 0.0 110.712 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.22 77.67 0.33 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.502 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -95.69 19.3 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.244 2.63 . . . . 0.0 111.425 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 26.8 m -106.78 134.77 19.69 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.798 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.18 115.21 2.37 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.593 2.195 . . . . 0.0 111.126 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -78.51 -0.05 27.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.742 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -75.44 -13.27 60.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.101 0.96 . . . . 0.0 112.281 177.684 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 6.5 m -70.06 -38.94 75.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 0.0 111.218 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . 0.588 ' HA ' HD23 ' A' ' 888' ' ' LEU . . . -139.46 108.78 6.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 111.583 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.07 -83.94 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.199 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.97 -16.55 15.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.563 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 885' ' ' ALA . 2.6 pt? -75.33 -19.74 59.45 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.016 -0.273 . . . . 0.0 110.545 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 47.48 67.58 0.79 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.887 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 66.8 m -106.96 144.4 33.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 111.474 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.83 140.0 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.43 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -100.88 124.43 46.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.042 0.449 . . . . 0.0 110.944 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 895' ' ' ASN . 7.0 p -117.07 123.93 72.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.299 -176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 67.63 -7.86 0.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.09 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 893' ' ' VAL . 3.6 m-20 60.51 22.29 12.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.015 0.926 . . . . 0.0 110.089 -168.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.69 -28.65 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.881 171.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . 0.537 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -138.93 158.68 25.27 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.105 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.852 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 0.8 OUTLIER -122.65 136.2 54.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -114.2 130.89 56.62 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.969 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 89.9 m -109.93 124.61 51.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -97.27 115.44 27.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.0 111.224 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.476 HD13 ' HB1' ' A' ' 906' ' ' ALA . 98.0 mt -90.22 130.37 36.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 16.9 m -67.06 -9.29 37.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.088 0.471 . . . . 0.0 111.064 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.4 m -80.68 -0.24 37.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.1 60.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.59 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' A' ' 902' ' ' LEU . . . -91.94 138.71 31.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.66 122.27 69.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.126 0.488 . . . . 0.0 109.844 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -108.4 113.38 26.4 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 955' ' ' LEU . 38.3 t -115.11 118.2 58.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.852 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 11.8 pt20 -103.43 171.32 7.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.798 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -118.44 169.66 9.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -66.19 -17.33 64.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.807 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.66 -0.76 48.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.565 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.2 90.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.017 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 157.6 18.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 910' ' ' GLN . 4.2 pt20 -132.27 154.71 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.583 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 4.6 pp -137.05 137.38 39.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 169.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.16 121.76 65.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.966 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 926' ' ' ILE . 20.5 t -120.73 134.55 63.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.366 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -92.76 139.68 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -58.06 127.12 30.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.93 0.395 . . . . 0.0 111.34 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.48 -6.25 83.35 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.986 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.731 HG11 ' H ' ' A' ' 925' ' ' SER . 46.4 t -99.86 139.56 21.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.996 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.5 p -91.19 -8.37 48.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.404 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.731 ' H ' HG11 ' A' ' 923' ' ' VAL . 14.1 m -93.34 124.84 37.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.472 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.57 HG22 HG21 ' A' ' 919' ' ' VAL . 55.1 mt -114.48 145.8 19.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.675 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 11.0 p -117.67 116.41 26.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.583 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 79.7 t80 -110.96 127.02 55.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.031 0.443 . . . . 0.0 110.17 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.483 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 14.2 m -114.5 121.97 45.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.534 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.5 t -115.91 123.72 30.72 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.317 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.59 -0.97 5.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.349 2.7 . . . . 0.0 112.489 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.62 -6.63 45.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.717 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.05 31.45 4.73 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.122 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -143.69 118.99 10.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.931 0.395 . . . . 0.0 111.828 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 5.5 t -104.57 127.19 52.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 31.8 m -118.59 128.79 54.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 111.393 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -100.55 127.65 46.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.563 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 60.1 t80 -109.1 126.27 53.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.388 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.31 161.11 14.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.78 -4.78 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.986 0.422 . . . . 0.0 112.046 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.76 2.98 56.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.036 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.64 176.03 8.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.05 143.76 29.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.545 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 948' ' ' ILE . 51.6 mt -97.37 147.1 32.48 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.224 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.559 ' HB2' HD13 ' A' ' 948' ' ' ILE . 31.9 Cg_exo -59.23 154.96 42.81 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.454 2.103 . . . . 0.0 110.447 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -57.32 -43.25 83.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -170.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . 0.601 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 85.4 m-85 -68.31 -35.3 77.6 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.324 -176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.644 HG21 HD23 ' A' ' 944' ' ' LEU . 2.5 mp -70.92 -43.36 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 944' ' ' LEU . 18.0 tppt? -63.7 -39.61 94.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -44.55 97.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.777 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 947' ' ' TYR . 13.5 mmmm -65.29 -42.92 92.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 919' ' ' VAL . 3.7 mm? -63.04 -35.71 81.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -69.48 -34.88 74.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.12 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 85.0 m -70.53 -24.72 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.543 HD21 HG23 ' A' ' 909' ' ' VAL . 85.9 mt -70.96 -14.74 62.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 18.0 t -56.85 -38.9 73.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.606 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 17.8 p -66.54 -39.94 88.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.122 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.66 -40.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 109.853 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.03 -40.72 96.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.341 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.11 -40.95 95.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.558 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 15.6 tpt -70.54 -26.56 63.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.136 0.493 . . . . 0.0 110.399 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -85.37 -5.91 59.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 18.0 t -93.34 8.58 39.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.149 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 39.9 m-80 72.64 136.48 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 17.1 Cg_exo -67.08 125.11 13.08 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.668 2.245 . . . . 0.0 112.012 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 3.1 m -94.05 118.65 67.23 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.243 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.83 145.57 40.96 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.427 2.084 . . . . 0.0 112.388 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.22 20.73 9.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -130.19 125.37 34.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 -179.236 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 16.3 m -89.92 126.51 35.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -69.35 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.145 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -165.34 127.28 2.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 110.517 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -122.99 135.62 54.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.409 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 9.3 mp -99.87 148.11 24.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? 63.23 25.33 14.73 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.431 0.457 . . . . 0.0 111.678 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 57.9 p -106.75 141.57 37.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.511 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.7 140.15 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.59 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -106.53 130.51 54.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.962 0.411 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.17 117.94 46.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 45.55 17.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.96 1.412 . . . . 0.0 112.749 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.74 24.38 12.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.4 t -102.09 -30.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.13 157.55 24.95 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.643 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -124.89 136.55 53.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 909' ' ' VAL . . . -124.65 131.78 53.45 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.197 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 17.1 m -105.01 125.54 51.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -85.76 116.66 24.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.23 158.43 23.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.885 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.3 m -66.79 -22.04 66.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.733 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 7.8 t -83.38 0.63 45.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.976 0.417 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.33 4.88 67.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.341 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.07 140.69 29.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 955' ' ' LEU . 36.4 t -106.06 123.55 60.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -102.24 111.96 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.643 HG11 ' HG ' ' A' ' 917' ' ' LEU . 3.2 p -114.51 118.29 58.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.601 0.715 . . . . 0.0 111.119 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 1.013 ' HB3' ' HG2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -106.88 148.02 29.07 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.229 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 951' ' ' LYS . 36.5 m-85 -91.47 175.05 7.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.185 0.517 . . . . 0.0 110.956 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -65.23 -17.39 64.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.698 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.62 -2.44 50.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.37 0.605 . . . . 0.0 111.201 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.01 90.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 63.5 m -95.68 152.29 18.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 1.013 ' HG2' ' HB3' ' A' ' 910' ' ' GLN . 32.0 mt-30 -132.05 154.86 48.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.726 0.298 . . . . 0.0 111.269 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.643 ' HG ' HG11 ' A' ' 909' ' ' VAL . 0.8 OUTLIER -137.83 137.98 38.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.927 0.394 . . . . 0.0 110.003 169.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 15.7 t -104.27 123.39 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.008 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 926' ' ' ILE . 42.5 t -118.21 129.9 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.788 176.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -94.59 139.6 30.98 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.32 127.61 32.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.874 0.369 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.74 83.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.61 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.574 HG11 ' H ' ' A' ' 925' ' ' SER . 30.7 t -115.78 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 122.792 -0.24 . . . . 0.0 110.508 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 35.0 t -91.06 -10.35 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.574 ' H ' HG11 ' A' ' 923' ' ' VAL . 12.5 m -82.61 111.52 18.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.732 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.51 HG23 HD12 ' A' ' 952' ' ' LEU . 40.4 pt -113.3 155.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 0.0 110.918 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 14.4 m -117.49 116.34 26.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.421 ' HE2' ' HE2' ' A' ' 911' ' ' PHE . 39.7 t80 -101.0 124.68 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.0 t -116.31 128.37 55.5 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.065 0.46 . . . . 0.0 110.046 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.2 t -132.88 120.71 16.58 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.43 -12.96 30.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.076 2.518 . . . . 0.0 111.732 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -76.72 -15.87 59.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.097 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.09 -68.38 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . 0.74 ' HG3' ' H ' ' A' ' 935' ' ' THR . 4.0 tp-100 166.1 -164.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.74 ' H ' ' HG3' ' A' ' 934' ' ' GLN . 18.9 m -103.42 127.11 50.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.001 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.6 t -119.06 143.34 47.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.255 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 937' ' ' ARG . 8.1 ptt180 -97.78 135.18 39.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.214 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.477 ' HB3' HD23 ' A' ' 944' ' ' LEU . 76.9 m-85 -110.78 126.88 55.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 170.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -146.21 -170.74 15.05 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.231 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.89 -27.41 68.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.828 0.347 . . . . 0.0 110.832 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.89 1.38 57.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.113 0.483 . . . . 0.0 110.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . 0.599 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 1.3 mp0 -108.07 174.47 5.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.679 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -99.17 124.19 44.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 938' ' ' TYR . 62.5 mt -97.01 131.04 28.47 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.984 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -72.03 154.67 57.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.903 2.402 . . . . 0.0 111.033 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.26 -48.08 82.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.12 -176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . 0.714 ' O ' ' HD3' ' A' ' 951' ' ' LYS . 44.9 m-85 -66.82 -30.67 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.6 -40.81 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.821 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -63.34 -37.63 88.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.004 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -61.08 -44.63 97.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.047 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.714 ' HD3' ' O ' ' A' ' 947' ' ' TYR . 2.3 mptp? -68.61 -42.96 77.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.313 0.578 . . . . 0.0 109.483 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.51 HD12 HG23 ' A' ' 926' ' ' ILE . 62.1 tp -59.38 -38.34 80.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.605 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.19 -25.59 63.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 71.3 m -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.932 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.444 HD11 HG11 ' A' ' 907' ' ' VAL . 2.8 mm? -70.6 -20.27 62.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.602 0.239 . . . . 0.0 111.435 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 7.3 m -58.53 -39.73 81.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.623 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 46.5 p -65.67 -37.67 87.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.64 -40.51 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.789 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.71 -43.24 98.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.12 -38.58 91.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.154 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 17.1 tpt -66.67 -27.15 67.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 110.611 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -87.27 -5.41 58.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.599 . . . . 0.0 110.245 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' SER . . . . . 0.566 ' O ' ' HD3' ' A' ' 965' ' ' PRO . 56.8 m -86.08 14.43 6.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.814 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -98.16 102.16 13.19 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.736 0.779 . . . . 0.0 109.247 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 963' ' ' SER . 74.8 Cg_endo -104.91 -178.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.367 2.712 . . . . 0.0 113.685 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 9.1 t -114.89 143.47 30.15 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.83 92.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.356 2.038 . . . . 0.0 112.098 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -97.65 3.25 50.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.759 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.95 -47.46 77.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 109.351 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.122 175.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 23.2 p -87.11 39.0 0.84 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.984 0.421 . . . . 0.0 111.292 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -145.12 139.9 27.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.055 0.455 . . . . 0.0 111.275 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.34 152.41 39.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.63 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.985 HD13 HG21 ' A' ' 891' ' ' VAL . 0.2 OUTLIER -123.01 129.82 52.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 -175.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 888' ' ' LEU . 2.5 mm? -98.8 -161.74 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.658 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -70.57 -25.79 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.384 0.611 . . . . 0.0 109.598 172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 14.5 m -107.52 148.36 29.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.629 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . 0.985 HG21 HD13 ' A' ' 887' ' ' LEU . 19.8 t -112.93 138.48 42.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -108.58 126.15 52.63 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.02 118.6 59.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.38 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.622 ' HB2' HG13 ' A' ' 896' ' ' VAL . 94.0 mttt 53.49 7.97 0.12 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.31 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.3 23.49 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.627 0.771 . . . . 0.0 109.854 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 894' ' ' LYS . 12.5 p -105.2 -28.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.65 158.14 24.92 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.876 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.467 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 2.9 m95 -122.97 136.53 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.664 ' HB1' ' HB ' ' A' ' 891' ' ' VAL . . . -110.87 130.07 55.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.026 0.441 . . . . 0.0 110.124 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 900' ' ' THR . . . . . 0.751 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 10.1 m -116.99 125.37 51.28 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.758 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.92 117.08 29.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.228 0.537 . . . . 0.0 110.112 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.685 HD22 ' HE3' ' A' ' 908' ' ' TRP . 3.6 mm? -95.56 137.05 35.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.807 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.7 t -63.34 -17.82 62.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 22.7 t -81.81 1.04 36.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.07 11.31 61.55 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.029 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.43 140.63 29.58 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.823 -0.222 . . . . 0.0 110.443 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.698 HG12 HD13 ' A' ' 955' ' ' LEU . 46.7 t -107.59 122.83 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.751 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 1.5 t90 -110.23 115.74 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.452 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 57.5 t -112.41 119.39 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.436 0.636 . . . . 0.0 110.245 173.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.652 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.1 tt0 -104.4 143.33 33.14 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.478 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.52 171.06 9.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.56 -21.04 66.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.25 1.87 49.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.642 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.0 5.35 87.78 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.085 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.5 m -94.63 152.07 18.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.652 ' HG2' ' HG3' ' A' ' 910' ' ' GLN . 51.6 mt-30 -134.5 159.15 42.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.507 HD12 HG23 ' A' ' 926' ' ' ILE . 1.3 pt? -137.91 136.07 36.7 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 169.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 907' ' ' VAL . 7.0 m -114.3 128.08 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.43 . . . . 0.0 111.545 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.93 136.69 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -92.3 140.86 29.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.21 128.5 37.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.32 -6.14 83.6 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.693 HG11 ' H ' ' A' ' 925' ' ' SER . 41.6 t -111.61 134.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.109 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.8 m -91.0 -5.34 55.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.743 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.693 ' H ' HG11 ' A' ' 923' ' ' VAL . 15.0 m -95.43 131.58 41.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.475 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.507 HG23 HD12 ' A' ' 917' ' ' LEU . 3.7 mp -113.15 146.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 15.2 m -115.34 117.1 29.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.614 ' HB2' ' HE1' ' A' ' 938' ' ' TYR . 43.8 t80 -96.24 127.18 42.01 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 8.9 t -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.333 0.587 . . . . 0.0 110.918 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 22.8 t -118.01 111.18 39.1 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.01 144.83 93.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.0 12.62 8.05 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.577 0.548 . . . . 0.0 110.396 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . 0.63 ' O ' ' HG3' ' A' ' 934' ' ' GLN . . . -131.39 -91.46 0.54 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 933' ' ' GLY . 30.0 mt-30 178.01 168.1 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.621 0.768 . . . . 0.0 109.9 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 50.3 m -105.24 126.2 51.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.663 0.268 . . . . 0.0 110.359 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 24.7 m -118.96 128.84 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.414 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.58 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 13.7 ptm180 -99.67 127.4 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.369 0.604 . . . . 0.0 111.278 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.614 ' HE1' ' HB2' ' A' ' 928' ' ' TYR . 26.0 p90 -110.06 138.53 46.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.011 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -90.94 -179.71 43.0 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.615 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.45 -13.01 60.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.813 0.34 . . . . 0.0 111.152 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.83 -0.16 57.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -92.67 141.07 28.88 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.94 -0.475 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -92.99 123.5 36.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.32 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -96.51 135.53 22.34 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 33.9 Cg_exo -61.62 -73.43 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.909 2.406 . . . . 0.0 113.148 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -145.61 -71.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -64.1 -32.77 74.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.667 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 32.5 mm -68.53 -43.06 83.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -64.01 -39.68 94.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.807 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.56 -43.7 96.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 951' ' ' LYS . 2.8 mptp? -67.95 -38.69 83.11 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.208 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 89.2 mt -62.97 -31.74 72.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.159 0.504 . . . . 0.0 110.494 175.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -69.27 -36.42 77.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.5 -11.71 60.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.588 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.698 HD13 HG12 ' A' ' 907' ' ' VAL . 3.1 mm? -64.28 -19.55 65.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.821 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 956' ' ' SER . . . . . 0.427 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 48.2 t -58.9 -35.84 73.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.005 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 14.7 m -65.42 -39.86 92.64 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 955' ' ' LEU . 10.5 tp -69.67 -36.41 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 46.5 tp -61.64 -41.36 97.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.202 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 956' ' ' SER . 96.8 mt -66.18 -36.58 83.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 54.3 tpp -65.51 -26.23 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.791 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -86.63 -0.01 55.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.297 0.57 . . . . 0.0 110.364 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 15.2 m -89.29 9.41 26.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.068 0.461 . . . . 0.0 110.337 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -64.2 135.71 96.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.307 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.465 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 3.8 Cg_endo -46.35 -38.95 21.3 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.032 3.155 . . . . 0.0 113.745 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 2.8 p -104.49 100.02 20.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.95 0.405 . . . . 0.0 110.776 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 965' ' ' PRO . 4.9 Cg_exo -80.95 43.41 1.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.368 2.712 . . . . 0.0 112.25 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -80.48 24.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.632 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 967' ' ' PRO . 97.8 m-85 -67.91 -24.42 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 176.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.374 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 38.1 t -142.48 125.3 16.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -90.13 174.82 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.671 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -71.19 93.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.233 175.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 61.7 tp -88.9 110.27 20.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.48 -85.47 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 125.99 26.38 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 11.1 p -106.64 143.92 34.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.944 0.402 . . . . 0.0 110.823 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.17 142.63 41.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.001 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -106.76 129.16 54.68 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.25 121.03 54.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.609 ' HB3' HG13 ' A' ' 896' ' ' VAL . 58.9 tttm 57.8 4.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.136 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.66 24.42 14.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.779 0.799 . . . . 0.0 109.178 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 894' ' ' LYS . 13.9 p -103.71 -28.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.21 158.47 25.34 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.849 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.686 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.7 OUTLIER -121.6 135.43 54.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.4 130.18 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.067 0.46 . . . . 0.0 110.865 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 28.8 m -115.66 132.85 56.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.047 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -94.82 115.79 27.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.33 153.67 19.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -19.11 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.239 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.3 m -85.2 1.03 49.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.715 0.293 . . . . 0.0 111.262 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.73 69.11 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.943 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.35 141.76 28.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.6 122.31 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.415 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 2.0 t-105 -104.01 114.62 29.0 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 48.7 t -112.41 117.29 54.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.265 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.686 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 42.7 mt-30 -103.62 143.51 32.66 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.907 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 152.41 20.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.418 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' A' ' 896' ' ' VAL . 26.7 p30 -65.09 -16.24 63.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.35 2.34 50.63 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.289 -0.257 . . . . 0.0 111.555 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.53 5.81 60.04 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.602 -0.808 . . . . 0.0 114.202 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 14.0 m -96.53 157.93 15.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.749 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.8 OUTLIER -133.2 154.68 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.02 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 917' ' ' LEU . 5.6 mp -123.07 134.85 54.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.495 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.67 118.66 59.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.25 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 955' ' ' LEU . 12.5 p -123.22 144.61 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 906' ' ' ALA . 61.8 tt0 -93.17 139.55 30.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.146 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.99 128.93 38.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 99.24 -4.01 58.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.981 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 925' ' ' SER . 9.9 p -139.69 151.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 117.257 0.529 . . . . 0.0 110.521 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 940' ' ' GLU . 5.1 p -91.45 -6.74 52.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 923' ' ' VAL . 16.4 p -68.49 108.85 3.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.25 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.05 145.28 25.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.343 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 6.2 p -117.61 122.41 43.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.795 0.331 . . . . 0.0 110.292 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -96.1 127.89 42.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.749 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 20.9 m -113.96 123.39 49.61 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.323 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 930' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 48.0 t -107.35 115.06 60.24 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 23.3 Cg_exo -65.59 2.48 1.57 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.673 2.915 . . . . 0.0 112.861 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.33 -3.48 57.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.55 . . . . 0.0 109.563 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.45 44.28 1.59 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.373 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.29 102.57 2.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 11.9 t -105.43 129.67 53.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.042 0.448 . . . . 0.0 110.57 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 14.8 p -116.93 128.64 55.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.033 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 7.2 ptp85 -107.8 126.89 53.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.552 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.46 139.65 46.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.574 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -109.39 173.1 16.75 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.033 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . 0.407 ' HB2' ' OG ' ' A' ' 924' ' ' SER . 30.5 tt0 -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.83 0.347 . . . . 0.0 111.569 -176.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -95.34 2.22 54.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.322 0.582 . . . . 0.0 110.688 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -91.48 172.32 8.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . 0.704 ' HZ1' ' HB2' ' A' ' 943' ' ' LYS . 0.1 OUTLIER -100.32 130.77 46.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.952 0.406 . . . . 0.0 110.111 178.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -94.84 133.2 26.9 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.866 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 31.4 Cg_exo -59.82 -65.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 0.0 111.683 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -165.68 -64.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.46 -33.59 72.79 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.57 -172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.24 -42.72 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.2 -44.27 92.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.452 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.6 -43.98 96.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.682 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 951' ' ' LYS . 35.4 mmtm -71.15 -38.02 72.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 955' ' ' LEU . 28.0 tp -57.98 -36.56 72.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.858 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.51 -35.09 79.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.885 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 27.8 t -72.1 -25.26 61.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.256 0.55 . . . . 0.0 110.602 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.611 ' O ' HG13 ' A' ' 958' ' ' ILE . 96.5 mt -71.33 -25.67 62.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 956' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 16.7 m -58.2 -25.82 62.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.446 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 19.8 m -62.67 -37.87 88.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 955' ' ' LEU . 2.4 pp -69.68 -34.78 62.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.078 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.14 -42.53 99.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 956' ' ' SER . 92.7 mt -66.03 -35.95 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.682 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -68.59 -27.18 65.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 110.095 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.41 0.624 . . . . 0.0 109.844 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 7.6 t -92.05 17.61 9.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.497 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 9.6 t30 66.61 94.06 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.032 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.33 -179.26 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.744 2.296 . . . . 0.0 111.175 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 35.5 m -117.68 98.04 51.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.63 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.82 100.54 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.479 2.12 . . . . 0.0 111.175 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.24 19.8 12.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.75 -171.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.73 114.62 8.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.772 176.782 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . 0.467 ' HA2' ' OE1' ' A' ' 910' ' ' GLN . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 38.6 m 72.62 133.25 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.505 0.669 . . . . 0.0 112.111 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -133.0 148.94 52.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.189 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -87.51 151.6 22.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . 0.476 ' O ' HD11 ' A' ' 887' ' ' LEU . 0.5 OUTLIER -81.17 126.08 31.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 110.832 -177.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 31.9 tp -169.54 -74.98 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.776 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -124.56 0.81 8.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.995 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 t -107.36 143.42 35.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.754 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 35.0 t -126.42 140.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.272 . . . . 0.0 110.565 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -92.07 130.68 37.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 954' ' ' CYS . 14.4 m -111.2 122.26 65.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.972 0.415 . . . . 0.0 111.597 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . 0.71 ' HB3' HG13 ' A' ' 896' ' ' VAL . 39.8 ttmt 60.91 1.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.932 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.08 22.52 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.074 -170.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 894' ' ' LYS . 13.3 p -104.22 -29.19 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.9 160.32 26.17 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.327 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.544 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -120.68 133.79 55.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -125.14 130.66 52.63 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.243 -0.583 . . . . 0.0 112.188 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 52.0 m -115.52 125.65 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.296 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -86.59 124.13 32.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.14 141.7 28.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 3.6 m -66.65 -8.4 27.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 3.0 m -85.49 0.5 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.32 4.21 71.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.68 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.02 142.67 27.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.2 123.18 68.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -107.71 112.55 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 917' ' ' LEU . 6.0 p -116.85 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.748 0.785 . . . . 0.0 110.767 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.544 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 7.6 tt0 -91.91 143.14 26.8 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.857 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . 0.75 ' HD1' ' H ' ' A' ' 913' ' ' ASP . 19.7 t80 -92.66 150.0 20.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.8 -19.72 60.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . 0.75 ' H ' ' HD1' ' A' ' 911' ' ' PHE . 37.9 t70 -79.97 1.1 28.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.188 0.518 . . . . 0.0 111.264 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 91.94 5.71 65.93 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.94 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.7 p -96.05 153.3 17.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -121.83 155.48 35.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.549 0.214 . . . . 0.0 110.555 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.625 ' HB3' HG11 ' A' ' 909' ' ' VAL . 7.9 tt -137.75 131.0 30.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.54 120.8 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.33 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.22 145.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.74 139.33 30.66 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.42 128.68 37.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.811 0.338 . . . . 0.0 111.691 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.02 -6.63 64.19 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.09 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.07 156.36 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 122.511 -0.405 . . . . 0.0 111.1 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' SER . . . . . 0.411 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 42.0 m -90.32 -5.68 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 15.3 t -69.2 112.35 5.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.218 0.532 . . . . 0.0 109.839 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 948' ' ' ILE . 0.0 OUTLIER -120.64 146.61 25.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.897 -174.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 5.8 m -116.15 117.63 30.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -108.02 129.37 55.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 23.6 m -100.44 121.94 42.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 44.6 t -123.02 125.03 26.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -11.92 32.42 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.348 2.032 . . . . 0.0 111.422 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -105.06 -14.5 15.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.916 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -149.33 22.3 1.22 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.458 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . 0.8 ' HG2' ' H ' ' A' ' 935' ' ' THR . 39.3 tt0 68.3 -161.26 0.2 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.051 0.426 . . . . 0.0 109.906 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.8 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 3.3 p -97.29 126.0 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.439 . . . . 0.0 110.972 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 19.9 p -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.851 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -98.95 128.99 45.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.855 0.36 . . . . 0.0 110.369 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . 0.413 ' HB2' HG23 ' A' ' 926' ' ' ILE . 58.4 m-85 -101.84 127.85 48.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.41 141.74 15.67 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.676 -167.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 43.3 tt0 -66.35 -21.88 66.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.533 0.682 . . . . 0.0 109.802 175.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.18 2.04 37.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.862 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -142.02 -140.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.838 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -100.01 136.26 40.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.706 -169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.96 132.74 22.35 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.836 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.54 155.29 70.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.677 2.251 . . . . 0.0 111.42 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 950' ' ' GLN . 24.8 t70 -60.21 -46.74 88.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.376 -176.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -61.69 -31.81 71.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 111.348 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.601 HG21 HG22 ' A' ' 926' ' ' ILE . 45.3 mm -69.35 -42.56 81.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.44 . . . . 0.0 109.966 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -63.01 -37.24 86.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.104 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 946' ' ' ASP . 81.1 mm-40 -61.11 -44.14 97.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.609 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.63 -43.64 79.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.4 -36.24 83.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.855 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -59.4 -34.18 72.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.261 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 893' ' ' VAL . 61.2 m -69.9 -25.41 63.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.651 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 11.0 mp -71.29 -31.55 67.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.7 m -59.61 -32.53 70.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.414 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 15.0 m -60.1 -36.22 76.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.544 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.46 -40.81 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.336 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.3 -41.23 98.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.107 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.78 -35.08 79.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.007 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 27.7 ttt -69.54 -26.21 64.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.81 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -84.34 -5.81 59.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.161 0.505 . . . . 0.0 110.245 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 22.9 t -91.2 11.29 23.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 0.0 109.811 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.16 144.78 99.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.022 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.07 -35.38 3.21 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.671 2.914 . . . . 0.0 114.381 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 10.9 t -140.36 114.87 7.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.345 0.593 . . . . 0.0 110.895 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 966' ' ' THR . 6.1 Cg_endo -87.23 150.1 7.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.139 2.56 . . . . 0.0 111.804 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -97.44 -0.73 45.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 109.743 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -71.9 -29.85 64.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.197 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.743 -178.049 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 19.9 p -78.79 -63.91 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.023 0.439 . . . . 0.0 110.847 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -94.76 113.57 25.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.404 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -81.22 65.94 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.156 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 95.3 mt -101.52 106.63 17.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.257 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 888' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 890' ' ' SER . 2.1 pt? -154.56 164.84 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -85.16 -15.08 44.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.056 0.455 . . . . 0.0 110.791 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.555 ' O ' ' HG ' ' A' ' 888' ' ' LEU . 3.8 p -107.08 154.0 21.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.804 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.63 139.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -97.08 130.13 44.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.51 119.46 62.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.629 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 56.37 4.96 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.622 1.201 . . . . 0.0 112.316 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 59.07 23.58 11.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.333 0.653 . . . . 0.0 109.944 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.57 -29.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.78 158.77 25.76 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.448 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 898' ' ' TRP . . . . . 0.455 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 3.6 m95 -121.03 136.0 55.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.49 130.16 52.76 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.104 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 23.9 m -116.62 127.07 54.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.483 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -88.63 117.55 27.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.887 0.375 . . . . 0.0 110.427 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 902' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 908' ' ' TRP . 3.1 mm? -80.21 149.42 30.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.975 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 8.4 t -65.88 -20.28 66.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.446 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 39.9 t -83.95 0.77 46.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 111.041 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.62 6.5 63.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.912 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -85.24 152.34 23.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 907' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 919' ' ' VAL . 45.2 t -112.08 122.92 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.252 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 908' ' ' TRP . . . . . 0.668 ' HB2' HD22 ' A' ' 902' ' ' LEU . 22.6 t90 -110.08 113.68 26.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 909' ' ' VAL . . . . . 0.768 ' HB ' ' HG ' ' A' ' 917' ' ' LEU . 45.7 t -115.2 129.01 72.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 -175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 910' ' ' GLN . . . . . 0.448 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 35.1 mt-30 -98.61 150.05 22.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -108.5 162.25 14.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.475 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.9 -27.77 61.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.347 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.71 1.53 42.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.489 0.662 . . . . 0.0 111.103 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.76 8.19 83.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.065 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.68 165.38 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -0.627 . . . . 0.0 109.519 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 151.99 50.63 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.2 -177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.768 ' HG ' ' HB ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -137.67 134.82 35.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.013 0.435 . . . . 0.0 110.018 173.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' VAL . . . . . 0.599 HG23 ' HD1' ' A' ' 908' ' ' TRP . 42.4 t -114.2 124.3 70.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.157 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 907' ' ' VAL . 14.6 p -118.8 132.55 68.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 110.331 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.04 141.66 28.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.162 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.19 40.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 101.33 6.48 50.89 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.647 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.696 HG23 ' H ' ' A' ' 925' ' ' SER . 8.1 p -149.78 141.14 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' SER . . . . . 0.581 ' HB3' ' HB3' ' A' ' 940' ' ' GLU . 35.1 t -87.1 -5.57 58.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.874 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 925' ' ' SER . . . . . 0.696 ' H ' HG23 ' A' ' 923' ' ' VAL . 19.6 m -82.31 131.16 35.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.3 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.776 HD12 HD13 ' A' ' 952' ' ' LEU . 3.6 mt -120.0 146.43 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.252 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 917' ' ' LEU . 23.3 t -104.35 115.41 30.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 928' ' ' TYR . . . . . 0.569 ' CZ ' HD13 ' A' ' 917' ' ' LEU . 19.7 m-85 -102.12 125.81 48.91 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 929' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.5 t -114.99 123.52 49.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.57 0.7 . . . . 0.0 110.661 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 43.2 t -105.07 106.61 56.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.697 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.66 -39.0 93.6 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.346 2.697 . . . . 0.0 112.932 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -97.0 16.18 20.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.785 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -137.63 -75.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.532 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 175.54 169.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 935' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 29.1 m -104.43 124.51 49.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 11.1 m -121.54 130.0 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.62 128.96 44.73 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.145 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.56 127.44 53.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.803 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.15 169.55 22.89 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.332 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 940' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 924' ' ' SER . 11.7 pt-20 -64.68 -15.93 62.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.449 0.299 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.45 1.61 55.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -100.93 146.43 27.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.339 . . . . 0.0 110.684 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.38 123.38 31.56 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 944' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 948' ' ' ILE . 2.2 mm? -91.43 133.57 31.12 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.407 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -71.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.271 2.647 . . . . 0.0 113.334 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -147.26 -75.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.754 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 948' ' ' ILE . . . . . 0.562 HG22 ' CZ ' ' A' ' 928' ' ' TYR . 4.0 mp -67.72 -42.66 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 949' ' ' LYS . . . . . 0.419 ' HB3' ' HZ1' ' A' ' 949' ' ' LYS . 2.4 ttpm? -63.31 -44.05 96.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.781 175.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -62.25 -42.63 99.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.854 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 951' ' ' LYS . . . . . 0.499 ' O ' HD12 ' A' ' 955' ' ' LEU . 25.5 mmmt -68.81 -40.58 79.49 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.149 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 926' ' ' ILE . 56.5 tp -62.15 -39.65 93.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.847 175.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -73.2 -35.45 66.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.38 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 954' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 31.8 p -71.53 -20.68 62.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.031 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 955' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 951' ' ' LYS . 4.4 mp -70.71 -17.49 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 40.5 m -58.89 -28.49 66.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.817 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 32.2 t -65.43 -37.92 88.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.258 0.551 . . . . 0.0 109.952 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 58.2 mt -68.2 -40.29 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.441 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.65 -37.66 82.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.276 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.43 -39.9 94.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.456 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 15.6 tpt -70.26 -27.09 64.16 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.847 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -81.73 -5.35 58.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.281 0.562 . . . . 0.0 110.785 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 46.5 m -92.2 4.49 53.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.502 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 70.71 151.23 0.14 Allowed Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.907 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.29 170.6 10.48 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.901 2.401 . . . . 0.0 112.054 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.02 122.03 63.11 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.211 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.75 29.66 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.468 2.778 . . . . 0.0 114.143 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.07 12.76 18.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 0.0 110.481 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -72.65 -17.68 61.64 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 36.1 t60 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.102 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 889' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 889' ' ' LYS . 41.1 mmtm . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 890' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 50.8 m -106.98 142.63 36.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.533 172.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.44 139.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -105.2 119.51 39.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.868 0.366 . . . . 0.0 110.291 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.08 119.25 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.051 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.452 ' HB3' HG12 ' A' ' 896' ' ' VAL . 34.8 ttpt 55.01 5.13 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.842 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.99 24.96 14.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.602 0.761 . . . . 0.0 110.15 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 894' ' ' LYS . 9.7 p -103.18 -27.33 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.64 24.99 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.283 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.2 135.16 54.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 27.1 m -103.7 126.03 50.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.714 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -86.68 116.14 24.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.906 0.384 . . . . 0.0 110.675 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.84 145.6 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 10.0 p -67.18 -20.26 65.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.9 m -81.84 2.61 29.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.308 . . . . 0.0 111.714 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.47 7.9 63.01 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.496 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.53 140.1 30.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 919' ' ' VAL . 4.2 p -117.19 123.17 71.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.282 0.563 . . . . 0.0 109.866 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -101.2 112.23 24.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 917' ' ' LEU . 5.9 p -114.61 117.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.812 0.815 . . . . 0.0 111.046 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 53.2 tt0 -104.53 143.28 33.25 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.52 166.26 10.91 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.779 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -64.85 -20.45 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.698 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.6 1.3 26.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 111.122 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 92.14 5.5 65.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.289 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.0 m -97.23 153.21 18.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.599 ' C ' HD12 ' A' ' 917' ' ' LEU . 83.1 mt-30 -125.4 153.28 43.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.733 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.9 mp -134.22 137.78 44.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.69 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.79 120.66 62.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.519 ' HB ' HG13 ' A' ' 907' ' ' VAL . 74.2 t -119.7 132.65 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.72 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -93.48 138.3 31.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.6 127.1 29.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.58 0.229 . . . . 0.0 110.847 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.41 -0.13 82.95 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.693 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 925' ' ' SER . 27.8 t -120.19 140.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.5 t -91.35 -14.83 30.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 111.131 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.645 ' H ' HG12 ' A' ' 923' ' ' VAL . 22.5 p -87.95 114.67 24.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.361 0.6 . . . . 0.0 110.718 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 938' ' ' TYR . 2.4 pp -116.68 162.89 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.819 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 7.2 t -117.47 117.01 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 935' ' ' THR . 56.2 t80 -105.3 128.63 53.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.795 0.331 . . . . 0.0 110.681 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 31.3 m -114.71 128.91 56.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.512 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.0 m -105.88 138.38 19.62 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.38 -7.41 15.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.681 2.921 . . . . 0.0 113.611 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -78.72 -1.44 34.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.312 0.577 . . . . 0.0 109.791 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 92.62 39.32 5.32 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.577 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -133.66 106.17 7.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.213 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 928' ' ' TYR . 9.3 t -104.65 126.49 51.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.247 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 20.6 m -117.97 136.4 53.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.593 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.66 127.58 43.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.591 ' HD2' HG13 ' A' ' 926' ' ' ILE . 7.7 t80 -99.2 126.59 45.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.97 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -117.74 169.56 13.29 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.38 -15.61 58.03 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.507 0.653 . . . . 0.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.09 23.38 9.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.045 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -127.55 147.02 50.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -100.69 140.24 35.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.853 0.359 . . . . 0.0 111.084 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 948' ' ' ILE . 2.3 mm? -93.23 140.1 23.19 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.555 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 948' ' ' ILE . 24.0 Cg_exo -65.52 170.11 11.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.372 2.048 . . . . 0.0 110.596 165.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.88 -52.51 57.24 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 947' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 67.1 m-85 -66.04 -33.94 76.94 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 944' ' ' LEU . 23.1 mm -71.19 -43.47 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-O 121.346 0.593 . . . . 0.0 109.827 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -64.38 -38.96 92.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.851 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -61.47 -47.39 85.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.5 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 12.7 ptpt -70.11 -38.15 75.54 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 955' ' ' LEU . 37.3 mt -58.03 -30.97 66.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 111.406 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -60.13 -33.8 72.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.55 -24.23 63.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.11 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.427 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 38.5 pttt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.7 m -107.34 155.7 19.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.535 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.6 138.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.319 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -100.22 131.3 46.24 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.012 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.65 HG13 ' SG ' ' A' ' 954' ' ' CYS . 55.3 t -95.18 117.06 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.533 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.529 ' HE2' ' H ' ' A' ' 894' ' ' LYS . 0.7 OUTLIER 51.64 9.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.002 0.921 . . . . 0.0 112.881 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.54 22.37 12.1 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.606 0.763 . . . . 0.0 109.893 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.55 -27.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 109.786 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.1 160.83 25.91 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.382 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.0 OUTLIER -121.55 136.26 54.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.68 56.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.1 m -114.37 132.77 56.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.83 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -96.26 123.56 39.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.087 0.47 . . . . 0.0 111.6 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.3 mm? -96.84 139.03 33.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.5 t -67.12 -10.67 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 11.1 t -85.99 0.38 53.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.479 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.3 10.09 59.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.437 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 906' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 902' ' ' LEU . . . -92.01 141.47 28.59 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.31 122.58 70.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.477 ' HE3' HD21 ' A' ' 902' ' ' LEU . 0.0 OUTLIER -103.74 114.96 29.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.423 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.0 t -110.0 118.42 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.27 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 51.1 mt-30 -101.67 143.01 32.16 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.827 0.346 . . . . 0.0 110.165 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.559 ' CZ ' ' HE2' ' A' ' 951' ' ' LYS . 0.3 OUTLIER -92.71 151.55 20.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 912' ' ' ASN . . . . . 0.457 ' N ' ' HD1' ' A' ' 911' ' ' PHE . 28.0 t-20 -58.39 -26.89 63.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.45 2.47 47.63 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.67 5.09 60.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.551 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 65.4 m -83.29 162.45 21.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -132.94 151.41 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.455 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 7.0 mp -124.58 136.64 54.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.448 HG22 ' NE1' ' A' ' 908' ' ' TRP . 27.8 t -111.76 118.27 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 926' ' ' ILE . 34.2 t -122.99 131.86 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.902 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 923' ' ' VAL . 34.7 tt0 -94.47 139.03 31.67 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.22 127.41 31.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.063 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 100.16 -5.65 57.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.967 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 925' ' ' SER . 7.7 p -124.88 140.24 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.955 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 26.4 m -89.13 -5.9 57.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.416 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 923' ' ' VAL . 34.7 m -73.26 117.8 15.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.671 0.272 . . . . 0.0 110.565 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.621 HG23 HG22 ' A' ' 919' ' ' VAL . 1.5 mp -112.58 144.42 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.228 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 15.6 m -119.15 113.79 21.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 938' ' ' TYR . 24.1 p90 -111.39 130.13 55.79 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.981 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 11.4 t -113.1 136.99 52.11 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 4.0 t -122.65 125.62 26.36 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.85 135.97 72.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.944 3.096 . . . . 0.0 113.156 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 65.16 11.44 7.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 933' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -118.76 -84.46 0.94 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.303 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 934' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 933' ' ' GLY . 6.5 tp-100 169.53 160.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 6.9 t -103.08 128.86 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.461 . . . . 0.0 109.936 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 936' ' ' THR . . . . . 0.623 ' HB ' ' CE1' ' A' ' 928' ' ' TYR . 38.0 m -116.9 136.41 52.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.681 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.583 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -116.33 128.06 55.22 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.132 0.491 . . . . 0.0 110.628 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 928' ' ' TYR . 56.1 m-85 -109.88 131.46 55.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.054 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -92.68 179.41 40.06 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.517 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 940' ' ' GLU . . . . . 0.955 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 24.7 mp0 -63.72 -26.04 68.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.855 0.327 . . . . 0.0 111.294 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -87.23 1.58 52.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.935 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 938' ' ' TYR . 34.0 mt-10 -108.6 142.48 39.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.427 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -76.84 129.85 36.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.629 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 91.2 mt -93.83 134.17 26.67 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.255 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 27.0 Cg_exo -63.78 164.53 21.22 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.015 2.477 . . . . 0.0 112.071 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.61 -62.81 1.27 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.686 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -68.06 -33.03 73.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.391 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.43 -43.88 83.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.121 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -63.28 -43.41 97.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.24 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -59.82 -44.16 94.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.309 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 911' ' ' PHE . 4.5 mttp -68.41 -43.47 77.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.653 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -64.24 -35.97 82.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.0 110.816 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -61.47 -35.2 76.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.507 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 954' ' ' CYS . . . . . 0.65 ' SG ' HG13 ' A' ' 893' ' ' VAL . 35.6 t -73.5 -26.68 61.0 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -179.754 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 p -107.38 143.61 35.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.296 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.04 154.96 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.712 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -106.98 130.61 54.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.656 0.265 . . . . 0.0 110.681 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.09 119.08 59.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.458 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.588 ' HB2' HG12 ' A' ' 896' ' ' VAL . 3.2 mmmp? 54.16 7.62 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.86 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.01 22.55 10.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.064 0.546 . . . . 0.0 110.261 -171.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.588 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.8 p -103.69 -27.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 897' ' ' GLY . . . . . 0.919 ' HA3' ' HE3' ' A' ' 951' ' ' LYS . . . -140.12 158.89 25.99 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.568 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 2.0 m95 -121.93 135.54 54.88 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.026 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.1 m -115.6 124.72 51.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.02 117.18 34.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.261 0.553 . . . . 0.0 110.717 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.72 137.3 33.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.265 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 5.9 m -64.53 -13.24 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.262 0.554 . . . . 0.0 111.189 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 13.5 m -79.93 0.42 31.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 94.47 6.67 60.99 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.629 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.5 137.84 32.05 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -110.53 111.96 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 43.8 t -116.56 116.92 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 46.4 mt-30 -94.04 160.65 14.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.893 0.377 . . . . 0.0 110.5 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.454 ' HD1' ' HZ2' ' A' ' 951' ' ' LYS . 38.3 t80 -104.47 164.48 11.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -60.29 -26.01 66.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.3 0.1 54.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.54 4.8 60.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.707 . . . . 0.0 113.726 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 60.5 p -81.24 162.86 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.571 0.686 . . . . 0.0 109.332 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.6 OUTLIER -132.51 153.45 50.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 112.318 -177.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 916' ' ' GLN . 5.9 mp -126.92 135.97 51.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 32.8 t -112.39 122.69 67.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.73 137.16 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.127 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 923' ' ' VAL . 77.1 mm-40 -93.39 138.46 31.69 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.64 129.42 40.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.641 0.258 . . . . 0.0 111.062 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.17 -6.84 61.94 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.412 174.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 920' ' ' GLN . 33.5 m -130.14 156.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.393 0.596 . . . . 0.0 110.821 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 4.6 p -91.05 -6.7 53.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.297 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 21.7 m -72.06 128.54 36.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.956 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -126.88 146.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.529 -175.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 13.0 m -114.01 116.43 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -97.12 127.21 42.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.045 0.45 . . . . 0.0 109.873 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.738 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 17.1 m -114.28 123.63 50.01 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.394 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 33.8 t -122.91 106.21 34.33 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 37.5 Cg_endo -66.41 -5.74 13.42 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.938 2.425 . . . . 0.0 111.993 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -93.18 -6.81 46.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.43 -66.5 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.638 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 179.74 169.06 1.17 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -169.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 18.2 m -103.23 124.78 49.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 53.5 m -119.66 130.17 54.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -97.85 130.25 44.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 926' ' ' ILE . 77.4 m-85 -109.62 127.64 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.024 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.88 172.56 24.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.66 -18.31 64.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.569 0.685 . . . . 0.0 110.721 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.05 2.29 47.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.565 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.87 143.97 26.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -95.95 125.69 40.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.915 0.388 . . . . 0.0 110.472 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.83 133.54 39.27 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.22 -66.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.601 2.201 . . . . 0.0 112.068 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -163.36 -64.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.688 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -59.74 -32.07 70.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.795 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.52 -43.56 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 0.0 110.385 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -64.23 -42.72 96.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.868 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -60.01 -43.78 95.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.219 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.919 ' HE3' ' HA3' ' A' ' 897' ' ' GLY . 23.2 tptm -68.1 -43.29 78.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.261 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.29 -37.74 88.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.883 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.76 -21.38 62.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.397 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.18 -23.07 67.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 110.712 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.771 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.388 0.614 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.6 m -103.2 141.08 36.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.832 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.56 140.55 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 892' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 898' ' ' TRP . 36.0 p90 -90.37 125.54 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.066 0.46 . . . . 0.0 110.736 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 894' ' ' LYS . 7.3 p -95.26 123.44 47.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.089 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 893' ' ' VAL . 33.3 mmtp 57.91 8.29 0.71 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.678 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.99 22.56 11.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.69 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.74 -30.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.827 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.2 163.85 25.34 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.139 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.643 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 2.1 m95 -121.36 134.89 55.13 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.45 129.98 55.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.883 0.373 . . . . 0.0 110.633 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 24.9 m -116.88 126.89 53.67 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.419 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -94.34 116.14 28.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.249 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.7 p -66.4 -15.56 63.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.8 p -85.54 0.55 52.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.739 0.304 . . . . 0.0 111.213 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.21 9.71 60.29 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.235 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.85 139.67 30.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.403 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.84 122.31 68.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.14 0.495 . . . . 0.0 109.735 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.592 ' HE1' ' HG3' ' A' ' 916' ' ' GLN . 8.6 t90 -108.66 113.52 26.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 35.9 t -116.03 115.88 50.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 110.346 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.643 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 23.2 pt20 -105.26 163.22 12.76 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.502 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 23.9 m-85 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -65.45 -17.24 64.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.369 0.604 . . . . 0.0 110.147 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.76 3.33 41.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.725 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.5 6.78 59.55 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.798 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.502 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 14.6 m -88.81 158.42 18.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.883 0.342 . . . . 0.0 110.456 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.8 ' HB3' ' HB ' ' A' ' 929' ' ' THR . 50.5 tt0 -132.1 150.91 52.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.073 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 926' ' ' ILE . 6.4 mp -137.82 135.88 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 171.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.96 121.59 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.641 HG11 ' HG ' ' A' ' 955' ' ' LEU . 11.6 t -120.04 135.97 58.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.15 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.23 139.41 30.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.84 128.1 35.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.029 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.37 -6.02 83.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.635 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 925' ' ' SER . 24.2 t -107.84 138.05 36.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.721 0.296 . . . . 0.0 110.644 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 38.1 m -91.29 -6.19 53.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.13 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.691 ' H ' HG12 ' A' ' 923' ' ' VAL . 21.5 p -95.44 123.8 39.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.527 HD13 HD23 ' A' ' 917' ' ' LEU . 2.6 pp -116.03 150.16 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.514 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 21.0 m -105.43 116.63 32.27 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -96.81 128.43 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 916' ' ' GLN . 40.1 m -112.39 122.89 49.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.056 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.9 t -123.68 99.29 39.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.49 -12.29 32.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.73 2.287 . . . . 0.0 111.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -86.26 -14.26 44.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.484 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.95 -62.05 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.178 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -173.28 159.27 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.106 0.453 . . . . 0.0 110.513 -167.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 929' ' ' THR . 67.1 p -102.81 125.29 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 169.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 27.2 m -120.59 132.23 55.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.477 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -97.29 129.04 44.63 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.204 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.59 ' HB3' ' CD2' ' A' ' 944' ' ' LEU . 98.4 m-85 -107.17 139.61 41.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 939' ' ' GLY . . . . . 0.78 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -147.02 -172.73 17.57 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.92 -1.133 . . . . 0.0 112.818 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -26.61 67.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.899 0.48 . . . . 0.0 111.576 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -97.25 7.27 46.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.78 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 5.9 mm-40 -113.13 150.76 31.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 111.031 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -74.52 122.25 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.837 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.59 ' CD2' ' HB3' ' A' ' 938' ' ' TYR . 77.7 mt -98.6 132.3 24.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.354 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 55.4 Cg_endo -84.25 172.36 9.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.618 2.212 . . . . 0.0 111.423 171.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -53.43 -60.93 2.67 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -64.79 -31.3 72.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.696 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.639 ' HB ' ' HD2' ' A' ' 945' ' ' PRO . 45.1 mm -68.78 -41.77 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.41 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.9 -39.12 88.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.506 ' HZ2' HD22 ' A' ' 917' ' ' LEU . 5.6 mmmp? -65.43 -42.73 92.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.471 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 952' ' ' LEU . 3.7 mm? -61.39 -36.46 80.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -69.02 -31.5 70.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.96 -25.35 64.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.641 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.0 mm? . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.4 p -107.24 143.83 34.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.844 170.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.33 155.21 14.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.677 0.275 . . . . 0.0 110.319 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -101.84 130.54 48.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.58 120.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.689 ' HB2' HG12 ' A' ' 896' ' ' VAL . 2.9 mptp? 57.36 4.28 0.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.091 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 59.89 22.1 11.09 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.533 0.733 . . . . 0.0 110.47 -170.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.9 p -105.57 -28.43 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 0.0 109.639 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.05 25.54 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.072 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.731 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 1.2 m95 -122.18 135.76 54.82 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -115.42 131.35 56.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.984 0.421 . . . . 0.0 110.733 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 15.8 m -116.02 130.46 56.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.765 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -94.88 115.31 27.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.66 HD11 ' HE3' ' A' ' 908' ' ' TRP . 86.3 mt -82.28 154.43 25.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -20.41 65.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.24 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.3 m -84.7 0.84 49.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 110.893 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.38 14.56 58.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.475 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 906' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -90.03 139.14 30.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.626 0.25 . . . . 0.0 110.429 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.44 122.31 55.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.66 ' HE3' HD11 ' A' ' 902' ' ' LEU . 1.6 t-105 -110.75 114.72 28.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.821 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.79 117.7 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 111.071 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.731 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 22.3 pt20 -105.41 161.62 14.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.452 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.523 ' HE1' HD21 ' A' ' 917' ' ' LEU . 43.3 m-85 -121.61 -179.91 4.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.875 0.369 . . . . 0.0 111.515 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.52 -26.86 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.774 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -87.82 1.18 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.234 0.54 . . . . 0.0 111.006 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.52 4.84 87.43 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.495 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.8 t -79.43 151.12 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.57 ' HB3' ' HE1' ' A' ' 908' ' ' TRP . 29.5 mt-30 -133.46 154.92 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.476 -171.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.659 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 0.9 OUTLIER -139.66 136.04 33.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 165.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.6 p -113.28 126.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.148 0.499 . . . . 0.0 110.533 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 926' ' ' ILE . 32.7 t -117.29 132.5 66.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.911 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 83.8 mm-40 -88.15 138.02 31.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.14 125.35 23.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 86.85 -6.06 83.76 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.25 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 925' ' ' SER . 36.4 t -107.56 138.22 34.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 59.8 m -91.44 -6.44 52.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.836 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 923' ' ' VAL . 72.1 p -90.62 114.98 27.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.018 0.437 . . . . 0.0 110.077 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 919' ' ' VAL . 78.6 mt -112.77 146.61 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.045 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 14.0 m -117.31 115.64 25.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 52.0 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.126 0.489 . . . . 0.0 110.3 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.543 HG23 HG22 ' A' ' 935' ' ' THR . 24.4 m -113.1 121.99 46.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' ' 932' ' ' ASN . 7.2 p -122.23 99.05 43.66 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.61 -26.73 80.24 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.61 2.873 . . . . 0.0 112.19 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 932' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' ' 930' ' ' SER . 27.4 p-10 -71.63 -2.12 16.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.231 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -154.03 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.763 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -163.64 -175.43 4.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.898 0.38 . . . . 0.0 110.203 -168.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 929' ' ' THR . 82.4 p -104.02 133.53 48.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 936' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 928' ' ' TYR . 14.2 t -117.47 140.93 48.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -107.09 130.46 54.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.088 0.471 . . . . 0.0 111.503 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.47 ' CE1' HD21 ' A' ' 944' ' ' LEU . 12.0 t80 -104.57 127.81 52.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.986 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -130.45 174.7 19.6 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -54.62 -27.04 36.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 0.0 111.68 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.02 2.85 53.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.48 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -104.67 141.29 36.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 111.857 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -99.46 123.93 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.069 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 938' ' ' TYR . 1.5 mm? -79.84 133.23 58.84 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 18.8 Cg_exo -67.35 -66.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.938 2.426 . . . . 0.0 112.931 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -152.62 -74.97 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.271 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -64.18 -29.75 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.489 ' O ' HD13 ' A' ' 952' ' ' LEU . 45.2 mm -68.21 -44.09 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.866 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.47 -39.19 91.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 950' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 953' ' ' GLN . 5.6 tp-100 -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.015 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 13.8 ptpt -69.22 -36.75 77.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.996 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 948' ' ' ILE . 4.7 mp -56.95 -31.61 65.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 953' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 950' ' ' GLN . 5.7 tp-100 -58.63 -31.04 67.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.165 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 38.1 t -69.41 -20.91 63.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 952' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.5 mttm . . . . . 0 C--O 1.233 0.215 0 CA-C-O 121.431 0.634 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 16.6 p -106.8 142.9 35.69 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.956 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.85 140.7 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.05 119.4 30.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 109.951 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.56 122.61 50.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 62.14 2.88 0.88 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.524 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.15 22.33 11.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.633 0.773 . . . . 0.0 110.24 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.41 -30.47 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.379 0.609 . . . . 0.0 110.099 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.73 168.33 25.03 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.674 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.561 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.2 OUTLIER -117.1 134.72 54.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -119.51 131.07 55.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.096 0.474 . . . . 0.0 111.334 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 14.9 m -115.41 126.72 54.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.336 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -89.82 138.77 31.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.899 0.381 . . . . 0.0 110.264 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.29 142.32 44.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 18.7 p -66.86 -15.01 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 0.0 111.077 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 4.0 m -79.48 0.3 30.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.957 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.8 3.98 65.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.599 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -93.2 141.49 28.37 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 919' ' ' VAL . 3.4 p -119.05 122.71 69.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.452 0.644 . . . . 0.0 109.428 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 11.5 t-105 -97.71 113.83 25.67 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.351 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 917' ' ' LEU . 3.3 p -114.56 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.596 0.712 . . . . 0.0 110.363 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.561 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 53.0 tt0 -98.68 142.63 30.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.975 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -91.79 151.62 20.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.674 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -64.13 -22.97 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.68 2.18 38.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 96.48 6.55 58.5 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.219 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.2 m -95.47 158.72 15.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.839 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 17.7 pm0 -132.91 154.96 49.91 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.254 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.795 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.3 mp -129.04 139.81 51.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.97 122.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 907' ' ' VAL . 61.4 t -117.24 132.54 66.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.785 0.326 . . . . 0.0 110.217 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -92.23 139.4 30.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -52.81 128.96 28.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.53 -6.41 63.01 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.962 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 923' ' ' VAL . 14.6 t 61.31 32.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 121.885 0.85 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 15.5 m -72.87 -14.94 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.394 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 22.8 t -173.51 125.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.617 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.615 HG22 HG13 ' A' ' 919' ' ' VAL . 0.2 OUTLIER -125.02 144.16 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.527 ' OG ' ' HG2' ' A' ' 937' ' ' ARG . 10.2 m -118.82 122.04 41.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -96.66 124.08 40.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.883 HG23 ' HB ' ' A' ' 935' ' ' THR . 14.1 m -115.5 122.75 46.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 23.0 p -125.88 102.35 28.45 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.04 -40.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.752 2.968 . . . . 0.0 113.366 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.0 -29.74 71.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.552 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -116.61 -75.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.309 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -163.71 153.4 14.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.658 0.266 . . . . 0.0 111.118 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.883 ' HB ' HG23 ' A' ' 929' ' ' THR . 8.9 t -104.87 125.37 50.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 936' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 927' ' ' SER . 27.2 m -120.07 135.64 54.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.405 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.527 ' HG2' ' OG ' ' A' ' 927' ' ' SER . 40.2 mtp180 -98.11 126.79 43.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.92 140.46 45.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.163 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 939' ' ' GLY . . . . . 0.555 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -106.4 161.68 14.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.404 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -5.76 20.65 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.391 0.615 . . . . 0.0 110.526 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -90.61 2.11 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.84 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 11.8 pt-20 -129.07 170.9 12.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.227 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -80.14 129.9 34.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.467 . . . . 0.0 110.521 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 948' ' ' ILE . 32.2 mt -98.05 133.38 23.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.006 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.64 ' HB2' HD13 ' A' ' 948' ' ' ILE . 26.6 Cg_exo -63.74 156.11 59.51 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 111.629 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.89 -53.07 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.62 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 947' ' ' TYR . . . . . 0.409 ' O ' ' HD2' ' A' ' 951' ' ' LYS . 78.4 m-85 -63.24 -31.3 72.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.573 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -67.82 -42.94 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.836 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -63.31 -39.9 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.125 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.35 -43.77 98.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.599 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.529 ' HE2' ' N ' ' A' ' 951' ' ' LYS . 0.7 OUTLIER -68.34 -40.41 81.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.328 0.585 . . . . 0.0 109.694 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.76 -36.04 77.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -27.44 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.125 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.3 -20.58 63.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.54 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.91 -178.65 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.2 m -102.34 143.28 32.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.863 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.05 139.11 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -94.3 130.44 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.842 0.353 . . . . 0.0 110.598 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.46 118.79 54.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.0 9.68 0.33 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.415 1.072 . . . . 0.0 112.061 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 59.58 22.85 11.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.307 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.6 t -104.86 -30.42 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.29 159.33 25.66 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.024 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.3 135.97 54.82 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.64 129.85 53.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.84 0.353 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 43.9 m -107.09 132.89 52.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.116 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -93.6 115.07 27.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.964 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.17 146.43 23.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.9 t -63.82 -14.24 51.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.479 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 6.0 p -86.59 0.37 54.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.104 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.84 13.64 66.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.832 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 955' ' ' LEU . 42.7 t -109.81 123.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 7.1 t-105 -109.42 113.62 26.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 46.4 t -115.28 117.26 55.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 60.5 tt0 -106.52 142.99 35.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.48 160.81 16.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.73 -16.35 63.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.351 0.596 . . . . 0.0 110.127 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -73.9 -1.47 19.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.817 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.72 2.61 89.82 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.104 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.6 m -97.44 151.1 20.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.479 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 1.2 pm0 -133.3 162.45 31.78 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.357 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 917' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.23 137.41 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.828 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 927' ' ' SER . 21.2 t -104.67 123.81 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.767 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 30.9 t -117.28 132.77 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.205 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -92.36 138.95 31.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.41 126.84 29.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.006 0.432 . . . . 0.0 111.002 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.53 83.5 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.639 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 925' ' ' SER . 25.3 t -110.17 128.4 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.596 -0.355 . . . . 0.0 110.737 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 32.4 t -89.28 -7.22 55.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.628 ' H ' HG12 ' A' ' 923' ' ' VAL . 23.8 m -90.89 111.97 23.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 952' ' ' LEU . 43.1 pt -113.75 165.77 8.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.439 -171.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 918' ' ' VAL . 9.1 p -116.97 116.02 26.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.281 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.19 131.07 44.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.758 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 7.3 m -111.35 124.35 52.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 48.3 t -115.92 127.44 26.77 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.513 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.64 -7.7 7.78 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.21 3.273 . . . . 0.0 112.695 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -54.54 -28.62 46.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.494 0.664 . . . . 0.0 109.572 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 117.07 35.54 1.11 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.327 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.82 140.0 11.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.769 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 7.2 t -104.31 127.31 51.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.273 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 15.0 t -117.92 138.64 52.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.618 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -98.35 130.34 45.01 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.53 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.29 127.41 53.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.8 13.3 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.339 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.0 -25.72 67.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.315 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -94.29 1.55 55.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.24 0.543 . . . . 0.0 110.649 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.8 160.98 16.25 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.034 -0.416 . . . . 0.0 110.974 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -85.31 122.85 30.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.426 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 948' ' ' ILE . 82.6 mt -97.43 133.52 23.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.242 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 15.3 Cg_exo -71.21 169.78 19.84 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.092 2.528 . . . . 0.0 112.444 175.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.45 -56.84 16.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -62.2 -32.38 73.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.477 HG21 HD22 ' A' ' 944' ' ' LEU . 47.8 mm -69.91 -43.56 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.919 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -63.53 -44.92 92.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.51 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -61.4 -44.66 96.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.596 ' O ' ' HG ' ' A' ' 955' ' ' LEU . 11.1 mptt -68.98 -40.19 78.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.768 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.647 HD11 HD13 ' A' ' 926' ' ' ILE . 7.8 mp -63.05 -36.75 84.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.937 0.399 . . . . 0.0 110.273 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -70.63 -35.03 72.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.522 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 954' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 29.6 p -72.5 -24.63 61.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.795 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 951' ' ' LYS . 92.6 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.226 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 889' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 901' ' ' GLN . 3.4 mppt? . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 890' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 15.7 p -98.64 144.36 28.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.952 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 891' ' ' VAL . . . . . 0.732 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 60.6 t -126.23 140.25 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.679 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 892' ' ' PHE . . . . . 0.617 ' HD1' ' HE3' ' A' ' 898' ' ' TRP . 78.0 m-85 -106.6 119.99 40.77 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' A' ' 894' ' ' LYS . 97.3 t -108.76 117.79 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.428 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.443 ' HD3' HG12 ' A' ' 893' ' ' VAL . 2.0 mptm? 54.12 3.87 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.371 1.068 . . . . 0.0 112.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.82 23.98 12.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.196 0.599 . . . . 0.0 110.12 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.34 -29.75 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.96 158.25 25.12 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.985 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.617 ' HE3' ' HD1' ' A' ' 892' ' ' PHE . 0.5 OUTLIER -121.81 136.43 54.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -109.61 132.42 54.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 900' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 8.1 m -101.87 125.84 48.64 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 901' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 889' ' ' LYS . 28.2 mm-40 -94.99 116.51 28.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.007 0.432 . . . . 0.0 110.981 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.13 129.04 49.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.888 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.9 t -67.53 -4.61 12.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.384 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 33.5 t -85.71 -0.09 54.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.69 62.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.319 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.65 138.7 31.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 919' ' ' VAL . 44.0 t -112.4 122.97 67.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 3.1 t-105 -110.27 118.77 37.23 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.1 t -107.21 125.96 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.035 0.445 . . . . 0.0 111.08 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.52 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 76.7 mm-40 -103.46 143.28 32.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.572 173.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.68 167.15 9.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.73 0.3 . . . . 0.0 110.481 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -63.41 -26.43 68.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.75 0.08 55.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.061 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.54 72.34 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.279 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 18.1 m -75.74 153.29 37.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.732 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 47.4 mt-30 -132.03 153.57 50.26 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.058 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.788 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 8.7 mp -130.73 135.36 47.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.141 171.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 927' ' ' SER . 47.4 t -113.34 121.71 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 907' ' ' VAL . 48.2 t -118.08 130.84 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.695 0.284 . . . . 0.0 110.575 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -93.23 139.86 30.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.24 129.52 21.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.072 0.463 . . . . 0.0 111.114 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.16 61.37 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.479 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 923' ' ' VAL . 12.6 t 57.54 34.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.949 0.88 . . . . 0.0 110.317 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.9 m -74.02 -17.53 60.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.34 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 48.3 p -169.64 135.08 1.47 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.343 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.62 144.23 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.604 ' HB3' ' HB ' ' A' ' 918' ' ' VAL . 23.0 t -118.65 117.44 28.96 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -96.76 127.43 42.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 63.5 m -113.07 121.44 44.6 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.585 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 59.5 p -127.84 103.37 21.52 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.23 -12.4 30.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.265 2.643 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -81.76 -10.51 59.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.042 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -151.68 -68.36 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -171.13 164.57 7.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.214 0.507 . . . . 0.0 111.272 -166.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 929' ' ' THR . 39.9 p -104.07 123.85 47.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.7 m -120.47 129.2 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.605 0.241 . . . . 0.0 111.108 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.738 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -98.44 128.56 44.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 110.151 178.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.8 128.0 54.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.384 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.66 166.34 27.72 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.91 -20.54 65.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.0 111.161 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -92.97 2.82 56.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.801 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -96.75 -178.84 4.38 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -100.56 128.42 46.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 945' ' ' PRO . 5.5 tp -92.29 132.74 31.37 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.942 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.774 ' HB2' HD13 ' A' ' 948' ' ' ILE . 37.1 Cg_exo -61.84 152.46 74.5 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.484 2.122 . . . . 0.0 111.435 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -52.99 -64.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.525 0.515 . . . . 0.0 111.922 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -59.91 -32.18 70.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.645 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.774 HD13 ' HB2' ' A' ' 945' ' ' PRO . 2.4 mp -69.55 -42.81 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -40.94 97.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.941 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -42.37 93.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.361 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.986 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 4.5 mmpt? -64.94 -43.45 92.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.211 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.44 -36.62 84.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 110.865 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -66.95 -34.42 77.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.832 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.06 -28.78 64.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.164 0.506 . . . . 0.0 109.893 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 951' ' ' LYS . 7.9 mp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.225 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 121.39 0.614 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 43.5 m -106.96 144.81 33.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.676 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 891' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 88.7 t -114.43 139.56 39.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -106.66 119.97 40.72 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.106 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 895' ' ' ASN . 48.7 t -103.23 120.21 52.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.652 ' HB3' HG12 ' A' ' 896' ' ' VAL . 53.0 tttm 56.98 3.71 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.367 1.042 . . . . 0.0 111.358 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 895' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 893' ' ' VAL . 2.7 t30 60.03 23.65 12.83 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.994 0.918 . . . . 0.0 109.787 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.1 p -104.7 -28.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.225 173.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.77 159.05 24.87 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.854 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.97 136.03 54.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.629 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -107.29 131.69 53.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 900' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 4.2 m -115.14 132.86 56.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.71 116.04 25.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.341 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.29 142.24 40.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.648 0.261 . . . . 0.0 110.389 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.7 p -68.14 -8.62 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.697 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 44.6 t -80.95 -0.8 41.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.223 0.535 . . . . 0.0 110.163 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.94 4.42 87.1 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.66 139.33 30.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.813 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.65 122.58 56.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.492 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 6.5 t-105 -100.66 114.11 27.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.008 -176.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 48.4 t -104.04 115.98 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 110.036 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.854 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 37.3 mt-30 -106.17 142.96 34.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.711 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.479 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 44.8 m-85 -97.24 160.1 14.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.86 -25.78 68.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.471 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -86.38 2.18 48.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.354 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 93.79 5.05 63.14 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.361 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 45.5 m -84.33 152.12 24.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.635 0.718 . . . . 0.0 109.274 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.712 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 40.3 mt-30 -132.47 153.38 50.95 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.799 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.646 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 9.7 mp -130.59 136.24 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.13 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 41.5 t -113.12 120.43 63.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 926' ' ' ILE . 42.9 t -119.35 132.02 70.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.4 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 79.8 mm-40 -90.27 137.93 31.94 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.55 126.77 28.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.52 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.4 -0.42 83.28 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.258 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 925' ' ' SER . 54.5 t -115.06 138.05 46.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.234 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 3.1 p -91.24 -6.13 53.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 923' ' ' VAL . 39.3 m -90.45 138.74 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.643 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.637 HD11 HD22 ' A' ' 952' ' ' LEU . 2.9 mp -118.02 146.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.495 -175.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.688 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 16.0 m -110.68 116.29 31.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.461 ' HB3' HG23 ' A' ' 936' ' ' THR . 24.2 t80 -96.42 126.24 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 47.2 m -113.71 122.8 48.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.09 0.471 . . . . 0.0 111.329 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 10.3 p -122.99 120.35 27.55 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.271 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 -2.13 5.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.399 2.732 . . . . 0.0 112.181 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -59.17 -22.86 61.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.41 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.05 0.87 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.109 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -157.77 133.29 9.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.209 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -105.89 126.87 52.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 166.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 936' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 928' ' ' TYR . 4.3 t -118.32 128.74 54.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.391 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.628 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -103.24 130.79 50.56 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.403 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -108.91 138.76 44.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.726 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 939' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -115.76 156.37 15.68 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.146 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -7.2 26.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.771 0.319 . . . . 0.0 111.855 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -82.34 0.68 40.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.428 0.632 . . . . 0.0 110.209 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 17.2 pt-20 -132.66 -171.95 2.79 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -95.42 122.4 38.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.975 0.417 . . . . 0.0 109.929 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.22 138.42 45.49 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.788 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.68 ' HG2' HD12 ' A' ' 948' ' ' ILE . 48.4 Cg_exo -57.58 142.2 95.5 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.535 2.156 . . . . 0.0 111.231 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -43.24 -63.3 0.84 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.038 0.836 . . . . 0.0 112.935 -172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -67.89 -28.24 67.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 945' ' ' PRO . 59.1 mt -69.72 -44.98 78.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.69 -38.12 88.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.075 0.464 . . . . 0.0 109.985 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 950' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 953' ' ' GLN . 17.2 tm0? -60.16 -42.65 95.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.074 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 1.072 ' HA ' ' HE3' ' A' ' 951' ' ' LYS . 0.0 OUTLIER -69.86 -37.94 76.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.442 0.639 . . . . 0.0 110.003 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.637 HD22 HD11 ' A' ' 926' ' ' ILE . 62.7 tp -57.58 -36.9 72.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 953' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 950' ' ' GLN . 4.9 pp0? -69.61 -21.15 63.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.32 -28.04 65.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.023 0.44 . . . . 0.0 109.981 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.288 175.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 31.0 p -108.31 144.77 35.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.228 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.06 140.13 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.08 125.17 47.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 954' ' ' CYS . 23.2 m -109.76 121.18 62.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 120.834 0.35 . . . . 0.0 110.83 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.718 ' HB2' HG12 ' A' ' 896' ' ' VAL . 71.8 mmtt 58.62 -1.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.709 0.804 . . . . 0.0 112.675 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.46 22.64 12.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.942 0.877 . . . . 0.0 109.154 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 894' ' ' LYS . 9.9 p -104.09 -24.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.096 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 897' ' ' GLY . . . . . 0.412 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -140.78 159.75 26.5 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.057 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.717 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.0 OUTLIER -120.82 135.3 55.2 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 173.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.38 131.45 56.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 9.1 m -110.41 125.24 53.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.835 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -82.44 115.93 21.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.878 0.37 . . . . 0.0 110.022 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.74 149.79 21.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.079 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 13.2 t -66.91 -15.89 63.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.009 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.0 m -80.13 0.26 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 110.734 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.87 87.71 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.715 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.3 157.54 17.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.341 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.61 123.48 71.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.808 0.337 . . . . 0.0 110.223 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -98.12 113.42 25.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.94 117.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.032 0.444 . . . . 0.0 110.615 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.717 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 47.6 tt0 -94.38 143.13 26.66 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.585 ' HD2' ' H ' ' A' ' 913' ' ' ASP . 25.7 t80 -93.51 148.6 21.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -55.13 -25.45 31.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' ASP . . . . . 0.585 ' H ' ' HD2' ' A' ' 911' ' ' PHE . 19.8 t70 -86.24 0.35 53.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.49 5.74 60.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.407 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 50.3 m -85.3 164.1 18.2 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -125.01 151.95 44.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.41 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.605 ' CD2' HG23 ' A' ' 919' ' ' VAL . 10.4 tt -141.49 135.0 29.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 51.2 t -115.98 122.57 69.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 122.384 -0.198 . . . . 0.0 111.209 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.605 HG23 ' CD2' ' A' ' 917' ' ' LEU . 76.4 t -120.07 134.27 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.531 0.205 . . . . 0.0 111.037 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -89.81 136.97 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -62.9 126.9 28.89 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.161 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.2 -2.49 85.29 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.672 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 925' ' ' SER . 54.4 t -106.01 137.61 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.754 0.312 . . . . 0.0 110.865 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.5 m -78.26 -15.89 58.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.817 ' H ' HG12 ' A' ' 923' ' ' VAL . 34.1 m -85.61 117.18 24.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -113.24 145.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.113 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 21.5 m -113.63 116.39 29.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -106.09 128.63 54.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 20.2 m -112.51 121.68 45.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.126 0.489 . . . . 0.0 110.886 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 931' ' ' PRO . 73.5 m -99.77 165.16 15.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.745 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 930' ' ' SER . 72.5 Cg_exo -49.74 156.68 2.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.027 2.485 . . . . 0.0 112.664 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 932' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 931' ' ' PRO . 80.2 m-20 75.01 5.35 4.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 75.44 50.42 8.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.991 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.05 101.06 9.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 8.9 t -100.59 129.18 46.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.428 0.632 . . . . 0.0 111.103 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 32.0 p -116.88 141.4 48.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.448 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -101.55 126.51 48.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.251 0.548 . . . . 0.0 110.698 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.457 ' HB3' HD23 ' A' ' 944' ' ' LEU . 90.2 m-85 -109.91 138.22 46.58 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -154.09 -160.31 9.72 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 119.128 -1.51 . . . . 0.0 113.927 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.03 -27.1 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.432 -0.884 . . . . 0.0 112.441 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.46 1.2 56.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.176 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -132.6 -177.15 4.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -99.23 138.18 36.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 948' ' ' ILE . 63.6 mt -95.22 133.1 26.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' A' ' 948' ' ' ILE . 18.3 Cg_exo -67.44 154.79 72.76 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.883 2.388 . . . . 0.0 111.044 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.78 -37.52 87.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.46 -33.47 75.95 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.436 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.611 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -70.98 -39.55 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.994 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 949' ' ' LYS . . . . . 0.606 ' HE3' ' HB2' ' A' ' 944' ' ' LEU . 33.0 mmtp -56.93 -43.8 81.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.319 0.581 . . . . 0.0 109.714 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.55 -42.32 98.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.341 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 67.3 mmtt -62.51 -43.18 99.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.77 -32.43 72.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.748 0.308 . . . . 0.0 110.498 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.49 -34.84 77.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 954' ' ' CYS . . . . . 0.533 ' HB3' HG11 ' A' ' 893' ' ' VAL . 59.2 m -70.32 -26.64 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.537 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.1 mm? . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.767 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.9 m -104.21 142.46 34.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.89 139.6 40.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.1 127.71 36.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.47 HG13 ' SG ' ' A' ' 954' ' ' CYS . 80.7 t -114.14 119.54 61.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm 59.18 7.52 0.89 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.369 1.043 . . . . 0.0 111.194 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.63 20.45 9.07 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.926 0.89 . . . . 0.0 110.758 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 41.6 t -107.2 -29.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.337 0.589 . . . . 0.0 110.364 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.96 163.04 26.32 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.467 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -121.41 136.94 54.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.117 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -116.36 133.87 55.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.751 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 21.0 m -101.09 125.28 47.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.675 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.45 120.92 37.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.886 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 906' ' ' ALA . 7.4 mp -98.44 144.45 27.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.634 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 15.9 m -67.28 -16.48 64.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.0 p -82.58 0.93 40.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.229 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.86 12.15 62.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.645 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 906' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.44 138.4 31.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.16 121.64 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.507 ' CZ2' ' HG2' ' A' ' 916' ' ' GLN . 30.2 t90 -110.63 113.39 25.96 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.17 116.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.756 0.313 . . . . 0.0 110.951 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 898' ' ' TRP . 35.7 tt0 -105.64 142.85 34.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.455 ' HE2' HD11 ' A' ' 917' ' ' LEU . 38.9 m-85 -88.09 160.64 17.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.598 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -63.81 -16.72 61.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.781 0.801 . . . . 0.0 108.865 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 913' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 911' ' ' PHE . 32.5 t70 -81.84 -0.25 42.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.14 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.19 5.98 86.82 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.628 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 2.0 p -97.78 153.38 18.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.048 0.424 . . . . 0.0 110.132 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 908' ' ' TRP . 0.3 OUTLIER -125.78 154.48 42.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.281 -175.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.455 HD11 ' HE2' ' A' ' 911' ' ' PHE . 5.5 mp -127.78 132.83 49.47 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 119.06 60.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.089 170.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 926' ' ' ILE . 7.8 p -124.66 132.83 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.501 170.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 923' ' ' VAL . 25.6 tt0 -94.61 139.86 30.63 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 170.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.03 39.99 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.552 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 105.43 -6.15 41.76 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.083 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 920' ' ' GLN . 8.6 m -102.28 155.43 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.456 0.628 . . . . 0.0 110.426 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.4 p -92.2 -4.85 53.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.841 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 12.9 p -133.54 135.89 44.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.281 0.562 . . . . 0.0 111.763 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 919' ' ' VAL . 4.4 mp -111.42 146.68 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.779 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 20.0 m -108.47 116.76 32.58 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.404 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -96.62 125.38 41.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 934' ' ' GLN . 8.8 t -116.3 135.03 54.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.741 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 20.1 m -103.74 144.28 28.35 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.795 171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.84 -7.72 1.76 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 124.127 3.218 . . . . 0.0 114.493 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -16.96 62.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 99.12 28.69 7.56 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 934' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 929' ' ' THR . 43.1 tt0 -104.64 110.32 22.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.758 -174.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 929' ' ' THR . 18.2 p -103.54 125.52 50.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.61 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 35.5 m -118.21 134.89 54.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -97.79 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 0.0 110.899 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 944' ' ' LEU . 81.9 m-85 -112.05 134.82 53.37 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.667 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 939' ' ' GLY . . . . . 0.74 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -153.07 -165.7 13.71 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.968 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.11 -27.28 67.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.791 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -97.69 -0.84 44.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.449 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.74 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 8.7 mm-40 -116.97 109.68 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 943' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 943' ' ' LYS . 47.6 mtpt -73.05 138.94 46.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.396 0.617 . . . . 0.0 112.008 -169.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.591 ' CB ' ' HB3' ' A' ' 949' ' ' LYS . 3.3 mm? -94.11 133.82 26.86 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.531 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 25.8 Cg_exo -63.6 -70.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 111.806 177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.29 -77.69 0.1 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -56.8 -32.75 66.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.575 ' HB ' HD12 ' A' ' 944' ' ' LEU . 26.4 mm -70.3 -45.11 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.996 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 949' ' ' LYS . . . . . 0.591 ' HB3' ' CB ' ' A' ' 944' ' ' LEU . 11.8 pttm -66.66 -36.63 83.0 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.568 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.05 -40.8 90.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.912 0.387 . . . . 0.0 110.501 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -66.89 -43.79 82.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 87.4 mt -65.14 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.002 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -61.65 -33.7 74.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.001 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 954' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' A' ' 893' ' ' VAL . 16.7 t -71.47 -24.89 62.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.411 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.446 -177.222 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.2 mttm . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.307 0.575 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 22.9 m -106.8 143.62 34.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.003 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.53 155.38 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.041 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -99.53 130.74 45.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 895' ' ' ASN . 5.9 p -105.39 121.13 57.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.057 0.456 . . . . 0.0 110.27 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.704 ' HB3' HG12 ' A' ' 896' ' ' VAL . 14.4 tmtt? 61.68 -1.44 0.33 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.747 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 895' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 893' ' ' VAL . 19.5 t-20 61.3 23.7 13.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.842 0.829 . . . . 0.0 109.409 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.704 HG12 ' HB3' ' A' ' 894' ' ' LYS . 12.4 p -105.84 -27.89 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -136.01 160.6 24.68 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.812 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.619 ' HB2' ' HG3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.9 136.77 54.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.61 130.38 56.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 32.4 m -115.64 135.83 53.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.981 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -95.03 125.35 39.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.162 0.506 . . . . 0.0 110.118 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.76 146.99 24.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.746 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.4 m -65.13 -20.33 66.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.626 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 0.12 33.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.153 0.502 . . . . 0.0 110.698 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.09 8.88 68.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.444 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.24 148.52 22.87 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.584 ' HB ' HG13 ' A' ' 919' ' ' VAL . 47.4 t -110.37 124.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -104.31 114.56 28.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.06 120.14 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.457 0.646 . . . . 0.0 110.817 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.619 ' HG3' ' HB2' ' A' ' 898' ' ' TRP . 1.1 pt20 -104.65 143.26 33.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -119.6 157.93 27.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.092 0.472 . . . . 0.0 111.763 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.3 -17.9 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -77.4 1.44 19.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.635 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.62 8.4 84.73 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 5.8 p -98.23 153.47 18.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.768 0.318 . . . . 0.0 111.198 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.768 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 77.2 mm-40 -122.78 150.88 42.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.983 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.583 HD12 ' C ' ' A' ' 916' ' ' GLN . 7.1 mp -138.69 133.81 32.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.5 p -116.83 123.94 72.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 168.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 923' ' ' VAL . 2.2 p -117.86 138.27 49.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -93.48 150.62 20.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -49.81 128.38 18.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 922' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 923' ' ' VAL . . . 99.48 -8.35 60.22 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.776 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 919' ' ' VAL . 0.8 OUTLIER 58.2 2.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.238 1.415 . . . . 0.0 113.947 172.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 47.4 m -74.76 -5.66 44.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.152 -0.343 . . . . 0.0 111.639 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 1.9 p -142.01 114.79 8.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.962 0.41 . . . . 0.0 111.318 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.567 HG22 ' HB ' ' A' ' 919' ' ' VAL . 0.2 OUTLIER -126.99 145.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.368 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.53 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 20.1 m -118.24 122.46 43.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -97.34 129.96 44.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.768 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 34.2 m -111.7 121.87 46.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 25.8 m -97.24 135.47 21.86 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.581 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.03 -13.99 17.33 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 113.205 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.48 -25.79 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 109.667 174.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 106.15 35.53 2.92 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -126.8 116.54 21.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.999 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 36.6 p -105.31 126.46 52.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.3 m -117.79 128.66 55.08 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -98.37 126.58 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 110.358 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -112.52 131.12 55.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.44 170.97 16.9 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.62 -20.63 66.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.299 0.55 . . . . 0.0 110.692 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.17 -0.65 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -108.21 147.83 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -99.93 130.97 46.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 111.13 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.1 133.6 72.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.63 -68.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.562 2.174 . . . . 0.0 111.939 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.94 -70.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.751 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -58.62 -29.67 66.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 25.9 mm -67.61 -43.66 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.77 -39.42 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.271 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.08 -43.18 91.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 9.7 mmpt? -68.29 -41.58 80.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.54 -34.99 79.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.697 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.86 -25.66 68.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.626 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.0 -23.15 65.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 36.0 tp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.705 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.309 0.576 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 10.1 m -106.96 147.55 29.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.928 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.03 139.97 45.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -98.91 131.34 45.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.72 120.77 64.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 58.09 4.63 0.32 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.112 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 59.8 23.12 12.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.136 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 95.2 t -104.8 -31.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.44 158.53 25.49 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.172 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -123.27 134.96 54.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.29 130.83 53.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.112 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.2 m -115.98 125.73 52.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.39 115.66 21.52 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.3 148.3 25.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.372 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 2.4 p -67.37 -9.58 42.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.74 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 14.3 m -87.54 1.14 54.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.92 4.53 82.07 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.146 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.2 152.6 20.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.7 123.71 64.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.511 ' HD1' HG22 ' A' ' 918' ' ' VAL . 38.6 t90 -106.83 112.91 26.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 7.7 p -115.51 118.82 59.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 111.151 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 46.7 tt0 -102.34 142.47 33.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.931 175.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -112.06 160.05 17.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.694 0.283 . . . . 0.0 110.876 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.38 -17.62 54.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.774 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.82 1.43 12.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.366 0.603 . . . . 0.0 110.654 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.22 4.59 88.06 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.975 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.4 t -99.48 155.58 17.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 917' ' ' LEU . 15.4 mp0 -130.74 151.7 50.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.92 HD22 ' HD1' ' A' ' 928' ' ' TYR . 1.5 mt -133.62 136.01 44.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.511 HG22 ' HD1' ' A' ' 908' ' ' TRP . 25.2 t -113.6 119.58 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 926' ' ' ILE . 6.7 p -120.14 133.65 66.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 0.0 110.591 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -82.05 143.98 31.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.42 129.69 22.33 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.587 0.554 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 103.12 -8.13 53.09 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.459 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 923' ' ' VAL . 13.7 t 48.49 44.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.953 0.882 . . . . 0.0 111.279 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 5.7 p -82.72 -23.76 33.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.889 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 63.8 m -162.16 130.53 4.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.256 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.619 HG12 HG23 ' A' ' 919' ' ' VAL . 16.3 mt -119.15 145.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.024 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.6 m -118.01 117.35 28.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.92 ' HD1' HD22 ' A' ' 917' ' ' LEU . 41.8 m-85 -99.02 130.05 45.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 916' ' ' GLN . 22.8 p -112.26 122.3 47.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 0.0 110.733 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 45.3 m -140.2 109.75 6.97 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.11 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 931' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 20.8 Cg_endo -60.99 -16.74 47.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.243 2.629 . . . . 0.0 112.61 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -74.89 -10.17 59.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 933' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.25 -68.1 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 934' ' ' GLN . . . . . 0.702 ' HG2' ' H ' ' A' ' 935' ' ' THR . 29.8 tt0 169.14 -168.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.702 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 10.0 t -105.33 128.85 53.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.94 0.4 . . . . 0.0 110.279 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 936' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 928' ' ' TYR . 10.0 t -117.02 142.11 47.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.71 128.66 54.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.1 0.476 . . . . 0.0 111.204 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 53.2 t80 -109.57 128.06 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.114 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -112.37 162.54 12.36 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.69 -5.7 4.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.478 0.639 . . . . 0.0 112.077 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.85 4.65 49.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.425 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 943' ' ' LYS . 6.7 tp10 -122.98 162.2 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 943' ' ' LYS . . . . . 0.819 ' HD3' ' H ' ' A' ' 943' ' ' LYS . 0.0 OUTLIER -99.92 138.81 36.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.023 176.188 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 948' ' ' ILE . 60.7 mt -97.06 140.6 22.18 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.826 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 22.8 Cg_exo -66.18 165.37 24.52 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.806 2.337 . . . . 0.0 111.254 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 946' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 950' ' ' GLN . 58.0 m-20 -53.47 -56.91 12.96 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -61.22 -34.18 74.7 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.662 HG21 HD22 ' A' ' 944' ' ' LEU . 3.2 mp -69.53 -43.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.69 -40.2 96.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.681 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 950' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 946' ' ' ASP . 97.0 mt-30 -61.46 -44.47 97.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.991 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -69.31 -39.91 77.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.292 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.66 -36.79 85.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.331 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -64.58 -24.91 67.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 83.3 m -69.31 -22.29 63.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.455 HD21 HG11 ' A' ' 909' ' ' VAL . 4.1 mm? . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.163 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 49.5 pttt . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.748 0.309 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 39.9 m -91.16 142.89 27.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 34.7 t -125.47 141.41 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -89.1 132.14 34.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.0 121.09 56.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.439 ' HB2' HG12 ' A' ' 896' ' ' VAL . 42.8 mtmt 52.13 11.78 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 59.76 22.47 11.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.438 0.695 . . . . 0.0 110.735 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 894' ' ' LYS . 14.9 p -105.4 -29.06 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.54 162.24 26.16 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.13 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.785 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.3 m95 -118.73 136.09 54.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.91 130.14 54.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.876 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.8 m -117.58 125.31 50.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.253 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -92.0 116.02 28.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 902' ' ' LEU . 3.3 mm? -91.38 152.55 20.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 19.1 p -67.0 -20.06 65.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.538 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 16.2 m -84.88 3.57 37.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 85.2 11.12 76.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.4 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.06 148.91 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.88 122.89 68.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HB2' HD21 ' A' ' 902' ' ' LEU . 4.1 t-105 -108.49 113.64 26.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 39.9 t -115.8 117.75 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 110.768 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.785 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 17.7 mp0 -101.71 148.8 24.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.447 ' HE2' HD22 ' A' ' 917' ' ' LEU . 57.2 m-85 -118.52 159.75 22.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.946 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.1 -17.05 63.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.89 1.53 17.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.651 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.97 5.53 87.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.14 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.2 m -97.21 156.87 16.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 79.4 mt-30 -123.15 152.43 41.17 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.731 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 916' ' ' GLN . 10.6 mp -133.96 136.3 44.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 36.4 t -112.52 121.15 64.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.93 138.54 49.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -92.58 137.15 32.61 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.73 127.96 33.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.538 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.47 84.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.456 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 925' ' ' SER . 8.4 t -122.53 146.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 117.334 0.567 . . . . 0.0 110.331 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.0 t -86.06 -6.62 58.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.492 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.575 ' H ' HG12 ' A' ' 923' ' ' VAL . 59.6 p -74.1 121.13 20.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 110.287 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 926' ' ' ILE . 0.2 OUTLIER -124.39 146.91 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.825 -177.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 31.7 m -107.86 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.99 128.32 42.77 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 27.3 m -113.0 122.05 46.47 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.387 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 20.2 m -102.93 124.04 40.03 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.352 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 931' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 31.6 Cg_exo -60.59 -10.99 15.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.568 2.845 . . . . 0.0 113.426 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.91 -15.45 63.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.26 0.553 . . . . 0.0 110.164 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 111.25 44.29 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.866 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -140.58 111.78 7.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.549 0.214 . . . . 0.0 111.098 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 20.8 m -104.59 123.57 47.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 26.5 m -121.75 128.31 51.61 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 0.1 OUTLIER -104.65 128.87 52.83 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.274 176.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -107.86 127.14 53.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.745 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -94.26 167.54 27.72 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.806 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.27 -27.48 67.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.219 0.533 . . . . 0.0 110.609 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.21 1.92 48.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.24 -173.62 2.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -99.14 119.11 37.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 945' ' ' PRO . 13.3 tp -101.67 131.77 22.51 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 944' ' ' LEU . 19.2 Cg_exo -68.55 153.53 73.46 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.767 2.312 . . . . 0.0 111.993 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.91 -46.44 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.487 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.14 -32.2 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.774 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 47.4 mm -69.32 -44.03 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 110.013 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -64.69 -44.18 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -61.16 -43.65 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -38.61 83.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.546 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 83.1 mt -64.01 -36.39 83.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 110.569 175.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -63.13 -23.08 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.867 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.94 -25.27 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 178.924 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.008 0.432 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 890' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 66.8 m -106.96 144.4 33.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 111.474 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.83 140.0 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.43 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -100.88 124.43 46.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.042 0.449 . . . . 0.0 110.944 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.0 p -117.07 123.93 72.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.299 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 67.63 -7.86 0.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.09 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 60.51 22.29 12.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.015 0.926 . . . . 0.0 110.089 -168.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.69 -28.65 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.881 171.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 897' ' ' GLY . . . . . 0.551 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -138.93 158.68 25.27 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.105 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.844 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 0.8 OUTLIER -122.65 136.2 54.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -114.2 130.89 56.62 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.969 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 89.9 m -109.93 124.61 51.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -97.27 115.44 27.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.0 111.224 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 906' ' ' ALA . 98.0 mt -90.22 130.37 36.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 16.9 m -67.06 -9.29 37.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.088 0.471 . . . . 0.0 111.064 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.4 m -80.68 -0.24 37.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.1 60.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.59 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 906' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -91.94 138.71 31.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.66 122.27 69.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.126 0.488 . . . . 0.0 109.844 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -108.4 113.38 26.4 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 955' ' ' LEU . 38.3 t -115.11 118.2 58.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.844 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 11.8 pt20 -103.43 171.32 7.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.798 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -118.44 169.66 9.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -66.19 -17.33 64.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.807 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.66 -0.76 48.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.565 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.2 90.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.017 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 157.6 18.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 910' ' ' GLN . 4.2 pt20 -132.27 154.71 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.59 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 4.6 pp -137.05 137.38 39.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 169.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.16 121.76 65.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.966 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 926' ' ' ILE . 20.5 t -120.73 134.55 63.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.366 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -92.76 139.68 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -58.06 127.12 30.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.93 0.395 . . . . 0.0 111.34 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.48 -6.25 83.35 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.986 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.802 HG12 ' H ' ' A' ' 925' ' ' SER . 46.4 t -99.86 139.56 21.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.996 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.5 p -91.19 -8.37 48.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.404 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.802 ' H ' HG12 ' A' ' 923' ' ' VAL . 14.1 m -93.34 124.84 37.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.472 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 919' ' ' VAL . 55.1 mt -114.48 145.8 19.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.675 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 11.0 p -117.67 116.41 26.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.59 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 79.7 t80 -110.96 127.02 55.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.031 0.443 . . . . 0.0 110.17 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.505 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 14.2 m -114.5 121.97 45.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.534 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 928' ' ' TYR . 32.5 t -115.91 123.72 30.72 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.59 -0.97 5.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.349 2.7 . . . . 0.0 112.489 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.62 -6.63 45.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.717 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.05 31.45 4.73 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.122 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -143.69 118.99 10.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.931 0.395 . . . . 0.0 111.828 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 5.5 t -104.57 127.19 52.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 31.8 m -118.59 128.79 54.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 111.393 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -100.55 127.65 46.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.567 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 60.1 t80 -109.1 126.27 53.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.388 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.31 161.11 14.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.78 -4.78 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.986 0.422 . . . . 0.0 112.046 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.76 2.98 56.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.036 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.64 176.03 8.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.05 143.76 29.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.545 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 948' ' ' ILE . 51.6 mt -97.37 147.1 32.48 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.224 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.583 ' HB2' HD13 ' A' ' 948' ' ' ILE . 31.9 Cg_exo -59.23 154.96 42.81 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.454 2.103 . . . . 0.0 110.447 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -57.32 -43.25 83.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -170.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 947' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 85.4 m-85 -68.31 -35.3 77.6 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.324 -176.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 944' ' ' LEU . 2.5 mp -70.92 -43.36 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 949' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 944' ' ' LEU . 18.0 tppt? -63.7 -39.61 94.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -44.55 97.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.777 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 947' ' ' TYR . 13.5 mmmm -65.29 -42.92 92.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 919' ' ' VAL . 3.7 mm? -63.04 -35.71 81.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -69.48 -34.88 74.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.12 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 85.0 m -70.53 -24.72 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 909' ' ' VAL . 85.9 mt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.617 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 57.9 p -106.75 141.57 37.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.511 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.7 140.15 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.59 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -106.53 130.51 54.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.962 0.411 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.17 117.94 46.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 45.55 17.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.96 1.412 . . . . 0.0 112.749 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.74 24.38 12.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.4 t -102.09 -30.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.13 157.55 24.95 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.643 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -124.89 136.55 53.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 909' ' ' VAL . . . -124.65 131.78 53.45 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.197 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 17.1 m -105.01 125.54 51.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -85.76 116.66 24.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.23 158.43 23.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.885 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.3 m -66.79 -22.04 66.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.733 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 7.8 t -83.38 0.63 45.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.976 0.417 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.33 4.88 67.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.341 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.07 140.69 29.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.476 HG11 HD12 ' A' ' 955' ' ' LEU . 36.4 t -106.06 123.55 60.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HE1' ' HB3' ' A' ' 916' ' ' GLN . 3.0 t90 -102.24 111.96 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.611 HG13 ' HG ' ' A' ' 917' ' ' LEU . 3.2 p -114.51 118.29 58.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.601 0.715 . . . . 0.0 111.119 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 1.033 ' HB3' ' HG2' ' A' ' 916' ' ' GLN . 1.3 pm0 -106.88 148.02 29.07 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.229 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 951' ' ' LYS . 36.5 m-85 -91.47 175.05 7.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.185 0.517 . . . . 0.0 110.956 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -65.23 -17.39 64.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.698 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.62 -2.44 50.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.37 0.605 . . . . 0.0 111.201 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.01 90.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 63.5 m -95.68 152.29 18.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 1.033 ' HG2' ' HB3' ' A' ' 910' ' ' GLN . 32.0 mt-30 -132.05 154.86 48.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.726 0.298 . . . . 0.0 111.269 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.611 ' HG ' HG13 ' A' ' 909' ' ' VAL . 0.8 OUTLIER -137.83 137.98 38.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.927 0.394 . . . . 0.0 110.003 169.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 15.7 t -104.27 123.39 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.008 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 926' ' ' ILE . 42.5 t -118.21 129.9 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.788 176.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -94.59 139.6 30.98 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.32 127.61 32.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.874 0.369 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.74 83.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.61 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 925' ' ' SER . 30.7 t -115.78 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 122.792 -0.24 . . . . 0.0 110.508 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 35.0 t -91.06 -10.35 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 923' ' ' VAL . 12.5 m -82.61 111.52 18.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.732 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 952' ' ' LEU . 40.4 pt -113.3 155.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 0.0 110.918 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 14.4 m -117.49 116.34 26.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 911' ' ' PHE . 39.7 t80 -101.0 124.68 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.0 t -116.31 128.37 55.5 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.065 0.46 . . . . 0.0 110.046 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.2 t -132.88 120.71 16.58 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.43 -12.96 30.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.076 2.518 . . . . 0.0 111.732 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -76.72 -15.87 59.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.097 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 933' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.09 -68.38 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 934' ' ' GLN . . . . . 0.723 ' HG3' ' H ' ' A' ' 935' ' ' THR . 4.0 tp-100 166.1 -164.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.723 ' H ' ' HG3' ' A' ' 934' ' ' GLN . 18.9 m -103.42 127.11 50.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.001 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.6 t -119.06 143.34 47.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.255 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 937' ' ' ARG . 8.1 ptt180 -97.78 135.18 39.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.214 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.515 ' HB3' HD21 ' A' ' 944' ' ' LEU . 76.9 m-85 -110.78 126.88 55.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 170.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 939' ' ' GLY . . . . . 0.669 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -146.21 -170.74 15.05 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.231 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.89 -27.41 68.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.828 0.347 . . . . 0.0 110.832 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.89 1.38 57.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.113 0.483 . . . . 0.0 110.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.669 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 1.3 mp0 -108.07 174.47 5.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.679 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -99.17 124.19 44.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 938' ' ' TYR . 62.5 mt -97.01 131.04 28.47 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.984 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 15.7 Cg_exo -72.03 154.67 57.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.903 2.402 . . . . 0.0 111.033 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.26 -48.08 82.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.12 -176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 947' ' ' TYR . . . . . 0.728 ' O ' ' HD3' ' A' ' 951' ' ' LYS . 44.9 m-85 -66.82 -30.67 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.6 -40.81 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.821 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -63.34 -37.63 88.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.004 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -61.08 -44.63 97.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.047 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.728 ' HD3' ' O ' ' A' ' 947' ' ' TYR . 2.3 mptp? -68.61 -42.96 77.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.313 0.578 . . . . 0.0 109.483 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.527 HD13 HG21 ' A' ' 926' ' ' ILE . 62.1 tp -59.38 -38.34 80.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.605 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.19 -25.59 63.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 71.3 m -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.932 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.476 HD12 HG11 ' A' ' 907' ' ' VAL . 2.8 mm? . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.602 0.239 . . . . 0.0 111.435 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.384 0.611 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 14.5 m -107.52 148.36 29.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.629 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 891' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 19.8 t -112.93 138.48 42.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -108.58 126.15 52.63 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.02 118.6 59.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.38 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.641 ' HB2' HG12 ' A' ' 896' ' ' VAL . 94.0 mttt 53.49 7.97 0.12 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.31 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.3 23.49 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.627 0.771 . . . . 0.0 109.854 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.5 p -105.2 -28.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.65 158.14 24.92 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.876 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.447 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 2.9 m95 -122.97 136.53 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -110.87 130.07 55.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.026 0.441 . . . . 0.0 110.124 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 900' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 10.1 m -116.99 125.37 51.28 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.758 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.92 117.08 29.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.228 0.537 . . . . 0.0 110.112 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.6 mm? -95.56 137.05 35.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.807 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.7 t -63.34 -17.82 62.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 22.7 t -81.81 1.04 36.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.07 11.31 61.55 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.029 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.43 140.63 29.58 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.823 -0.222 . . . . 0.0 110.443 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.735 HG11 HD11 ' A' ' 955' ' ' LEU . 46.7 t -107.59 122.83 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.77 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 1.5 t90 -110.23 115.74 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.452 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 57.5 t -112.41 119.39 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.436 0.636 . . . . 0.0 110.245 173.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.665 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 50.0 tt0 -104.4 143.33 33.14 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.478 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.52 171.06 9.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.56 -21.04 66.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.25 1.87 49.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.642 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.0 5.35 87.78 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.085 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.5 m -94.63 152.07 18.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.665 ' HG2' ' HG3' ' A' ' 910' ' ' GLN . 51.6 mt-30 -134.5 159.15 42.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 926' ' ' ILE . 1.3 pt? -137.91 136.07 36.7 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 169.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 907' ' ' VAL . 7.0 m -114.3 128.08 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.43 . . . . 0.0 111.545 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.93 136.69 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -92.3 140.86 29.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.21 128.5 37.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.32 -6.14 83.6 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 925' ' ' SER . 41.6 t -111.61 134.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.109 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.8 m -91.0 -5.34 55.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.743 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.745 ' H ' HG12 ' A' ' 923' ' ' VAL . 15.0 m -95.43 131.58 41.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.475 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 917' ' ' LEU . 3.7 mp -113.15 146.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 15.2 m -115.34 117.1 29.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.632 ' HB2' ' HE1' ' A' ' 938' ' ' TYR . 43.8 t80 -96.24 127.18 42.01 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 8.9 t -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.333 0.587 . . . . 0.0 110.918 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 22.8 t -118.01 111.18 39.1 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.01 144.83 93.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.0 12.62 8.05 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.577 0.548 . . . . 0.0 110.396 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 933' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 934' ' ' GLN . . . -131.39 -91.46 0.54 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 934' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 933' ' ' GLY . 30.0 mt-30 178.01 168.1 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.621 0.768 . . . . 0.0 109.9 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 50.3 m -105.24 126.2 51.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.663 0.268 . . . . 0.0 110.359 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 24.7 m -118.96 128.84 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.414 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 13.7 ptm180 -99.67 127.4 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.369 0.604 . . . . 0.0 111.278 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 928' ' ' TYR . 26.0 p90 -110.06 138.53 46.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.011 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -90.94 -179.71 43.0 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.615 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.45 -13.01 60.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.813 0.34 . . . . 0.0 111.152 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.83 -0.16 57.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -92.67 141.07 28.88 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.94 -0.475 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 943' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 943' ' ' LYS . 23.5 mtmm -92.99 123.5 36.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.32 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -96.51 135.53 22.34 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 33.9 Cg_exo -61.62 -73.43 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.909 2.406 . . . . 0.0 113.148 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -145.61 -71.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -64.1 -32.77 74.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.667 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 32.5 mm -68.53 -43.06 83.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -64.01 -39.68 94.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.807 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.56 -43.7 96.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 951' ' ' LYS . 2.8 mptp? -67.95 -38.69 83.11 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.208 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 89.2 mt -62.97 -31.74 72.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.159 0.504 . . . . 0.0 110.494 175.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -69.27 -36.42 77.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.5 -11.71 60.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.588 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.735 HD11 HG11 ' A' ' 907' ' ' VAL . 3.1 mm? . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.821 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 11.1 p -106.64 143.92 34.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.944 0.402 . . . . 0.0 110.823 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.17 142.63 41.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.001 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -106.76 129.16 54.68 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.25 121.03 54.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.62 ' HB3' HG12 ' A' ' 896' ' ' VAL . 58.9 tttm 57.8 4.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.136 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.66 24.42 14.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.779 0.799 . . . . 0.0 109.178 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.9 p -103.71 -28.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.21 158.47 25.34 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.849 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.701 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.7 OUTLIER -121.6 135.43 54.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 899' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.4 130.18 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.067 0.46 . . . . 0.0 110.865 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 28.8 m -115.66 132.85 56.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.047 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -94.82 115.79 27.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.33 153.67 19.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -19.11 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.239 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.3 m -85.2 1.03 49.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.715 0.293 . . . . 0.0 111.262 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.73 69.11 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.943 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 906' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.35 141.76 28.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.6 122.31 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 2.0 t-105 -104.01 114.62 29.0 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 48.7 t -112.41 117.29 54.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.265 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.701 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 42.7 mt-30 -103.62 143.51 32.66 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.907 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 152.41 20.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.418 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 912' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 896' ' ' VAL . 26.7 p30 -65.09 -16.24 63.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.35 2.34 50.63 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.289 -0.257 . . . . 0.0 111.555 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.53 5.81 60.04 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.602 -0.808 . . . . 0.0 114.202 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 14.0 m -96.53 157.93 15.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.756 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.8 OUTLIER -133.2 154.68 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.02 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 917' ' ' LEU . 5.6 mp -123.07 134.85 54.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.495 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.67 118.66 59.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.25 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 955' ' ' LEU . 12.5 p -123.22 144.61 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 906' ' ' ALA . 61.8 tt0 -93.17 139.55 30.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.146 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.99 128.93 38.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 99.24 -4.01 58.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.981 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 925' ' ' SER . 9.9 p -139.69 151.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 117.257 0.529 . . . . 0.0 110.521 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 940' ' ' GLU . 5.1 p -91.45 -6.74 52.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.499 ' H ' HG22 ' A' ' 923' ' ' VAL . 16.4 p -68.49 108.85 3.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.25 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.05 145.28 25.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.343 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 6.2 p -117.61 122.41 43.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.795 0.331 . . . . 0.0 110.292 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -96.1 127.89 42.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.756 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 20.9 m -113.96 123.39 49.61 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.323 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 930' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 48.0 t -107.35 115.06 60.24 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 931' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 23.3 Cg_exo -65.59 2.48 1.57 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.673 2.915 . . . . 0.0 112.861 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.33 -3.48 57.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.55 . . . . 0.0 109.563 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.45 44.28 1.59 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.373 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.29 102.57 2.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 11.9 t -105.43 129.67 53.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.042 0.448 . . . . 0.0 110.57 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 14.8 p -116.93 128.64 55.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.033 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 7.2 ptp85 -107.8 126.89 53.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.552 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.46 139.65 46.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.574 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 939' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 942' ' ' GLU . . . -109.39 173.1 16.75 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.033 174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 940' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 924' ' ' SER . 30.5 tt0 -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.83 0.347 . . . . 0.0 111.569 -176.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -95.34 2.22 54.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.322 0.582 . . . . 0.0 110.688 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 942' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 939' ' ' GLY . 33.4 mm-40 -91.48 172.32 8.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 130.77 46.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.952 0.406 . . . . 0.0 110.111 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -94.84 133.2 26.9 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.866 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 945' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 31.4 Cg_exo -59.82 -65.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 0.0 111.683 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -165.68 -64.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.46 -33.59 72.79 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.57 -172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.24 -42.72 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.2 -44.27 92.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.452 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.6 -43.98 96.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.682 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 951' ' ' LYS . 35.4 mmtm -71.15 -38.02 72.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 955' ' ' LEU . 28.0 tp -57.98 -36.56 72.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.858 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.51 -35.09 79.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.885 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 27.8 t -72.1 -25.26 61.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.256 0.55 . . . . 0.0 110.602 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 952' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 t -107.36 143.42 35.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.754 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 35.0 t -126.42 140.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.272 . . . . 0.0 110.565 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -92.07 130.68 37.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 954' ' ' CYS . 14.4 m -111.2 122.26 65.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.972 0.415 . . . . 0.0 111.597 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 894' ' ' LYS . . . . . 0.726 ' HB3' HG12 ' A' ' 896' ' ' VAL . 39.8 ttmt 60.91 1.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.932 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.08 22.52 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.074 -170.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 896' ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.3 p -104.22 -29.19 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.9 160.32 26.17 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.327 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.537 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -120.68 133.79 55.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -125.14 130.66 52.63 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.243 -0.583 . . . . 0.0 112.188 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 52.0 m -115.52 125.65 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.296 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -86.59 124.13 32.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.14 141.7 28.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 3.6 m -66.65 -8.4 27.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 3.0 m -85.49 0.5 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.32 4.21 71.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.68 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.02 142.67 27.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.2 123.18 68.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -107.71 112.55 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 917' ' ' LEU . 6.0 p -116.85 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.748 0.785 . . . . 0.0 110.767 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.537 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 7.6 tt0 -91.91 143.14 26.8 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.857 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 911' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 913' ' ' ASP . 19.7 t80 -92.66 150.0 20.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.8 -19.72 60.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 913' ' ' ASP . . . . . 0.809 ' H ' ' HD1' ' A' ' 911' ' ' PHE . 37.9 t70 -79.97 1.1 28.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.188 0.518 . . . . 0.0 111.264 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 91.94 5.71 65.93 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.94 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.7 p -96.05 153.3 17.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -121.83 155.48 35.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.549 0.214 . . . . 0.0 110.555 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 909' ' ' VAL . 7.9 tt -137.75 131.0 30.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.54 120.8 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.33 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.22 145.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.74 139.33 30.66 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.42 128.68 37.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.811 0.338 . . . . 0.0 111.691 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.02 -6.63 64.19 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.09 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.07 156.36 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 122.511 -0.405 . . . . 0.0 111.1 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 944' ' ' LEU . 42.0 m -90.32 -5.68 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 15.3 t -69.2 112.35 5.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.218 0.532 . . . . 0.0 109.839 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 948' ' ' ILE . 0.0 OUTLIER -120.64 146.61 25.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.897 -174.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 5.8 m -116.15 117.63 30.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -108.02 129.37 55.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 23.6 m -100.44 121.94 42.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 44.6 t -123.02 125.03 26.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -11.92 32.42 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.348 2.032 . . . . 0.0 111.422 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -105.06 -14.5 15.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.916 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -149.33 22.3 1.22 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.458 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 934' ' ' GLN . . . . . 0.803 ' HG2' ' H ' ' A' ' 935' ' ' THR . 39.3 tt0 68.3 -161.26 0.2 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.051 0.426 . . . . 0.0 109.906 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.803 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 3.3 p -97.29 126.0 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.439 . . . . 0.0 110.972 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 19.9 p -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.851 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -98.95 128.99 45.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.855 0.36 . . . . 0.0 110.369 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 938' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 926' ' ' ILE . 58.4 m-85 -101.84 127.85 48.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.41 141.74 15.67 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.676 -167.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.35 -21.88 66.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.533 0.682 . . . . 0.0 109.802 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.18 2.04 37.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.862 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -142.02 -140.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.838 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -100.01 136.26 40.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.706 -169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 924' ' ' SER . 24.6 mt -99.96 132.74 22.35 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.836 169.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.54 155.29 70.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.677 2.251 . . . . 0.0 111.42 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 946' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 950' ' ' GLN . 24.8 t70 -60.21 -46.74 88.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.376 -176.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -61.69 -31.81 71.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 111.348 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 926' ' ' ILE . 45.3 mm -69.35 -42.56 81.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.44 . . . . 0.0 109.966 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -63.01 -37.24 86.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.104 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 950' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 946' ' ' ASP . 81.1 mm-40 -61.11 -44.14 97.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.609 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.63 -43.64 79.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.4 -36.24 83.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.855 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -59.4 -34.18 72.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.261 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 954' ' ' CYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 893' ' ' VAL . 61.2 m -69.9 -25.41 63.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.651 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -178.397 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.056 0.455 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 3.8 p -107.08 154.0 21.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.804 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.63 139.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -97.08 130.13 44.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 893' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 954' ' ' CYS . 44.7 t -116.51 119.46 62.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.629 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 56.37 4.96 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.622 1.201 . . . . 0.0 112.316 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 59.07 23.58 11.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.333 0.653 . . . . 0.0 109.944 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.57 -29.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.78 158.77 25.76 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.448 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 898' ' ' TRP . . . . . 0.463 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 3.6 m95 -121.03 136.0 55.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.49 130.16 52.76 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.104 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 23.9 m -116.62 127.07 54.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.483 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -88.63 117.55 27.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.887 0.375 . . . . 0.0 110.427 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 908' ' ' TRP . 3.1 mm? -80.21 149.42 30.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.975 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 8.4 t -65.88 -20.28 66.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.446 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 39.9 t -83.95 0.77 46.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 111.041 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.62 6.5 63.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.912 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -85.24 152.34 23.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 907' ' ' VAL . . . . . 0.536 ' HB ' ' CG1' ' A' ' 919' ' ' VAL . 45.2 t -112.08 122.92 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.252 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 908' ' ' TRP . . . . . 0.699 ' HB2' HD21 ' A' ' 902' ' ' LEU . 22.6 t90 -110.08 113.68 26.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 909' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 917' ' ' LEU . 45.7 t -115.2 129.01 72.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 -175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 910' ' ' GLN . . . . . 0.463 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 35.1 mt-30 -98.61 150.05 22.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -108.5 162.25 14.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.475 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.9 -27.77 61.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.347 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.71 1.53 42.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.489 0.662 . . . . 0.0 111.103 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.76 8.19 83.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.065 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.68 165.38 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -0.627 . . . . 0.0 109.519 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -130.8 151.99 50.63 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.2 -177.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -137.67 134.82 35.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.013 0.435 . . . . 0.0 110.018 173.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 918' ' ' VAL . . . . . 0.619 HG22 ' HD1' ' A' ' 908' ' ' TRP . 42.4 t -114.2 124.3 70.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.157 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 907' ' ' VAL . 14.6 p -118.8 132.55 68.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 110.331 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.04 141.66 28.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.162 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.19 40.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 101.33 6.48 50.89 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.647 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 925' ' ' SER . 8.1 p -149.78 141.14 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 940' ' ' GLU . 35.1 t -87.1 -5.57 58.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.874 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 925' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 923' ' ' VAL . 19.6 m -82.31 131.16 35.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.3 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.773 HD11 HD13 ' A' ' 952' ' ' LEU . 3.6 mt -120.0 146.43 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.252 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 917' ' ' LEU . 23.3 t -104.35 115.41 30.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 928' ' ' TYR . . . . . 0.574 ' CZ ' HD13 ' A' ' 917' ' ' LEU . 19.7 m-85 -102.12 125.81 48.91 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 929' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.5 t -114.99 123.52 49.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.57 0.7 . . . . 0.0 110.661 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 43.2 t -105.07 106.61 56.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.697 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.66 -39.0 93.6 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.346 2.697 . . . . 0.0 112.932 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -97.0 16.18 20.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.785 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -137.63 -75.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.532 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 175.54 169.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 935' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 29.1 m -104.43 124.51 49.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 11.1 m -121.54 130.0 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 937' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -97.62 128.96 44.73 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.145 174.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.56 127.44 53.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.803 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.15 169.55 22.89 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.332 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 940' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 924' ' ' SER . 11.7 pt-20 -64.68 -15.93 62.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.449 0.299 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -94.45 1.61 55.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -100.93 146.43 27.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.339 . . . . 0.0 110.684 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.38 123.38 31.56 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 944' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 948' ' ' ILE . 2.2 mm? -91.43 133.57 31.12 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.407 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -71.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.271 2.647 . . . . 0.0 113.334 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -147.26 -75.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.754 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 948' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 948' ' ' ILE . 4.0 mp -67.72 -42.66 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -63.31 -44.05 96.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.781 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -62.25 -42.63 99.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.854 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 951' ' ' LYS . . . . . 0.508 ' O ' HD13 ' A' ' 955' ' ' LEU . 25.5 mmmt -68.81 -40.58 79.49 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.149 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 926' ' ' ILE . 56.5 tp -62.15 -39.65 93.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.847 175.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -73.2 -35.45 66.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.38 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 954' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 31.8 p -71.53 -20.68 62.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.031 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 955' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 951' ' ' LYS . 4.4 mp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 112.246 -0.342 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 97.04 9.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.479 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -156.78 142.43 17.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.237 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -77.74 -65.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.83 133.65 52.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.769 0.318 . . . . 0.0 110.804 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.1 132.08 55.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.845 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 889' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 889' ' ' LYS . 41.1 mmtm -93.07 -4.17 52.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 50.8 m -106.98 142.63 36.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.533 172.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.44 139.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -105.2 119.51 39.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.868 0.366 . . . . 0.0 110.291 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.08 119.25 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.051 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.452 ' HB3' HG12 ' A' ' 896' ' ' VAL . 34.8 ttpt 55.01 5.13 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.842 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.99 24.96 14.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.602 0.761 . . . . 0.0 110.15 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 894' ' ' LYS . 9.7 p -103.18 -27.33 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.64 24.99 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.283 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.2 135.16 54.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 27.1 m -103.7 126.03 50.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.714 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -86.68 116.14 24.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.906 0.384 . . . . 0.0 110.675 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.84 145.6 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 10.0 p -67.18 -20.26 65.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.9 m -81.84 2.61 29.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.308 . . . . 0.0 111.714 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.47 7.9 63.01 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.496 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.53 140.1 30.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 919' ' ' VAL . 4.2 p -117.19 123.17 71.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.282 0.563 . . . . 0.0 109.866 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -101.2 112.23 24.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 917' ' ' LEU . 5.9 p -114.61 117.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.812 0.815 . . . . 0.0 111.046 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 53.2 tt0 -104.53 143.28 33.25 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.52 166.26 10.91 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.779 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -64.85 -20.45 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.698 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.6 1.3 26.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 111.122 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 92.14 5.5 65.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.289 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.0 m -97.23 153.21 18.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.599 ' C ' HD12 ' A' ' 917' ' ' LEU . 83.1 mt-30 -125.4 153.28 43.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.733 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.9 mp -134.22 137.78 44.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.69 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.79 120.66 62.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.519 ' HB ' HG13 ' A' ' 907' ' ' VAL . 74.2 t -119.7 132.65 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.72 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -93.48 138.3 31.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.6 127.1 29.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.58 0.229 . . . . 0.0 110.847 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.41 -0.13 82.95 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.693 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 925' ' ' SER . 27.8 t -120.19 140.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.5 t -91.35 -14.83 30.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 111.131 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.645 ' H ' HG12 ' A' ' 923' ' ' VAL . 22.5 p -87.95 114.67 24.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.361 0.6 . . . . 0.0 110.718 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 938' ' ' TYR . 2.4 pp -116.68 162.89 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.819 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 7.2 t -117.47 117.01 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 935' ' ' THR . 56.2 t80 -105.3 128.63 53.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.795 0.331 . . . . 0.0 110.681 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 31.3 m -114.71 128.91 56.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.512 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.0 m -105.88 138.38 19.62 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.38 -7.41 15.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.681 2.921 . . . . 0.0 113.611 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -78.72 -1.44 34.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.312 0.577 . . . . 0.0 109.791 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 92.62 39.32 5.32 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.577 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -133.66 106.17 7.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.213 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 928' ' ' TYR . 9.3 t -104.65 126.49 51.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.247 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 20.6 m -117.97 136.4 53.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.593 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.66 127.58 43.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.591 ' HD2' HG13 ' A' ' 926' ' ' ILE . 7.7 t80 -99.2 126.59 45.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.97 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -117.74 169.56 13.29 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.38 -15.61 58.03 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.507 0.653 . . . . 0.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.09 23.38 9.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.045 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -127.55 147.02 50.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -100.69 140.24 35.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.853 0.359 . . . . 0.0 111.084 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 948' ' ' ILE . 2.3 mm? -93.23 140.1 23.19 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.555 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 948' ' ' ILE . 24.0 Cg_exo -65.52 170.11 11.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.372 2.048 . . . . 0.0 110.596 165.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.88 -52.51 57.24 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 947' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 67.1 m-85 -66.04 -33.94 76.94 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 944' ' ' LEU . 23.1 mm -71.19 -43.47 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-O 121.346 0.593 . . . . 0.0 109.827 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -64.38 -38.96 92.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.851 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -61.47 -47.39 85.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.5 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 12.7 ptpt -70.11 -38.15 75.54 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 955' ' ' LEU . 37.3 mt -58.03 -30.97 66.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 111.406 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -60.13 -33.8 72.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.55 -24.23 63.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.11 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -70.32 -15.74 62.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.427 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 14.6 t -58.61 -30.85 67.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.931 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 46.7 p -59.66 -37.59 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 49.4 mt -68.35 -39.31 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.226 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.97 -41.73 96.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.175 0.512 . . . . 0.0 110.208 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.26 -34.73 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.748 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 961' ' ' MET . . . . . 0.488 ' HA ' ' CE ' ' A' ' 961' ' ' MET . 1.5 tpt -64.57 -26.39 68.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.346 . . . . 0.0 110.702 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -84.96 -5.81 59.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 111.008 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 33.1 m -89.18 3.98 50.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.182 0.515 . . . . 0.0 110.082 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' A' ' 965' ' ' PRO . 47.7 t30 -65.58 127.08 92.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.633 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.435 ' HD2' ' OD1' ' A' ' 964' ' ' ASN . 92.9 Cg_exo -43.64 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.606 2.871 . . . . 0.0 113.605 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 3.3 p -145.83 152.71 48.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.659 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.47 -19.93 54.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.929 2.42 . . . . 0.0 112.579 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.86 -0.43 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.82 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -119.68 144.59 47.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.755 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.7 t -75.26 164.4 26.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -72.64 111.98 8.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.48 . . . . 0.0 110.37 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.17 147.69 23.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.395 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.417 HD13 ' HE2' ' A' ' 889' ' ' LYS . 97.3 mt -111.62 134.29 53.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.78 45.55 1.08 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.268 0.556 . . . . 0.0 111.584 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 889' ' ' LYS . . . . . 0.417 ' HE2' HD13 ' A' ' 887' ' ' LEU . 38.5 pttt -128.47 96.26 4.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.244 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.7 m -107.34 155.7 19.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.535 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.6 138.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.319 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -100.22 131.3 46.24 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.012 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.65 HG13 ' SG ' ' A' ' 954' ' ' CYS . 55.3 t -95.18 117.06 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.533 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.529 ' HE2' ' H ' ' A' ' 894' ' ' LYS . 0.7 OUTLIER 51.64 9.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.002 0.921 . . . . 0.0 112.881 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.54 22.37 12.1 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.606 0.763 . . . . 0.0 109.893 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.55 -27.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 109.786 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.1 160.83 25.91 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.382 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.0 OUTLIER -121.55 136.26 54.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.68 56.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.1 m -114.37 132.77 56.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.83 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -96.26 123.56 39.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.087 0.47 . . . . 0.0 111.6 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.3 mm? -96.84 139.03 33.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.5 t -67.12 -10.67 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 11.1 t -85.99 0.38 53.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.479 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.3 10.09 59.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.437 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 906' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 902' ' ' LEU . . . -92.01 141.47 28.59 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.31 122.58 70.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.477 ' HE3' HD21 ' A' ' 902' ' ' LEU . 0.0 OUTLIER -103.74 114.96 29.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.423 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.0 t -110.0 118.42 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.27 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 51.1 mt-30 -101.67 143.01 32.16 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.827 0.346 . . . . 0.0 110.165 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.559 ' CZ ' ' HE2' ' A' ' 951' ' ' LYS . 0.3 OUTLIER -92.71 151.55 20.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 912' ' ' ASN . . . . . 0.457 ' N ' ' HD1' ' A' ' 911' ' ' PHE . 28.0 t-20 -58.39 -26.89 63.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.45 2.47 47.63 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.67 5.09 60.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.551 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 65.4 m -83.29 162.45 21.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -132.94 151.41 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.455 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 7.0 mp -124.58 136.64 54.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.448 HG22 ' NE1' ' A' ' 908' ' ' TRP . 27.8 t -111.76 118.27 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 926' ' ' ILE . 34.2 t -122.99 131.86 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.902 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 923' ' ' VAL . 34.7 tt0 -94.47 139.03 31.67 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.22 127.41 31.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.063 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 100.16 -5.65 57.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.967 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 925' ' ' SER . 7.7 p -124.88 140.24 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.955 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 26.4 m -89.13 -5.9 57.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.416 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 923' ' ' VAL . 34.7 m -73.26 117.8 15.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.671 0.272 . . . . 0.0 110.565 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.621 HG23 HG22 ' A' ' 919' ' ' VAL . 1.5 mp -112.58 144.42 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.228 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 15.6 m -119.15 113.79 21.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 938' ' ' TYR . 24.1 p90 -111.39 130.13 55.79 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.981 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 11.4 t -113.1 136.99 52.11 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 4.0 t -122.65 125.62 26.36 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.85 135.97 72.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.944 3.096 . . . . 0.0 113.156 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 65.16 11.44 7.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 933' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -118.76 -84.46 0.94 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.303 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 934' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 933' ' ' GLY . 6.5 tp-100 169.53 160.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 6.9 t -103.08 128.86 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.461 . . . . 0.0 109.936 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 936' ' ' THR . . . . . 0.623 ' HB ' ' CE1' ' A' ' 928' ' ' TYR . 38.0 m -116.9 136.41 52.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.681 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.583 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -116.33 128.06 55.22 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.132 0.491 . . . . 0.0 110.628 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 928' ' ' TYR . 56.1 m-85 -109.88 131.46 55.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.054 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -92.68 179.41 40.06 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.517 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 940' ' ' GLU . . . . . 0.955 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 24.7 mp0 -63.72 -26.04 68.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.855 0.327 . . . . 0.0 111.294 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -87.23 1.58 52.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.935 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 938' ' ' TYR . 34.0 mt-10 -108.6 142.48 39.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.427 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -76.84 129.85 36.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.629 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 91.2 mt -93.83 134.17 26.67 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.255 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 27.0 Cg_exo -63.78 164.53 21.22 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.015 2.477 . . . . 0.0 112.071 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.61 -62.81 1.27 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.686 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -68.06 -33.03 73.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.391 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.43 -43.88 83.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.121 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -63.28 -43.41 97.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.24 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -59.82 -44.16 94.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.309 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 911' ' ' PHE . 4.5 mttp -68.41 -43.47 77.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.653 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -64.24 -35.97 82.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.0 110.816 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -61.47 -35.2 76.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.507 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 954' ' ' CYS . . . . . 0.65 ' SG ' HG13 ' A' ' 893' ' ' VAL . 35.6 t -73.5 -26.68 61.0 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.21 -20.61 63.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 47.9 t -58.12 -38.86 77.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 109.948 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 17.4 t -65.82 -38.07 87.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.121 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.98 -40.09 80.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.186 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.93 -43.96 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.62 -39.47 88.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 27.4 ttt -69.42 -27.03 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -84.83 -5.82 59.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 28.2 t -93.54 21.42 6.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.502 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 10.1 p30 -77.05 131.02 73.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.922 0.392 . . . . 0.0 110.561 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 1.7 Cg_endo -83.89 150.98 12.68 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.99 2.46 . . . . 0.0 111.905 176.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 40.1 m -136.46 103.88 9.39 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.762 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.86 90.9 0.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.491 2.128 . . . . 0.0 112.445 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -93.94 -0.58 55.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.491 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -89.57 -1.14 57.94 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.241 0.544 . . . . 0.0 109.869 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.54 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 14.2 m -90.74 -6.59 54.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.781 0.291 . . . . 0.0 110.748 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 69.78 2.38 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.213 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 886' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 886' ' ' GLN . 15.2 mm-40 -92.85 -10.36 36.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.862 0.363 . . . . 0.0 111.107 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 90.9 mt -124.23 118.42 26.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.11 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.18 114.26 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.201 0.524 . . . . 0.0 110.932 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -121.09 -32.18 3.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.0 173.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 p -107.38 143.61 35.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.296 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.04 154.96 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.712 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -106.98 130.61 54.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.656 0.265 . . . . 0.0 110.681 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.09 119.08 59.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.458 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.588 ' HB2' HG12 ' A' ' 896' ' ' VAL . 3.2 mmmp? 54.16 7.62 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.86 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.01 22.55 10.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.064 0.546 . . . . 0.0 110.261 -171.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.588 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.8 p -103.69 -27.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 897' ' ' GLY . . . . . 0.919 ' HA3' ' HE3' ' A' ' 951' ' ' LYS . . . -140.12 158.89 25.99 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.568 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 2.0 m95 -121.93 135.54 54.88 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.026 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.1 m -115.6 124.72 51.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.02 117.18 34.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.261 0.553 . . . . 0.0 110.717 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.72 137.3 33.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.265 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 5.9 m -64.53 -13.24 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.262 0.554 . . . . 0.0 111.189 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 13.5 m -79.93 0.42 31.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 94.47 6.67 60.99 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.629 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.5 137.84 32.05 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -110.53 111.96 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 43.8 t -116.56 116.92 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 46.4 mt-30 -94.04 160.65 14.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.893 0.377 . . . . 0.0 110.5 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.454 ' HD1' ' HZ2' ' A' ' 951' ' ' LYS . 38.3 t80 -104.47 164.48 11.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -60.29 -26.01 66.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.3 0.1 54.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.54 4.8 60.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.707 . . . . 0.0 113.726 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 60.5 p -81.24 162.86 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.571 0.686 . . . . 0.0 109.332 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.6 OUTLIER -132.51 153.45 50.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 112.318 -177.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 916' ' ' GLN . 5.9 mp -126.92 135.97 51.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 32.8 t -112.39 122.69 67.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.73 137.16 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.127 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 923' ' ' VAL . 77.1 mm-40 -93.39 138.46 31.69 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.64 129.42 40.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.641 0.258 . . . . 0.0 111.062 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.17 -6.84 61.94 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.412 174.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 920' ' ' GLN . 33.5 m -130.14 156.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.393 0.596 . . . . 0.0 110.821 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 4.6 p -91.05 -6.7 53.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.297 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 21.7 m -72.06 128.54 36.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.956 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -126.88 146.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.529 -175.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 13.0 m -114.01 116.43 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -97.12 127.21 42.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.045 0.45 . . . . 0.0 109.873 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.738 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 17.1 m -114.28 123.63 50.01 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.394 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 33.8 t -122.91 106.21 34.33 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 37.5 Cg_endo -66.41 -5.74 13.42 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.938 2.425 . . . . 0.0 111.993 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -93.18 -6.81 46.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.43 -66.5 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.638 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 179.74 169.06 1.17 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -169.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 18.2 m -103.23 124.78 49.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 53.5 m -119.66 130.17 54.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -97.85 130.25 44.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 926' ' ' ILE . 77.4 m-85 -109.62 127.64 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.024 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.88 172.56 24.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.66 -18.31 64.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.569 0.685 . . . . 0.0 110.721 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.05 2.29 47.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.565 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.87 143.97 26.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -95.95 125.69 40.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.915 0.388 . . . . 0.0 110.472 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.83 133.54 39.27 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.22 -66.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.601 2.201 . . . . 0.0 112.068 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -163.36 -64.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.688 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -59.74 -32.07 70.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.795 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.52 -43.56 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 0.0 110.385 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -64.23 -42.72 96.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.868 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -60.01 -43.78 95.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.219 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.919 ' HE3' ' HA3' ' A' ' 897' ' ' GLY . 23.2 tptm -68.1 -43.29 78.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.261 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.29 -37.74 88.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.883 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.76 -21.38 62.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.397 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.18 -23.07 67.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 110.712 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.35 -14.07 62.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.771 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 956' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 959' ' ' LEU . 37.3 m -53.64 -35.14 60.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.712 0.291 . . . . 0.0 111.565 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 12.4 m -62.96 -38.25 90.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.044 0.45 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.88 -43.93 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 956' ' ' SER . 4.5 pp -64.18 -34.27 77.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 110.2 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.11 -39.82 94.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.558 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 47.5 ttm -66.01 -27.24 67.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.232 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -80.77 -7.7 59.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.868 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 20.0 m -95.64 0.59 52.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.072 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 65.07 106.46 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.276 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.94 126.15 21.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.036 2.491 . . . . 0.0 112.446 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 9.5 t -102.1 148.48 35.43 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.461 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.55 108.07 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.836 2.358 . . . . 0.0 111.973 172.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.4 22.67 3.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.114 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.18 117.38 5.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.419 -179.717 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.3 t -86.11 101.94 13.42 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -108.69 87.28 2.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.203 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -103.56 105.26 15.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.648 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 6.0 tt -100.1 103.26 14.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.909 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.07 -154.91 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.862 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -73.98 -12.81 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.388 0.614 . . . . 0.0 109.36 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.6 m -103.2 141.08 36.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.832 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.56 140.55 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 898' ' ' TRP . 36.0 p90 -90.37 125.54 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.066 0.46 . . . . 0.0 110.736 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 894' ' ' LYS . 7.3 p -95.26 123.44 47.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.089 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 893' ' ' VAL . 33.3 mmtp 57.91 8.29 0.71 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.678 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.99 22.56 11.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.69 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.74 -30.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.827 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.2 163.85 25.34 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.139 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.643 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 2.1 m95 -121.36 134.89 55.13 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.45 129.98 55.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.883 0.373 . . . . 0.0 110.633 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 24.9 m -116.88 126.89 53.67 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.419 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -94.34 116.14 28.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.249 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.7 p -66.4 -15.56 63.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.8 p -85.54 0.55 52.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.739 0.304 . . . . 0.0 111.213 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.21 9.71 60.29 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.235 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.85 139.67 30.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.403 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.84 122.31 68.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.14 0.495 . . . . 0.0 109.735 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.592 ' HE1' ' HG3' ' A' ' 916' ' ' GLN . 8.6 t90 -108.66 113.52 26.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 35.9 t -116.03 115.88 50.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 110.346 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.643 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 23.2 pt20 -105.26 163.22 12.76 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.502 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 23.9 m-85 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -65.45 -17.24 64.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.369 0.604 . . . . 0.0 110.147 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.76 3.33 41.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.725 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.5 6.78 59.55 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.798 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.502 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 14.6 m -88.81 158.42 18.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.883 0.342 . . . . 0.0 110.456 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.8 ' HB3' ' HB ' ' A' ' 929' ' ' THR . 50.5 tt0 -132.1 150.91 52.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.073 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 926' ' ' ILE . 6.4 mp -137.82 135.88 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 171.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.96 121.59 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.641 HG11 ' HG ' ' A' ' 955' ' ' LEU . 11.6 t -120.04 135.97 58.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.15 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.23 139.41 30.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.84 128.1 35.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.029 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.37 -6.02 83.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.635 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 925' ' ' SER . 24.2 t -107.84 138.05 36.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.721 0.296 . . . . 0.0 110.644 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 38.1 m -91.29 -6.19 53.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.13 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.691 ' H ' HG12 ' A' ' 923' ' ' VAL . 21.5 p -95.44 123.8 39.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.527 HD13 HD23 ' A' ' 917' ' ' LEU . 2.6 pp -116.03 150.16 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.514 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 21.0 m -105.43 116.63 32.27 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -96.81 128.43 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 916' ' ' GLN . 40.1 m -112.39 122.89 49.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.056 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.9 t -123.68 99.29 39.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.49 -12.29 32.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.73 2.287 . . . . 0.0 111.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -86.26 -14.26 44.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.484 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.95 -62.05 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.178 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -173.28 159.27 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.106 0.453 . . . . 0.0 110.513 -167.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 929' ' ' THR . 67.1 p -102.81 125.29 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 169.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 27.2 m -120.59 132.23 55.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.477 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -97.29 129.04 44.63 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.204 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.59 ' HB3' ' CD2' ' A' ' 944' ' ' LEU . 98.4 m-85 -107.17 139.61 41.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 939' ' ' GLY . . . . . 0.78 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -147.02 -172.73 17.57 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.92 -1.133 . . . . 0.0 112.818 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -26.61 67.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.899 0.48 . . . . 0.0 111.576 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -97.25 7.27 46.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.78 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 5.9 mm-40 -113.13 150.76 31.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 111.031 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -74.52 122.25 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.837 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.59 ' CD2' ' HB3' ' A' ' 938' ' ' TYR . 77.7 mt -98.6 132.3 24.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.354 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 55.4 Cg_endo -84.25 172.36 9.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.618 2.212 . . . . 0.0 111.423 171.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -53.43 -60.93 2.67 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -64.79 -31.3 72.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.696 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.639 ' HB ' ' HD2' ' A' ' 945' ' ' PRO . 45.1 mm -68.78 -41.77 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.41 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.9 -39.12 88.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.506 ' HZ2' HD22 ' A' ' 917' ' ' LEU . 5.6 mmmp? -65.43 -42.73 92.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.471 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 952' ' ' LEU . 3.7 mm? -61.39 -36.46 80.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -69.02 -31.5 70.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.96 -25.35 64.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.641 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.0 mm? -72.48 -15.88 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 78.1 p -59.41 -39.91 84.97 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.412 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 15.8 m -65.84 -39.94 91.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.13 -39.45 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.135 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 959' ' ' LEU . 2.4 tm? -62.02 -44.22 97.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.167 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.344 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 56.0 ttp -70.04 -26.33 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -89.35 -3.88 58.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.557 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 32.3 t -83.08 21.83 1.03 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.446 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.63 123.56 71.69 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 121.18 0.514 . . . . 0.0 110.984 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.81 176.02 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.892 2.395 . . . . 0.0 113.116 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 8.6 t -149.05 138.55 12.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.761 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.65 48.88 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 112.121 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 18.24 2.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -95.74 -1.07 50.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.779 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 17.9 m -114.21 20.62 15.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -84.86 148.36 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.435 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -85.36 -27.67 25.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.0 110.397 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 887' ' ' LEU . 4.0 mm? -122.9 130.44 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.09 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.82 135.31 42.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.052 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.94 -42.92 20.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.4 p -107.24 143.83 34.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.844 170.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.33 155.21 14.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.677 0.275 . . . . 0.0 110.319 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -101.84 130.54 48.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.58 120.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.689 ' HB2' HG12 ' A' ' 896' ' ' VAL . 2.9 mptp? 57.36 4.28 0.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.091 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 59.89 22.1 11.09 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.533 0.733 . . . . 0.0 110.47 -170.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.9 p -105.57 -28.43 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 0.0 109.639 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.05 25.54 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.072 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.731 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 1.2 m95 -122.18 135.76 54.82 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -115.42 131.35 56.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.984 0.421 . . . . 0.0 110.733 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 15.8 m -116.02 130.46 56.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.765 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -94.88 115.31 27.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.66 HD11 ' HE3' ' A' ' 908' ' ' TRP . 86.3 mt -82.28 154.43 25.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -20.41 65.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.24 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.3 m -84.7 0.84 49.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 110.893 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.38 14.56 58.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.475 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 906' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -90.03 139.14 30.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.626 0.25 . . . . 0.0 110.429 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.44 122.31 55.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.66 ' HE3' HD11 ' A' ' 902' ' ' LEU . 1.6 t-105 -110.75 114.72 28.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.821 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.79 117.7 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 111.071 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.731 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 22.3 pt20 -105.41 161.62 14.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.452 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.523 ' HE1' HD21 ' A' ' 917' ' ' LEU . 43.3 m-85 -121.61 -179.91 4.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.875 0.369 . . . . 0.0 111.515 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.52 -26.86 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.774 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -87.82 1.18 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.234 0.54 . . . . 0.0 111.006 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.52 4.84 87.43 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.495 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.8 t -79.43 151.12 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.57 ' HB3' ' HE1' ' A' ' 908' ' ' TRP . 29.5 mt-30 -133.46 154.92 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.476 -171.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.659 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 0.9 OUTLIER -139.66 136.04 33.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 165.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.6 p -113.28 126.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.148 0.499 . . . . 0.0 110.533 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 926' ' ' ILE . 32.7 t -117.29 132.5 66.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.911 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 83.8 mm-40 -88.15 138.02 31.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.14 125.35 23.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 86.85 -6.06 83.76 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.25 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 925' ' ' SER . 36.4 t -107.56 138.22 34.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 59.8 m -91.44 -6.44 52.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.836 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 923' ' ' VAL . 72.1 p -90.62 114.98 27.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.018 0.437 . . . . 0.0 110.077 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 919' ' ' VAL . 78.6 mt -112.77 146.61 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.045 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 14.0 m -117.31 115.64 25.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 52.0 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.126 0.489 . . . . 0.0 110.3 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.543 HG23 HG22 ' A' ' 935' ' ' THR . 24.4 m -113.1 121.99 46.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' ' 932' ' ' ASN . 7.2 p -122.23 99.05 43.66 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.61 -26.73 80.24 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.61 2.873 . . . . 0.0 112.19 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 932' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' ' 930' ' ' SER . 27.4 p-10 -71.63 -2.12 16.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.231 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -154.03 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.763 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -163.64 -175.43 4.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.898 0.38 . . . . 0.0 110.203 -168.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 929' ' ' THR . 82.4 p -104.02 133.53 48.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 936' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 928' ' ' TYR . 14.2 t -117.47 140.93 48.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -107.09 130.46 54.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.088 0.471 . . . . 0.0 111.503 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.47 ' CE1' HD21 ' A' ' 944' ' ' LEU . 12.0 t80 -104.57 127.81 52.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.986 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -130.45 174.7 19.6 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -54.62 -27.04 36.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 0.0 111.68 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.02 2.85 53.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.48 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -104.67 141.29 36.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 111.857 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -99.46 123.93 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.069 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 938' ' ' TYR . 1.5 mm? -79.84 133.23 58.84 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 18.8 Cg_exo -67.35 -66.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.938 2.426 . . . . 0.0 112.931 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -152.62 -74.97 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.271 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -64.18 -29.75 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.489 ' O ' HD13 ' A' ' 952' ' ' LEU . 45.2 mm -68.21 -44.09 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.866 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.47 -39.19 91.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 950' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 953' ' ' GLN . 5.6 tp-100 -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.015 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 951' ' ' LYS . 13.8 ptpt -69.22 -36.75 77.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.996 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 948' ' ' ILE . 4.7 mp -56.95 -31.61 65.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 953' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 950' ' ' GLN . 5.7 tp-100 -58.63 -31.04 67.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.165 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 38.1 t -69.41 -20.91 63.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 952' ' ' LEU . 4.0 mm? -72.15 -19.66 61.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 77.2 p -59.73 -38.84 82.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.0 p -66.08 -39.85 90.37 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 955' ' ' LEU . 15.1 tt -69.58 -37.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.855 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.86 -38.82 89.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 0.0 110.282 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 960' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 960' ' ' LEU . 5.6 tt -63.75 -39.29 93.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.769 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 67.3 mtt -64.6 -26.09 68.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.861 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -85.94 -6.85 58.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.284 0.564 . . . . 0.0 110.25 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 33.7 t -91.18 5.27 49.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.837 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -56.55 124.41 62.22 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.475 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -34.3 104.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.408 3.405 . . . . 0.0 113.987 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.25 128.23 22.04 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.982 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 -24.37 79.23 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.717 2.278 . . . . 0.0 112.586 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -97.11 9.86 40.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.339 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.91 -21.77 17.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.443 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.178 -177.433 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 20.1 m -96.64 93.59 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.364 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -76.39 97.65 4.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -129.87 163.08 27.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.948 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 9.5 mp 63.25 21.43 12.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 110.559 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.61 165.26 23.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.692 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -87.66 40.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 110.455 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 16.6 p -106.8 142.9 35.69 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.956 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.85 140.7 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.05 119.4 30.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 109.951 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.56 122.61 50.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 62.14 2.88 0.88 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.524 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.15 22.33 11.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.633 0.773 . . . . 0.0 110.24 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.41 -30.47 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.379 0.609 . . . . 0.0 110.099 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.73 168.33 25.03 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.674 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.561 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.2 OUTLIER -117.1 134.72 54.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -119.51 131.07 55.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.096 0.474 . . . . 0.0 111.334 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 14.9 m -115.41 126.72 54.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.336 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -89.82 138.77 31.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.899 0.381 . . . . 0.0 110.264 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.29 142.32 44.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 18.7 p -66.86 -15.01 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 0.0 111.077 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 4.0 m -79.48 0.3 30.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.957 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.8 3.98 65.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.599 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -93.2 141.49 28.37 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 919' ' ' VAL . 3.4 p -119.05 122.71 69.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.452 0.644 . . . . 0.0 109.428 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 11.5 t-105 -97.71 113.83 25.67 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.351 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 917' ' ' LEU . 3.3 p -114.56 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.596 0.712 . . . . 0.0 110.363 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.561 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 53.0 tt0 -98.68 142.63 30.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.975 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -91.79 151.62 20.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.674 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -64.13 -22.97 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.68 2.18 38.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 96.48 6.55 58.5 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.219 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.2 m -95.47 158.72 15.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.839 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 17.7 pm0 -132.91 154.96 49.91 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.254 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.795 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.3 mp -129.04 139.81 51.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.97 122.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 907' ' ' VAL . 61.4 t -117.24 132.54 66.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.785 0.326 . . . . 0.0 110.217 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -92.23 139.4 30.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -52.81 128.96 28.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.53 -6.41 63.01 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.962 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 923' ' ' VAL . 14.6 t 61.31 32.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 121.885 0.85 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 15.5 m -72.87 -14.94 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.394 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 22.8 t -173.51 125.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.617 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.615 HG22 HG13 ' A' ' 919' ' ' VAL . 0.2 OUTLIER -125.02 144.16 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.527 ' OG ' ' HG2' ' A' ' 937' ' ' ARG . 10.2 m -118.82 122.04 41.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -96.66 124.08 40.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.883 HG23 ' HB ' ' A' ' 935' ' ' THR . 14.1 m -115.5 122.75 46.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 23.0 p -125.88 102.35 28.45 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.04 -40.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.752 2.968 . . . . 0.0 113.366 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.0 -29.74 71.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.552 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -116.61 -75.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.309 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -163.71 153.4 14.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.658 0.266 . . . . 0.0 111.118 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.883 ' HB ' HG23 ' A' ' 929' ' ' THR . 8.9 t -104.87 125.37 50.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 936' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 927' ' ' SER . 27.2 m -120.07 135.64 54.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.405 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.527 ' HG2' ' OG ' ' A' ' 927' ' ' SER . 40.2 mtp180 -98.11 126.79 43.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.92 140.46 45.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.163 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 939' ' ' GLY . . . . . 0.555 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -106.4 161.68 14.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.404 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -5.76 20.65 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.391 0.615 . . . . 0.0 110.526 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -90.61 2.11 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.84 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 11.8 pt-20 -129.07 170.9 12.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.227 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -80.14 129.9 34.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.467 . . . . 0.0 110.521 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 948' ' ' ILE . 32.2 mt -98.05 133.38 23.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.006 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.64 ' HB2' HD13 ' A' ' 948' ' ' ILE . 26.6 Cg_exo -63.74 156.11 59.51 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 111.629 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.89 -53.07 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.62 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 947' ' ' TYR . . . . . 0.409 ' O ' ' HD2' ' A' ' 951' ' ' LYS . 78.4 m-85 -63.24 -31.3 72.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.573 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -67.82 -42.94 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.836 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -63.31 -39.9 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.125 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.35 -43.77 98.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.599 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.529 ' HE2' ' N ' ' A' ' 951' ' ' LYS . 0.7 OUTLIER -68.34 -40.41 81.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.328 0.585 . . . . 0.0 109.694 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.76 -36.04 77.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -27.44 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.125 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.3 -20.58 63.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.54 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.91 -14.75 63.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.91 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.5 m -57.8 -27.31 63.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 111.281 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 24.4 p -60.41 -37.57 81.28 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.65 -39.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.709 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.1 tt -60.77 -42.9 98.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.14 -40.4 94.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.028 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 961' ' ' MET . . . . . 0.468 ' HA ' ' CE ' ' A' ' 961' ' ' MET . 2.4 tpt -70.52 -26.68 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.592 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -93.6 11.66 28.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.739 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 50.0 m -78.25 11.37 2.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.106 0.479 . . . . 0.0 110.819 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -120.09 82.51 29.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.512 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.68 -13.94 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.646 2.231 . . . . 0.0 111.202 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 30.5 p 49.79 81.0 0.27 Allowed Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.77 0.828 . . . . 0.0 112.482 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 112.75 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.918 2.412 . . . . 0.0 110.819 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -86.23 19.66 2.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.025 0.44 . . . . 0.0 110.349 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 71.32 -0.65 3.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.454 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.818 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 39.3 p -141.2 138.48 33.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 111.102 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -74.36 159.48 32.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.22 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.88 -173.62 3.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.5 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.79 -15.31 59.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.232 0.539 . . . . 0.0 110.045 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.83 179.5 7.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.48 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -80.45 94.27 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.928 0.394 . . . . 0.0 110.567 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.2 m -102.34 143.28 32.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.863 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.05 139.11 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -94.3 130.44 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.842 0.353 . . . . 0.0 110.598 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.46 118.79 54.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.0 9.68 0.33 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.415 1.072 . . . . 0.0 112.061 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 59.58 22.85 11.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.307 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.6 t -104.86 -30.42 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.29 159.33 25.66 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.024 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.3 135.97 54.82 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.64 129.85 53.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.84 0.353 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 43.9 m -107.09 132.89 52.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.116 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -93.6 115.07 27.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.964 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.17 146.43 23.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.9 t -63.82 -14.24 51.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.479 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 6.0 p -86.59 0.37 54.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.104 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.84 13.64 66.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.832 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 955' ' ' LEU . 42.7 t -109.81 123.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 7.1 t-105 -109.42 113.62 26.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 46.4 t -115.28 117.26 55.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 60.5 tt0 -106.52 142.99 35.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.48 160.81 16.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.73 -16.35 63.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.351 0.596 . . . . 0.0 110.127 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -73.9 -1.47 19.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.817 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.72 2.61 89.82 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.104 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.6 m -97.44 151.1 20.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.479 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 1.2 pm0 -133.3 162.45 31.78 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.357 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 917' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.23 137.41 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.828 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 927' ' ' SER . 21.2 t -104.67 123.81 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.767 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 30.9 t -117.28 132.77 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.205 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -92.36 138.95 31.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.41 126.84 29.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.006 0.432 . . . . 0.0 111.002 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.53 83.5 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.639 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 925' ' ' SER . 25.3 t -110.17 128.4 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.596 -0.355 . . . . 0.0 110.737 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 32.4 t -89.28 -7.22 55.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.628 ' H ' HG12 ' A' ' 923' ' ' VAL . 23.8 m -90.89 111.97 23.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 952' ' ' LEU . 43.1 pt -113.75 165.77 8.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.439 -171.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 918' ' ' VAL . 9.1 p -116.97 116.02 26.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.281 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.19 131.07 44.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.758 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 7.3 m -111.35 124.35 52.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 48.3 t -115.92 127.44 26.77 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.513 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.64 -7.7 7.78 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.21 3.273 . . . . 0.0 112.695 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -54.54 -28.62 46.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.494 0.664 . . . . 0.0 109.572 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 117.07 35.54 1.11 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.327 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.82 140.0 11.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.769 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 7.2 t -104.31 127.31 51.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.273 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 15.0 t -117.92 138.64 52.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.618 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -98.35 130.34 45.01 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.53 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.29 127.41 53.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.8 13.3 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.339 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.0 -25.72 67.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.315 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -94.29 1.55 55.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.24 0.543 . . . . 0.0 110.649 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.8 160.98 16.25 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.034 -0.416 . . . . 0.0 110.974 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -85.31 122.85 30.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.426 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 948' ' ' ILE . 82.6 mt -97.43 133.52 23.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.242 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 15.3 Cg_exo -71.21 169.78 19.84 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.092 2.528 . . . . 0.0 112.444 175.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.45 -56.84 16.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -62.2 -32.38 73.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.477 HG21 HD22 ' A' ' 944' ' ' LEU . 47.8 mm -69.91 -43.56 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.919 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -63.53 -44.92 92.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.51 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -61.4 -44.66 96.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.596 ' O ' ' HG ' ' A' ' 955' ' ' LEU . 11.1 mptt -68.98 -40.19 78.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.768 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.647 HD11 HD13 ' A' ' 926' ' ' ILE . 7.8 mp -63.05 -36.75 84.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.937 0.399 . . . . 0.0 110.273 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -70.63 -35.03 72.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.522 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 954' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 29.6 p -72.5 -24.63 61.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.795 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 958' ' ' ILE . 92.6 mt -71.53 -15.02 62.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.226 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 45.0 t -56.96 -24.1 50.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.74 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.9 p -63.44 -38.22 90.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 955' ' ' LEU . 15.8 tt -69.31 -35.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.51 -43.55 98.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.65 -34.99 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.033 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 961' ' ' MET . . . . . 0.731 ' HA ' ' HG3' ' A' ' 965' ' ' PRO . 15.4 tmm? -67.54 -27.02 66.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 110.288 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -89.01 -7.11 56.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.243 0.544 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 11.4 t -95.13 14.25 22.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.159 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 63.18 91.0 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.997 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.731 ' HG3' ' HA ' ' A' ' 961' ' ' MET . 6.3 Cg_endo -85.45 95.74 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.796 2.33 . . . . 0.0 111.419 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 29.6 m -134.91 86.44 32.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.009 0.433 . . . . 0.0 111.009 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.57 -7.75 9.62 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.128 2.552 . . . . 0.0 111.098 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.22 23.44 6.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.386 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -51.79 138.4 23.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.445 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 45.4 m80 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.557 -176.079 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 41.9 m -87.96 7.35 31.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.579 0.228 . . . . 0.0 110.86 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 66.82 9.97 7.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.911 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -113.01 86.89 2.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.857 0.36 . . . . 0.0 110.147 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.862 ' H ' HD23 ' A' ' 887' ' ' LEU . 0.9 OUTLIER -81.98 127.07 32.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.691 177.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.9 129.7 38.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.358 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 889' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 901' ' ' GLN . 3.4 mppt? 61.29 74.17 0.45 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.088 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.677 ' HB3' ' HG ' ' A' ' 887' ' ' LEU . 15.7 p -98.64 144.36 28.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.952 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 891' ' ' VAL . . . . . 0.732 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 60.6 t -126.23 140.25 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.679 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 892' ' ' PHE . . . . . 0.617 ' HD1' ' HE3' ' A' ' 898' ' ' TRP . 78.0 m-85 -106.6 119.99 40.77 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' A' ' 894' ' ' LYS . 97.3 t -108.76 117.79 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.428 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.443 ' HD3' HG12 ' A' ' 893' ' ' VAL . 2.0 mptm? 54.12 3.87 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.371 1.068 . . . . 0.0 112.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.82 23.98 12.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.196 0.599 . . . . 0.0 110.12 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.34 -29.75 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.96 158.25 25.12 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.985 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.617 ' HE3' ' HD1' ' A' ' 892' ' ' PHE . 0.5 OUTLIER -121.81 136.43 54.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -109.61 132.42 54.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 900' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 8.1 m -101.87 125.84 48.64 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 901' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 889' ' ' LYS . 28.2 mm-40 -94.99 116.51 28.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.007 0.432 . . . . 0.0 110.981 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.13 129.04 49.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.888 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.9 t -67.53 -4.61 12.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.384 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 33.5 t -85.71 -0.09 54.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.69 62.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.319 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.65 138.7 31.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 919' ' ' VAL . 44.0 t -112.4 122.97 67.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 3.1 t-105 -110.27 118.77 37.23 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.1 t -107.21 125.96 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.035 0.445 . . . . 0.0 111.08 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.52 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 76.7 mm-40 -103.46 143.28 32.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.572 173.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.68 167.15 9.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.73 0.3 . . . . 0.0 110.481 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -63.41 -26.43 68.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.75 0.08 55.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.061 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.54 72.34 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.279 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 18.1 m -75.74 153.29 37.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.732 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 47.4 mt-30 -132.03 153.57 50.26 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.058 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.788 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 8.7 mp -130.73 135.36 47.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.141 171.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 927' ' ' SER . 47.4 t -113.34 121.71 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 907' ' ' VAL . 48.2 t -118.08 130.84 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.695 0.284 . . . . 0.0 110.575 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -93.23 139.86 30.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.24 129.52 21.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.072 0.463 . . . . 0.0 111.114 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.16 61.37 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.479 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 923' ' ' VAL . 12.6 t 57.54 34.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.949 0.88 . . . . 0.0 110.317 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.9 m -74.02 -17.53 60.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.34 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 48.3 p -169.64 135.08 1.47 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.343 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.62 144.23 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.604 ' HB3' ' HB ' ' A' ' 918' ' ' VAL . 23.0 t -118.65 117.44 28.96 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -96.76 127.43 42.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 63.5 m -113.07 121.44 44.6 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.585 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 59.5 p -127.84 103.37 21.52 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.23 -12.4 30.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.265 2.643 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -81.76 -10.51 59.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.042 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -151.68 -68.36 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -171.13 164.57 7.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.214 0.507 . . . . 0.0 111.272 -166.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 929' ' ' THR . 39.9 p -104.07 123.85 47.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.7 m -120.47 129.2 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.605 0.241 . . . . 0.0 111.108 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.738 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -98.44 128.56 44.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 110.151 178.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.8 128.0 54.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.384 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.66 166.34 27.72 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.91 -20.54 65.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.0 111.161 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -92.97 2.82 56.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.801 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -96.75 -178.84 4.38 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -100.56 128.42 46.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 945' ' ' PRO . 5.5 tp -92.29 132.74 31.37 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.942 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.774 ' HB2' HD13 ' A' ' 948' ' ' ILE . 37.1 Cg_exo -61.84 152.46 74.5 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.484 2.122 . . . . 0.0 111.435 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -52.99 -64.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.525 0.515 . . . . 0.0 111.922 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -59.91 -32.18 70.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.645 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.774 HD13 ' HB2' ' A' ' 945' ' ' PRO . 2.4 mp -69.55 -42.81 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -40.94 97.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.941 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -42.37 93.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.361 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.986 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 4.5 mmpt? -64.94 -43.45 92.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.211 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.44 -36.62 84.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 110.865 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -66.95 -34.42 77.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.832 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.06 -28.78 64.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.164 0.506 . . . . 0.0 109.893 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 951' ' ' LYS . 7.9 mp -73.84 -30.99 62.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.225 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 46.1 t -58.58 -39.59 80.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.311 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 28.4 t -66.34 -38.3 87.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 110.009 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.96 -41.21 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.555 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.56 -41.31 97.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.49 -40.03 96.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.548 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 53.9 tpp -70.1 -24.76 63.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.888 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -83.61 -5.84 59.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.487 0.661 . . . . 0.0 110.16 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 963' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 10.7 t -87.65 13.96 9.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.479 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 963' ' ' SER . 25.6 m-80 72.98 149.88 0.13 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.791 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 36.0 Cg_endo -66.31 117.29 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.614 2.209 . . . . 0.0 112.268 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 55.2 m -88.56 104.1 6.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 965' ' ' PRO . 86.5 Cg_endo -85.63 151.78 10.19 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.564 2.176 . . . . 0.0 113.167 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -85.75 0.1 53.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.386 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.28 124.22 22.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.118 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 48.7 m80 . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.124 179.077 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 18.6 p -76.95 153.98 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.37 0.129 . . . . 0.0 110.954 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 61.73 81.4 0.2 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.872 0.732 . . . . 0.0 111.353 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.44 -64.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.645 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 8.0 mp 56.17 56.23 6.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.917 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 888' ' ' LEU . 3.2 mm? -99.45 -166.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -86.35 10.94 13.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.39 0.614 . . . . 0.0 110.157 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 43.5 m -106.96 144.81 33.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.676 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 891' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 88.7 t -114.43 139.56 39.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -106.66 119.97 40.72 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.106 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 895' ' ' ASN . 48.7 t -103.23 120.21 52.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.652 ' HB3' HG12 ' A' ' 896' ' ' VAL . 53.0 tttm 56.98 3.71 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.367 1.042 . . . . 0.0 111.358 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 895' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 893' ' ' VAL . 2.7 t30 60.03 23.65 12.83 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.994 0.918 . . . . 0.0 109.787 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.1 p -104.7 -28.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.225 173.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.77 159.05 24.87 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.854 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.97 136.03 54.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.629 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -107.29 131.69 53.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 900' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 4.2 m -115.14 132.86 56.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.71 116.04 25.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.341 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.29 142.24 40.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.648 0.261 . . . . 0.0 110.389 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.7 p -68.14 -8.62 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.697 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 44.6 t -80.95 -0.8 41.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.223 0.535 . . . . 0.0 110.163 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.94 4.42 87.1 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.66 139.33 30.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.813 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.65 122.58 56.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.492 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 6.5 t-105 -100.66 114.11 27.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.008 -176.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 48.4 t -104.04 115.98 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 110.036 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.854 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 37.3 mt-30 -106.17 142.96 34.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.711 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.479 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 44.8 m-85 -97.24 160.1 14.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.86 -25.78 68.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.471 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -86.38 2.18 48.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.354 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 93.79 5.05 63.14 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.361 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 45.5 m -84.33 152.12 24.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.635 0.718 . . . . 0.0 109.274 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.712 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 40.3 mt-30 -132.47 153.38 50.95 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.799 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.646 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 9.7 mp -130.59 136.24 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.13 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 41.5 t -113.12 120.43 63.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 926' ' ' ILE . 42.9 t -119.35 132.02 70.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.4 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 79.8 mm-40 -90.27 137.93 31.94 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.55 126.77 28.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.52 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.4 -0.42 83.28 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.258 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 925' ' ' SER . 54.5 t -115.06 138.05 46.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.234 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 3.1 p -91.24 -6.13 53.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 923' ' ' VAL . 39.3 m -90.45 138.74 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.643 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.637 HD11 HD22 ' A' ' 952' ' ' LEU . 2.9 mp -118.02 146.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.495 -175.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.688 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 16.0 m -110.68 116.29 31.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.461 ' HB3' HG23 ' A' ' 936' ' ' THR . 24.2 t80 -96.42 126.24 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 47.2 m -113.71 122.8 48.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.09 0.471 . . . . 0.0 111.329 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 10.3 p -122.99 120.35 27.55 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.271 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 -2.13 5.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.399 2.732 . . . . 0.0 112.181 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -59.17 -22.86 61.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.41 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.05 0.87 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.109 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -157.77 133.29 9.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.209 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -105.89 126.87 52.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 166.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 936' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 928' ' ' TYR . 4.3 t -118.32 128.74 54.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.391 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.628 ' HD3' ' H ' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -103.24 130.79 50.56 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.403 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -108.91 138.76 44.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.726 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 939' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -115.76 156.37 15.68 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.146 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -7.2 26.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.771 0.319 . . . . 0.0 111.855 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -82.34 0.68 40.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.428 0.632 . . . . 0.0 110.209 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 17.2 pt-20 -132.66 -171.95 2.79 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -95.42 122.4 38.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.975 0.417 . . . . 0.0 109.929 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.22 138.42 45.49 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.788 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.68 ' HG2' HD12 ' A' ' 948' ' ' ILE . 48.4 Cg_exo -57.58 142.2 95.5 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.535 2.156 . . . . 0.0 111.231 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -43.24 -63.3 0.84 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.038 0.836 . . . . 0.0 112.935 -172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -67.89 -28.24 67.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 945' ' ' PRO . 59.1 mt -69.72 -44.98 78.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.69 -38.12 88.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.075 0.464 . . . . 0.0 109.985 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 950' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 953' ' ' GLN . 17.2 tm0? -60.16 -42.65 95.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.074 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 1.072 ' HA ' ' HE3' ' A' ' 951' ' ' LYS . 0.0 OUTLIER -69.86 -37.94 76.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.442 0.639 . . . . 0.0 110.003 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.637 HD22 HD11 ' A' ' 926' ' ' ILE . 62.7 tp -57.58 -36.9 72.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 953' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 950' ' ' GLN . 4.9 pp0? -69.61 -21.15 63.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.32 -28.04 65.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.023 0.44 . . . . 0.0 109.981 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.98 -31.47 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.288 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 956' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 55.8 m -59.7 -39.02 83.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 957' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 961' ' ' MET . 21.9 t -65.69 -38.14 88.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 109.966 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.44 -40.24 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.866 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.39 -39.59 91.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.568 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 956' ' ' SER . 93.5 mt -64.11 -35.02 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.374 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 961' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 957' ' ' SER . 93.8 mmm -63.59 -25.51 68.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.282 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.15 -2.65 58.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.145 0.498 . . . . 0.0 110.621 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 963' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 42.6 t -94.08 14.51 19.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.084 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.502 ' HB3' ' HD2' ' A' ' 965' ' ' PRO . 44.8 m-80 69.53 170.67 0.11 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.679 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 964' ' ' ASN . 50.5 Cg_exo -54.77 96.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.924 1.749 . . . . 0.0 111.233 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 966' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 27.6 m -98.21 115.63 65.72 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.901 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 966' ' ' THR . 8.2 Cg_exo -71.77 102.33 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.492 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.61 0.16 47.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 110.439 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -97.14 165.21 12.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.011 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.3 t -97.15 122.67 40.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -70.45 143.43 51.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.505 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -72.84 132.41 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.93 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.19 -13.13 62.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 888' ' ' LEU . 3.8 mm? -74.38 -10.31 59.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.925 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -94.1 -10.49 33.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.091 0.472 . . . . 0.0 110.393 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 31.0 p -108.31 144.77 35.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.228 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.06 140.13 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.08 125.17 47.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 954' ' ' CYS . 23.2 m -109.76 121.18 62.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 120.834 0.35 . . . . 0.0 110.83 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.718 ' HB2' HG12 ' A' ' 896' ' ' VAL . 71.8 mmtt 58.62 -1.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.709 0.804 . . . . 0.0 112.675 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.46 22.64 12.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.942 0.877 . . . . 0.0 109.154 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 894' ' ' LYS . 9.9 p -104.09 -24.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.096 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 897' ' ' GLY . . . . . 0.412 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -140.78 159.75 26.5 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.057 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.717 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.0 OUTLIER -120.82 135.3 55.2 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 173.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.38 131.45 56.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 9.1 m -110.41 125.24 53.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.835 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -82.44 115.93 21.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.878 0.37 . . . . 0.0 110.022 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.74 149.79 21.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.079 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 13.2 t -66.91 -15.89 63.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.009 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.0 m -80.13 0.26 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 110.734 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.87 87.71 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.715 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.3 157.54 17.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.341 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.61 123.48 71.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.808 0.337 . . . . 0.0 110.223 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -98.12 113.42 25.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.94 117.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.032 0.444 . . . . 0.0 110.615 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.717 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 47.6 tt0 -94.38 143.13 26.66 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.585 ' HD2' ' H ' ' A' ' 913' ' ' ASP . 25.7 t80 -93.51 148.6 21.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -55.13 -25.45 31.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' ASP . . . . . 0.585 ' H ' ' HD2' ' A' ' 911' ' ' PHE . 19.8 t70 -86.24 0.35 53.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.49 5.74 60.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.407 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 50.3 m -85.3 164.1 18.2 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -125.01 151.95 44.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.41 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.605 ' CD2' HG23 ' A' ' 919' ' ' VAL . 10.4 tt -141.49 135.0 29.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 51.2 t -115.98 122.57 69.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 122.384 -0.198 . . . . 0.0 111.209 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.605 HG23 ' CD2' ' A' ' 917' ' ' LEU . 76.4 t -120.07 134.27 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.531 0.205 . . . . 0.0 111.037 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -89.81 136.97 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -62.9 126.9 28.89 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.161 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.2 -2.49 85.29 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.672 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 925' ' ' SER . 54.4 t -106.01 137.61 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.754 0.312 . . . . 0.0 110.865 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.5 m -78.26 -15.89 58.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.817 ' H ' HG12 ' A' ' 923' ' ' VAL . 34.1 m -85.61 117.18 24.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -113.24 145.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.113 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 21.5 m -113.63 116.39 29.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -106.09 128.63 54.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 20.2 m -112.51 121.68 45.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.126 0.489 . . . . 0.0 110.886 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 931' ' ' PRO . 73.5 m -99.77 165.16 15.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.745 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 930' ' ' SER . 72.5 Cg_exo -49.74 156.68 2.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.027 2.485 . . . . 0.0 112.664 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 932' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 931' ' ' PRO . 80.2 m-20 75.01 5.35 4.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 75.44 50.42 8.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.991 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.05 101.06 9.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 8.9 t -100.59 129.18 46.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.428 0.632 . . . . 0.0 111.103 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 32.0 p -116.88 141.4 48.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.448 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -101.55 126.51 48.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.251 0.548 . . . . 0.0 110.698 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.457 ' HB3' HD23 ' A' ' 944' ' ' LEU . 90.2 m-85 -109.91 138.22 46.58 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -154.09 -160.31 9.72 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 119.128 -1.51 . . . . 0.0 113.927 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.03 -27.1 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.432 -0.884 . . . . 0.0 112.441 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.46 1.2 56.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.176 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -132.6 -177.15 4.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -99.23 138.18 36.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 948' ' ' ILE . 63.6 mt -95.22 133.1 26.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' A' ' 948' ' ' ILE . 18.3 Cg_exo -67.44 154.79 72.76 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.883 2.388 . . . . 0.0 111.044 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.78 -37.52 87.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.46 -33.47 75.95 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.436 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.611 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -70.98 -39.55 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.994 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 949' ' ' LYS . . . . . 0.606 ' HE3' ' HB2' ' A' ' 944' ' ' LEU . 33.0 mmtp -56.93 -43.8 81.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.319 0.581 . . . . 0.0 109.714 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.55 -42.32 98.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.341 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 67.3 mmtt -62.51 -43.18 99.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.77 -32.43 72.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.748 0.308 . . . . 0.0 110.498 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.49 -34.84 77.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 954' ' ' CYS . . . . . 0.533 ' HB3' HG11 ' A' ' 893' ' ' VAL . 59.2 m -70.32 -26.64 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.537 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.1 mm? -72.36 -14.5 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.767 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 37.3 m -56.6 -31.22 64.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.4 p -64.09 -40.64 96.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -173.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 955' ' ' LEU . 16.2 tt -70.55 -35.51 61.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.222 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.82 -43.93 97.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.23 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 960' ' ' LEU . 4.3 mm? -68.27 -37.18 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 49.5 tpp -66.56 -28.15 68.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 111.021 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -94.12 3.88 54.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.442 . . . . 0.0 110.999 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 32.7 t -93.67 2.44 56.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.273 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 44.3 t30 69.95 119.36 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.724 0.64 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.37 -25.29 56.42 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.098 2.532 . . . . 0.0 112.816 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 88.1 m -88.42 119.04 70.09 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.67 178.07 3.6 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -87.03 19.33 3.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.366 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 70.15 -53.85 0.63 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.787 0.835 . . . . 0.0 110.818 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 67.7 t60 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.687 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 14.9 m -75.78 -70.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.829 0.347 . . . . 0.0 110.967 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -113.67 178.43 4.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.764 -176.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -66.11 129.36 39.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.765 ' H ' HD23 ' A' ' 887' ' ' LEU . 2.3 pt? -76.64 18.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.304 -173.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 888' ' ' LEU . 4.1 mm? -98.3 -23.57 15.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.285 175.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -105.61 -48.0 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.629 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 887' ' ' LEU . 8.9 m -104.21 142.46 34.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.89 139.6 40.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.1 127.71 36.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.47 HG13 ' SG ' ' A' ' 954' ' ' CYS . 80.7 t -114.14 119.54 61.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm 59.18 7.52 0.89 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.369 1.043 . . . . 0.0 111.194 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.63 20.45 9.07 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.926 0.89 . . . . 0.0 110.758 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 41.6 t -107.2 -29.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.337 0.589 . . . . 0.0 110.364 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.96 163.04 26.32 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.467 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -121.41 136.94 54.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -116.36 133.87 55.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.751 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 21.0 m -101.09 125.28 47.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.675 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.45 120.92 37.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.886 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 906' ' ' ALA . 7.4 mp -98.44 144.45 27.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.634 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 15.9 m -67.28 -16.48 64.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.0 p -82.58 0.93 40.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.229 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.86 12.15 62.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.645 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 906' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.44 138.4 31.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.16 121.64 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.507 ' CZ2' ' HG2' ' A' ' 916' ' ' GLN . 30.2 t90 -110.63 113.39 25.96 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.17 116.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.756 0.313 . . . . 0.0 110.951 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 898' ' ' TRP . 35.7 tt0 -105.64 142.85 34.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.455 ' HE2' HD11 ' A' ' 917' ' ' LEU . 38.9 m-85 -88.09 160.64 17.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.598 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -63.81 -16.72 61.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.781 0.801 . . . . 0.0 108.865 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 913' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 911' ' ' PHE . 32.5 t70 -81.84 -0.25 42.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.14 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.19 5.98 86.82 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.628 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 2.0 p -97.78 153.38 18.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.048 0.424 . . . . 0.0 110.132 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 908' ' ' TRP . 0.3 OUTLIER -125.78 154.48 42.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.281 -175.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.455 HD11 ' HE2' ' A' ' 911' ' ' PHE . 5.5 mp -127.78 132.83 49.47 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 119.06 60.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.089 170.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 926' ' ' ILE . 7.8 p -124.66 132.83 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.501 170.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 923' ' ' VAL . 25.6 tt0 -94.61 139.86 30.63 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 170.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.03 39.99 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.552 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 105.43 -6.15 41.76 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.083 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 920' ' ' GLN . 8.6 m -102.28 155.43 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.456 0.628 . . . . 0.0 110.426 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.4 p -92.2 -4.85 53.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.841 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 12.9 p -133.54 135.89 44.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.281 0.562 . . . . 0.0 111.763 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 919' ' ' VAL . 4.4 mp -111.42 146.68 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.779 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 20.0 m -108.47 116.76 32.58 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.404 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -96.62 125.38 41.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 934' ' ' GLN . 8.8 t -116.3 135.03 54.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.741 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 20.1 m -103.74 144.28 28.35 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.795 171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.84 -7.72 1.76 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 124.127 3.218 . . . . 0.0 114.493 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -16.96 62.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 99.12 28.69 7.56 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 934' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 929' ' ' THR . 43.1 tt0 -104.64 110.32 22.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.758 -174.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 929' ' ' THR . 18.2 p -103.54 125.52 50.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.61 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 35.5 m -118.21 134.89 54.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -97.79 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 0.0 110.899 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 944' ' ' LEU . 81.9 m-85 -112.05 134.82 53.37 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.667 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 939' ' ' GLY . . . . . 0.74 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -153.07 -165.7 13.71 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.968 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.11 -27.28 67.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.791 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -97.69 -0.84 44.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.449 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.74 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 8.7 mm-40 -116.97 109.68 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 943' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 943' ' ' LYS . 47.6 mtpt -73.05 138.94 46.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.396 0.617 . . . . 0.0 112.008 -169.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.591 ' CB ' ' HB3' ' A' ' 949' ' ' LYS . 3.3 mm? -94.11 133.82 26.86 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.531 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 25.8 Cg_exo -63.6 -70.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 111.806 177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.29 -77.69 0.1 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -56.8 -32.75 66.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.575 ' HB ' HD12 ' A' ' 944' ' ' LEU . 26.4 mm -70.3 -45.11 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.996 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 949' ' ' LYS . . . . . 0.591 ' HB3' ' CB ' ' A' ' 944' ' ' LEU . 11.8 pttm -66.66 -36.63 83.0 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.568 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.05 -40.8 90.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.912 0.387 . . . . 0.0 110.501 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -66.89 -43.79 82.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 87.4 mt -65.14 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.002 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -61.65 -33.7 74.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.001 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 954' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' A' ' 893' ' ' VAL . 16.7 t -71.47 -24.89 62.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.411 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.14 -16.55 62.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.446 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 50.2 m -58.62 -23.97 60.02 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.043 0.449 . . . . 0.0 111.287 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 5.9 m -59.38 -34.27 72.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.177 0.513 . . . . 0.0 110.339 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.402 HG22 ' CE2' ' A' ' 962' ' ' PHE . 44.5 mm -67.4 -38.22 80.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.63 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.86 -42.45 97.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.536 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.82 -34.82 78.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.887 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 88.3 mtp -64.96 -25.67 67.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.709 0.29 . . . . 0.0 111.043 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 962' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 958' ' ' ILE . 40.4 m-85 -86.41 -0.45 55.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 110.929 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 23.1 t -91.96 11.75 24.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 24.8 t-20 -73.51 122.52 87.82 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.971 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 56.2 Cg_endo -90.45 101.81 0.28 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.728 2.285 . . . . 0.0 112.895 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 28.8 m -110.45 101.79 49.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.87 5.66 3.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.983 2.455 . . . . 0.0 113.334 -173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.76 -2.09 57.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.139 0.495 . . . . 0.0 110.281 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.71 132.78 55.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.97 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.608 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 20.3 m -85.69 134.64 33.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.867 0.365 . . . . 0.0 110.675 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -75.13 99.71 4.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.771 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 886' ' ' GLN . . . . . 0.444 ' HB3' HD13 ' A' ' 888' ' ' LEU . 15.4 mm100 -84.31 112.6 20.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 890' ' ' SER . 37.2 tp -91.93 73.85 5.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.362 0.601 . . . . 0.0 110.562 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 886' ' ' GLN . 8.0 mp -121.34 107.33 12.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.669 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.2 mttm 55.89 34.72 24.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.307 0.575 . . . . 0.0 110.79 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.536 ' HB2' HD12 ' A' ' 887' ' ' LEU . 22.9 m -106.8 143.62 34.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.003 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.53 155.38 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.041 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -99.53 130.74 45.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 958' ' ' ILE . 5.9 p -105.39 121.13 57.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.057 0.456 . . . . 0.0 110.27 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.704 ' HB3' HG12 ' A' ' 896' ' ' VAL . 14.4 tmtt? 61.68 -1.44 0.33 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.747 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 895' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 893' ' ' VAL . 19.5 t-20 61.3 23.7 13.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.842 0.829 . . . . 0.0 109.409 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.704 HG12 ' HB3' ' A' ' 894' ' ' LYS . 12.4 p -105.84 -27.89 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -136.01 160.6 24.68 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.812 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.619 ' HB2' ' HG3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.9 136.77 54.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.61 130.38 56.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 32.4 m -115.64 135.83 53.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.981 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -95.03 125.35 39.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.162 0.506 . . . . 0.0 110.118 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.76 146.99 24.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.746 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.4 m -65.13 -20.33 66.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.626 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 0.12 33.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.153 0.502 . . . . 0.0 110.698 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.09 8.88 68.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.444 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.24 148.52 22.87 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.584 ' HB ' HG13 ' A' ' 919' ' ' VAL . 47.4 t -110.37 124.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -104.31 114.56 28.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.06 120.14 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.457 0.646 . . . . 0.0 110.817 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.619 ' HG3' ' HB2' ' A' ' 898' ' ' TRP . 1.1 pt20 -104.65 143.26 33.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -119.6 157.93 27.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.092 0.472 . . . . 0.0 111.763 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.3 -17.9 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -77.4 1.44 19.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.635 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.62 8.4 84.73 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 5.8 p -98.23 153.47 18.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.768 0.318 . . . . 0.0 111.198 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.768 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 77.2 mm-40 -122.78 150.88 42.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.983 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.583 HD12 ' C ' ' A' ' 916' ' ' GLN . 7.1 mp -138.69 133.81 32.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.5 p -116.83 123.94 72.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 168.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 923' ' ' VAL . 2.2 p -117.86 138.27 49.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -93.48 150.62 20.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -49.81 128.38 18.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 922' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 923' ' ' VAL . . . 99.48 -8.35 60.22 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.776 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 919' ' ' VAL . 0.8 OUTLIER 58.2 2.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.238 1.415 . . . . 0.0 113.947 172.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 47.4 m -74.76 -5.66 44.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.152 -0.343 . . . . 0.0 111.639 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 1.9 p -142.01 114.79 8.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.962 0.41 . . . . 0.0 111.318 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.567 HG22 ' HB ' ' A' ' 919' ' ' VAL . 0.2 OUTLIER -126.99 145.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.368 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.53 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 20.1 m -118.24 122.46 43.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -97.34 129.96 44.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.768 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 34.2 m -111.7 121.87 46.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 25.8 m -97.24 135.47 21.86 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.581 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.03 -13.99 17.33 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 113.205 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.48 -25.79 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 109.667 174.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 106.15 35.53 2.92 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -126.8 116.54 21.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.999 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 36.6 p -105.31 126.46 52.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.3 m -117.79 128.66 55.08 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -98.37 126.58 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 110.358 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -112.52 131.12 55.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.44 170.97 16.9 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.62 -20.63 66.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.299 0.55 . . . . 0.0 110.692 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.17 -0.65 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -108.21 147.83 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -99.93 130.97 46.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 111.13 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.1 133.6 72.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.63 -68.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.562 2.174 . . . . 0.0 111.939 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.94 -70.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.751 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -58.62 -29.67 66.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 25.9 mm -67.61 -43.66 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.77 -39.42 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.271 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -59.08 -43.18 91.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 9.7 mmpt? -68.29 -41.58 80.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.54 -34.99 79.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.697 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.86 -25.66 68.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.626 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.0 -23.15 65.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.72 -17.59 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.1 m -58.42 -31.55 67.83 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.651 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 957' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 893' ' ' VAL . 16.4 m -60.7 -36.5 78.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.449 HD11 ' HB ' ' A' ' 893' ' ' VAL . 50.6 mm -67.95 -39.4 81.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.047 0.451 . . . . 0.0 109.924 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 63.0 tp -60.85 -43.28 98.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.51 -37.23 84.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 25.7 ttt -66.9 -26.33 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 0.0 110.63 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.82 -5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.32 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 963' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 46.6 t -93.89 6.1 49.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 963' ' ' SER . 5.3 m-20 73.76 148.0 0.12 Allowed Pre-proline 0 N--CA 1.469 0.5 0 O-C-N 123.785 0.678 . . . . 0.0 111.276 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.58 99.11 1.03 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.532 2.155 . . . . 0.0 112.711 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 99.3 m -89.23 114.81 61.8 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.87 69.74 6.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.947 2.431 . . . . 0.0 111.176 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -86.15 0.39 53.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.273 0.559 . . . . 0.0 110.78 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -126.87 148.29 50.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 80.8 m80 . . . . . 0 C--N 1.322 -0.624 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.297 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 21.8 t -86.8 -20.23 27.86 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.752 -0.263 . . . . 0.0 111.061 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -84.24 -13.5 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -108.04 107.57 18.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.534 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 890' ' ' SER . 92.0 mt -98.46 108.34 21.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 112.034 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 889' ' ' LYS . 2.9 mm? -109.59 136.35 49.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.362 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 889' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 888' ' ' LEU . 4.8 mptp? 69.77 21.73 6.33 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.709 0.631 . . . . 0.0 110.325 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 887' ' ' LEU . 10.1 m -106.96 147.55 29.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.928 -178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.03 139.97 45.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -98.91 131.34 45.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.72 120.77 64.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 58.09 4.63 0.32 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.112 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 59.8 23.12 12.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.136 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 95.2 t -104.8 -31.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.44 158.53 25.49 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.172 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -123.27 134.96 54.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.29 130.83 53.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.112 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.2 m -115.98 125.73 52.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.39 115.66 21.52 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.3 148.3 25.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.372 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 2.4 p -67.37 -9.58 42.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.74 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 14.3 m -87.54 1.14 54.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.92 4.53 82.07 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.146 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.2 152.6 20.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.7 123.71 64.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.511 ' HD1' HG22 ' A' ' 918' ' ' VAL . 38.6 t90 -106.83 112.91 26.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 7.7 p -115.51 118.82 59.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 111.151 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 46.7 tt0 -102.34 142.47 33.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.931 175.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -112.06 160.05 17.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.694 0.283 . . . . 0.0 110.876 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.38 -17.62 54.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.774 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.82 1.43 12.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.366 0.603 . . . . 0.0 110.654 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.22 4.59 88.06 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.975 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.4 t -99.48 155.58 17.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 917' ' ' LEU . 15.4 mp0 -130.74 151.7 50.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.92 HD22 ' HD1' ' A' ' 928' ' ' TYR . 1.5 mt -133.62 136.01 44.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.511 HG22 ' HD1' ' A' ' 908' ' ' TRP . 25.2 t -113.6 119.58 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 926' ' ' ILE . 6.7 p -120.14 133.65 66.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 0.0 110.591 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -82.05 143.98 31.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.42 129.69 22.33 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.587 0.554 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 103.12 -8.13 53.09 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.459 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 923' ' ' VAL . 13.7 t 48.49 44.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.953 0.882 . . . . 0.0 111.279 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 5.7 p -82.72 -23.76 33.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.889 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 63.8 m -162.16 130.53 4.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.256 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.619 HG12 HG23 ' A' ' 919' ' ' VAL . 16.3 mt -119.15 145.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.024 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.6 m -118.01 117.35 28.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.92 ' HD1' HD22 ' A' ' 917' ' ' LEU . 41.8 m-85 -99.02 130.05 45.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 916' ' ' GLN . 22.8 p -112.26 122.3 47.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 0.0 110.733 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 45.3 m -140.2 109.75 6.97 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.11 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 931' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 20.8 Cg_endo -60.99 -16.74 47.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.243 2.629 . . . . 0.0 112.61 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -74.89 -10.17 59.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 933' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.25 -68.1 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 934' ' ' GLN . . . . . 0.702 ' HG2' ' H ' ' A' ' 935' ' ' THR . 29.8 tt0 169.14 -168.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.702 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 10.0 t -105.33 128.85 53.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.94 0.4 . . . . 0.0 110.279 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 936' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 928' ' ' TYR . 10.0 t -117.02 142.11 47.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.71 128.66 54.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.1 0.476 . . . . 0.0 111.204 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 53.2 t80 -109.57 128.06 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.114 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -112.37 162.54 12.36 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.69 -5.7 4.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.478 0.639 . . . . 0.0 112.077 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.85 4.65 49.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.425 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 943' ' ' LYS . 6.7 tp10 -122.98 162.2 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 943' ' ' LYS . . . . . 0.819 ' HD3' ' H ' ' A' ' 943' ' ' LYS . 0.0 OUTLIER -99.92 138.81 36.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.023 176.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 948' ' ' ILE . 60.7 mt -97.06 140.6 22.18 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.826 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 22.8 Cg_exo -66.18 165.37 24.52 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.806 2.337 . . . . 0.0 111.254 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 946' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 950' ' ' GLN . 58.0 m-20 -53.47 -56.91 12.96 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -61.22 -34.18 74.7 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.662 HG21 HD22 ' A' ' 944' ' ' LEU . 3.2 mp -69.53 -43.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.69 -40.2 96.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.681 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 950' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 946' ' ' ASP . 97.0 mt-30 -61.46 -44.47 97.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.991 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -69.31 -39.91 77.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.292 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.66 -36.79 85.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.331 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -64.58 -24.91 67.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 83.3 m -69.31 -22.29 63.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.657 ' HA ' HD13 ' A' ' 958' ' ' ILE . 4.1 mm? -69.89 -15.97 63.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.163 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 9.0 t -58.14 -36.24 72.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.49 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 23.1 t -65.71 -37.63 86.96 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 955' ' ' LEU . 3.4 mp -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.971 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 59.8 tp -66.72 -39.76 88.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.801 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 46.1 tpp -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.503 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -77.91 -5.89 52.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 14.2 t -88.09 4.19 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 8.9 t30 63.65 89.18 0.11 Allowed Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.549 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.45 123.18 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.778 2.319 . . . . 0.0 112.029 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 26.6 m -119.9 89.07 41.51 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.056 0.455 . . . . 0.0 110.33 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.0 49.02 3.05 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.067 2.511 . . . . 0.0 113.014 -176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.98 0.28 57.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 0.0 110.249 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.94 160.46 39.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.53 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.0 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 9.2 m -96.83 -45.42 6.65 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -97.46 -21.71 16.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.527 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -83.71 122.4 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.245 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.96 133.64 36.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.07 123.99 44.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.66 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -82.91 -14.85 53.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.748 0.309 . . . . 0.0 110.98 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 39.9 m -91.16 142.89 27.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 34.7 t -125.47 141.41 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -89.1 132.14 34.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.0 121.09 56.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.439 ' HB2' HG12 ' A' ' 896' ' ' VAL . 42.8 mtmt 52.13 11.78 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 59.76 22.47 11.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.438 0.695 . . . . 0.0 110.735 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 894' ' ' LYS . 14.9 p -105.4 -29.06 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.54 162.24 26.16 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.13 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.785 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.3 m95 -118.73 136.09 54.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.91 130.14 54.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.876 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.8 m -117.58 125.31 50.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.253 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -92.0 116.02 28.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 902' ' ' LEU . 3.3 mm? -91.38 152.55 20.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 19.1 p -67.0 -20.06 65.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.538 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 16.2 m -84.88 3.57 37.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 85.2 11.12 76.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.4 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.06 148.91 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.88 122.89 68.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HB2' HD21 ' A' ' 902' ' ' LEU . 4.1 t-105 -108.49 113.64 26.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 39.9 t -115.8 117.75 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 110.768 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.785 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 17.7 mp0 -101.71 148.8 24.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.447 ' HE2' HD22 ' A' ' 917' ' ' LEU . 57.2 m-85 -118.52 159.75 22.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.946 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.1 -17.05 63.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.89 1.53 17.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.651 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.97 5.53 87.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.14 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.2 m -97.21 156.87 16.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 79.4 mt-30 -123.15 152.43 41.17 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.731 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 916' ' ' GLN . 10.6 mp -133.96 136.3 44.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 36.4 t -112.52 121.15 64.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.93 138.54 49.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -92.58 137.15 32.61 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.73 127.96 33.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.538 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.47 84.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.456 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 925' ' ' SER . 8.4 t -122.53 146.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 117.334 0.567 . . . . 0.0 110.331 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.0 t -86.06 -6.62 58.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.492 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.575 ' H ' HG12 ' A' ' 923' ' ' VAL . 59.6 p -74.1 121.13 20.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 110.287 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 926' ' ' ILE . 0.2 OUTLIER -124.39 146.91 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.825 -177.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 31.7 m -107.86 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.99 128.32 42.77 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 27.3 m -113.0 122.05 46.47 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.387 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 20.2 m -102.93 124.04 40.03 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.352 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 931' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 31.6 Cg_exo -60.59 -10.99 15.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.568 2.845 . . . . 0.0 113.426 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.91 -15.45 63.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.26 0.553 . . . . 0.0 110.164 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 111.25 44.29 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.866 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -140.58 111.78 7.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.549 0.214 . . . . 0.0 111.098 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 20.8 m -104.59 123.57 47.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 26.5 m -121.75 128.31 51.61 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 0.1 OUTLIER -104.65 128.87 52.83 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.274 176.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -107.86 127.14 53.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.745 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -94.26 167.54 27.72 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.806 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.27 -27.48 67.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.219 0.533 . . . . 0.0 110.609 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.21 1.92 48.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.24 -173.62 2.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -99.14 119.11 37.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 945' ' ' PRO . 13.3 tp -101.67 131.77 22.51 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 944' ' ' LEU . 19.2 Cg_exo -68.55 153.53 73.46 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.767 2.312 . . . . 0.0 111.993 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.91 -46.44 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.487 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.14 -32.2 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.774 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 47.4 mm -69.32 -44.03 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 110.013 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -64.69 -44.18 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -61.16 -43.65 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -38.61 83.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.546 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 83.1 mt -64.01 -36.39 83.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 110.569 175.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -63.13 -23.08 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.867 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.94 -25.27 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 958' ' ' ILE . 3.8 mm? -71.83 -30.38 65.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 16.4 m -59.22 -24.32 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.943 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 16.4 m -64.78 -39.4 93.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 955' ' ' LEU . 10.9 tp -69.63 -36.46 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.242 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 51.4 tp -62.34 -41.66 98.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.056 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.09 -39.92 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.232 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 23.9 ttt -67.25 -24.34 65.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 110.476 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -89.58 0.23 57.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 7.7 t -78.79 13.88 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.122 0.487 . . . . 0.0 110.712 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.22 77.67 0.33 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.502 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -95.69 19.3 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.244 2.63 . . . . 0.0 111.425 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 26.8 m -106.78 134.77 19.69 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.798 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.18 115.21 2.37 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.593 2.195 . . . . 0.0 111.126 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -78.51 -0.05 27.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.742 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -75.44 -13.27 60.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.101 0.96 . . . . 0.0 112.281 177.684 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 6.5 m -70.06 -38.94 75.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 0.0 111.218 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 885' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' A' ' 888' ' ' LEU . . . -139.46 108.78 6.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 111.583 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.07 -83.94 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.199 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.97 -16.55 15.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.563 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' A' ' 885' ' ' ALA . 2.6 pt? -75.33 -19.74 59.45 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.016 -0.273 . . . . 0.0 110.545 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 47.48 67.58 0.79 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.887 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 66.8 m -106.96 144.4 33.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 111.474 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.83 140.0 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.43 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -100.88 124.43 46.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.042 0.449 . . . . 0.0 110.944 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.0 p -117.07 123.93 72.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.299 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 67.63 -7.86 0.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.09 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 60.51 22.29 12.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.015 0.926 . . . . 0.0 110.089 -168.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.69 -28.65 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.881 171.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 897' ' ' GLY . . . . . 0.551 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -138.93 158.68 25.27 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.105 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.844 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 0.8 OUTLIER -122.65 136.2 54.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -114.2 130.89 56.62 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.969 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 89.9 m -109.93 124.61 51.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -97.27 115.44 27.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.0 111.224 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 906' ' ' ALA . 98.0 mt -90.22 130.37 36.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 16.9 m -67.06 -9.29 37.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.088 0.471 . . . . 0.0 111.064 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.4 m -80.68 -0.24 37.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.1 60.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.59 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 906' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -91.94 138.71 31.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.66 122.27 69.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.126 0.488 . . . . 0.0 109.844 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -108.4 113.38 26.4 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 955' ' ' LEU . 38.3 t -115.11 118.2 58.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.844 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 11.8 pt20 -103.43 171.32 7.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.798 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -118.44 169.66 9.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -66.19 -17.33 64.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.807 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.66 -0.76 48.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.565 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.2 90.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.017 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 157.6 18.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 910' ' ' GLN . 4.2 pt20 -132.27 154.71 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.59 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 4.6 pp -137.05 137.38 39.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 169.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.16 121.76 65.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.966 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 926' ' ' ILE . 20.5 t -120.73 134.55 63.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.366 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -92.76 139.68 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -58.06 127.12 30.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.93 0.395 . . . . 0.0 111.34 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.48 -6.25 83.35 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.986 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.802 HG12 ' H ' ' A' ' 925' ' ' SER . 46.4 t -99.86 139.56 21.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.996 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.5 p -91.19 -8.37 48.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.404 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.802 ' H ' HG12 ' A' ' 923' ' ' VAL . 14.1 m -93.34 124.84 37.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.472 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 919' ' ' VAL . 55.1 mt -114.48 145.8 19.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.675 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 11.0 p -117.67 116.41 26.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.59 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 79.7 t80 -110.96 127.02 55.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.031 0.443 . . . . 0.0 110.17 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.505 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 14.2 m -114.5 121.97 45.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.534 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 928' ' ' TYR . 32.5 t -115.91 123.72 30.72 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.59 -0.97 5.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.349 2.7 . . . . 0.0 112.489 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.62 -6.63 45.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.717 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.05 31.45 4.73 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.122 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -143.69 118.99 10.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.931 0.395 . . . . 0.0 111.828 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 5.5 t -104.57 127.19 52.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 31.8 m -118.59 128.79 54.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 111.393 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -100.55 127.65 46.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.567 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 60.1 t80 -109.1 126.27 53.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.388 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.31 161.11 14.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.78 -4.78 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.986 0.422 . . . . 0.0 112.046 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.76 2.98 56.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.036 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.64 176.03 8.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.05 143.76 29.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.545 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 948' ' ' ILE . 51.6 mt -97.37 147.1 32.48 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.224 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.583 ' HB2' HD13 ' A' ' 948' ' ' ILE . 31.9 Cg_exo -59.23 154.96 42.81 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.454 2.103 . . . . 0.0 110.447 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -57.32 -43.25 83.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -170.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 947' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 85.4 m-85 -68.31 -35.3 77.6 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.324 -176.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 944' ' ' LEU . 2.5 mp -70.92 -43.36 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 949' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 944' ' ' LEU . 18.0 tppt? -63.7 -39.61 94.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -44.55 97.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.777 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 947' ' ' TYR . 13.5 mmmm -65.29 -42.92 92.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 919' ' ' VAL . 3.7 mm? -63.04 -35.71 81.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -69.48 -34.88 74.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.12 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 85.0 m -70.53 -24.72 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 909' ' ' VAL . 85.9 mt -70.96 -14.74 62.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 18.0 t -56.85 -38.9 73.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.606 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 17.8 p -66.54 -39.94 88.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.122 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.66 -40.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 109.853 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.03 -40.72 96.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.341 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.11 -40.95 95.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.558 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 15.6 tpt -70.54 -26.56 63.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.136 0.493 . . . . 0.0 110.399 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -85.37 -5.91 59.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 18.0 t -93.34 8.58 39.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.149 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 39.9 m-80 72.64 136.48 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 17.1 Cg_exo -67.08 125.11 13.08 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.668 2.245 . . . . 0.0 112.012 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 3.1 m -94.05 118.65 67.23 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.243 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.83 145.57 40.96 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.427 2.084 . . . . 0.0 112.388 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.22 20.73 9.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -130.19 125.37 34.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 -179.236 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 16.3 m -89.92 126.51 35.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -69.35 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.145 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -165.34 127.28 2.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 110.517 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -122.99 135.62 54.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.409 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 9.3 mp -99.87 148.11 24.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? 63.23 25.33 14.73 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.431 0.457 . . . . 0.0 111.678 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 57.9 p -106.75 141.57 37.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.511 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.7 140.15 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.59 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -106.53 130.51 54.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.962 0.411 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.17 117.94 46.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 45.55 17.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.96 1.412 . . . . 0.0 112.749 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.74 24.38 12.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.4 t -102.09 -30.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.13 157.55 24.95 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.643 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -124.89 136.55 53.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 909' ' ' VAL . . . -124.65 131.78 53.45 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.197 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 17.1 m -105.01 125.54 51.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -85.76 116.66 24.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.23 158.43 23.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.885 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.3 m -66.79 -22.04 66.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.733 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 7.8 t -83.38 0.63 45.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.976 0.417 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.33 4.88 67.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.341 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.07 140.69 29.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.476 HG11 HD12 ' A' ' 955' ' ' LEU . 36.4 t -106.06 123.55 60.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HE1' ' HB3' ' A' ' 916' ' ' GLN . 3.0 t90 -102.24 111.96 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.611 HG13 ' HG ' ' A' ' 917' ' ' LEU . 3.2 p -114.51 118.29 58.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.601 0.715 . . . . 0.0 111.119 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 1.033 ' HB3' ' HG2' ' A' ' 916' ' ' GLN . 1.3 pm0 -106.88 148.02 29.07 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.229 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 951' ' ' LYS . 36.5 m-85 -91.47 175.05 7.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.185 0.517 . . . . 0.0 110.956 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -65.23 -17.39 64.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.698 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.62 -2.44 50.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.37 0.605 . . . . 0.0 111.201 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.01 90.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 63.5 m -95.68 152.29 18.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 1.033 ' HG2' ' HB3' ' A' ' 910' ' ' GLN . 32.0 mt-30 -132.05 154.86 48.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.726 0.298 . . . . 0.0 111.269 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.611 ' HG ' HG13 ' A' ' 909' ' ' VAL . 0.8 OUTLIER -137.83 137.98 38.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.927 0.394 . . . . 0.0 110.003 169.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 15.7 t -104.27 123.39 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.008 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 926' ' ' ILE . 42.5 t -118.21 129.9 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.788 176.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -94.59 139.6 30.98 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.32 127.61 32.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.874 0.369 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.74 83.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.61 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 925' ' ' SER . 30.7 t -115.78 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 122.792 -0.24 . . . . 0.0 110.508 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 35.0 t -91.06 -10.35 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 923' ' ' VAL . 12.5 m -82.61 111.52 18.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.732 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 952' ' ' LEU . 40.4 pt -113.3 155.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 0.0 110.918 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 14.4 m -117.49 116.34 26.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 911' ' ' PHE . 39.7 t80 -101.0 124.68 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.0 t -116.31 128.37 55.5 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.065 0.46 . . . . 0.0 110.046 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.2 t -132.88 120.71 16.58 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.43 -12.96 30.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.076 2.518 . . . . 0.0 111.732 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -76.72 -15.87 59.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.097 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 933' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.09 -68.38 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 934' ' ' GLN . . . . . 0.723 ' HG3' ' H ' ' A' ' 935' ' ' THR . 4.0 tp-100 166.1 -164.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.723 ' H ' ' HG3' ' A' ' 934' ' ' GLN . 18.9 m -103.42 127.11 50.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.001 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.6 t -119.06 143.34 47.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.255 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 937' ' ' ARG . 8.1 ptt180 -97.78 135.18 39.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.214 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.515 ' HB3' HD21 ' A' ' 944' ' ' LEU . 76.9 m-85 -110.78 126.88 55.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 170.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 939' ' ' GLY . . . . . 0.669 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -146.21 -170.74 15.05 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.231 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.89 -27.41 68.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.828 0.347 . . . . 0.0 110.832 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.89 1.38 57.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.113 0.483 . . . . 0.0 110.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.669 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 1.3 mp0 -108.07 174.47 5.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.679 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -99.17 124.19 44.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 938' ' ' TYR . 62.5 mt -97.01 131.04 28.47 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.984 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 15.7 Cg_exo -72.03 154.67 57.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.903 2.402 . . . . 0.0 111.033 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.26 -48.08 82.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.12 -176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 947' ' ' TYR . . . . . 0.728 ' O ' ' HD3' ' A' ' 951' ' ' LYS . 44.9 m-85 -66.82 -30.67 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.6 -40.81 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.821 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -63.34 -37.63 88.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.004 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -61.08 -44.63 97.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.047 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.728 ' HD3' ' O ' ' A' ' 947' ' ' TYR . 2.3 mptp? -68.61 -42.96 77.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.313 0.578 . . . . 0.0 109.483 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.527 HD13 HG21 ' A' ' 926' ' ' ILE . 62.1 tp -59.38 -38.34 80.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.605 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.19 -25.59 63.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 71.3 m -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.932 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.476 HD12 HG11 ' A' ' 907' ' ' VAL . 2.8 mm? -70.6 -20.27 62.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.602 0.239 . . . . 0.0 111.435 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 7.3 m -58.53 -39.73 81.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.623 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 46.5 p -65.67 -37.67 87.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.64 -40.51 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.789 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.71 -43.24 98.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.12 -38.58 91.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.154 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 17.1 tpt -66.67 -27.15 67.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 110.611 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -87.27 -5.41 58.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.599 . . . . 0.0 110.245 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 963' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 965' ' ' PRO . 56.8 m -86.08 14.43 6.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.814 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -98.16 102.16 13.19 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.736 0.779 . . . . 0.0 109.247 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 963' ' ' SER . 74.8 Cg_endo -104.91 -178.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.367 2.712 . . . . 0.0 113.685 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 9.1 t -114.89 143.47 30.15 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.83 92.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.356 2.038 . . . . 0.0 112.098 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -97.65 3.25 50.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.759 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.95 -47.46 77.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 109.351 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.122 175.954 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 23.2 p -87.11 39.0 0.84 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.984 0.421 . . . . 0.0 111.292 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -145.12 139.9 27.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.055 0.455 . . . . 0.0 111.275 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.34 152.41 39.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.63 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 891' ' ' VAL . 0.2 OUTLIER -123.01 129.82 52.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 -175.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 888' ' ' LEU . 2.5 mm? -98.8 -161.74 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.658 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -70.57 -25.79 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.384 0.611 . . . . 0.0 109.598 172.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 14.5 m -107.52 148.36 29.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.629 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 891' ' ' VAL . . . . . 1.001 HG22 HD11 ' A' ' 887' ' ' LEU . 19.8 t -112.93 138.48 42.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -108.58 126.15 52.63 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.02 118.6 59.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.38 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.641 ' HB2' HG12 ' A' ' 896' ' ' VAL . 94.0 mttt 53.49 7.97 0.12 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.31 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.3 23.49 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.627 0.771 . . . . 0.0 109.854 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.5 p -105.2 -28.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.65 158.14 24.92 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.876 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.447 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 2.9 m95 -122.97 136.53 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -110.87 130.07 55.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.026 0.441 . . . . 0.0 110.124 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 900' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 10.1 m -116.99 125.37 51.28 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.758 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.92 117.08 29.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.228 0.537 . . . . 0.0 110.112 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.6 mm? -95.56 137.05 35.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.807 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.7 t -63.34 -17.82 62.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 22.7 t -81.81 1.04 36.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.07 11.31 61.55 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.029 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.43 140.63 29.58 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.823 -0.222 . . . . 0.0 110.443 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.735 HG11 HD11 ' A' ' 955' ' ' LEU . 46.7 t -107.59 122.83 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.77 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 1.5 t90 -110.23 115.74 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.452 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 57.5 t -112.41 119.39 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.436 0.636 . . . . 0.0 110.245 173.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.665 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 50.0 tt0 -104.4 143.33 33.14 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.478 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.52 171.06 9.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.56 -21.04 66.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.25 1.87 49.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.642 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.0 5.35 87.78 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.085 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.5 m -94.63 152.07 18.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.665 ' HG2' ' HG3' ' A' ' 910' ' ' GLN . 51.6 mt-30 -134.5 159.15 42.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 926' ' ' ILE . 1.3 pt? -137.91 136.07 36.7 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 169.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 907' ' ' VAL . 7.0 m -114.3 128.08 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.43 . . . . 0.0 111.545 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.93 136.69 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -92.3 140.86 29.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.21 128.5 37.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.32 -6.14 83.6 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 925' ' ' SER . 41.6 t -111.61 134.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.109 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.8 m -91.0 -5.34 55.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.743 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.745 ' H ' HG12 ' A' ' 923' ' ' VAL . 15.0 m -95.43 131.58 41.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.475 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 917' ' ' LEU . 3.7 mp -113.15 146.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 15.2 m -115.34 117.1 29.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.632 ' HB2' ' HE1' ' A' ' 938' ' ' TYR . 43.8 t80 -96.24 127.18 42.01 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 8.9 t -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.333 0.587 . . . . 0.0 110.918 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 22.8 t -118.01 111.18 39.1 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.01 144.83 93.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.0 12.62 8.05 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.577 0.548 . . . . 0.0 110.396 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 933' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 934' ' ' GLN . . . -131.39 -91.46 0.54 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 934' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 933' ' ' GLY . 30.0 mt-30 178.01 168.1 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.621 0.768 . . . . 0.0 109.9 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 50.3 m -105.24 126.2 51.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.663 0.268 . . . . 0.0 110.359 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 24.7 m -118.96 128.84 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.414 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 13.7 ptm180 -99.67 127.4 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.369 0.604 . . . . 0.0 111.278 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 928' ' ' TYR . 26.0 p90 -110.06 138.53 46.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.011 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -90.94 -179.71 43.0 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.615 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.45 -13.01 60.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.813 0.34 . . . . 0.0 111.152 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.83 -0.16 57.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -92.67 141.07 28.88 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.94 -0.475 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 943' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 943' ' ' LYS . 23.5 mtmm -92.99 123.5 36.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.32 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -96.51 135.53 22.34 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 33.9 Cg_exo -61.62 -73.43 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.909 2.406 . . . . 0.0 113.148 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -145.61 -71.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -64.1 -32.77 74.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.667 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 32.5 mm -68.53 -43.06 83.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -64.01 -39.68 94.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.807 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.56 -43.7 96.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 951' ' ' LYS . 2.8 mptp? -67.95 -38.69 83.11 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.208 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 89.2 mt -62.97 -31.74 72.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.159 0.504 . . . . 0.0 110.494 175.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -69.27 -36.42 77.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.5 -11.71 60.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.588 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.735 HD11 HG11 ' A' ' 907' ' ' VAL . 3.1 mm? -64.28 -19.55 65.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.821 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 956' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 48.2 t -58.9 -35.84 73.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.005 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 14.7 m -65.42 -39.86 92.64 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 955' ' ' LEU . 10.5 tp -69.67 -36.41 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 46.5 tp -61.64 -41.36 97.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.202 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 960' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 956' ' ' SER . 96.8 mt -66.18 -36.58 83.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 54.3 tpp -65.51 -26.23 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.791 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -86.63 -0.01 55.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.297 0.57 . . . . 0.0 110.364 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 15.2 m -89.29 9.41 26.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.068 0.461 . . . . 0.0 110.337 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -64.2 135.71 96.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.307 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 3.8 Cg_endo -46.35 -38.95 21.3 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.032 3.155 . . . . 0.0 113.745 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 2.8 p -104.49 100.02 20.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.95 0.405 . . . . 0.0 110.776 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 965' ' ' PRO . 4.9 Cg_exo -80.95 43.41 1.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.368 2.712 . . . . 0.0 112.25 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -80.48 24.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.632 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -67.91 -24.42 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.374 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 38.1 t -142.48 125.3 16.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -90.13 174.82 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.671 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -71.19 93.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.233 175.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 61.7 tp -88.9 110.27 20.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.48 -85.47 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 125.99 26.38 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 11.1 p -106.64 143.92 34.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.944 0.402 . . . . 0.0 110.823 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.17 142.63 41.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.001 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -106.76 129.16 54.68 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.25 121.03 54.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.62 ' HB3' HG12 ' A' ' 896' ' ' VAL . 58.9 tttm 57.8 4.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.136 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.66 24.42 14.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.779 0.799 . . . . 0.0 109.178 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.9 p -103.71 -28.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.21 158.47 25.34 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.849 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.701 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.7 OUTLIER -121.6 135.43 54.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 899' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.4 130.18 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.067 0.46 . . . . 0.0 110.865 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 28.8 m -115.66 132.85 56.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.047 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -94.82 115.79 27.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.33 153.67 19.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -19.11 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.239 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.3 m -85.2 1.03 49.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.715 0.293 . . . . 0.0 111.262 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.73 69.11 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.943 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 906' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.35 141.76 28.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.6 122.31 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 2.0 t-105 -104.01 114.62 29.0 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 48.7 t -112.41 117.29 54.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.265 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.701 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 42.7 mt-30 -103.62 143.51 32.66 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.907 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 152.41 20.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.418 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 912' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 896' ' ' VAL . 26.7 p30 -65.09 -16.24 63.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.35 2.34 50.63 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.289 -0.257 . . . . 0.0 111.555 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.53 5.81 60.04 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.602 -0.808 . . . . 0.0 114.202 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 14.0 m -96.53 157.93 15.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.756 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.8 OUTLIER -133.2 154.68 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.02 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 917' ' ' LEU . 5.6 mp -123.07 134.85 54.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.495 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.67 118.66 59.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.25 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 955' ' ' LEU . 12.5 p -123.22 144.61 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 906' ' ' ALA . 61.8 tt0 -93.17 139.55 30.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.146 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.99 128.93 38.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 99.24 -4.01 58.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.981 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 925' ' ' SER . 9.9 p -139.69 151.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 117.257 0.529 . . . . 0.0 110.521 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 940' ' ' GLU . 5.1 p -91.45 -6.74 52.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.499 ' H ' HG22 ' A' ' 923' ' ' VAL . 16.4 p -68.49 108.85 3.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.25 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.05 145.28 25.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.343 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 6.2 p -117.61 122.41 43.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.795 0.331 . . . . 0.0 110.292 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -96.1 127.89 42.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.756 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 20.9 m -113.96 123.39 49.61 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.323 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 930' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 48.0 t -107.35 115.06 60.24 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 931' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 23.3 Cg_exo -65.59 2.48 1.57 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.673 2.915 . . . . 0.0 112.861 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.33 -3.48 57.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.55 . . . . 0.0 109.563 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.45 44.28 1.59 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.373 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.29 102.57 2.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 11.9 t -105.43 129.67 53.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.042 0.448 . . . . 0.0 110.57 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 14.8 p -116.93 128.64 55.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.033 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 7.2 ptp85 -107.8 126.89 53.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.552 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.46 139.65 46.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.574 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 939' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 942' ' ' GLU . . . -109.39 173.1 16.75 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.033 174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 940' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 924' ' ' SER . 30.5 tt0 -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.83 0.347 . . . . 0.0 111.569 -176.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -95.34 2.22 54.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.322 0.582 . . . . 0.0 110.688 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 942' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 939' ' ' GLY . 33.4 mm-40 -91.48 172.32 8.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 130.77 46.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.952 0.406 . . . . 0.0 110.111 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -94.84 133.2 26.9 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.866 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 945' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 31.4 Cg_exo -59.82 -65.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 0.0 111.683 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -165.68 -64.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.46 -33.59 72.79 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.57 -172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.24 -42.72 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.2 -44.27 92.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.452 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.6 -43.98 96.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.682 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 951' ' ' LYS . 35.4 mmtm -71.15 -38.02 72.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 955' ' ' LEU . 28.0 tp -57.98 -36.56 72.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.858 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.51 -35.09 79.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.885 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 27.8 t -72.1 -25.26 61.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.256 0.55 . . . . 0.0 110.602 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.628 ' O ' HG13 ' A' ' 958' ' ' ILE . 96.5 mt -71.33 -25.67 62.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 956' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 16.7 m -58.2 -25.82 62.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.446 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 19.8 m -62.67 -37.87 88.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 958' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 955' ' ' LEU . 2.4 pp -69.68 -34.78 62.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.078 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.14 -42.53 99.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 960' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 956' ' ' SER . 92.7 mt -66.03 -35.95 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.682 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 961' ' ' MET . . . . . 0.401 ' O ' ' HD3' ' A' ' 965' ' ' PRO . 14.4 tmm? -68.59 -27.18 65.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 110.095 176.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.41 0.624 . . . . 0.0 109.844 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 7.6 t -92.05 17.61 9.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.497 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 9.6 t30 66.61 94.06 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.032 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 961' ' ' MET . 93.3 Cg_endo -85.33 -179.26 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.744 2.296 . . . . 0.0 111.175 173.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 966' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 967' ' ' PRO . 35.5 m -117.68 98.04 51.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.63 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 966' ' ' THR . 37.0 Cg_endo -67.82 100.54 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.479 2.12 . . . . 0.0 111.175 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -97.24 19.8 12.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.75 -171.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.73 114.62 8.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.772 176.782 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 883' ' ' GLY . . . . . 0.47 ' HA2' ' OE1' ' A' ' 910' ' ' GLN . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 38.6 m 72.62 133.25 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.505 0.669 . . . . 0.0 112.111 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -133.0 148.94 52.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.189 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -87.51 151.6 22.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 887' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 887' ' ' LEU . 0.5 OUTLIER -81.17 126.08 31.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 110.832 -177.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 31.9 tp -169.54 -74.98 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.776 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -124.56 0.81 8.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.995 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 t -107.36 143.42 35.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.754 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 35.0 t -126.42 140.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.272 . . . . 0.0 110.565 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -92.07 130.68 37.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 954' ' ' CYS . 14.4 m -111.2 122.26 65.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.972 0.415 . . . . 0.0 111.597 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 894' ' ' LYS . . . . . 0.726 ' HB3' HG12 ' A' ' 896' ' ' VAL . 39.8 ttmt 60.91 1.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.932 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.08 22.52 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.074 -170.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 896' ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.3 p -104.22 -29.19 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.9 160.32 26.17 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.327 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.537 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -120.68 133.79 55.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -125.14 130.66 52.63 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.243 -0.583 . . . . 0.0 112.188 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 52.0 m -115.52 125.65 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.296 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -86.59 124.13 32.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.14 141.7 28.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 3.6 m -66.65 -8.4 27.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 3.0 m -85.49 0.5 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.32 4.21 71.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.68 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.02 142.67 27.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.2 123.18 68.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -107.71 112.55 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 917' ' ' LEU . 6.0 p -116.85 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.748 0.785 . . . . 0.0 110.767 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.537 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 7.6 tt0 -91.91 143.14 26.8 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.857 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 911' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 913' ' ' ASP . 19.7 t80 -92.66 150.0 20.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.8 -19.72 60.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 913' ' ' ASP . . . . . 0.809 ' H ' ' HD1' ' A' ' 911' ' ' PHE . 37.9 t70 -79.97 1.1 28.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.188 0.518 . . . . 0.0 111.264 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 91.94 5.71 65.93 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.94 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.7 p -96.05 153.3 17.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -121.83 155.48 35.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.549 0.214 . . . . 0.0 110.555 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 909' ' ' VAL . 7.9 tt -137.75 131.0 30.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.54 120.8 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.33 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.22 145.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.74 139.33 30.66 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.42 128.68 37.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.811 0.338 . . . . 0.0 111.691 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.02 -6.63 64.19 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.09 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.07 156.36 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 122.511 -0.405 . . . . 0.0 111.1 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 944' ' ' LEU . 42.0 m -90.32 -5.68 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 15.3 t -69.2 112.35 5.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.218 0.532 . . . . 0.0 109.839 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 948' ' ' ILE . 0.0 OUTLIER -120.64 146.61 25.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.897 -174.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 5.8 m -116.15 117.63 30.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -108.02 129.37 55.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 23.6 m -100.44 121.94 42.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 44.6 t -123.02 125.03 26.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -11.92 32.42 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.348 2.032 . . . . 0.0 111.422 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -105.06 -14.5 15.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.916 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -149.33 22.3 1.22 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.458 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 934' ' ' GLN . . . . . 0.803 ' HG2' ' H ' ' A' ' 935' ' ' THR . 39.3 tt0 68.3 -161.26 0.2 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.051 0.426 . . . . 0.0 109.906 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.803 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 3.3 p -97.29 126.0 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.439 . . . . 0.0 110.972 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 19.9 p -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.851 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -98.95 128.99 45.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.855 0.36 . . . . 0.0 110.369 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 938' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 926' ' ' ILE . 58.4 m-85 -101.84 127.85 48.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.41 141.74 15.67 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.676 -167.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.35 -21.88 66.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.533 0.682 . . . . 0.0 109.802 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.18 2.04 37.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.862 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -142.02 -140.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.838 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -100.01 136.26 40.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.706 -169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 924' ' ' SER . 24.6 mt -99.96 132.74 22.35 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.836 169.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.54 155.29 70.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.677 2.251 . . . . 0.0 111.42 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 946' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 950' ' ' GLN . 24.8 t70 -60.21 -46.74 88.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.376 -176.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -61.69 -31.81 71.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 111.348 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 926' ' ' ILE . 45.3 mm -69.35 -42.56 81.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.44 . . . . 0.0 109.966 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -63.01 -37.24 86.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.104 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 950' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 946' ' ' ASP . 81.1 mm-40 -61.11 -44.14 97.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.609 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.63 -43.64 79.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.4 -36.24 83.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.855 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -59.4 -34.18 72.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.261 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 954' ' ' CYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 893' ' ' VAL . 61.2 m -69.9 -25.41 63.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.651 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 11.0 mp -71.29 -31.55 67.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.7 m -59.61 -32.53 70.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.414 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 15.0 m -60.1 -36.22 76.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.544 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.46 -40.81 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.336 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.3 -41.23 98.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.107 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.78 -35.08 79.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.007 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 27.7 ttt -69.54 -26.21 64.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.81 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -84.34 -5.81 59.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.161 0.505 . . . . 0.0 110.245 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 22.9 t -91.2 11.29 23.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 0.0 109.811 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.16 144.78 99.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.022 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.07 -35.38 3.21 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.671 2.914 . . . . 0.0 114.381 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 966' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 10.9 t -140.36 114.87 7.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.345 0.593 . . . . 0.0 110.895 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 966' ' ' THR . 6.1 Cg_endo -87.23 150.1 7.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.139 2.56 . . . . 0.0 111.804 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -97.44 -0.73 45.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 109.743 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -71.9 -29.85 64.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.197 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.743 -178.049 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 19.9 p -78.79 -63.91 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.023 0.439 . . . . 0.0 110.847 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -94.76 113.57 25.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.404 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -81.22 65.94 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.156 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 95.3 mt -101.52 106.63 17.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.257 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 888' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 890' ' ' SER . 2.1 pt? -154.56 164.84 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -85.16 -15.08 44.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.056 0.455 . . . . 0.0 110.791 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.537 ' O ' ' HG ' ' A' ' 888' ' ' LEU . 3.8 p -107.08 154.0 21.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.804 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.63 139.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -97.08 130.13 44.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 893' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 954' ' ' CYS . 44.7 t -116.51 119.46 62.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.629 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 56.37 4.96 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.622 1.201 . . . . 0.0 112.316 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 59.07 23.58 11.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.333 0.653 . . . . 0.0 109.944 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.57 -29.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.78 158.77 25.76 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.448 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 898' ' ' TRP . . . . . 0.463 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 3.6 m95 -121.03 136.0 55.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.49 130.16 52.76 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.104 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 23.9 m -116.62 127.07 54.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.483 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -88.63 117.55 27.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.887 0.375 . . . . 0.0 110.427 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 908' ' ' TRP . 3.1 mm? -80.21 149.42 30.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.975 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 8.4 t -65.88 -20.28 66.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.446 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 39.9 t -83.95 0.77 46.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 111.041 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.62 6.5 63.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.912 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -85.24 152.34 23.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 907' ' ' VAL . . . . . 0.536 ' HB ' ' CG1' ' A' ' 919' ' ' VAL . 45.2 t -112.08 122.92 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.252 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 908' ' ' TRP . . . . . 0.699 ' HB2' HD21 ' A' ' 902' ' ' LEU . 22.6 t90 -110.08 113.68 26.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 909' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 917' ' ' LEU . 45.7 t -115.2 129.01 72.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 -175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 910' ' ' GLN . . . . . 0.463 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 35.1 mt-30 -98.61 150.05 22.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -108.5 162.25 14.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.475 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.9 -27.77 61.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.347 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.71 1.53 42.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.489 0.662 . . . . 0.0 111.103 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.76 8.19 83.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.065 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.68 165.38 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -0.627 . . . . 0.0 109.519 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -130.8 151.99 50.63 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.2 -177.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -137.67 134.82 35.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.013 0.435 . . . . 0.0 110.018 173.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 918' ' ' VAL . . . . . 0.619 HG22 ' HD1' ' A' ' 908' ' ' TRP . 42.4 t -114.2 124.3 70.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.157 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 907' ' ' VAL . 14.6 p -118.8 132.55 68.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 110.331 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.04 141.66 28.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.162 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.19 40.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 101.33 6.48 50.89 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.647 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 925' ' ' SER . 8.1 p -149.78 141.14 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 940' ' ' GLU . 35.1 t -87.1 -5.57 58.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.874 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 925' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 923' ' ' VAL . 19.6 m -82.31 131.16 35.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.3 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.773 HD11 HD13 ' A' ' 952' ' ' LEU . 3.6 mt -120.0 146.43 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.252 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 917' ' ' LEU . 23.3 t -104.35 115.41 30.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 928' ' ' TYR . . . . . 0.574 ' CZ ' HD13 ' A' ' 917' ' ' LEU . 19.7 m-85 -102.12 125.81 48.91 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 929' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.5 t -114.99 123.52 49.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.57 0.7 . . . . 0.0 110.661 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 43.2 t -105.07 106.61 56.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.697 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.66 -39.0 93.6 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.346 2.697 . . . . 0.0 112.932 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -97.0 16.18 20.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.785 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -137.63 -75.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.532 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 175.54 169.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 935' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 29.1 m -104.43 124.51 49.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 11.1 m -121.54 130.0 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 937' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -97.62 128.96 44.73 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.145 174.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.56 127.44 53.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.803 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.15 169.55 22.89 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.332 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 940' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 924' ' ' SER . 11.7 pt-20 -64.68 -15.93 62.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.449 0.299 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -94.45 1.61 55.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -100.93 146.43 27.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.339 . . . . 0.0 110.684 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.38 123.38 31.56 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 944' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 948' ' ' ILE . 2.2 mm? -91.43 133.57 31.12 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.407 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -71.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.271 2.647 . . . . 0.0 113.334 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -147.26 -75.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.754 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 948' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 948' ' ' ILE . 4.0 mp -67.72 -42.66 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -63.31 -44.05 96.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.781 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -62.25 -42.63 99.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.854 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 951' ' ' LYS . . . . . 0.508 ' O ' HD13 ' A' ' 955' ' ' LEU . 25.5 mmmt -68.81 -40.58 79.49 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.149 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 926' ' ' ILE . 56.5 tp -62.15 -39.65 93.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.847 175.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -73.2 -35.45 66.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.38 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 954' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 31.8 p -71.53 -20.68 62.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.031 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 955' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 951' ' ' LYS . 4.4 mp -70.71 -17.49 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 40.5 m -58.89 -28.49 66.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.817 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 32.2 t -65.43 -37.92 88.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.258 0.551 . . . . 0.0 109.952 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 58.2 mt -68.2 -40.29 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.441 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.65 -37.66 82.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.276 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.43 -39.9 94.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.456 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 15.6 tpt -70.26 -27.09 64.16 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.847 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -81.73 -5.35 58.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.281 0.562 . . . . 0.0 110.785 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 46.5 m -92.2 4.49 53.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.502 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 964' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 91.9 m-20 70.71 151.23 0.14 Allowed Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.907 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 23.6 Cg_exo -65.29 170.6 10.48 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.901 2.401 . . . . 0.0 112.054 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.02 122.03 63.11 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.211 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.75 29.66 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.468 2.778 . . . . 0.0 114.143 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.07 12.76 18.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 0.0 110.481 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -72.65 -17.68 61.64 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 36.1 t60 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.102 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 889' ' ' LYS . 41.1 mmtm . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 50.8 m -106.98 142.63 36.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.533 172.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.44 139.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -105.2 119.51 39.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.868 0.366 . . . . 0.0 110.291 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.08 119.25 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.051 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.452 ' HB3' HG12 ' A' ' 896' ' ' VAL . 34.8 ttpt 55.01 5.13 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.842 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.99 24.96 14.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.602 0.761 . . . . 0.0 110.15 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 894' ' ' LYS . 9.7 p -103.18 -27.33 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.64 24.99 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.283 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.2 135.16 54.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 27.1 m -103.7 126.03 50.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.714 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -86.68 116.14 24.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.906 0.384 . . . . 0.0 110.675 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.84 145.6 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 10.0 p -67.18 -20.26 65.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.9 m -81.84 2.61 29.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.308 . . . . 0.0 111.714 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.47 7.9 63.01 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.496 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.53 140.1 30.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 919' ' ' VAL . 4.2 p -117.19 123.17 71.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.282 0.563 . . . . 0.0 109.866 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -101.2 112.23 24.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 917' ' ' LEU . 5.9 p -114.61 117.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.812 0.815 . . . . 0.0 111.046 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.3 tt0 -104.53 143.28 33.25 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.52 166.26 10.91 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.779 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -64.85 -20.45 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.698 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.6 1.3 26.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 111.122 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 92.14 5.5 65.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.289 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.0 m -97.23 153.21 18.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.599 ' C ' HD12 ' A' ' 917' ' ' LEU . 83.1 mt-30 -125.4 153.28 43.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.733 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.9 mp -134.22 137.78 44.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.69 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.79 120.66 62.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.519 ' HB ' HG13 ' A' ' 907' ' ' VAL . 74.2 t -119.7 132.65 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.72 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -93.48 138.3 31.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.6 127.1 29.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.58 0.229 . . . . 0.0 110.847 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.41 -0.13 82.95 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.693 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 925' ' ' SER . 27.8 t -120.19 140.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.5 t -91.35 -14.83 30.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 111.131 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.645 ' H ' HG12 ' A' ' 923' ' ' VAL . 22.5 p -87.95 114.67 24.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.361 0.6 . . . . 0.0 110.718 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 938' ' ' TYR . 2.4 pp -116.68 162.89 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.819 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 7.2 t -117.47 117.01 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 935' ' ' THR . 56.2 t80 -105.3 128.63 53.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.795 0.331 . . . . 0.0 110.681 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 31.3 m -114.71 128.91 56.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.512 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.0 m -105.88 138.38 19.62 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.38 -7.41 15.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.681 2.921 . . . . 0.0 113.611 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -78.72 -1.44 34.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.312 0.577 . . . . 0.0 109.791 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 92.62 39.32 5.32 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.577 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -133.66 106.17 7.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.213 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 928' ' ' TYR . 9.3 t -104.65 126.49 51.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.247 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 20.6 m -117.97 136.4 53.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.593 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.66 127.58 43.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.591 ' HD2' HG13 ' A' ' 926' ' ' ILE . 7.7 t80 -99.2 126.59 45.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.97 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -117.74 169.56 13.29 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.38 -15.61 58.03 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.507 0.653 . . . . 0.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.09 23.38 9.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.045 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -127.55 147.02 50.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -100.69 140.24 35.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.853 0.359 . . . . 0.0 111.084 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 948' ' ' ILE . 2.3 mm? -93.23 140.1 23.19 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.555 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 948' ' ' ILE . 24.0 Cg_exo -65.52 170.11 11.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.372 2.048 . . . . 0.0 110.596 165.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.88 -52.51 57.24 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 67.1 m-85 -66.04 -33.94 76.94 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 944' ' ' LEU . 23.1 mm -71.19 -43.47 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-O 121.346 0.593 . . . . 0.0 109.827 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -64.38 -38.96 92.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.851 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -61.47 -47.39 85.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.5 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.47 ' HB3' ' HE2' ' A' ' 951' ' ' LYS . 12.7 ptpt -70.11 -38.15 75.54 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 955' ' ' LEU . 37.3 mt -58.03 -30.97 66.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 111.406 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -60.13 -33.8 72.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.55 -24.23 63.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.11 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.427 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 38.5 pttt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.7 m -107.34 155.7 19.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.535 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.6 138.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.319 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -100.22 131.3 46.24 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.012 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.65 HG13 ' SG ' ' A' ' 954' ' ' CYS . 55.3 t -95.18 117.06 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.533 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.529 ' H ' ' HE2' ' A' ' 894' ' ' LYS . 0.7 OUTLIER 51.64 9.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.002 0.921 . . . . 0.0 112.881 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.54 22.37 12.1 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.606 0.763 . . . . 0.0 109.893 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.55 -27.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 109.786 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.1 160.83 25.91 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.382 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.0 OUTLIER -121.55 136.26 54.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.68 56.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.1 m -114.37 132.77 56.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.83 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.26 123.56 39.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.087 0.47 . . . . 0.0 111.6 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.3 mm? -96.84 139.03 33.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.5 t -67.12 -10.67 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 11.1 t -85.99 0.38 53.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.479 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.3 10.09 59.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.437 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 902' ' ' LEU . . . -92.01 141.47 28.59 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.31 122.58 70.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.477 ' HE3' HD21 ' A' ' 902' ' ' LEU . 0.0 OUTLIER -103.74 114.96 29.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.423 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.0 t -110.0 118.42 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.27 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 51.1 mt-30 -101.67 143.01 32.16 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.827 0.346 . . . . 0.0 110.165 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.559 ' CZ ' ' HE2' ' A' ' 951' ' ' LYS . 0.3 OUTLIER -92.71 151.55 20.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . 0.457 ' N ' ' HD1' ' A' ' 911' ' ' PHE . 28.0 t-20 -58.39 -26.89 63.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.45 2.47 47.63 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.67 5.09 60.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.551 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 65.4 m -83.29 162.45 21.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -132.94 151.41 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.455 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 7.0 mp -124.58 136.64 54.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.448 HG22 ' NE1' ' A' ' 908' ' ' TRP . 27.8 t -111.76 118.27 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 926' ' ' ILE . 34.2 t -122.99 131.86 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.902 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 923' ' ' VAL . 34.7 tt0 -94.47 139.03 31.67 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.22 127.41 31.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.063 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 100.16 -5.65 57.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.967 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 925' ' ' SER . 7.7 p -124.88 140.24 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.955 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 26.4 m -89.13 -5.9 57.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.416 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 923' ' ' VAL . 34.7 m -73.26 117.8 15.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.671 0.272 . . . . 0.0 110.565 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.621 HG23 HG22 ' A' ' 919' ' ' VAL . 1.5 mp -112.58 144.42 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.228 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 15.6 m -119.15 113.79 21.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 938' ' ' TYR . 24.1 p90 -111.39 130.13 55.79 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.981 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 11.4 t -113.1 136.99 52.11 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 4.0 t -122.65 125.62 26.36 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.85 135.97 72.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.944 3.096 . . . . 0.0 113.156 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 65.16 11.44 7.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -118.76 -84.46 0.94 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.303 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 933' ' ' GLY . 6.5 tp-100 169.53 160.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 6.9 t -103.08 128.86 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.461 . . . . 0.0 109.936 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . 0.623 ' HB ' ' CE1' ' A' ' 928' ' ' TYR . 38.0 m -116.9 136.41 52.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.681 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.583 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -116.33 128.06 55.22 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.132 0.491 . . . . 0.0 110.628 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 928' ' ' TYR . 56.1 m-85 -109.88 131.46 55.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.054 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -92.68 179.41 40.06 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.517 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . 0.955 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 24.7 mp0 -63.72 -26.04 68.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.855 0.327 . . . . 0.0 111.294 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -87.23 1.58 52.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.935 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 938' ' ' TYR . 34.0 mt-10 -108.6 142.48 39.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.427 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -76.84 129.85 36.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.629 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 91.2 mt -93.83 134.17 26.67 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.255 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 27.0 Cg_exo -63.78 164.53 21.22 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.015 2.477 . . . . 0.0 112.071 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.61 -62.81 1.27 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.686 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -68.06 -33.03 73.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.391 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.43 -43.88 83.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.121 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -63.28 -43.41 97.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.24 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -59.82 -44.16 94.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.309 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 911' ' ' PHE . 4.5 mttp -68.41 -43.47 77.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.653 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -64.24 -35.97 82.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.0 110.816 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -61.47 -35.2 76.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.507 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . 0.65 ' SG ' HG13 ' A' ' 893' ' ' VAL . 35.6 t -73.5 -26.68 61.0 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -179.754 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 p -107.38 143.61 35.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.296 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.04 154.96 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.712 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -106.98 130.61 54.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.656 0.265 . . . . 0.0 110.681 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.09 119.08 59.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.458 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.588 ' HB2' HG12 ' A' ' 896' ' ' VAL . 3.2 mmmp? 54.16 7.62 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.86 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.01 22.55 10.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.064 0.546 . . . . 0.0 110.261 -171.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.588 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.8 p -103.69 -27.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . 0.919 ' HA3' ' HE3' ' A' ' 951' ' ' LYS . . . -140.12 158.89 25.99 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.568 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 2.0 m95 -121.93 135.54 54.88 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.026 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.1 m -115.6 124.72 51.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.02 117.18 34.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.261 0.553 . . . . 0.0 110.717 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.72 137.3 33.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.265 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 5.9 m -64.53 -13.24 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.262 0.554 . . . . 0.0 111.189 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 13.5 m -79.93 0.42 31.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 94.47 6.67 60.99 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.629 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.5 137.84 32.05 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -110.53 111.96 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 43.8 t -116.56 116.92 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 46.4 mt-30 -94.04 160.65 14.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.893 0.377 . . . . 0.0 110.5 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.454 ' HD1' ' HZ2' ' A' ' 951' ' ' LYS . 38.3 t80 -104.47 164.48 11.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -60.29 -26.01 66.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.3 0.1 54.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.54 4.8 60.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.707 . . . . 0.0 113.726 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 60.5 p -81.24 162.86 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.571 0.686 . . . . 0.0 109.332 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.6 OUTLIER -132.51 153.45 50.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 112.318 -177.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 916' ' ' GLN . 5.9 mp -126.92 135.97 51.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 32.8 t -112.39 122.69 67.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.73 137.16 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.127 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 923' ' ' VAL . 77.1 mm-40 -93.39 138.46 31.69 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.64 129.42 40.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.641 0.258 . . . . 0.0 111.062 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.17 -6.84 61.94 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.412 174.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 920' ' ' GLN . 33.5 m -130.14 156.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.393 0.596 . . . . 0.0 110.821 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 4.6 p -91.05 -6.7 53.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.297 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 21.7 m -72.06 128.54 36.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.956 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -126.88 146.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.529 -175.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 13.0 m -114.01 116.43 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -97.12 127.21 42.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.045 0.45 . . . . 0.0 109.873 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.738 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 17.1 m -114.28 123.63 50.01 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.394 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 33.8 t -122.91 106.21 34.33 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 37.5 Cg_endo -66.41 -5.74 13.42 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.938 2.425 . . . . 0.0 111.993 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -93.18 -6.81 46.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.43 -66.5 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.638 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 179.74 169.06 1.17 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -169.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 18.2 m -103.23 124.78 49.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 53.5 m -119.66 130.17 54.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -97.85 130.25 44.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 926' ' ' ILE . 77.4 m-85 -109.62 127.64 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.024 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.88 172.56 24.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.66 -18.31 64.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.569 0.685 . . . . 0.0 110.721 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.05 2.29 47.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.565 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.87 143.97 26.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -95.95 125.69 40.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.915 0.388 . . . . 0.0 110.472 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.83 133.54 39.27 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.22 -66.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.601 2.201 . . . . 0.0 112.068 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -163.36 -64.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.688 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -59.74 -32.07 70.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.795 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.52 -43.56 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 0.0 110.385 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -64.23 -42.72 96.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.868 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -60.01 -43.78 95.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.219 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.919 ' HE3' ' HA3' ' A' ' 897' ' ' GLY . 23.2 tptm -68.1 -43.29 78.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.261 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.29 -37.74 88.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.883 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.76 -21.38 62.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.397 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.18 -23.07 67.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 110.712 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.771 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.388 0.614 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.6 m -103.2 141.08 36.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.832 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.56 140.55 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 898' ' ' TRP . 36.0 p90 -90.37 125.54 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.066 0.46 . . . . 0.0 110.736 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 894' ' ' LYS . 7.3 p -95.26 123.44 47.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.089 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 893' ' ' VAL . 33.3 mmtp 57.91 8.29 0.71 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.678 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.99 22.56 11.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.69 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.74 -30.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.827 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.2 163.85 25.34 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.139 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.643 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 2.1 m95 -121.36 134.89 55.13 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.45 129.98 55.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.883 0.373 . . . . 0.0 110.633 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 24.9 m -116.88 126.89 53.67 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.419 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -94.34 116.14 28.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.249 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.7 p -66.4 -15.56 63.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.8 p -85.54 0.55 52.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.739 0.304 . . . . 0.0 111.213 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.21 9.71 60.29 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.235 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.85 139.67 30.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.403 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.84 122.31 68.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.14 0.495 . . . . 0.0 109.735 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.592 ' HE1' ' HG3' ' A' ' 916' ' ' GLN . 8.6 t90 -108.66 113.52 26.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 35.9 t -116.03 115.88 50.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 110.346 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.643 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 23.2 pt20 -105.26 163.22 12.76 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.502 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 23.9 m-85 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -65.45 -17.24 64.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.369 0.604 . . . . 0.0 110.147 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.76 3.33 41.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.725 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.5 6.78 59.55 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.798 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.502 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 14.6 m -88.81 158.42 18.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.883 0.342 . . . . 0.0 110.456 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.8 ' HB3' ' HB ' ' A' ' 929' ' ' THR . 50.5 tt0 -132.1 150.91 52.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.073 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 926' ' ' ILE . 6.4 mp -137.82 135.88 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 171.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.96 121.59 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.641 HG11 ' HG ' ' A' ' 955' ' ' LEU . 11.6 t -120.04 135.97 58.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.15 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.23 139.41 30.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.84 128.1 35.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.029 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.37 -6.02 83.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.635 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 925' ' ' SER . 24.2 t -107.84 138.05 36.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.721 0.296 . . . . 0.0 110.644 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 38.1 m -91.29 -6.19 53.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.13 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.691 ' H ' HG12 ' A' ' 923' ' ' VAL . 21.5 p -95.44 123.8 39.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.527 HD13 HD23 ' A' ' 917' ' ' LEU . 2.6 pp -116.03 150.16 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.514 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 21.0 m -105.43 116.63 32.27 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -96.81 128.43 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 916' ' ' GLN . 40.1 m -112.39 122.89 49.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.056 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.9 t -123.68 99.29 39.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.49 -12.29 32.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.73 2.287 . . . . 0.0 111.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -86.26 -14.26 44.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.484 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.95 -62.05 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.178 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -173.28 159.27 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.106 0.453 . . . . 0.0 110.513 -167.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 929' ' ' THR . 67.1 p -102.81 125.29 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 169.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 27.2 m -120.59 132.23 55.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.477 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -97.29 129.04 44.63 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.204 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.59 ' HB3' ' CD2' ' A' ' 944' ' ' LEU . 98.4 m-85 -107.17 139.61 41.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . 0.78 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -147.02 -172.73 17.57 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.92 -1.133 . . . . 0.0 112.818 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -26.61 67.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.899 0.48 . . . . 0.0 111.576 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -97.25 7.27 46.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.78 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 5.9 mm-40 -113.13 150.76 31.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 111.031 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -74.52 122.25 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.837 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.59 ' CD2' ' HB3' ' A' ' 938' ' ' TYR . 77.7 mt -98.6 132.3 24.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.354 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 55.4 Cg_endo -84.25 172.36 9.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.618 2.212 . . . . 0.0 111.423 171.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -53.43 -60.93 2.67 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -64.79 -31.3 72.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.696 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.639 ' HB ' ' HD2' ' A' ' 945' ' ' PRO . 45.1 mm -68.78 -41.77 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.41 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.9 -39.12 88.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.506 ' HZ2' HD22 ' A' ' 917' ' ' LEU . 5.6 mmmp? -65.43 -42.73 92.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.471 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 952' ' ' LEU . 3.7 mm? -61.39 -36.46 80.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -69.02 -31.5 70.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.96 -25.35 64.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.641 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.0 mm? . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.4 p -107.24 143.83 34.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.844 170.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.33 155.21 14.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.677 0.275 . . . . 0.0 110.319 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -101.84 130.54 48.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.58 120.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.689 ' HB2' HG12 ' A' ' 896' ' ' VAL . 2.9 mptp? 57.36 4.28 0.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.091 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 59.89 22.1 11.09 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.533 0.733 . . . . 0.0 110.47 -170.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.9 p -105.57 -28.43 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 0.0 109.639 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.05 25.54 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.072 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.731 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 1.2 m95 -122.18 135.76 54.82 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -115.42 131.35 56.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.984 0.421 . . . . 0.0 110.733 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 15.8 m -116.02 130.46 56.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.765 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -94.88 115.31 27.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.66 HD11 ' HE3' ' A' ' 908' ' ' TRP . 86.3 mt -82.28 154.43 25.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -20.41 65.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.24 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.3 m -84.7 0.84 49.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 110.893 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.38 14.56 58.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.475 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -90.03 139.14 30.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.626 0.25 . . . . 0.0 110.429 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.44 122.31 55.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.66 ' HE3' HD11 ' A' ' 902' ' ' LEU . 1.6 t-105 -110.75 114.72 28.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.821 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.79 117.7 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 111.071 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.731 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 22.3 pt20 -105.41 161.62 14.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.452 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.523 ' HE1' HD21 ' A' ' 917' ' ' LEU . 43.3 m-85 -121.61 -179.91 4.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.875 0.369 . . . . 0.0 111.515 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.52 -26.86 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.774 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -87.82 1.18 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.234 0.54 . . . . 0.0 111.006 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.52 4.84 87.43 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.495 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.8 t -79.43 151.12 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.57 ' HB3' ' HE1' ' A' ' 908' ' ' TRP . 29.5 mt-30 -133.46 154.92 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.476 -171.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.659 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 0.9 OUTLIER -139.66 136.04 33.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 165.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.6 p -113.28 126.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.148 0.499 . . . . 0.0 110.533 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 926' ' ' ILE . 32.7 t -117.29 132.5 66.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.911 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 83.8 mm-40 -88.15 138.02 31.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.14 125.35 23.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 86.85 -6.06 83.76 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.25 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 925' ' ' SER . 36.4 t -107.56 138.22 34.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 59.8 m -91.44 -6.44 52.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.836 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 923' ' ' VAL . 72.1 p -90.62 114.98 27.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.018 0.437 . . . . 0.0 110.077 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 919' ' ' VAL . 78.6 mt -112.77 146.61 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.045 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 14.0 m -117.31 115.64 25.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 52.0 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.126 0.489 . . . . 0.0 110.3 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.543 HG23 HG22 ' A' ' 935' ' ' THR . 24.4 m -113.1 121.99 46.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' ' 932' ' ' ASN . 7.2 p -122.23 99.05 43.66 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.61 -26.73 80.24 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.61 2.873 . . . . 0.0 112.19 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' ' 930' ' ' SER . 27.4 p-10 -71.63 -2.12 16.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.231 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -154.03 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.763 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -163.64 -175.43 4.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.898 0.38 . . . . 0.0 110.203 -168.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 929' ' ' THR . 82.4 p -104.02 133.53 48.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 928' ' ' TYR . 14.2 t -117.47 140.93 48.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -107.09 130.46 54.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.088 0.471 . . . . 0.0 111.503 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.47 ' CE1' HD21 ' A' ' 944' ' ' LEU . 12.0 t80 -104.57 127.81 52.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.986 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -130.45 174.7 19.6 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -54.62 -27.04 36.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 0.0 111.68 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.02 2.85 53.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.48 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -104.67 141.29 36.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 111.857 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -99.46 123.93 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.069 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 938' ' ' TYR . 1.5 mm? -79.84 133.23 58.84 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 18.8 Cg_exo -67.35 -66.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.938 2.426 . . . . 0.0 112.931 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -152.62 -74.97 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.271 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -64.18 -29.75 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.489 ' O ' HD13 ' A' ' 952' ' ' LEU . 45.2 mm -68.21 -44.09 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.866 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.47 -39.19 91.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 953' ' ' GLN . 5.6 tp-100 -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.015 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 951' ' ' LYS . 13.8 ptpt -69.22 -36.75 77.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.996 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 948' ' ' ILE . 4.7 mp -56.95 -31.61 65.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 950' ' ' GLN . 5.7 tp-100 -58.63 -31.04 67.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.165 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 38.1 t -69.41 -20.91 63.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 952' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . 0.422 ' HD3' ' NE2' ' A' ' 901' ' ' GLN . 60.5 mttm . . . . . 0 C--O 1.233 0.215 0 CA-C-O 121.431 0.634 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 16.6 p -106.8 142.9 35.69 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.956 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.85 140.7 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.05 119.4 30.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 109.951 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.56 122.61 50.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 62.14 2.88 0.88 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.524 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.15 22.33 11.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.633 0.773 . . . . 0.0 110.24 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.41 -30.47 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.379 0.609 . . . . 0.0 110.099 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.73 168.33 25.03 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.674 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.561 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.2 OUTLIER -117.1 134.72 54.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -119.51 131.07 55.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.096 0.474 . . . . 0.0 111.334 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 14.9 m -115.41 126.72 54.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.336 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . 0.422 ' NE2' ' HD3' ' A' ' 889' ' ' LYS . 10.6 pt20 -89.82 138.77 31.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.899 0.381 . . . . 0.0 110.264 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.29 142.32 44.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 18.7 p -66.86 -15.01 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 0.0 111.077 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 4.0 m -79.48 0.3 30.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.957 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.8 3.98 65.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.599 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -93.2 141.49 28.37 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 919' ' ' VAL . 3.4 p -119.05 122.71 69.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.452 0.644 . . . . 0.0 109.428 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 11.5 t-105 -97.71 113.83 25.67 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.351 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 917' ' ' LEU . 3.3 p -114.56 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.596 0.712 . . . . 0.0 110.363 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.561 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 53.0 tt0 -98.68 142.63 30.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.975 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -91.79 151.62 20.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.674 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -64.13 -22.97 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.68 2.18 38.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 96.48 6.55 58.5 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.219 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.2 m -95.47 158.72 15.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.839 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 17.7 pm0 -132.91 154.96 49.91 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.254 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.795 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.3 mp -129.04 139.81 51.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.97 122.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 907' ' ' VAL . 61.4 t -117.24 132.54 66.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.785 0.326 . . . . 0.0 110.217 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -92.23 139.4 30.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -52.81 128.96 28.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.53 -6.41 63.01 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.962 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 923' ' ' VAL . 14.6 t 61.31 32.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 121.885 0.85 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 15.5 m -72.87 -14.94 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.394 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 22.8 t -173.51 125.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.617 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.615 HG22 HG13 ' A' ' 919' ' ' VAL . 0.2 OUTLIER -125.02 144.16 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.527 ' OG ' ' HG2' ' A' ' 937' ' ' ARG . 10.2 m -118.82 122.04 41.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -96.66 124.08 40.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.883 HG23 ' HB ' ' A' ' 935' ' ' THR . 14.1 m -115.5 122.75 46.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 23.0 p -125.88 102.35 28.45 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.04 -40.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.752 2.968 . . . . 0.0 113.366 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.0 -29.74 71.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.552 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -116.61 -75.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.309 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -163.71 153.4 14.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.658 0.266 . . . . 0.0 111.118 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.883 ' HB ' HG23 ' A' ' 929' ' ' THR . 8.9 t -104.87 125.37 50.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 927' ' ' SER . 27.2 m -120.07 135.64 54.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.405 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.527 ' HG2' ' OG ' ' A' ' 927' ' ' SER . 40.2 mtp180 -98.11 126.79 43.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.92 140.46 45.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.163 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . 0.555 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -106.4 161.68 14.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.404 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -5.76 20.65 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.391 0.615 . . . . 0.0 110.526 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -90.61 2.11 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.84 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 11.8 pt-20 -129.07 170.9 12.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.227 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -80.14 129.9 34.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.467 . . . . 0.0 110.521 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 948' ' ' ILE . 32.2 mt -98.05 133.38 23.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.006 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.64 ' HB2' HD13 ' A' ' 948' ' ' ILE . 26.6 Cg_exo -63.74 156.11 59.51 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 111.629 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.89 -53.07 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.62 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . 0.409 ' O ' ' HD2' ' A' ' 951' ' ' LYS . 78.4 m-85 -63.24 -31.3 72.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.573 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -67.82 -42.94 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.836 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -63.31 -39.9 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.125 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.35 -43.77 98.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.599 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.529 ' N ' ' HE2' ' A' ' 951' ' ' LYS . 0.7 OUTLIER -68.34 -40.41 81.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.328 0.585 . . . . 0.0 109.694 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.76 -36.04 77.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -27.44 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.125 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.3 -20.58 63.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.54 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.91 -178.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.2 m -102.34 143.28 32.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.863 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.05 139.11 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -94.3 130.44 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.842 0.353 . . . . 0.0 110.598 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.46 118.79 54.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.0 9.68 0.33 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.415 1.072 . . . . 0.0 112.061 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 59.58 22.85 11.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.307 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.6 t -104.86 -30.42 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.29 159.33 25.66 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.024 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.3 135.97 54.82 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.64 129.85 53.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.84 0.353 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 43.9 m -107.09 132.89 52.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.116 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -93.6 115.07 27.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.964 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.17 146.43 23.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.9 t -63.82 -14.24 51.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.479 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 6.0 p -86.59 0.37 54.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.104 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.84 13.64 66.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.832 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 955' ' ' LEU . 42.7 t -109.81 123.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 7.1 t-105 -109.42 113.62 26.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 46.4 t -115.28 117.26 55.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 60.5 tt0 -106.52 142.99 35.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.48 160.81 16.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.73 -16.35 63.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.351 0.596 . . . . 0.0 110.127 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -73.9 -1.47 19.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.817 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.72 2.61 89.82 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.104 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.6 m -97.44 151.1 20.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.479 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 1.2 pm0 -133.3 162.45 31.78 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.357 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.23 137.41 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.828 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 927' ' ' SER . 21.2 t -104.67 123.81 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.767 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 30.9 t -117.28 132.77 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.205 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -92.36 138.95 31.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.41 126.84 29.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.006 0.432 . . . . 0.0 111.002 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.53 83.5 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.639 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 925' ' ' SER . 25.3 t -110.17 128.4 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.596 -0.355 . . . . 0.0 110.737 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 32.4 t -89.28 -7.22 55.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.628 ' H ' HG12 ' A' ' 923' ' ' VAL . 23.8 m -90.89 111.97 23.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 952' ' ' LEU . 43.1 pt -113.75 165.77 8.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.439 -171.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 918' ' ' VAL . 9.1 p -116.97 116.02 26.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.281 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.19 131.07 44.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.758 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 7.3 m -111.35 124.35 52.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 48.3 t -115.92 127.44 26.77 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.513 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.64 -7.7 7.78 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.21 3.273 . . . . 0.0 112.695 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -54.54 -28.62 46.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.494 0.664 . . . . 0.0 109.572 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 117.07 35.54 1.11 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.327 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.82 140.0 11.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.769 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 7.2 t -104.31 127.31 51.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.273 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 15.0 t -117.92 138.64 52.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.618 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -98.35 130.34 45.01 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.53 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.29 127.41 53.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.8 13.3 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.339 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.0 -25.72 67.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.315 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -94.29 1.55 55.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.24 0.543 . . . . 0.0 110.649 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.8 160.98 16.25 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.034 -0.416 . . . . 0.0 110.974 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -85.31 122.85 30.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.426 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 948' ' ' ILE . 82.6 mt -97.43 133.52 23.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.242 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 15.3 Cg_exo -71.21 169.78 19.84 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.092 2.528 . . . . 0.0 112.444 175.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.45 -56.84 16.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -62.2 -32.38 73.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.477 HG21 HD22 ' A' ' 944' ' ' LEU . 47.8 mm -69.91 -43.56 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.919 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -63.53 -44.92 92.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.51 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -61.4 -44.66 96.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.596 ' O ' ' HG ' ' A' ' 955' ' ' LEU . 11.1 mptt -68.98 -40.19 78.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.768 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.647 HD11 HD13 ' A' ' 926' ' ' ILE . 7.8 mp -63.05 -36.75 84.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.937 0.399 . . . . 0.0 110.273 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -70.63 -35.03 72.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.522 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 29.6 p -72.5 -24.63 61.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.795 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 951' ' ' LYS . 92.6 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.226 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 901' ' ' GLN . 3.4 mppt? . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 15.7 p -98.64 144.36 28.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.952 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . 0.732 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 60.6 t -126.23 140.25 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.679 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . 0.617 ' HD1' ' HE3' ' A' ' 898' ' ' TRP . 78.0 m-85 -106.6 119.99 40.77 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' A' ' 894' ' ' LYS . 97.3 t -108.76 117.79 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.428 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.443 ' HD3' HG12 ' A' ' 893' ' ' VAL . 2.0 mptm? 54.12 3.87 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.371 1.068 . . . . 0.0 112.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.82 23.98 12.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.196 0.599 . . . . 0.0 110.12 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.34 -29.75 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.96 158.25 25.12 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.985 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.617 ' HE3' ' HD1' ' A' ' 892' ' ' PHE . 0.5 OUTLIER -121.81 136.43 54.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -109.61 132.42 54.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 8.1 m -101.87 125.84 48.64 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 889' ' ' LYS . 28.2 mm-40 -94.99 116.51 28.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.007 0.432 . . . . 0.0 110.981 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.13 129.04 49.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.888 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.9 t -67.53 -4.61 12.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.384 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 33.5 t -85.71 -0.09 54.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.69 62.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.319 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.65 138.7 31.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 919' ' ' VAL . 44.0 t -112.4 122.97 67.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 3.1 t-105 -110.27 118.77 37.23 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.1 t -107.21 125.96 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.035 0.445 . . . . 0.0 111.08 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.52 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 76.7 mm-40 -103.46 143.28 32.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.572 173.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.68 167.15 9.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.73 0.3 . . . . 0.0 110.481 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -63.41 -26.43 68.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.75 0.08 55.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.061 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.54 72.34 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.279 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 18.1 m -75.74 153.29 37.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.732 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 47.4 mt-30 -132.03 153.57 50.26 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.058 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.788 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 8.7 mp -130.73 135.36 47.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.141 171.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 927' ' ' SER . 47.4 t -113.34 121.71 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 907' ' ' VAL . 48.2 t -118.08 130.84 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.695 0.284 . . . . 0.0 110.575 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -93.23 139.86 30.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.24 129.52 21.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.072 0.463 . . . . 0.0 111.114 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.16 61.37 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.479 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 923' ' ' VAL . 12.6 t 57.54 34.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.949 0.88 . . . . 0.0 110.317 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.9 m -74.02 -17.53 60.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.34 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 48.3 p -169.64 135.08 1.47 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.343 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.62 144.23 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.604 ' HB3' ' HB ' ' A' ' 918' ' ' VAL . 23.0 t -118.65 117.44 28.96 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -96.76 127.43 42.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 63.5 m -113.07 121.44 44.6 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.585 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 59.5 p -127.84 103.37 21.52 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.23 -12.4 30.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.265 2.643 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -81.76 -10.51 59.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.042 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -151.68 -68.36 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -171.13 164.57 7.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.214 0.507 . . . . 0.0 111.272 -166.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 929' ' ' THR . 39.9 p -104.07 123.85 47.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.7 m -120.47 129.2 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.605 0.241 . . . . 0.0 111.108 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.738 ' H ' ' HD3' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -98.44 128.56 44.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 110.151 178.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.8 128.0 54.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.384 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.66 166.34 27.72 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.91 -20.54 65.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.0 111.161 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -92.97 2.82 56.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.801 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -96.75 -178.84 4.38 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -100.56 128.42 46.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 945' ' ' PRO . 5.5 tp -92.29 132.74 31.37 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.942 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.774 ' HB2' HD13 ' A' ' 948' ' ' ILE . 37.1 Cg_exo -61.84 152.46 74.5 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.484 2.122 . . . . 0.0 111.435 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -52.99 -64.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.525 0.515 . . . . 0.0 111.922 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -59.91 -32.18 70.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.645 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.774 HD13 ' HB2' ' A' ' 945' ' ' PRO . 2.4 mp -69.55 -42.81 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -40.94 97.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.941 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -42.37 93.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.361 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.986 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 4.5 mmpt? -64.94 -43.45 92.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.211 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.44 -36.62 84.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 110.865 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . 0.45 ' HB3' HE21 ' A' ' 953' ' ' GLN . 1.0 OUTLIER -66.95 -34.42 77.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.832 177.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.06 -28.78 64.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.164 0.506 . . . . 0.0 109.893 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 951' ' ' LYS . 7.9 mp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.225 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 121.39 0.614 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 43.5 m -106.96 144.81 33.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.676 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 88.7 t -114.43 139.56 39.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -106.66 119.97 40.72 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.106 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 895' ' ' ASN . 48.7 t -103.23 120.21 52.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.652 ' HB3' HG12 ' A' ' 896' ' ' VAL . 53.0 tttm 56.98 3.71 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.367 1.042 . . . . 0.0 111.358 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 893' ' ' VAL . 2.7 t30 60.03 23.65 12.83 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.994 0.918 . . . . 0.0 109.787 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.1 p -104.7 -28.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.225 173.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.77 159.05 24.87 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.854 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.97 136.03 54.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.629 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -107.29 131.69 53.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 4.2 m -115.14 132.86 56.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.71 116.04 25.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.341 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.29 142.24 40.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.648 0.261 . . . . 0.0 110.389 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.7 p -68.14 -8.62 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.697 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 44.6 t -80.95 -0.8 41.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.223 0.535 . . . . 0.0 110.163 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.94 4.42 87.1 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.66 139.33 30.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.813 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.65 122.58 56.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.492 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 6.5 t-105 -100.66 114.11 27.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.008 -176.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 48.4 t -104.04 115.98 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 110.036 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.854 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 37.3 mt-30 -106.17 142.96 34.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.711 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.479 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 44.8 m-85 -97.24 160.1 14.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.86 -25.78 68.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.471 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -86.38 2.18 48.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.354 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 93.79 5.05 63.14 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.361 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 45.5 m -84.33 152.12 24.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.635 0.718 . . . . 0.0 109.274 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.712 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 40.3 mt-30 -132.47 153.38 50.95 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.799 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.646 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 9.7 mp -130.59 136.24 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.13 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 41.5 t -113.12 120.43 63.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 926' ' ' ILE . 42.9 t -119.35 132.02 70.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.4 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 79.8 mm-40 -90.27 137.93 31.94 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.55 126.77 28.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.52 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.4 -0.42 83.28 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.258 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 925' ' ' SER . 54.5 t -115.06 138.05 46.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.234 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 3.1 p -91.24 -6.13 53.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 923' ' ' VAL . 39.3 m -90.45 138.74 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.643 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.637 HD11 HD22 ' A' ' 952' ' ' LEU . 2.9 mp -118.02 146.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.495 -175.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.688 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 16.0 m -110.68 116.29 31.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.461 ' HB3' HG23 ' A' ' 936' ' ' THR . 24.2 t80 -96.42 126.24 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 47.2 m -113.71 122.8 48.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.09 0.471 . . . . 0.0 111.329 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 10.3 p -122.99 120.35 27.55 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.271 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 -2.13 5.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.399 2.732 . . . . 0.0 112.181 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -59.17 -22.86 61.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.41 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.05 0.87 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.109 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -157.77 133.29 9.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.209 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -105.89 126.87 52.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 166.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 928' ' ' TYR . 4.3 t -118.32 128.74 54.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.391 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.628 ' H ' ' HD3' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -103.24 130.79 50.56 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.403 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -108.91 138.76 44.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.726 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -115.76 156.37 15.68 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.146 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -7.2 26.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.771 0.319 . . . . 0.0 111.855 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.34 0.68 40.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.428 0.632 . . . . 0.0 110.209 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 17.2 pt-20 -132.66 -171.95 2.79 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -95.42 122.4 38.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.975 0.417 . . . . 0.0 109.929 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.22 138.42 45.49 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.788 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.68 ' HG2' HD12 ' A' ' 948' ' ' ILE . 48.4 Cg_exo -57.58 142.2 95.5 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.535 2.156 . . . . 0.0 111.231 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -43.24 -63.3 0.84 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.038 0.836 . . . . 0.0 112.935 -172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -67.89 -28.24 67.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 945' ' ' PRO . 59.1 mt -69.72 -44.98 78.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.69 -38.12 88.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.075 0.464 . . . . 0.0 109.985 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 953' ' ' GLN . 17.2 tm0? -60.16 -42.65 95.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.074 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 1.072 ' HA ' ' HE3' ' A' ' 951' ' ' LYS . 0.0 OUTLIER -69.86 -37.94 76.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.442 0.639 . . . . 0.0 110.003 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.637 HD22 HD11 ' A' ' 926' ' ' ILE . 62.7 tp -57.58 -36.9 72.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 950' ' ' GLN . 4.9 pp0? -69.61 -21.15 63.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.32 -28.04 65.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.023 0.44 . . . . 0.0 109.981 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.288 175.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 31.0 p -108.31 144.77 35.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.228 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.06 140.13 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.08 125.17 47.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 954' ' ' CYS . 23.2 m -109.76 121.18 62.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 120.834 0.35 . . . . 0.0 110.83 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.718 ' HB2' HG12 ' A' ' 896' ' ' VAL . 71.8 mmtt 58.62 -1.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.709 0.804 . . . . 0.0 112.675 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.46 22.64 12.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.942 0.877 . . . . 0.0 109.154 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 894' ' ' LYS . 9.9 p -104.09 -24.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.096 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . 0.412 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -140.78 159.75 26.5 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.057 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.717 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.0 OUTLIER -120.82 135.3 55.2 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 173.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.38 131.45 56.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 9.1 m -110.41 125.24 53.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.835 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -82.44 115.93 21.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.878 0.37 . . . . 0.0 110.022 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.74 149.79 21.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.079 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 13.2 t -66.91 -15.89 63.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.009 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.0 m -80.13 0.26 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 110.734 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.87 87.71 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.715 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.3 157.54 17.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.341 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.61 123.48 71.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.808 0.337 . . . . 0.0 110.223 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -98.12 113.42 25.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.94 117.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.032 0.444 . . . . 0.0 110.615 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.717 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 8.3 tt0 -94.38 143.13 26.66 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.585 ' HD2' ' H ' ' A' ' 913' ' ' ASP . 25.7 t80 -93.51 148.6 21.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -55.13 -25.45 31.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . 0.585 ' H ' ' HD2' ' A' ' 911' ' ' PHE . 19.8 t70 -86.24 0.35 53.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.49 5.74 60.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.407 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 50.3 m -85.3 164.1 18.2 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -125.01 151.95 44.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.41 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.605 ' CD2' HG23 ' A' ' 919' ' ' VAL . 10.4 tt -141.49 135.0 29.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 51.2 t -115.98 122.57 69.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 122.384 -0.198 . . . . 0.0 111.209 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.605 HG23 ' CD2' ' A' ' 917' ' ' LEU . 76.4 t -120.07 134.27 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.531 0.205 . . . . 0.0 111.037 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -89.81 136.97 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -62.9 126.9 28.89 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.161 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.2 -2.49 85.29 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.672 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 925' ' ' SER . 54.4 t -106.01 137.61 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.754 0.312 . . . . 0.0 110.865 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.5 m -78.26 -15.89 58.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.817 ' H ' HG12 ' A' ' 923' ' ' VAL . 34.1 m -85.61 117.18 24.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -113.24 145.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.113 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 21.5 m -113.63 116.39 29.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -106.09 128.63 54.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 20.2 m -112.51 121.68 45.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.126 0.489 . . . . 0.0 110.886 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 931' ' ' PRO . 73.5 m -99.77 165.16 15.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.745 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 930' ' ' SER . 72.5 Cg_exo -49.74 156.68 2.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.027 2.485 . . . . 0.0 112.664 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 931' ' ' PRO . 14.6 m120 75.01 5.35 4.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 75.44 50.42 8.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.991 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.05 101.06 9.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 8.9 t -100.59 129.18 46.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.428 0.632 . . . . 0.0 111.103 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 32.0 p -116.88 141.4 48.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.448 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -101.55 126.51 48.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.251 0.548 . . . . 0.0 110.698 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.457 ' HB3' HD23 ' A' ' 944' ' ' LEU . 90.2 m-85 -109.91 138.22 46.58 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -154.09 -160.31 9.72 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 119.128 -1.51 . . . . 0.0 113.927 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.03 -27.1 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.432 -0.884 . . . . 0.0 112.441 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.46 1.2 56.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.176 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -132.6 -177.15 4.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -99.23 138.18 36.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 948' ' ' ILE . 63.6 mt -95.22 133.1 26.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' A' ' 948' ' ' ILE . 18.3 Cg_exo -67.44 154.79 72.76 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.883 2.388 . . . . 0.0 111.044 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.78 -37.52 87.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.46 -33.47 75.95 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.436 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.611 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -70.98 -39.55 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.994 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . 0.606 ' HE3' ' HB2' ' A' ' 944' ' ' LEU . 33.0 mmtp -56.93 -43.8 81.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.319 0.581 . . . . 0.0 109.714 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.55 -42.32 98.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.341 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 67.3 mmtt -62.51 -43.18 99.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.77 -32.43 72.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.748 0.308 . . . . 0.0 110.498 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.49 -34.84 77.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . 0.533 ' HB3' HG11 ' A' ' 893' ' ' VAL . 59.2 m -70.32 -26.64 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.537 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.1 mm? . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.767 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.9 m -104.21 142.46 34.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.89 139.6 40.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.1 127.71 36.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.47 HG13 ' SG ' ' A' ' 954' ' ' CYS . 80.7 t -114.14 119.54 61.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm 59.18 7.52 0.89 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.369 1.043 . . . . 0.0 111.194 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.63 20.45 9.07 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.926 0.89 . . . . 0.0 110.758 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 41.6 t -107.2 -29.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.337 0.589 . . . . 0.0 110.364 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.96 163.04 26.32 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.467 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -121.41 136.94 54.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -116.36 133.87 55.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.751 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 21.0 m -101.09 125.28 47.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.675 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.45 120.92 37.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.886 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 906' ' ' ALA . 7.4 mp -98.44 144.45 27.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.634 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 15.9 m -67.28 -16.48 64.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.0 p -82.58 0.93 40.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.229 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.86 12.15 62.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.645 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.44 138.4 31.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.16 121.64 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.507 ' CZ2' ' HG2' ' A' ' 916' ' ' GLN . 30.2 t90 -110.63 113.39 25.96 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.17 116.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.756 0.313 . . . . 0.0 110.951 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 898' ' ' TRP . 35.7 tt0 -105.64 142.85 34.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.455 ' HE2' HD11 ' A' ' 917' ' ' LEU . 38.9 m-85 -88.09 160.64 17.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.598 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -63.81 -16.72 61.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.781 0.801 . . . . 0.0 108.865 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 911' ' ' PHE . 32.5 t70 -81.84 -0.25 42.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.14 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.19 5.98 86.82 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.628 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 2.0 p -97.78 153.38 18.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.048 0.424 . . . . 0.0 110.132 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 908' ' ' TRP . 0.3 OUTLIER -125.78 154.48 42.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.281 -175.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.455 HD11 ' HE2' ' A' ' 911' ' ' PHE . 5.5 mp -127.78 132.83 49.47 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 119.06 60.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.089 170.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 926' ' ' ILE . 7.8 p -124.66 132.83 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.501 170.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 923' ' ' VAL . 25.6 tt0 -94.61 139.86 30.63 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 170.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.03 39.99 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.552 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 105.43 -6.15 41.76 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.083 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 920' ' ' GLN . 8.6 m -102.28 155.43 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.456 0.628 . . . . 0.0 110.426 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.4 p -92.2 -4.85 53.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.841 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 12.9 p -133.54 135.89 44.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.281 0.562 . . . . 0.0 111.763 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 919' ' ' VAL . 4.4 mp -111.42 146.68 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.779 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 20.0 m -108.47 116.76 32.58 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.404 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -96.62 125.38 41.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 934' ' ' GLN . 8.8 t -116.3 135.03 54.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.741 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 20.1 m -103.74 144.28 28.35 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.795 171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.84 -7.72 1.76 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 124.127 3.218 . . . . 0.0 114.493 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -16.96 62.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 99.12 28.69 7.56 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 929' ' ' THR . 43.1 tt0 -104.64 110.32 22.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.758 -174.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 929' ' ' THR . 18.2 p -103.54 125.52 50.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.61 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 35.5 m -118.21 134.89 54.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -97.79 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 0.0 110.899 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 944' ' ' LEU . 81.9 m-85 -112.05 134.82 53.37 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.667 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . 0.74 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -153.07 -165.7 13.71 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.968 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.11 -27.28 67.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.791 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -97.69 -0.84 44.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.449 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.74 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 8.7 mm-40 -116.97 109.68 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 943' ' ' LYS . 47.6 mtpt -73.05 138.94 46.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.396 0.617 . . . . 0.0 112.008 -169.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.591 ' CB ' ' HB3' ' A' ' 949' ' ' LYS . 3.3 mm? -94.11 133.82 26.86 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.531 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 25.8 Cg_exo -63.6 -70.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 111.806 177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.29 -77.69 0.1 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -56.8 -32.75 66.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.575 ' HB ' HD12 ' A' ' 944' ' ' LEU . 26.4 mm -70.3 -45.11 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.996 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . 0.591 ' HB3' ' CB ' ' A' ' 944' ' ' LEU . 11.8 pttm -66.66 -36.63 83.0 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.568 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.05 -40.8 90.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.912 0.387 . . . . 0.0 110.501 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -66.89 -43.79 82.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 87.4 mt -65.14 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.002 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -61.65 -33.7 74.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.001 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' A' ' 893' ' ' VAL . 16.7 t -71.47 -24.89 62.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.411 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.446 -177.222 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.2 mttm . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.307 0.575 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 22.9 m -106.8 143.62 34.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.003 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.53 155.38 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.041 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -99.53 130.74 45.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 895' ' ' ASN . 5.9 p -105.39 121.13 57.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.057 0.456 . . . . 0.0 110.27 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.704 ' HB3' HG12 ' A' ' 896' ' ' VAL . 14.4 tmtt? 61.68 -1.44 0.33 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.747 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 893' ' ' VAL . 19.5 t-20 61.3 23.7 13.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.842 0.829 . . . . 0.0 109.409 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.704 HG12 ' HB3' ' A' ' 894' ' ' LYS . 12.4 p -105.84 -27.89 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -136.01 160.6 24.68 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.812 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.619 ' HB2' ' HG3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.9 136.77 54.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.61 130.38 56.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 32.4 m -115.64 135.83 53.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.981 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -95.03 125.35 39.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.162 0.506 . . . . 0.0 110.118 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.76 146.99 24.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.746 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.4 m -65.13 -20.33 66.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.626 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 0.12 33.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.153 0.502 . . . . 0.0 110.698 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.09 8.88 68.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.444 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.24 148.52 22.87 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.584 ' HB ' HG13 ' A' ' 919' ' ' VAL . 47.4 t -110.37 124.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -104.31 114.56 28.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.06 120.14 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.457 0.646 . . . . 0.0 110.817 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.803 ' HB3' HE22 ' A' ' 916' ' ' GLN . 1.1 pt20 -104.65 143.26 33.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -119.6 157.93 27.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.092 0.472 . . . . 0.0 111.763 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.3 -17.9 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -77.4 1.44 19.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.635 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.62 8.4 84.73 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 5.8 p -98.23 153.47 18.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.768 0.318 . . . . 0.0 111.198 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.803 HE22 ' HB3' ' A' ' 910' ' ' GLN . 12.5 mm100 -122.78 150.88 42.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.983 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.583 HD12 ' C ' ' A' ' 916' ' ' GLN . 7.1 mp -138.69 133.81 32.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.5 p -116.83 123.94 72.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 168.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 923' ' ' VAL . 2.2 p -117.86 138.27 49.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -93.48 150.62 20.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -49.81 128.38 18.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 923' ' ' VAL . . . 99.48 -8.35 60.22 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.776 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 919' ' ' VAL . 0.8 OUTLIER 58.2 2.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.238 1.415 . . . . 0.0 113.947 172.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 47.4 m -74.76 -5.66 44.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.152 -0.343 . . . . 0.0 111.639 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 1.9 p -142.01 114.79 8.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.962 0.41 . . . . 0.0 111.318 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.567 HG22 ' HB ' ' A' ' 919' ' ' VAL . 0.2 OUTLIER -126.99 145.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.368 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.53 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 20.1 m -118.24 122.46 43.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -97.34 129.96 44.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.768 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 34.2 m -111.7 121.87 46.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 25.8 m -97.24 135.47 21.86 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.581 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.03 -13.99 17.33 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 113.205 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.48 -25.79 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 109.667 174.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 106.15 35.53 2.92 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -126.8 116.54 21.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.999 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 36.6 p -105.31 126.46 52.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.3 m -117.79 128.66 55.08 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -98.37 126.58 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 110.358 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -112.52 131.12 55.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.44 170.97 16.9 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.62 -20.63 66.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.299 0.55 . . . . 0.0 110.692 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.17 -0.65 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -108.21 147.83 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -99.93 130.97 46.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 111.13 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.1 133.6 72.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.63 -68.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.562 2.174 . . . . 0.0 111.939 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.94 -70.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.751 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -58.62 -29.67 66.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 25.9 mm -67.61 -43.66 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.77 -39.42 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.271 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.08 -43.18 91.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 9.7 mmpt? -68.29 -41.58 80.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.54 -34.99 79.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.697 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.86 -25.66 68.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.626 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.0 -23.15 65.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 36.0 tp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.309 0.576 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 10.1 m -106.96 147.55 29.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.928 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.03 139.97 45.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -98.91 131.34 45.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.72 120.77 64.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 58.09 4.63 0.32 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.112 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 59.8 23.12 12.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.136 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 95.2 t -104.8 -31.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.44 158.53 25.49 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.172 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -123.27 134.96 54.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.29 130.83 53.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.112 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.2 m -115.98 125.73 52.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.39 115.66 21.52 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.3 148.3 25.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.372 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 2.4 p -67.37 -9.58 42.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.74 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 14.3 m -87.54 1.14 54.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.92 4.53 82.07 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.146 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.2 152.6 20.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.7 123.71 64.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.511 ' HD1' HG22 ' A' ' 918' ' ' VAL . 38.6 t90 -106.83 112.91 26.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 7.7 p -115.51 118.82 59.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 111.151 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 46.7 tt0 -102.34 142.47 33.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.931 175.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -112.06 160.05 17.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.694 0.283 . . . . 0.0 110.876 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.38 -17.62 54.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.774 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.82 1.43 12.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.366 0.603 . . . . 0.0 110.654 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.22 4.59 88.06 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.975 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.4 t -99.48 155.58 17.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 917' ' ' LEU . 15.4 mp0 -130.74 151.7 50.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.92 HD22 ' HD1' ' A' ' 928' ' ' TYR . 1.5 mt -133.62 136.01 44.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.511 HG22 ' HD1' ' A' ' 908' ' ' TRP . 25.2 t -113.6 119.58 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 926' ' ' ILE . 6.7 p -120.14 133.65 66.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 0.0 110.591 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.05 143.98 31.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.42 129.69 22.33 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.587 0.554 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 103.12 -8.13 53.09 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.459 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 923' ' ' VAL . 13.7 t 48.49 44.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.953 0.882 . . . . 0.0 111.279 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 5.7 p -82.72 -23.76 33.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.889 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 63.8 m -162.16 130.53 4.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.256 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.619 HG12 HG23 ' A' ' 919' ' ' VAL . 16.3 mt -119.15 145.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.024 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.6 m -118.01 117.35 28.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.92 ' HD1' HD22 ' A' ' 917' ' ' LEU . 41.8 m-85 -99.02 130.05 45.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 916' ' ' GLN . 22.8 p -112.26 122.3 47.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 0.0 110.733 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 45.3 m -140.2 109.75 6.97 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.11 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 20.8 Cg_endo -60.99 -16.74 47.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.243 2.629 . . . . 0.0 112.61 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -74.89 -10.17 59.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.25 -68.1 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . 0.702 ' HG2' ' H ' ' A' ' 935' ' ' THR . 29.8 tt0 169.14 -168.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.702 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 10.0 t -105.33 128.85 53.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.94 0.4 . . . . 0.0 110.279 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 928' ' ' TYR . 10.0 t -117.02 142.11 47.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.71 128.66 54.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.1 0.476 . . . . 0.0 111.204 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 53.2 t80 -109.57 128.06 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.114 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -112.37 162.54 12.36 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.69 -5.7 4.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.478 0.639 . . . . 0.0 112.077 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.85 4.65 49.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.425 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 943' ' ' LYS . 6.7 tp10 -122.98 162.2 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . 0.819 ' HD3' ' H ' ' A' ' 943' ' ' LYS . 0.0 OUTLIER -99.92 138.81 36.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.023 176.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 948' ' ' ILE . 60.7 mt -97.06 140.6 22.18 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.826 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 22.8 Cg_exo -66.18 165.37 24.52 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.806 2.337 . . . . 0.0 111.254 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 950' ' ' GLN . 58.0 m-20 -53.47 -56.91 12.96 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -61.22 -34.18 74.7 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.662 HG21 HD22 ' A' ' 944' ' ' LEU . 3.2 mp -69.53 -43.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.69 -40.2 96.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.681 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 946' ' ' ASP . 97.0 mt-30 -61.46 -44.47 97.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.991 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -69.31 -39.91 77.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.292 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.66 -36.79 85.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.331 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -64.58 -24.91 67.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 83.3 m -69.31 -22.29 63.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.455 HD21 HG11 ' A' ' 909' ' ' VAL . 4.1 mm? . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.163 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 49.5 pttt . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.748 0.309 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 39.9 m -91.16 142.89 27.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 34.7 t -125.47 141.41 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -89.1 132.14 34.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.0 121.09 56.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.439 ' HB2' HG12 ' A' ' 896' ' ' VAL . 42.8 mtmt 52.13 11.78 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 59.76 22.47 11.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.438 0.695 . . . . 0.0 110.735 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 894' ' ' LYS . 14.9 p -105.4 -29.06 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.54 162.24 26.16 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.13 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.785 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.3 m95 -118.73 136.09 54.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.91 130.14 54.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.876 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.8 m -117.58 125.31 50.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.253 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -92.0 116.02 28.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 902' ' ' LEU . 3.3 mm? -91.38 152.55 20.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 19.1 p -67.0 -20.06 65.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.538 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 16.2 m -84.88 3.57 37.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 85.2 11.12 76.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.4 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.06 148.91 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.88 122.89 68.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HB2' HD21 ' A' ' 902' ' ' LEU . 4.1 t-105 -108.49 113.64 26.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 39.9 t -115.8 117.75 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 110.768 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.785 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 17.7 mp0 -101.71 148.8 24.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.447 ' HE2' HD22 ' A' ' 917' ' ' LEU . 57.2 m-85 -118.52 159.75 22.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.946 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.1 -17.05 63.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.89 1.53 17.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.651 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.97 5.53 87.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.14 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.2 m -97.21 156.87 16.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 79.4 mt-30 -123.15 152.43 41.17 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.731 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 916' ' ' GLN . 10.6 mp -133.96 136.3 44.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 36.4 t -112.52 121.15 64.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.93 138.54 49.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -92.58 137.15 32.61 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.73 127.96 33.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.538 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.47 84.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.456 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 925' ' ' SER . 8.4 t -122.53 146.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 117.334 0.567 . . . . 0.0 110.331 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.0 t -86.06 -6.62 58.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.492 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.575 ' H ' HG12 ' A' ' 923' ' ' VAL . 59.6 p -74.1 121.13 20.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 110.287 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 926' ' ' ILE . 0.2 OUTLIER -124.39 146.91 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.825 -177.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 31.7 m -107.86 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.99 128.32 42.77 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 27.3 m -113.0 122.05 46.47 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.387 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 20.2 m -102.93 124.04 40.03 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.352 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 31.6 Cg_exo -60.59 -10.99 15.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.568 2.845 . . . . 0.0 113.426 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.91 -15.45 63.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.26 0.553 . . . . 0.0 110.164 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 111.25 44.29 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.866 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -140.58 111.78 7.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.549 0.214 . . . . 0.0 111.098 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 20.8 m -104.59 123.57 47.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 26.5 m -121.75 128.31 51.61 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 0.1 OUTLIER -104.65 128.87 52.83 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.274 176.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -107.86 127.14 53.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.745 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -94.26 167.54 27.72 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.806 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.27 -27.48 67.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.219 0.533 . . . . 0.0 110.609 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.21 1.92 48.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.24 -173.62 2.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -99.14 119.11 37.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 945' ' ' PRO . 13.3 tp -101.67 131.77 22.51 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 944' ' ' LEU . 19.2 Cg_exo -68.55 153.53 73.46 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.767 2.312 . . . . 0.0 111.993 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.91 -46.44 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.487 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.14 -32.2 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.774 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 47.4 mm -69.32 -44.03 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 110.013 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -64.69 -44.18 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.16 -43.65 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -38.61 83.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.546 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 83.1 mt -64.01 -36.39 83.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 110.569 175.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -63.13 -23.08 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.867 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.94 -25.27 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 178.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.008 0.432 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 66.8 m -106.96 144.4 33.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 111.474 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.83 140.0 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.43 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -100.88 124.43 46.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.042 0.449 . . . . 0.0 110.944 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.0 p -117.07 123.93 72.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.299 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 67.63 -7.86 0.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.09 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 60.51 22.29 12.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.015 0.926 . . . . 0.0 110.089 -168.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.69 -28.65 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.881 171.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . 0.551 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -138.93 158.68 25.27 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.105 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.844 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 0.8 OUTLIER -122.65 136.2 54.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -114.2 130.89 56.62 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.969 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 89.9 m -109.93 124.61 51.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -97.27 115.44 27.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.0 111.224 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 906' ' ' ALA . 98.0 mt -90.22 130.37 36.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 16.9 m -67.06 -9.29 37.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.088 0.471 . . . . 0.0 111.064 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.4 m -80.68 -0.24 37.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.1 60.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.59 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -91.94 138.71 31.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.66 122.27 69.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.126 0.488 . . . . 0.0 109.844 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -108.4 113.38 26.4 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 955' ' ' LEU . 38.3 t -115.11 118.2 58.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.844 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 11.8 pt20 -103.43 171.32 7.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.798 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -118.44 169.66 9.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -66.19 -17.33 64.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.807 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.66 -0.76 48.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.565 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.2 90.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.017 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 157.6 18.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 910' ' ' GLN . 4.2 pt20 -132.27 154.71 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.59 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 4.6 pp -137.05 137.38 39.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 169.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.16 121.76 65.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.966 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 926' ' ' ILE . 20.5 t -120.73 134.55 63.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.366 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -92.76 139.68 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -58.06 127.12 30.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.93 0.395 . . . . 0.0 111.34 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.48 -6.25 83.35 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.986 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.802 HG12 ' H ' ' A' ' 925' ' ' SER . 46.4 t -99.86 139.56 21.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.996 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.5 p -91.19 -8.37 48.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.404 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.802 ' H ' HG12 ' A' ' 923' ' ' VAL . 14.1 m -93.34 124.84 37.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.472 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 919' ' ' VAL . 55.1 mt -114.48 145.8 19.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.675 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 11.0 p -117.67 116.41 26.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.59 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 79.7 t80 -110.96 127.02 55.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.031 0.443 . . . . 0.0 110.17 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.505 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 14.2 m -114.5 121.97 45.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.534 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 928' ' ' TYR . 32.5 t -115.91 123.72 30.72 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.59 -0.97 5.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.349 2.7 . . . . 0.0 112.489 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.62 -6.63 45.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.717 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.05 31.45 4.73 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.122 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -143.69 118.99 10.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.931 0.395 . . . . 0.0 111.828 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 5.5 t -104.57 127.19 52.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 31.8 m -118.59 128.79 54.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 111.393 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -100.55 127.65 46.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.567 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 60.1 t80 -109.1 126.27 53.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.388 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.31 161.11 14.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.78 -4.78 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.986 0.422 . . . . 0.0 112.046 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.76 2.98 56.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.036 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.64 176.03 8.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.05 143.76 29.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.545 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 948' ' ' ILE . 51.6 mt -97.37 147.1 32.48 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.224 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.583 ' HB2' HD13 ' A' ' 948' ' ' ILE . 31.9 Cg_exo -59.23 154.96 42.81 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.454 2.103 . . . . 0.0 110.447 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -57.32 -43.25 83.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -170.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 85.4 m-85 -68.31 -35.3 77.6 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.324 -176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 944' ' ' LEU . 2.5 mp -70.92 -43.36 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 944' ' ' LEU . 18.0 tppt? -63.7 -39.61 94.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -44.55 97.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.777 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 947' ' ' TYR . 13.5 mmmm -65.29 -42.92 92.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 919' ' ' VAL . 3.7 mm? -63.04 -35.71 81.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -69.48 -34.88 74.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.12 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 85.0 m -70.53 -24.72 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 909' ' ' VAL . 85.9 mt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.617 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 57.9 p -106.75 141.57 37.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.511 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.7 140.15 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.59 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -106.53 130.51 54.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.962 0.411 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.17 117.94 46.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 45.55 17.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.96 1.412 . . . . 0.0 112.749 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.74 24.38 12.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.4 t -102.09 -30.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.13 157.55 24.95 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.643 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -124.89 136.55 53.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 909' ' ' VAL . . . -124.65 131.78 53.45 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.197 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 17.1 m -105.01 125.54 51.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -85.76 116.66 24.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.23 158.43 23.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.885 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.3 m -66.79 -22.04 66.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.733 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 7.8 t -83.38 0.63 45.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.976 0.417 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.33 4.88 67.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.341 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.07 140.69 29.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.476 HG11 HD12 ' A' ' 955' ' ' LEU . 36.4 t -106.06 123.55 60.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HE1' ' HB3' ' A' ' 916' ' ' GLN . 3.0 t90 -102.24 111.96 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.611 HG13 ' HG ' ' A' ' 917' ' ' LEU . 3.2 p -114.51 118.29 58.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.601 0.715 . . . . 0.0 111.119 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 1.033 ' HB3' ' HG2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -106.88 148.02 29.07 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.229 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 951' ' ' LYS . 36.5 m-85 -91.47 175.05 7.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.185 0.517 . . . . 0.0 110.956 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -65.23 -17.39 64.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.698 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.62 -2.44 50.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.37 0.605 . . . . 0.0 111.201 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.01 90.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 63.5 m -95.68 152.29 18.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 1.033 ' HG2' ' HB3' ' A' ' 910' ' ' GLN . 32.0 mt-30 -132.05 154.86 48.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.726 0.298 . . . . 0.0 111.269 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.611 ' HG ' HG13 ' A' ' 909' ' ' VAL . 0.8 OUTLIER -137.83 137.98 38.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.927 0.394 . . . . 0.0 110.003 169.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 15.7 t -104.27 123.39 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.008 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 926' ' ' ILE . 42.5 t -118.21 129.9 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.788 176.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -94.59 139.6 30.98 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.32 127.61 32.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.874 0.369 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.74 83.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.61 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 925' ' ' SER . 30.7 t -115.78 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 122.792 -0.24 . . . . 0.0 110.508 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 35.0 t -91.06 -10.35 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 923' ' ' VAL . 12.5 m -82.61 111.52 18.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.732 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 952' ' ' LEU . 40.4 pt -113.3 155.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 0.0 110.918 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 14.4 m -117.49 116.34 26.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 911' ' ' PHE . 39.7 t80 -101.0 124.68 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.0 t -116.31 128.37 55.5 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.065 0.46 . . . . 0.0 110.046 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.2 t -132.88 120.71 16.58 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.43 -12.96 30.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.076 2.518 . . . . 0.0 111.732 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -76.72 -15.87 59.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.097 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.09 -68.38 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . 0.723 ' HG3' ' H ' ' A' ' 935' ' ' THR . 4.0 tp-100 166.1 -164.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.723 ' H ' ' HG3' ' A' ' 934' ' ' GLN . 18.9 m -103.42 127.11 50.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.001 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.6 t -119.06 143.34 47.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.255 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 937' ' ' ARG . 8.1 ptt180 -97.78 135.18 39.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.214 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.515 ' HB3' HD21 ' A' ' 944' ' ' LEU . 76.9 m-85 -110.78 126.88 55.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 170.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . 0.669 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -146.21 -170.74 15.05 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.231 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.89 -27.41 68.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.828 0.347 . . . . 0.0 110.832 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.89 1.38 57.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.113 0.483 . . . . 0.0 110.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.669 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 1.3 mp0 -108.07 174.47 5.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.679 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -99.17 124.19 44.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 938' ' ' TYR . 62.5 mt -97.01 131.04 28.47 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.984 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 15.7 Cg_exo -72.03 154.67 57.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.903 2.402 . . . . 0.0 111.033 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.26 -48.08 82.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.12 -176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . 0.728 ' O ' ' HD3' ' A' ' 951' ' ' LYS . 44.9 m-85 -66.82 -30.67 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.6 -40.81 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.821 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -63.34 -37.63 88.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.004 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -61.08 -44.63 97.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.047 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.728 ' HD3' ' O ' ' A' ' 947' ' ' TYR . 2.3 mptp? -68.61 -42.96 77.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.313 0.578 . . . . 0.0 109.483 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.527 HD13 HG21 ' A' ' 926' ' ' ILE . 62.1 tp -59.38 -38.34 80.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.605 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.19 -25.59 63.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 71.3 m -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.932 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.476 HD12 HG11 ' A' ' 907' ' ' VAL . 2.8 mm? . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.602 0.239 . . . . 0.0 111.435 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.384 0.611 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 14.5 m -107.52 148.36 29.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.629 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 19.8 t -112.93 138.48 42.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -108.58 126.15 52.63 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.02 118.6 59.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.38 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.641 ' HB2' HG12 ' A' ' 896' ' ' VAL . 94.0 mttt 53.49 7.97 0.12 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.31 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.3 23.49 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.627 0.771 . . . . 0.0 109.854 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.5 p -105.2 -28.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.65 158.14 24.92 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.876 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.447 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 2.9 m95 -122.97 136.53 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -110.87 130.07 55.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.026 0.441 . . . . 0.0 110.124 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 10.1 m -116.99 125.37 51.28 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.758 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.92 117.08 29.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.228 0.537 . . . . 0.0 110.112 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.6 mm? -95.56 137.05 35.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.807 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.7 t -63.34 -17.82 62.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 22.7 t -81.81 1.04 36.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.07 11.31 61.55 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.029 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.43 140.63 29.58 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.823 -0.222 . . . . 0.0 110.443 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.735 HG11 HD11 ' A' ' 955' ' ' LEU . 46.7 t -107.59 122.83 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.77 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 1.5 t90 -110.23 115.74 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.452 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 57.5 t -112.41 119.39 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.436 0.636 . . . . 0.0 110.245 173.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.665 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.1 tt0 -104.4 143.33 33.14 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.478 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.52 171.06 9.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.56 -21.04 66.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.25 1.87 49.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.642 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.0 5.35 87.78 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.085 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.5 m -94.63 152.07 18.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.665 ' HG2' ' HG3' ' A' ' 910' ' ' GLN . 51.6 mt-30 -134.5 159.15 42.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 926' ' ' ILE . 1.3 pt? -137.91 136.07 36.7 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 169.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 907' ' ' VAL . 7.0 m -114.3 128.08 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.43 . . . . 0.0 111.545 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.93 136.69 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -92.3 140.86 29.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.21 128.5 37.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.32 -6.14 83.6 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 925' ' ' SER . 41.6 t -111.61 134.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.109 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.8 m -91.0 -5.34 55.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.743 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.745 ' H ' HG12 ' A' ' 923' ' ' VAL . 15.0 m -95.43 131.58 41.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.475 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 917' ' ' LEU . 3.7 mp -113.15 146.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 15.2 m -115.34 117.1 29.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.632 ' HB2' ' HE1' ' A' ' 938' ' ' TYR . 43.8 t80 -96.24 127.18 42.01 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 8.9 t -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.333 0.587 . . . . 0.0 110.918 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 22.8 t -118.01 111.18 39.1 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.01 144.83 93.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.0 12.62 8.05 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.577 0.548 . . . . 0.0 110.396 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 934' ' ' GLN . . . -131.39 -91.46 0.54 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 933' ' ' GLY . 30.0 mt-30 178.01 168.1 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.621 0.768 . . . . 0.0 109.9 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 50.3 m -105.24 126.2 51.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.663 0.268 . . . . 0.0 110.359 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 24.7 m -118.96 128.84 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.414 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 13.7 ptm180 -99.67 127.4 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.369 0.604 . . . . 0.0 111.278 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 928' ' ' TYR . 26.0 p90 -110.06 138.53 46.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.011 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -90.94 -179.71 43.0 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.615 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.45 -13.01 60.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.813 0.34 . . . . 0.0 111.152 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.83 -0.16 57.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -92.67 141.07 28.88 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.94 -0.475 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 943' ' ' LYS . 23.5 mtmm -92.99 123.5 36.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.32 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -96.51 135.53 22.34 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 33.9 Cg_exo -61.62 -73.43 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.909 2.406 . . . . 0.0 113.148 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -145.61 -71.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -64.1 -32.77 74.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.667 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 32.5 mm -68.53 -43.06 83.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -64.01 -39.68 94.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.807 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.56 -43.7 96.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 951' ' ' LYS . 2.8 mptp? -67.95 -38.69 83.11 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.208 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 89.2 mt -62.97 -31.74 72.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.159 0.504 . . . . 0.0 110.494 175.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -69.27 -36.42 77.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.5 -11.71 60.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.588 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.735 HD11 HG11 ' A' ' 907' ' ' VAL . 3.1 mm? . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.821 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 11.1 p -106.64 143.92 34.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.944 0.402 . . . . 0.0 110.823 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.17 142.63 41.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.001 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -106.76 129.16 54.68 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.25 121.03 54.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.62 ' HB3' HG12 ' A' ' 896' ' ' VAL . 58.9 tttm 57.8 4.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.136 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.66 24.42 14.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.779 0.799 . . . . 0.0 109.178 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.9 p -103.71 -28.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.21 158.47 25.34 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.849 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.701 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.7 OUTLIER -121.6 135.43 54.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.4 130.18 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.067 0.46 . . . . 0.0 110.865 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 28.8 m -115.66 132.85 56.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.047 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -94.82 115.79 27.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.33 153.67 19.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -19.11 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.239 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.3 m -85.2 1.03 49.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.715 0.293 . . . . 0.0 111.262 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.73 69.11 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.943 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.35 141.76 28.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.6 122.31 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 2.0 t-105 -104.01 114.62 29.0 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 48.7 t -112.41 117.29 54.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.265 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.701 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 42.7 mt-30 -103.62 143.51 32.66 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.907 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 152.41 20.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.418 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 896' ' ' VAL . 26.7 p30 -65.09 -16.24 63.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.35 2.34 50.63 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.289 -0.257 . . . . 0.0 111.555 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.53 5.81 60.04 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.602 -0.808 . . . . 0.0 114.202 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 14.0 m -96.53 157.93 15.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.756 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.8 OUTLIER -133.2 154.68 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.02 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 917' ' ' LEU . 5.6 mp -123.07 134.85 54.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.495 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.67 118.66 59.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.25 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 955' ' ' LEU . 12.5 p -123.22 144.61 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 906' ' ' ALA . 61.8 tt0 -93.17 139.55 30.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.146 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.99 128.93 38.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 99.24 -4.01 58.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.981 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 925' ' ' SER . 9.9 p -139.69 151.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 117.257 0.529 . . . . 0.0 110.521 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 940' ' ' GLU . 5.1 p -91.45 -6.74 52.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.499 ' H ' HG22 ' A' ' 923' ' ' VAL . 16.4 p -68.49 108.85 3.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.25 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.05 145.28 25.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.343 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 6.2 p -117.61 122.41 43.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.795 0.331 . . . . 0.0 110.292 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -96.1 127.89 42.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.756 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 20.9 m -113.96 123.39 49.61 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.323 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 48.0 t -107.35 115.06 60.24 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 23.3 Cg_exo -65.59 2.48 1.57 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.673 2.915 . . . . 0.0 112.861 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.33 -3.48 57.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.55 . . . . 0.0 109.563 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.45 44.28 1.59 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.373 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.29 102.57 2.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 11.9 t -105.43 129.67 53.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.042 0.448 . . . . 0.0 110.57 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 14.8 p -116.93 128.64 55.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.033 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 7.2 ptp85 -107.8 126.89 53.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.552 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.46 139.65 46.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.574 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 942' ' ' GLU . . . -109.39 173.1 16.75 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.033 174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 924' ' ' SER . 30.5 tt0 -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.83 0.347 . . . . 0.0 111.569 -176.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -95.34 2.22 54.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.322 0.582 . . . . 0.0 110.688 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 939' ' ' GLY . 33.4 mm-40 -91.48 172.32 8.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 130.77 46.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.952 0.406 . . . . 0.0 110.111 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -94.84 133.2 26.9 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.866 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 31.4 Cg_exo -59.82 -65.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 0.0 111.683 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -165.68 -64.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.46 -33.59 72.79 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.57 -172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.24 -42.72 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.2 -44.27 92.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.452 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.6 -43.98 96.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.682 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 35.4 mmtm -71.15 -38.02 72.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 955' ' ' LEU . 28.0 tp -57.98 -36.56 72.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.858 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.51 -35.09 79.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.885 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 27.8 t -72.1 -25.26 61.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.256 0.55 . . . . 0.0 110.602 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 952' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 t -107.36 143.42 35.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.754 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 35.0 t -126.42 140.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.272 . . . . 0.0 110.565 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -92.07 130.68 37.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 954' ' ' CYS . 14.4 m -111.2 122.26 65.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.972 0.415 . . . . 0.0 111.597 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . 0.726 ' HB3' HG12 ' A' ' 896' ' ' VAL . 39.8 ttmt 60.91 1.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.932 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.08 22.52 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.074 -170.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.3 p -104.22 -29.19 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.9 160.32 26.17 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.327 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.537 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -120.68 133.79 55.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -125.14 130.66 52.63 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.243 -0.583 . . . . 0.0 112.188 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 52.0 m -115.52 125.65 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.296 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -86.59 124.13 32.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.14 141.7 28.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 3.6 m -66.65 -8.4 27.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 3.0 m -85.49 0.5 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.32 4.21 71.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.68 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.02 142.67 27.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.2 123.18 68.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -107.71 112.55 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 917' ' ' LEU . 6.0 p -116.85 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.748 0.785 . . . . 0.0 110.767 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.537 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 7.6 tt0 -91.91 143.14 26.8 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.857 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 913' ' ' ASP . 19.7 t80 -92.66 150.0 20.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.8 -19.72 60.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . 0.809 ' H ' ' HD1' ' A' ' 911' ' ' PHE . 37.9 t70 -79.97 1.1 28.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.188 0.518 . . . . 0.0 111.264 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 91.94 5.71 65.93 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.94 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.7 p -96.05 153.3 17.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -121.83 155.48 35.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.549 0.214 . . . . 0.0 110.555 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 909' ' ' VAL . 7.9 tt -137.75 131.0 30.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.54 120.8 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.33 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.22 145.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.74 139.33 30.66 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.42 128.68 37.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.811 0.338 . . . . 0.0 111.691 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.02 -6.63 64.19 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.09 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.07 156.36 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 122.511 -0.405 . . . . 0.0 111.1 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 944' ' ' LEU . 42.0 m -90.32 -5.68 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 15.3 t -69.2 112.35 5.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.218 0.532 . . . . 0.0 109.839 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 948' ' ' ILE . 0.0 OUTLIER -120.64 146.61 25.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.897 -174.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 5.8 m -116.15 117.63 30.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -108.02 129.37 55.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 23.6 m -100.44 121.94 42.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 44.6 t -123.02 125.03 26.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -11.92 32.42 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.348 2.032 . . . . 0.0 111.422 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -105.06 -14.5 15.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.916 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -149.33 22.3 1.22 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.458 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . 0.803 ' HG2' ' H ' ' A' ' 935' ' ' THR . 39.3 tt0 68.3 -161.26 0.2 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.051 0.426 . . . . 0.0 109.906 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.803 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 3.3 p -97.29 126.0 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.439 . . . . 0.0 110.972 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 19.9 p -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.851 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -98.95 128.99 45.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.855 0.36 . . . . 0.0 110.369 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 926' ' ' ILE . 58.4 m-85 -101.84 127.85 48.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.41 141.74 15.67 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.676 -167.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.35 -21.88 66.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.533 0.682 . . . . 0.0 109.802 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.18 2.04 37.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.862 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -142.02 -140.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.838 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -100.01 136.26 40.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.706 -169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 924' ' ' SER . 24.6 mt -99.96 132.74 22.35 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.836 169.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.54 155.29 70.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.677 2.251 . . . . 0.0 111.42 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 950' ' ' GLN . 24.8 t70 -60.21 -46.74 88.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.376 -176.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -61.69 -31.81 71.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 111.348 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 926' ' ' ILE . 45.3 mm -69.35 -42.56 81.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.44 . . . . 0.0 109.966 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -63.01 -37.24 86.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.104 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 946' ' ' ASP . 81.1 mm-40 -61.11 -44.14 97.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.609 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.63 -43.64 79.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.4 -36.24 83.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.855 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -59.4 -34.18 72.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.261 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 893' ' ' VAL . 61.2 m -69.9 -25.41 63.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.651 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -178.397 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.056 0.455 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 3.8 p -107.08 154.0 21.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.804 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.63 139.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -97.08 130.13 44.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 893' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 954' ' ' CYS . 44.7 t -116.51 119.46 62.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.629 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 56.37 4.96 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.622 1.201 . . . . 0.0 112.316 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 59.07 23.58 11.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.333 0.653 . . . . 0.0 109.944 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.57 -29.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.78 158.77 25.76 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.448 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 898' ' ' TRP . . . . . 0.463 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 3.6 m95 -121.03 136.0 55.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.49 130.16 52.76 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.104 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 23.9 m -116.62 127.07 54.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.483 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -88.63 117.55 27.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.887 0.375 . . . . 0.0 110.427 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 908' ' ' TRP . 3.1 mm? -80.21 149.42 30.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.975 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 8.4 t -65.88 -20.28 66.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.446 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 39.9 t -83.95 0.77 46.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 111.041 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.62 6.5 63.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.912 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -85.24 152.34 23.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 907' ' ' VAL . . . . . 0.536 ' HB ' ' CG1' ' A' ' 919' ' ' VAL . 45.2 t -112.08 122.92 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.252 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 908' ' ' TRP . . . . . 0.699 ' HB2' HD21 ' A' ' 902' ' ' LEU . 22.6 t90 -110.08 113.68 26.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 909' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 917' ' ' LEU . 45.7 t -115.2 129.01 72.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 -175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 910' ' ' GLN . . . . . 0.463 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 35.1 mt-30 -98.61 150.05 22.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -108.5 162.25 14.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.475 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.9 -27.77 61.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.347 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.71 1.53 42.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.489 0.662 . . . . 0.0 111.103 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.76 8.19 83.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.065 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.68 165.38 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -0.627 . . . . 0.0 109.519 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -130.8 151.99 50.63 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.2 -177.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -137.67 134.82 35.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.013 0.435 . . . . 0.0 110.018 173.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 918' ' ' VAL . . . . . 0.619 HG22 ' HD1' ' A' ' 908' ' ' TRP . 42.4 t -114.2 124.3 70.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.157 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 907' ' ' VAL . 14.6 p -118.8 132.55 68.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 110.331 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.04 141.66 28.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.162 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.19 40.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 101.33 6.48 50.89 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.647 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 925' ' ' SER . 8.1 p -149.78 141.14 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 940' ' ' GLU . 35.1 t -87.1 -5.57 58.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.874 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 925' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 923' ' ' VAL . 19.6 m -82.31 131.16 35.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.3 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.773 HD11 HD13 ' A' ' 952' ' ' LEU . 3.6 mt -120.0 146.43 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.252 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 917' ' ' LEU . 23.3 t -104.35 115.41 30.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 928' ' ' TYR . . . . . 0.574 ' CZ ' HD13 ' A' ' 917' ' ' LEU . 19.7 m-85 -102.12 125.81 48.91 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 929' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.5 t -114.99 123.52 49.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.57 0.7 . . . . 0.0 110.661 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 43.2 t -105.07 106.61 56.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.697 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.66 -39.0 93.6 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.346 2.697 . . . . 0.0 112.932 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -97.0 16.18 20.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.785 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -137.63 -75.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.532 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 175.54 169.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 935' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 29.1 m -104.43 124.51 49.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 11.1 m -121.54 130.0 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 937' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -97.62 128.96 44.73 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.145 174.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.56 127.44 53.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.803 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.15 169.55 22.89 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.332 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 940' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 924' ' ' SER . 11.7 pt-20 -64.68 -15.93 62.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.449 0.299 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.45 1.61 55.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -100.93 146.43 27.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.339 . . . . 0.0 110.684 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.38 123.38 31.56 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 944' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 948' ' ' ILE . 2.2 mm? -91.43 133.57 31.12 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.407 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -71.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.271 2.647 . . . . 0.0 113.334 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -147.26 -75.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.754 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 948' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 948' ' ' ILE . 4.0 mp -67.72 -42.66 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -63.31 -44.05 96.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.781 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -62.25 -42.63 99.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.854 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 951' ' ' LYS . . . . . 0.508 ' O ' HD13 ' A' ' 955' ' ' LEU . 25.5 mmmt -68.81 -40.58 79.49 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.149 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 926' ' ' ILE . 56.5 tp -62.15 -39.65 93.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.847 175.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -73.2 -35.45 66.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.38 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 954' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 31.8 p -71.53 -20.68 62.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.031 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 955' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 951' ' ' LYS . 4.4 mp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 112.246 -0.342 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 97.04 9.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.479 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -156.78 142.43 17.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.237 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -77.74 -65.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.83 133.65 52.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.769 0.318 . . . . 0.0 110.804 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.1 132.08 55.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.845 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 889' ' ' LYS . 41.1 mmtm -93.07 -4.17 52.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 50.8 m -106.98 142.63 36.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.533 172.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.44 139.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -105.2 119.51 39.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.868 0.366 . . . . 0.0 110.291 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.08 119.25 42.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.051 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.452 ' HB3' HG12 ' A' ' 896' ' ' VAL . 34.8 ttpt 55.01 5.13 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.842 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.99 24.96 14.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.602 0.761 . . . . 0.0 110.15 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 894' ' ' LYS . 9.7 p -103.18 -27.33 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.64 24.99 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.283 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.2 135.16 54.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 27.1 m -103.7 126.03 50.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.714 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -86.68 116.14 24.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.906 0.384 . . . . 0.0 110.675 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.84 145.6 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 10.0 p -67.18 -20.26 65.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.9 m -81.84 2.61 29.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.308 . . . . 0.0 111.714 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.47 7.9 63.01 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.496 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.53 140.1 30.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 919' ' ' VAL . 4.2 p -117.19 123.17 71.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.282 0.563 . . . . 0.0 109.866 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -101.2 112.23 24.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 917' ' ' LEU . 5.9 p -114.61 117.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.812 0.815 . . . . 0.0 111.046 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.3 tt0 -104.53 143.28 33.25 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.52 166.26 10.91 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.779 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -64.85 -20.45 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.698 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.6 1.3 26.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 111.122 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 92.14 5.5 65.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.289 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.0 m -97.23 153.21 18.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.599 ' C ' HD12 ' A' ' 917' ' ' LEU . 83.1 mt-30 -125.4 153.28 43.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.733 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.9 mp -134.22 137.78 44.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.69 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.79 120.66 62.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.519 ' HB ' HG13 ' A' ' 907' ' ' VAL . 74.2 t -119.7 132.65 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.72 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -93.48 138.3 31.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.6 127.1 29.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.58 0.229 . . . . 0.0 110.847 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.41 -0.13 82.95 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.693 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 925' ' ' SER . 27.8 t -120.19 140.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.5 t -91.35 -14.83 30.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 111.131 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.645 ' H ' HG12 ' A' ' 923' ' ' VAL . 22.5 p -87.95 114.67 24.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.361 0.6 . . . . 0.0 110.718 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 938' ' ' TYR . 2.4 pp -116.68 162.89 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.819 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 7.2 t -117.47 117.01 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 935' ' ' THR . 56.2 t80 -105.3 128.63 53.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.795 0.331 . . . . 0.0 110.681 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 31.3 m -114.71 128.91 56.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.512 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.0 m -105.88 138.38 19.62 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.38 -7.41 15.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.681 2.921 . . . . 0.0 113.611 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -78.72 -1.44 34.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.312 0.577 . . . . 0.0 109.791 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 92.62 39.32 5.32 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.577 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -133.66 106.17 7.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.213 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 928' ' ' TYR . 9.3 t -104.65 126.49 51.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.247 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 20.6 m -117.97 136.4 53.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.593 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.66 127.58 43.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.591 ' HD2' HG13 ' A' ' 926' ' ' ILE . 7.7 t80 -99.2 126.59 45.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.97 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -117.74 169.56 13.29 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.38 -15.61 58.03 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.507 0.653 . . . . 0.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.09 23.38 9.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.045 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -127.55 147.02 50.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -100.69 140.24 35.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.853 0.359 . . . . 0.0 111.084 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 948' ' ' ILE . 2.3 mm? -93.23 140.1 23.19 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.555 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 948' ' ' ILE . 24.0 Cg_exo -65.52 170.11 11.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.372 2.048 . . . . 0.0 110.596 165.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.88 -52.51 57.24 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 67.1 m-85 -66.04 -33.94 76.94 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 944' ' ' LEU . 23.1 mm -71.19 -43.47 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-O 121.346 0.593 . . . . 0.0 109.827 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -64.38 -38.96 92.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.851 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -61.47 -47.39 85.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.5 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.47 ' HB3' ' HE2' ' A' ' 951' ' ' LYS . 12.7 ptpt -70.11 -38.15 75.54 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 955' ' ' LEU . 37.3 mt -58.03 -30.97 66.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 111.406 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -60.13 -33.8 72.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.55 -24.23 63.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.11 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -70.32 -15.74 62.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.427 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 14.6 t -58.61 -30.85 67.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.931 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 46.7 p -59.66 -37.59 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 49.4 mt -68.35 -39.31 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.226 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.97 -41.73 96.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.175 0.512 . . . . 0.0 110.208 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.26 -34.73 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.748 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . 0.488 ' HA ' ' CE ' ' A' ' 961' ' ' MET . 1.5 tpt -64.57 -26.39 68.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.346 . . . . 0.0 110.702 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -84.96 -5.81 59.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 111.008 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 33.1 m -89.18 3.98 50.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.182 0.515 . . . . 0.0 110.082 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' A' ' 965' ' ' PRO . 47.7 t30 -65.58 127.08 92.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.633 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.435 ' HD2' ' OD1' ' A' ' 964' ' ' ASN . 92.9 Cg_exo -43.64 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.606 2.871 . . . . 0.0 113.605 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 3.3 p -145.83 152.71 48.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.659 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.47 -19.93 54.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.929 2.42 . . . . 0.0 112.579 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.86 -0.43 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.82 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -119.68 144.59 47.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.7 t -75.26 164.4 26.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -72.64 111.98 8.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.48 . . . . 0.0 110.37 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.17 147.69 23.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.395 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.417 HD13 ' HE2' ' A' ' 889' ' ' LYS . 97.3 mt -111.62 134.29 53.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.78 45.55 1.08 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.268 0.556 . . . . 0.0 111.584 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . 0.417 ' HE2' HD13 ' A' ' 887' ' ' LEU . 38.5 pttt -128.47 96.26 4.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.244 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.7 m -107.34 155.7 19.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.535 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.6 138.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.319 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -100.22 131.3 46.24 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.012 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.65 HG13 ' SG ' ' A' ' 954' ' ' CYS . 55.3 t -95.18 117.06 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.533 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.529 ' H ' ' HE2' ' A' ' 894' ' ' LYS . 0.7 OUTLIER 51.64 9.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.002 0.921 . . . . 0.0 112.881 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.54 22.37 12.1 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.606 0.763 . . . . 0.0 109.893 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.55 -27.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 109.786 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.1 160.83 25.91 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.382 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.0 OUTLIER -121.55 136.26 54.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.68 56.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.1 m -114.37 132.77 56.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.83 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.26 123.56 39.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.087 0.47 . . . . 0.0 111.6 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.3 mm? -96.84 139.03 33.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.5 t -67.12 -10.67 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 11.1 t -85.99 0.38 53.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.479 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.3 10.09 59.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.437 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 902' ' ' LEU . . . -92.01 141.47 28.59 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.31 122.58 70.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.477 ' HE3' HD21 ' A' ' 902' ' ' LEU . 0.0 OUTLIER -103.74 114.96 29.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.423 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.0 t -110.0 118.42 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.27 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 51.1 mt-30 -101.67 143.01 32.16 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.827 0.346 . . . . 0.0 110.165 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.559 ' CZ ' ' HE2' ' A' ' 951' ' ' LYS . 0.3 OUTLIER -92.71 151.55 20.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . 0.457 ' N ' ' HD1' ' A' ' 911' ' ' PHE . 28.0 t-20 -58.39 -26.89 63.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.45 2.47 47.63 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.67 5.09 60.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.551 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 65.4 m -83.29 162.45 21.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -132.94 151.41 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.455 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 7.0 mp -124.58 136.64 54.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.448 HG22 ' NE1' ' A' ' 908' ' ' TRP . 27.8 t -111.76 118.27 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 926' ' ' ILE . 34.2 t -122.99 131.86 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.902 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 923' ' ' VAL . 34.7 tt0 -94.47 139.03 31.67 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.22 127.41 31.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.063 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 100.16 -5.65 57.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.967 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 925' ' ' SER . 7.7 p -124.88 140.24 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.955 ' HB2' ' HG3' ' A' ' 940' ' ' GLU . 26.4 m -89.13 -5.9 57.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.416 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 923' ' ' VAL . 34.7 m -73.26 117.8 15.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.671 0.272 . . . . 0.0 110.565 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.621 HG23 HG22 ' A' ' 919' ' ' VAL . 1.5 mp -112.58 144.42 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.228 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 15.6 m -119.15 113.79 21.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 938' ' ' TYR . 24.1 p90 -111.39 130.13 55.79 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.981 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 11.4 t -113.1 136.99 52.11 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 4.0 t -122.65 125.62 26.36 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.85 135.97 72.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.944 3.096 . . . . 0.0 113.156 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 65.16 11.44 7.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -118.76 -84.46 0.94 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.303 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 933' ' ' GLY . 6.5 tp-100 169.53 160.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 6.9 t -103.08 128.86 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.461 . . . . 0.0 109.936 173.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . 0.623 ' HB ' ' CE1' ' A' ' 928' ' ' TYR . 38.0 m -116.9 136.41 52.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.681 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.583 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -116.33 128.06 55.22 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.132 0.491 . . . . 0.0 110.628 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.626 ' HE1' ' HE1' ' A' ' 928' ' ' TYR . 56.1 m-85 -109.88 131.46 55.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.054 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -92.68 179.41 40.06 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.517 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . 0.955 ' HG3' ' HB2' ' A' ' 924' ' ' SER . 24.7 mp0 -63.72 -26.04 68.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.855 0.327 . . . . 0.0 111.294 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -87.23 1.58 52.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.935 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 938' ' ' TYR . 34.0 mt-10 -108.6 142.48 39.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.427 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -76.84 129.85 36.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.629 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 91.2 mt -93.83 134.17 26.67 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.255 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 27.0 Cg_exo -63.78 164.53 21.22 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.015 2.477 . . . . 0.0 112.071 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.61 -62.81 1.27 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.686 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -68.06 -33.03 73.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.391 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.43 -43.88 83.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.121 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -63.28 -43.41 97.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.24 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -59.82 -44.16 94.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.309 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 911' ' ' PHE . 4.5 mttp -68.41 -43.47 77.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.653 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 952' ' ' LEU . 3.9 mm? -64.24 -35.97 82.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.0 110.816 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -61.47 -35.2 76.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.507 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . 0.65 ' SG ' HG13 ' A' ' 893' ' ' VAL . 35.6 t -73.5 -26.68 61.0 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.21 -20.61 63.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 47.9 t -58.12 -38.86 77.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 109.948 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 17.4 t -65.82 -38.07 87.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.121 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.98 -40.09 80.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.186 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.93 -43.96 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.62 -39.47 88.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 27.4 ttt -69.42 -27.03 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -84.83 -5.82 59.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.371 0.605 . . . . 0.0 110.266 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 28.2 t -93.54 21.42 6.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.502 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 10.1 p30 -77.05 131.02 73.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.922 0.392 . . . . 0.0 110.561 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 1.7 Cg_endo -83.89 150.98 12.68 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.99 2.46 . . . . 0.0 111.905 176.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 40.1 m -136.46 103.88 9.39 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.762 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.86 90.9 0.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.491 2.128 . . . . 0.0 112.445 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -93.94 -0.58 55.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.491 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -89.57 -1.14 57.94 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.241 0.544 . . . . 0.0 109.869 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.54 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 14.2 m -90.74 -6.59 54.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.781 0.291 . . . . 0.0 110.748 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 69.78 2.38 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.213 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 886' ' ' GLN . 15.2 mm-40 -92.85 -10.36 36.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.862 0.363 . . . . 0.0 111.107 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 90.9 mt -124.23 118.42 26.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.11 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.18 114.26 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.201 0.524 . . . . 0.0 110.932 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -121.09 -32.18 3.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.0 173.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 p -107.38 143.61 35.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.296 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.04 154.96 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.712 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -106.98 130.61 54.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.656 0.265 . . . . 0.0 110.681 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.09 119.08 59.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.458 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.588 ' HB2' HG12 ' A' ' 896' ' ' VAL . 3.2 mmmp? 54.16 7.62 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.86 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.01 22.55 10.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.064 0.546 . . . . 0.0 110.261 -171.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.588 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.8 p -103.69 -27.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . 0.919 ' HA3' ' HE3' ' A' ' 951' ' ' LYS . . . -140.12 158.89 25.99 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.568 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 2.0 m95 -121.93 135.54 54.88 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -121.84 130.5 53.43 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.026 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.1 m -115.6 124.72 51.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -101.02 117.18 34.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.261 0.553 . . . . 0.0 110.717 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.72 137.3 33.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.265 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 5.9 m -64.53 -13.24 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.262 0.554 . . . . 0.0 111.189 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 13.5 m -79.93 0.42 31.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 94.47 6.67 60.99 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.629 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.5 137.84 32.05 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -110.53 111.96 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 43.8 t -116.56 116.92 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 46.4 mt-30 -94.04 160.65 14.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.893 0.377 . . . . 0.0 110.5 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.454 ' HD1' ' HZ2' ' A' ' 951' ' ' LYS . 38.3 t80 -104.47 164.48 11.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -60.29 -26.01 66.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.3 0.1 54.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.54 4.8 60.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.707 . . . . 0.0 113.726 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 60.5 p -81.24 162.86 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.571 0.686 . . . . 0.0 109.332 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.6 OUTLIER -132.51 153.45 50.92 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 112.318 -177.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 916' ' ' GLN . 5.9 mp -126.92 135.97 51.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 32.8 t -112.39 122.69 67.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.73 137.16 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.127 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 923' ' ' VAL . 77.1 mm-40 -93.39 138.46 31.69 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.64 129.42 40.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.641 0.258 . . . . 0.0 111.062 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.17 -6.84 61.94 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.412 174.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 920' ' ' GLN . 33.5 m -130.14 156.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.393 0.596 . . . . 0.0 110.821 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 4.6 p -91.05 -6.7 53.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.297 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 21.7 m -72.06 128.54 36.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.956 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -126.88 146.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.529 -175.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 13.0 m -114.01 116.43 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -97.12 127.21 42.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.045 0.45 . . . . 0.0 109.873 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.738 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 17.1 m -114.28 123.63 50.01 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.394 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 33.8 t -122.91 106.21 34.33 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 37.5 Cg_endo -66.41 -5.74 13.42 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.938 2.425 . . . . 0.0 111.993 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -93.18 -6.81 46.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.43 -66.5 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.638 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 179.74 169.06 1.17 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -169.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 18.2 m -103.23 124.78 49.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 53.5 m -119.66 130.17 54.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -97.85 130.25 44.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 926' ' ' ILE . 77.4 m-85 -109.62 127.64 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.024 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.88 172.56 24.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.66 -18.31 64.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.569 0.685 . . . . 0.0 110.721 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.05 2.29 47.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.565 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.87 143.97 26.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -95.95 125.69 40.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.915 0.388 . . . . 0.0 110.472 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.83 133.54 39.27 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.22 -66.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.601 2.201 . . . . 0.0 112.068 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -163.36 -64.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.688 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -59.74 -32.07 70.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.795 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.52 -43.56 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 0.0 110.385 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -64.23 -42.72 96.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.868 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -60.01 -43.78 95.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.219 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.919 ' HE3' ' HA3' ' A' ' 897' ' ' GLY . 23.2 tptm -68.1 -43.29 78.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.261 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.29 -37.74 88.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.883 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.76 -21.38 62.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.397 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.18 -23.07 67.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 110.712 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.35 -14.07 62.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.771 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 959' ' ' LEU . 37.3 m -53.64 -35.14 60.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.712 0.291 . . . . 0.0 111.565 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 12.4 m -62.96 -38.25 90.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.044 0.45 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 43.2 mm -70.88 -43.93 76.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 956' ' ' SER . 4.5 pp -64.18 -34.27 77.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 110.2 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.11 -39.82 94.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.558 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 47.5 ttm -66.01 -27.24 67.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.232 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -80.77 -7.7 59.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.868 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 20.0 m -95.64 0.59 52.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.072 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 65.07 106.46 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.276 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.94 126.15 21.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.036 2.491 . . . . 0.0 112.446 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 9.5 t -102.1 148.48 35.43 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.461 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.55 108.07 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.836 2.358 . . . . 0.0 111.973 172.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . 0.415 HD22 ' HA ' ' A' ' 968' ' ' ASN . 2.3 t-20 -90.4 22.67 3.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.114 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.18 117.38 5.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.493 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.419 -179.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.3 t -86.11 101.94 13.42 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -108.69 87.28 2.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.203 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -103.56 105.26 15.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.648 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 6.0 tt -100.1 103.26 14.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.909 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.07 -154.91 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.862 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -73.98 -12.81 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.388 0.614 . . . . 0.0 109.36 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.6 m -103.2 141.08 36.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.832 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.56 140.55 48.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 898' ' ' TRP . 36.0 p90 -90.37 125.54 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.066 0.46 . . . . 0.0 110.736 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 894' ' ' LYS . 7.3 p -95.26 123.44 47.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.089 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 893' ' ' VAL . 33.3 mmtp 57.91 8.29 0.71 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.678 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.99 22.56 11.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.69 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.74 -30.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.827 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.2 163.85 25.34 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.139 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.643 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 2.1 m95 -121.36 134.89 55.13 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.45 129.98 55.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.883 0.373 . . . . 0.0 110.633 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 24.9 m -116.88 126.89 53.67 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.419 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -94.34 116.14 28.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.249 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.7 p -66.4 -15.56 63.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.8 p -85.54 0.55 52.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.739 0.304 . . . . 0.0 111.213 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 93.21 9.71 60.29 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.235 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.85 139.67 30.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.403 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.84 122.31 68.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.14 0.495 . . . . 0.0 109.735 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.592 ' HE1' ' HG3' ' A' ' 916' ' ' GLN . 8.6 t90 -108.66 113.52 26.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 35.9 t -116.03 115.88 50.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 110.346 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.643 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 23.2 pt20 -105.26 163.22 12.76 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.502 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 23.9 m-85 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -65.45 -17.24 64.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.369 0.604 . . . . 0.0 110.147 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.76 3.33 41.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.725 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.5 6.78 59.55 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.798 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.502 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 14.6 m -88.81 158.42 18.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.883 0.342 . . . . 0.0 110.456 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.8 ' HB3' ' HB ' ' A' ' 929' ' ' THR . 50.5 tt0 -132.1 150.91 52.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.073 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 926' ' ' ILE . 6.4 mp -137.82 135.88 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 171.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.96 121.59 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.641 HG11 ' HG ' ' A' ' 955' ' ' LEU . 11.6 t -120.04 135.97 58.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.15 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.23 139.41 30.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.84 128.1 35.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.029 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.37 -6.02 83.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.635 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 925' ' ' SER . 24.2 t -107.84 138.05 36.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.721 0.296 . . . . 0.0 110.644 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 38.1 m -91.29 -6.19 53.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.13 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.691 ' H ' HG12 ' A' ' 923' ' ' VAL . 21.5 p -95.44 123.8 39.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.527 HD13 HD23 ' A' ' 917' ' ' LEU . 2.6 pp -116.03 150.16 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.514 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 21.0 m -105.43 116.63 32.27 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -96.81 128.43 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 916' ' ' GLN . 40.1 m -112.39 122.89 49.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.056 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 30.9 t -123.68 99.29 39.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.49 -12.29 32.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.73 2.287 . . . . 0.0 111.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -86.26 -14.26 44.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.484 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -146.95 -62.05 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.178 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -173.28 159.27 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.106 0.453 . . . . 0.0 110.513 -167.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 929' ' ' THR . 67.1 p -102.81 125.29 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 169.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 27.2 m -120.59 132.23 55.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.477 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -97.29 129.04 44.63 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.204 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.59 ' HB3' ' CD2' ' A' ' 944' ' ' LEU . 98.4 m-85 -107.17 139.61 41.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . 0.78 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -147.02 -172.73 17.57 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.92 -1.133 . . . . 0.0 112.818 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -26.61 67.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.899 0.48 . . . . 0.0 111.576 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -97.25 7.27 46.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.78 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 5.9 mm-40 -113.13 150.76 31.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 111.031 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -74.52 122.25 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.837 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.59 ' CD2' ' HB3' ' A' ' 938' ' ' TYR . 77.7 mt -98.6 132.3 24.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.354 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 55.4 Cg_endo -84.25 172.36 9.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.618 2.212 . . . . 0.0 111.423 171.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -53.43 -60.93 2.67 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -64.79 -31.3 72.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.696 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.639 ' HB ' ' HD2' ' A' ' 945' ' ' PRO . 45.1 mm -68.78 -41.77 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.41 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.9 -39.12 88.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.506 ' HZ2' HD22 ' A' ' 917' ' ' LEU . 5.6 mmmp? -65.43 -42.73 92.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.471 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 952' ' ' LEU . 3.7 mm? -61.39 -36.46 80.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -69.02 -31.5 70.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.574 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.96 -25.35 64.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.641 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.0 mm? -72.48 -15.88 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 78.1 p -59.41 -39.91 84.97 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.412 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 15.8 m -65.84 -39.94 91.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.13 -39.45 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.135 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 959' ' ' LEU . 2.4 tm? -62.02 -44.22 97.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.167 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.344 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 56.0 ttp -70.04 -26.33 63.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -89.35 -3.88 58.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.557 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 32.3 t -83.08 21.83 1.03 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.446 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.63 123.56 71.69 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 121.18 0.514 . . . . 0.0 110.984 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.81 176.02 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.892 2.395 . . . . 0.0 113.116 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 8.6 t -149.05 138.55 12.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.761 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.65 48.88 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 112.121 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 18.24 2.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -95.74 -1.07 50.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.707 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.779 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 17.9 m -114.21 20.62 15.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -84.86 148.36 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.435 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -85.36 -27.67 25.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.0 110.397 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 887' ' ' LEU . 4.0 mm? -122.9 130.44 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.09 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.82 135.31 42.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.052 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.94 -42.92 20.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.4 p -107.24 143.83 34.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.844 170.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.33 155.21 14.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.677 0.275 . . . . 0.0 110.319 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -101.84 130.54 48.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.58 120.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.689 ' HB2' HG12 ' A' ' 896' ' ' VAL . 2.9 mptp? 57.36 4.28 0.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.091 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 59.89 22.1 11.09 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.533 0.733 . . . . 0.0 110.47 -170.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.9 p -105.57 -28.43 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 0.0 109.639 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.05 25.54 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.072 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.731 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 1.2 m95 -122.18 135.76 54.82 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -115.42 131.35 56.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.984 0.421 . . . . 0.0 110.733 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 15.8 m -116.02 130.46 56.82 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.765 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -94.88 115.31 27.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.66 HD11 ' HE3' ' A' ' 908' ' ' TRP . 86.3 mt -82.28 154.43 25.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -20.41 65.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.24 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.3 m -84.7 0.84 49.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 110.893 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.38 14.56 58.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.475 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -90.03 139.14 30.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.626 0.25 . . . . 0.0 110.429 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.44 122.31 55.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.66 ' HE3' HD11 ' A' ' 902' ' ' LEU . 1.6 t-105 -110.75 114.72 28.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.821 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.79 117.7 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 111.071 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.731 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 22.3 pt20 -105.41 161.62 14.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.452 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.523 ' HE1' HD21 ' A' ' 917' ' ' LEU . 43.3 m-85 -121.61 -179.91 4.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.875 0.369 . . . . 0.0 111.515 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.52 -26.86 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.774 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -87.82 1.18 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.234 0.54 . . . . 0.0 111.006 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.52 4.84 87.43 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.495 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.8 t -79.43 151.12 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.57 ' HB3' ' HE1' ' A' ' 908' ' ' TRP . 29.5 mt-30 -133.46 154.92 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.476 -171.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.659 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 0.9 OUTLIER -139.66 136.04 33.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 165.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.6 p -113.28 126.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.148 0.499 . . . . 0.0 110.533 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 926' ' ' ILE . 32.7 t -117.29 132.5 66.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.911 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 83.8 mm-40 -88.15 138.02 31.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.14 125.35 23.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 86.85 -6.06 83.76 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.25 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 925' ' ' SER . 36.4 t -107.56 138.22 34.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 59.8 m -91.44 -6.44 52.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.836 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 923' ' ' VAL . 72.1 p -90.62 114.98 27.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.018 0.437 . . . . 0.0 110.077 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 919' ' ' VAL . 78.6 mt -112.77 146.61 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.045 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 14.0 m -117.31 115.64 25.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 52.0 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.126 0.489 . . . . 0.0 110.3 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.543 HG23 HG22 ' A' ' 935' ' ' THR . 24.4 m -113.1 121.99 46.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.566 ' HB2' ' OD1' ' A' ' 932' ' ' ASN . 7.2 p -122.23 99.05 43.66 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.61 -26.73 80.24 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.61 2.873 . . . . 0.0 112.19 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' ' 930' ' ' SER . 27.4 p-10 -71.63 -2.12 16.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.231 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -154.03 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.763 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -163.64 -175.43 4.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.898 0.38 . . . . 0.0 110.203 -168.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 929' ' ' THR . 82.4 p -104.02 133.53 48.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 928' ' ' TYR . 14.2 t -117.47 140.93 48.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -107.09 130.46 54.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.088 0.471 . . . . 0.0 111.503 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.47 ' CE1' HD21 ' A' ' 944' ' ' LEU . 12.0 t80 -104.57 127.81 52.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.986 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -130.45 174.7 19.6 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -54.62 -27.04 36.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 0.0 111.68 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.02 2.85 53.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.48 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -104.67 141.29 36.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 111.857 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -99.46 123.93 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.069 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 938' ' ' TYR . 1.5 mm? -79.84 133.23 58.84 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 18.8 Cg_exo -67.35 -66.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.938 2.426 . . . . 0.0 112.931 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -152.62 -74.97 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.271 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -64.18 -29.75 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.489 ' O ' HD13 ' A' ' 952' ' ' LEU . 45.2 mm -68.21 -44.09 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.866 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.47 -39.19 91.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 953' ' ' GLN . 5.6 tp-100 -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.015 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 951' ' ' LYS . 13.8 ptpt -69.22 -36.75 77.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.996 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 948' ' ' ILE . 4.7 mp -56.95 -31.61 65.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 950' ' ' GLN . 5.7 tp-100 -58.63 -31.04 67.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.165 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 38.1 t -69.41 -20.91 63.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 952' ' ' LEU . 4.0 mm? -72.15 -19.66 61.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 77.2 p -59.73 -38.84 82.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.0 p -66.08 -39.85 90.37 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 955' ' ' LEU . 15.1 tt -69.58 -37.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.855 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.86 -38.82 89.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 0.0 110.282 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 960' ' ' LEU . 5.6 tt -63.75 -39.29 93.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.769 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 67.3 mtt -64.6 -26.09 68.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.861 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -85.94 -6.85 58.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.284 0.564 . . . . 0.0 110.25 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 33.7 t -91.18 5.27 49.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.837 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -56.55 124.41 62.22 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.475 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -34.3 104.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.408 3.405 . . . . 0.0 113.987 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.25 128.23 22.04 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.982 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 -24.37 79.23 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.717 2.278 . . . . 0.0 112.586 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -97.11 9.86 40.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.339 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.91 -21.77 17.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.443 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.178 -177.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 20.1 m -96.64 93.59 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.364 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -76.39 97.65 4.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -129.87 163.08 27.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.948 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 9.5 mp 63.25 21.43 12.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 110.559 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.61 165.26 23.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.692 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . 0.422 ' HD3' ' NE2' ' A' ' 901' ' ' GLN . 60.5 mttm -87.66 40.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.431 0.634 . . . . 0.0 110.455 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 16.6 p -106.8 142.9 35.69 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.956 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.85 140.7 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.05 119.4 30.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 109.951 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.56 122.61 50.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 62.14 2.88 0.88 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.524 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.15 22.33 11.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.633 0.773 . . . . 0.0 110.24 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.41 -30.47 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.379 0.609 . . . . 0.0 110.099 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.73 168.33 25.03 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.674 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.561 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.2 OUTLIER -117.1 134.72 54.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -119.51 131.07 55.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.096 0.474 . . . . 0.0 111.334 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 14.9 m -115.41 126.72 54.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.336 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . 0.422 ' NE2' ' HD3' ' A' ' 889' ' ' LYS . 10.6 pt20 -89.82 138.77 31.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.899 0.381 . . . . 0.0 110.264 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.29 142.32 44.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 18.7 p -66.86 -15.01 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.165 0.507 . . . . 0.0 111.077 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 4.0 m -79.48 0.3 30.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.957 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.8 3.98 65.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.599 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -93.2 141.49 28.37 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 919' ' ' VAL . 3.4 p -119.05 122.71 69.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.452 0.644 . . . . 0.0 109.428 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 11.5 t-105 -97.71 113.83 25.67 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.351 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 917' ' ' LEU . 3.3 p -114.56 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.596 0.712 . . . . 0.0 110.363 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.561 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 53.0 tt0 -98.68 142.63 30.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.975 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -91.79 151.62 20.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.674 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -64.13 -22.97 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.68 2.18 38.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 96.48 6.55 58.5 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.219 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.2 m -95.47 158.72 15.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.839 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 17.7 pm0 -132.91 154.96 49.91 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.254 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.795 ' HB2' HG13 ' A' ' 909' ' ' VAL . 6.3 mp -129.04 139.81 51.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.97 122.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 907' ' ' VAL . 61.4 t -117.24 132.54 66.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.785 0.326 . . . . 0.0 110.217 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -92.23 139.4 30.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -52.81 128.96 28.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.53 -6.41 63.01 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.962 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 923' ' ' VAL . 14.6 t 61.31 32.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-O 121.885 0.85 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 15.5 m -72.87 -14.94 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.394 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 22.8 t -173.51 125.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.617 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.615 HG22 HG13 ' A' ' 919' ' ' VAL . 0.2 OUTLIER -125.02 144.16 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.527 ' OG ' ' HG2' ' A' ' 937' ' ' ARG . 10.2 m -118.82 122.04 41.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -96.66 124.08 40.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.883 HG23 ' HB ' ' A' ' 935' ' ' THR . 14.1 m -115.5 122.75 46.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 23.0 p -125.88 102.35 28.45 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.04 -40.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.752 2.968 . . . . 0.0 113.366 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.0 -29.74 71.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.552 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -116.61 -75.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.309 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -163.71 153.4 14.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.658 0.266 . . . . 0.0 111.118 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.883 ' HB ' HG23 ' A' ' 929' ' ' THR . 8.9 t -104.87 125.37 50.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 927' ' ' SER . 27.2 m -120.07 135.64 54.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.405 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.527 ' HG2' ' OG ' ' A' ' 927' ' ' SER . 40.2 mtp180 -98.11 126.79 43.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.92 140.46 45.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.163 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . 0.555 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -106.4 161.68 14.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.404 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -5.76 20.65 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.391 0.615 . . . . 0.0 110.526 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -90.61 2.11 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.84 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 11.8 pt-20 -129.07 170.9 12.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.227 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -80.14 129.9 34.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.467 . . . . 0.0 110.521 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 948' ' ' ILE . 32.2 mt -98.05 133.38 23.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.006 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.64 ' HB2' HD13 ' A' ' 948' ' ' ILE . 26.6 Cg_exo -63.74 156.11 59.51 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 111.629 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.89 -53.07 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.62 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . 0.409 ' O ' ' HD2' ' A' ' 951' ' ' LYS . 78.4 m-85 -63.24 -31.3 72.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.573 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -67.82 -42.94 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.836 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -63.31 -39.9 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.125 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.35 -43.77 98.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.599 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.529 ' N ' ' HE2' ' A' ' 951' ' ' LYS . 0.7 OUTLIER -68.34 -40.41 81.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.328 0.585 . . . . 0.0 109.694 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 30.6 tp -60.76 -36.04 77.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -27.44 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.125 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.3 -20.58 63.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.54 -175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.91 -14.75 63.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.91 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.5 m -57.8 -27.31 63.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 111.281 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 24.4 p -60.41 -37.57 81.28 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.65 -39.27 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.709 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.1 tt -60.77 -42.9 98.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.14 -40.4 94.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.028 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . 0.468 ' HA ' ' CE ' ' A' ' 961' ' ' MET . 2.4 tpt -70.52 -26.68 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.592 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -93.6 11.66 28.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.739 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 50.0 m -78.25 11.37 2.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.106 0.479 . . . . 0.0 110.819 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -120.09 82.51 29.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.512 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.68 -13.94 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.646 2.231 . . . . 0.0 111.202 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 30.5 p 49.79 81.0 0.27 Allowed Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.77 0.828 . . . . 0.0 112.482 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 112.75 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.918 2.412 . . . . 0.0 110.819 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -86.23 19.66 2.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.025 0.44 . . . . 0.0 110.349 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 71.32 -0.65 3.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.454 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.818 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 39.3 p -141.2 138.48 33.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 111.102 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -74.36 159.48 32.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.22 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.88 -173.62 3.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.5 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.79 -15.31 59.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.232 0.539 . . . . 0.0 110.045 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.83 179.5 7.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.48 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -80.45 94.27 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.928 0.394 . . . . 0.0 110.567 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 19.2 m -102.34 143.28 32.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.863 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.05 139.11 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -94.3 130.44 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.842 0.353 . . . . 0.0 110.598 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.46 118.79 54.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.0 9.68 0.33 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.415 1.072 . . . . 0.0 112.061 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 59.58 22.85 11.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.307 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.6 t -104.86 -30.42 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.29 159.33 25.66 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.024 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -122.3 135.97 54.82 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.64 129.85 53.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.84 0.353 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 43.9 m -107.09 132.89 52.48 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.116 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -93.6 115.07 27.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.964 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.17 146.43 23.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 14.9 t -63.82 -14.24 51.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.479 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 6.0 p -86.59 0.37 54.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.104 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.84 13.64 66.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.832 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.32 140.32 29.81 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 955' ' ' LEU . 42.7 t -109.81 123.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 7.1 t-105 -109.42 113.62 26.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 46.4 t -115.28 117.26 55.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 916' ' ' GLN . 60.5 tt0 -106.52 142.99 35.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.48 160.81 16.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.73 -16.35 63.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.351 0.596 . . . . 0.0 110.127 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -73.9 -1.47 19.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.817 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.72 2.61 89.82 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.104 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.6 m -97.44 151.1 20.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.479 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 1.2 pm0 -133.3 162.45 31.78 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.357 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.23 137.41 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.828 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 927' ' ' SER . 21.2 t -104.67 123.81 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.767 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 30.9 t -117.28 132.77 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.205 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -92.36 138.95 31.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.41 126.84 29.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.006 0.432 . . . . 0.0 111.002 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.53 83.5 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.639 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 925' ' ' SER . 25.3 t -110.17 128.4 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.596 -0.355 . . . . 0.0 110.737 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 32.4 t -89.28 -7.22 55.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.628 ' H ' HG12 ' A' ' 923' ' ' VAL . 23.8 m -90.89 111.97 23.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 952' ' ' LEU . 43.1 pt -113.75 165.77 8.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.439 -171.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 918' ' ' VAL . 9.1 p -116.97 116.02 26.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.281 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.19 131.07 44.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.758 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 7.3 m -111.35 124.35 52.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 48.3 t -115.92 127.44 26.77 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.513 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.64 -7.7 7.78 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.21 3.273 . . . . 0.0 112.695 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -54.54 -28.62 46.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.494 0.664 . . . . 0.0 109.572 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 117.07 35.54 1.11 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.327 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.82 140.0 11.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.769 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 7.2 t -104.31 127.31 51.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.273 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 15.0 t -117.92 138.64 52.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.618 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -98.35 130.34 45.01 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.53 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.29 127.41 53.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.8 13.3 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.339 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.0 -25.72 67.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.315 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -94.29 1.55 55.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.24 0.543 . . . . 0.0 110.649 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.8 160.98 16.25 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.034 -0.416 . . . . 0.0 110.974 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -85.31 122.85 30.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.426 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 948' ' ' ILE . 82.6 mt -97.43 133.52 23.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.242 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 948' ' ' ILE . 15.3 Cg_exo -71.21 169.78 19.84 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.092 2.528 . . . . 0.0 112.444 175.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.45 -56.84 16.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -62.2 -32.38 73.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.477 HG21 HD22 ' A' ' 944' ' ' LEU . 47.8 mm -69.91 -43.56 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.919 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -63.53 -44.92 92.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.51 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -61.4 -44.66 96.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.596 ' O ' ' HG ' ' A' ' 955' ' ' LEU . 11.1 mptt -68.98 -40.19 78.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.768 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.647 HD11 HD13 ' A' ' 926' ' ' ILE . 7.8 mp -63.05 -36.75 84.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.937 0.399 . . . . 0.0 110.273 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -70.63 -35.03 72.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.522 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 29.6 p -72.5 -24.63 61.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.795 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 958' ' ' ILE . 92.6 mt -71.53 -15.02 62.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.226 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 45.0 t -56.96 -24.1 50.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.74 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.9 p -63.44 -38.22 90.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 955' ' ' LEU . 15.8 tt -69.31 -35.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.51 -43.55 98.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.65 -34.99 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.033 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . 0.731 ' HA ' ' HG3' ' A' ' 965' ' ' PRO . 15.4 tmm? -67.54 -27.02 66.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 110.288 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -89.01 -7.11 56.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.243 0.544 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 11.4 t -95.13 14.25 22.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.159 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.18 91.0 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.997 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.731 ' HG3' ' HA ' ' A' ' 961' ' ' MET . 6.3 Cg_endo -85.45 95.74 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.796 2.33 . . . . 0.0 111.419 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 29.6 m -134.91 86.44 32.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.009 0.433 . . . . 0.0 111.009 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.57 -7.75 9.62 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.128 2.552 . . . . 0.0 111.098 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.22 23.44 6.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.386 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -51.79 138.4 23.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.445 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 45.4 m80 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.557 -176.079 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 41.9 m -87.96 7.35 31.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.579 0.228 . . . . 0.0 110.86 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 66.82 9.97 7.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.911 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -113.01 86.89 2.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.857 0.36 . . . . 0.0 110.147 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.862 ' H ' HD23 ' A' ' 887' ' ' LEU . 0.9 OUTLIER -81.98 127.07 32.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.691 177.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.9 129.7 38.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.358 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 901' ' ' GLN . 3.4 mppt? 61.29 74.17 0.45 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.088 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.677 ' HB3' ' HG ' ' A' ' 887' ' ' LEU . 15.7 p -98.64 144.36 28.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.952 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . 0.732 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 60.6 t -126.23 140.25 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.679 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . 0.617 ' HD1' ' HE3' ' A' ' 898' ' ' TRP . 78.0 m-85 -106.6 119.99 40.77 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' A' ' 894' ' ' LYS . 97.3 t -108.76 117.79 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.428 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.443 ' HD3' HG12 ' A' ' 893' ' ' VAL . 2.0 mptm? 54.12 3.87 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.371 1.068 . . . . 0.0 112.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.82 23.98 12.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.196 0.599 . . . . 0.0 110.12 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.34 -29.75 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.96 158.25 25.12 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.985 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.617 ' HE3' ' HD1' ' A' ' 892' ' ' PHE . 0.5 OUTLIER -121.81 136.43 54.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -109.61 132.42 54.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 8.1 m -101.87 125.84 48.64 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 889' ' ' LYS . 28.2 mm-40 -94.99 116.51 28.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.007 0.432 . . . . 0.0 110.981 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.13 129.04 49.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.888 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.9 t -67.53 -4.61 12.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.384 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 33.5 t -85.71 -0.09 54.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.69 62.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.319 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.65 138.7 31.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 919' ' ' VAL . 44.0 t -112.4 122.97 67.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 3.1 t-105 -110.27 118.77 37.23 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 55.1 t -107.21 125.96 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.035 0.445 . . . . 0.0 111.08 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.52 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 76.7 mm-40 -103.46 143.28 32.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.572 173.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.68 167.15 9.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.73 0.3 . . . . 0.0 110.481 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -63.41 -26.43 68.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.75 0.08 55.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.061 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 86.82 10.54 72.34 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.279 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 18.1 m -75.74 153.29 37.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.732 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 47.4 mt-30 -132.03 153.57 50.26 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.058 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.788 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 8.7 mp -130.73 135.36 47.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.141 171.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 927' ' ' SER . 47.4 t -113.34 121.71 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 907' ' ' VAL . 48.2 t -118.08 130.84 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.695 0.284 . . . . 0.0 110.575 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -93.23 139.86 30.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.24 129.52 21.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.072 0.463 . . . . 0.0 111.114 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.16 61.37 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.479 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 923' ' ' VAL . 12.6 t 57.54 34.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.949 0.88 . . . . 0.0 110.317 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.9 m -74.02 -17.53 60.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.34 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 48.3 p -169.64 135.08 1.47 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.343 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.62 144.23 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.604 ' HB3' ' HB ' ' A' ' 918' ' ' VAL . 23.0 t -118.65 117.44 28.96 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -96.76 127.43 42.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 63.5 m -113.07 121.44 44.6 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.585 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 59.5 p -127.84 103.37 21.52 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.23 -12.4 30.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.265 2.643 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -81.76 -10.51 59.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.042 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -151.68 -68.36 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -171.13 164.57 7.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.214 0.507 . . . . 0.0 111.272 -166.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 929' ' ' THR . 39.9 p -104.07 123.85 47.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.908 170.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.7 m -120.47 129.2 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.605 0.241 . . . . 0.0 111.108 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.738 ' H ' ' HD3' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -98.44 128.56 44.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 110.151 178.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.8 128.0 54.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.384 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.66 166.34 27.72 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.91 -20.54 65.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.0 111.161 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -92.97 2.82 56.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.801 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -96.75 -178.84 4.38 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -100.56 128.42 46.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 945' ' ' PRO . 5.5 tp -92.29 132.74 31.37 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.942 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.774 ' HB2' HD13 ' A' ' 948' ' ' ILE . 37.1 Cg_exo -61.84 152.46 74.5 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.484 2.122 . . . . 0.0 111.435 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -52.99 -64.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.525 0.515 . . . . 0.0 111.922 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -59.91 -32.18 70.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.645 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.774 HD13 ' HB2' ' A' ' 945' ' ' PRO . 2.4 mp -69.55 -42.81 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -40.94 97.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.941 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -42.37 93.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.361 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.986 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 4.5 mmpt? -64.94 -43.45 92.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.211 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.44 -36.62 84.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 110.865 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . 0.45 ' HB3' HE21 ' A' ' 953' ' ' GLN . 1.0 OUTLIER -66.95 -34.42 77.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.832 177.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.06 -28.78 64.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.164 0.506 . . . . 0.0 109.893 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 951' ' ' LYS . 7.9 mp -73.84 -30.99 62.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.225 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 46.1 t -58.58 -39.59 80.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.311 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 28.4 t -66.34 -38.3 87.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 110.009 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.96 -41.21 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.555 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.56 -41.31 97.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.49 -40.03 96.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.548 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 53.9 tpp -70.1 -24.76 63.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.888 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -83.61 -5.84 59.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.487 0.661 . . . . 0.0 110.16 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 10.7 t -87.65 13.96 9.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.479 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 963' ' ' SER . 25.6 m-80 72.98 149.88 0.13 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.791 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 36.0 Cg_endo -66.31 117.29 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.614 2.209 . . . . 0.0 112.268 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 55.2 m -88.56 104.1 6.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 965' ' ' PRO . 86.5 Cg_endo -85.63 151.78 10.19 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.564 2.176 . . . . 0.0 113.167 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -85.75 0.1 53.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.386 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.28 124.22 22.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.118 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 48.7 m80 . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.124 179.077 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 18.6 p -76.95 153.98 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.37 0.129 . . . . 0.0 110.954 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . 61.73 81.4 0.2 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.872 0.732 . . . . 0.0 111.353 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.44 -64.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.645 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 8.0 mp 56.17 56.23 6.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.917 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 888' ' ' LEU . 3.2 mm? -99.45 -166.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -86.35 10.94 13.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.39 0.614 . . . . 0.0 110.157 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 43.5 m -106.96 144.81 33.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.676 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 899' ' ' ALA . 88.7 t -114.43 139.56 39.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -106.66 119.97 40.72 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.106 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 895' ' ' ASN . 48.7 t -103.23 120.21 52.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.652 ' HB3' HG12 ' A' ' 896' ' ' VAL . 53.0 tttm 56.98 3.71 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.367 1.042 . . . . 0.0 111.358 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 893' ' ' VAL . 2.7 t30 60.03 23.65 12.83 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.994 0.918 . . . . 0.0 109.787 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.1 p -104.7 -28.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.225 173.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -137.77 159.05 24.87 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.854 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.97 136.03 54.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.629 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -107.29 131.69 53.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 4.2 m -115.14 132.86 56.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -87.71 116.04 25.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.341 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.29 142.24 40.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.648 0.261 . . . . 0.0 110.389 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 12.7 p -68.14 -8.62 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.697 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 44.6 t -80.95 -0.8 41.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.223 0.535 . . . . 0.0 110.163 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.94 4.42 87.1 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.66 139.33 30.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.813 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.65 122.58 56.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.492 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 6.5 t-105 -100.66 114.11 27.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.008 -176.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.646 ' HB ' ' HB2' ' A' ' 917' ' ' LEU . 48.4 t -104.04 115.98 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 110.036 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.854 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 37.3 mt-30 -106.17 142.96 34.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.711 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.479 ' HD2' ' HB2' ' A' ' 915' ' ' SER . 44.8 m-85 -97.24 160.1 14.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.86 -25.78 68.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.471 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -86.38 2.18 48.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.354 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 93.79 5.05 63.14 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.361 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 911' ' ' PHE . 45.5 m -84.33 152.12 24.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.635 0.718 . . . . 0.0 109.274 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.712 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 40.3 mt-30 -132.47 153.38 50.95 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.799 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.646 ' HB2' ' HB ' ' A' ' 909' ' ' VAL . 9.7 mp -130.59 136.24 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.13 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 41.5 t -113.12 120.43 63.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 926' ' ' ILE . 42.9 t -119.35 132.02 70.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.4 ' HB2' ' HB ' ' A' ' 923' ' ' VAL . 79.8 mm-40 -90.27 137.93 31.94 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.55 126.77 28.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.52 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.4 -0.42 83.28 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.258 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 925' ' ' SER . 54.5 t -115.06 138.05 46.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.234 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 3.1 p -91.24 -6.13 53.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 923' ' ' VAL . 39.3 m -90.45 138.74 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.643 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.637 HD11 HD22 ' A' ' 952' ' ' LEU . 2.9 mp -118.02 146.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.495 -175.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.688 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 16.0 m -110.68 116.29 31.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.461 ' HB3' HG23 ' A' ' 936' ' ' THR . 24.2 t80 -96.42 126.24 41.47 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 47.2 m -113.71 122.8 48.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.09 0.471 . . . . 0.0 111.329 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 10.3 p -122.99 120.35 27.55 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.271 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 -2.13 5.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.399 2.732 . . . . 0.0 112.181 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -59.17 -22.86 61.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.41 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.05 0.87 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.109 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -157.77 133.29 9.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.209 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 8.9 t -105.89 126.87 52.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 166.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 928' ' ' TYR . 4.3 t -118.32 128.74 54.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.391 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.628 ' H ' ' HD3' ' A' ' 937' ' ' ARG . 0.1 OUTLIER -103.24 130.79 50.56 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.403 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -108.91 138.76 44.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.726 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 942' ' ' GLU . . . -115.76 156.37 15.68 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.146 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -7.2 26.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.771 0.319 . . . . 0.0 111.855 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -82.34 0.68 40.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.428 0.632 . . . . 0.0 110.209 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 939' ' ' GLY . 17.2 pt-20 -132.66 -171.95 2.79 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -95.42 122.4 38.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.975 0.417 . . . . 0.0 109.929 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.22 138.42 45.49 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.788 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.68 ' HG2' HD12 ' A' ' 948' ' ' ILE . 48.4 Cg_exo -57.58 142.2 95.5 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.535 2.156 . . . . 0.0 111.231 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -43.24 -63.3 0.84 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.038 0.836 . . . . 0.0 112.935 -172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -67.89 -28.24 67.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 945' ' ' PRO . 59.1 mt -69.72 -44.98 78.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.69 -38.12 88.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.075 0.464 . . . . 0.0 109.985 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 953' ' ' GLN . 17.2 tm0? -60.16 -42.65 95.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.074 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 1.072 ' HA ' ' HE3' ' A' ' 951' ' ' LYS . 0.0 OUTLIER -69.86 -37.94 76.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.442 0.639 . . . . 0.0 110.003 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.637 HD22 HD11 ' A' ' 926' ' ' ILE . 62.7 tp -57.58 -36.9 72.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 950' ' ' GLN . 4.9 pp0? -69.61 -21.15 63.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.32 -28.04 65.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.023 0.44 . . . . 0.0 109.981 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.98 -31.47 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.288 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 55.8 m -59.7 -39.02 83.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 961' ' ' MET . 21.9 t -65.69 -38.14 88.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 109.966 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.44 -40.24 86.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.866 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.39 -39.59 91.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.568 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 956' ' ' SER . 93.5 mt -64.11 -35.02 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.374 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 957' ' ' SER . 93.8 mmm -63.59 -25.51 68.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.282 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.15 -2.65 58.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.145 0.498 . . . . 0.0 110.621 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 42.6 t -94.08 14.51 19.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.084 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.502 ' HB3' ' HD2' ' A' ' 965' ' ' PRO . 44.8 m-80 69.53 170.67 0.11 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.679 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 964' ' ' ASN . 50.5 Cg_exo -54.77 96.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.924 1.749 . . . . 0.0 111.233 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 27.6 m -98.21 115.63 65.72 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.901 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 966' ' ' THR . 8.2 Cg_exo -71.77 102.33 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.492 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.61 0.16 47.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 110.439 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -97.14 165.21 12.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.011 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 22.3 t -97.15 122.67 40.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -70.45 143.43 51.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.505 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -72.84 132.41 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.93 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.19 -13.13 62.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 888' ' ' LEU . 3.8 mm? -74.38 -10.31 59.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.925 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -94.1 -10.49 33.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.091 0.472 . . . . 0.0 110.393 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 31.0 p -108.31 144.77 35.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.228 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.06 140.13 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.08 125.17 47.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 954' ' ' CYS . 23.2 m -109.76 121.18 62.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 120.834 0.35 . . . . 0.0 110.83 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.718 ' HB2' HG12 ' A' ' 896' ' ' VAL . 71.8 mmtt 58.62 -1.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.709 0.804 . . . . 0.0 112.675 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.46 22.64 12.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.942 0.877 . . . . 0.0 109.154 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 894' ' ' LYS . 9.9 p -104.09 -24.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.096 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . 0.412 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -140.78 159.75 26.5 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.057 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.717 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.0 OUTLIER -120.82 135.3 55.2 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 173.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.38 131.45 56.77 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 9.1 m -110.41 125.24 53.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.835 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -82.44 115.93 21.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.878 0.37 . . . . 0.0 110.022 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.74 149.79 21.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.079 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 13.2 t -66.91 -15.89 63.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.009 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 12.0 m -80.13 0.26 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 110.734 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.87 87.71 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.715 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.3 157.54 17.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.341 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.61 123.48 71.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.808 0.337 . . . . 0.0 110.223 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -98.12 113.42 25.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.94 117.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.032 0.444 . . . . 0.0 110.615 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.717 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 8.3 tt0 -94.38 143.13 26.66 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.585 ' HD2' ' H ' ' A' ' 913' ' ' ASP . 25.7 t80 -93.51 148.6 21.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -55.13 -25.45 31.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . 0.585 ' H ' ' HD2' ' A' ' 911' ' ' PHE . 19.8 t70 -86.24 0.35 53.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.49 5.74 60.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.407 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 50.3 m -85.3 164.1 18.2 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -125.01 151.95 44.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.41 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.605 ' CD2' HG23 ' A' ' 919' ' ' VAL . 10.4 tt -141.49 135.0 29.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 51.2 t -115.98 122.57 69.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 122.384 -0.198 . . . . 0.0 111.209 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.605 HG23 ' CD2' ' A' ' 917' ' ' LEU . 76.4 t -120.07 134.27 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.531 0.205 . . . . 0.0 111.037 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -89.81 136.97 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -62.9 126.9 28.89 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.161 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.2 -2.49 85.29 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.672 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.817 HG12 ' H ' ' A' ' 925' ' ' SER . 54.4 t -106.01 137.61 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.754 0.312 . . . . 0.0 110.865 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.5 m -78.26 -15.89 58.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.817 ' H ' HG12 ' A' ' 923' ' ' VAL . 34.1 m -85.61 117.18 24.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 938' ' ' TYR . 0.0 OUTLIER -113.24 145.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.113 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 21.5 m -113.63 116.39 29.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -106.09 128.63 54.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 20.2 m -112.51 121.68 45.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.126 0.489 . . . . 0.0 110.886 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 931' ' ' PRO . 73.5 m -99.77 165.16 15.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.745 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 930' ' ' SER . 72.5 Cg_exo -49.74 156.68 2.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.027 2.485 . . . . 0.0 112.664 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 931' ' ' PRO . 14.6 m120 75.01 5.35 4.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 75.44 50.42 8.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.991 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.05 101.06 9.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 8.9 t -100.59 129.18 46.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.428 0.632 . . . . 0.0 111.103 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 32.0 p -116.88 141.4 48.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.448 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -101.55 126.51 48.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.251 0.548 . . . . 0.0 110.698 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.457 ' HB3' HD23 ' A' ' 944' ' ' LEU . 90.2 m-85 -109.91 138.22 46.58 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -154.09 -160.31 9.72 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 119.128 -1.51 . . . . 0.0 113.927 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.03 -27.1 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.432 -0.884 . . . . 0.0 112.441 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.46 1.2 56.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.176 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -132.6 -177.15 4.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -99.23 138.18 36.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 948' ' ' ILE . 63.6 mt -95.22 133.1 26.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' A' ' 948' ' ' ILE . 18.3 Cg_exo -67.44 154.79 72.76 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.883 2.388 . . . . 0.0 111.044 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.78 -37.52 87.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -64.46 -33.47 75.95 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.436 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.611 HG21 HD22 ' A' ' 944' ' ' LEU . 1.9 mp -70.98 -39.55 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.994 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . 0.606 ' HE3' ' HB2' ' A' ' 944' ' ' LEU . 33.0 mmtp -56.93 -43.8 81.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.319 0.581 . . . . 0.0 109.714 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.55 -42.32 98.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.341 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 67.3 mmtt -62.51 -43.18 99.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.77 -32.43 72.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.748 0.308 . . . . 0.0 110.498 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.49 -34.84 77.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . 0.533 ' HB3' HG11 ' A' ' 893' ' ' VAL . 59.2 m -70.32 -26.64 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.537 ' HG ' HG11 ' A' ' 919' ' ' VAL . 4.1 mm? -72.36 -14.5 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.767 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 37.3 m -56.6 -31.22 64.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 9.4 p -64.09 -40.64 96.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -173.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 955' ' ' LEU . 16.2 tt -70.55 -35.51 61.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.222 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.82 -43.93 97.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.23 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 960' ' ' LEU . 4.3 mm? -68.27 -37.18 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 49.5 tpp -66.56 -28.15 68.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 111.021 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -94.12 3.88 54.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.442 . . . . 0.0 110.999 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 32.7 t -93.67 2.44 56.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.273 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 44.3 t30 69.95 119.36 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.724 0.64 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.37 -25.29 56.42 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.098 2.532 . . . . 0.0 112.816 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 88.1 m -88.42 119.04 70.09 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.67 178.07 3.6 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -87.03 19.33 3.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.366 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 70.15 -53.85 0.63 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.787 0.835 . . . . 0.0 110.818 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 67.7 t60 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.687 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.228 -0.349 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 14.9 m -75.78 -70.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.829 0.347 . . . . 0.0 110.967 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -113.67 178.43 4.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.764 -176.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -66.11 129.36 39.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.765 ' H ' HD23 ' A' ' 887' ' ' LEU . 2.3 pt? -76.64 18.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.304 -173.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 888' ' ' LEU . 4.1 mm? -98.3 -23.57 15.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.285 175.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -105.61 -48.0 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.629 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 887' ' ' LEU . 8.9 m -104.21 142.46 34.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.89 139.6 40.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.1 127.71 36.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.47 HG13 ' SG ' ' A' ' 954' ' ' CYS . 80.7 t -114.14 119.54 61.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm 59.18 7.52 0.89 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.369 1.043 . . . . 0.0 111.194 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.63 20.45 9.07 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.926 0.89 . . . . 0.0 110.758 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 41.6 t -107.2 -29.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.337 0.589 . . . . 0.0 110.364 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.96 163.04 26.32 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.467 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -121.41 136.94 54.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -116.36 133.87 55.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.751 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 21.0 m -101.09 125.28 47.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.675 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.45 120.92 37.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.886 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 906' ' ' ALA . 7.4 mp -98.44 144.45 27.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.634 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 15.9 m -67.28 -16.48 64.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.0 p -82.58 0.93 40.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.229 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.86 12.15 62.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.645 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.44 138.4 31.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.16 121.64 67.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.507 ' CZ2' ' HG2' ' A' ' 916' ' ' GLN . 30.2 t90 -110.63 113.39 25.96 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.17 116.89 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.756 0.313 . . . . 0.0 110.951 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 898' ' ' TRP . 35.7 tt0 -105.64 142.85 34.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.455 ' HE2' HD11 ' A' ' 917' ' ' LEU . 38.9 m-85 -88.09 160.64 17.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.598 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -63.81 -16.72 61.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.781 0.801 . . . . 0.0 108.865 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 911' ' ' PHE . 32.5 t70 -81.84 -0.25 42.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.14 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.19 5.98 86.82 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.628 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 2.0 p -97.78 153.38 18.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.048 0.424 . . . . 0.0 110.132 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 908' ' ' TRP . 0.3 OUTLIER -125.78 154.48 42.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.281 -175.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.455 HD11 ' HE2' ' A' ' 911' ' ' PHE . 5.5 mp -127.78 132.83 49.47 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 119.06 60.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.089 170.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 926' ' ' ILE . 7.8 p -124.66 132.83 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.501 170.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 923' ' ' VAL . 25.6 tt0 -94.61 139.86 30.63 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 170.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.5 129.03 39.99 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.552 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 105.43 -6.15 41.76 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.083 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 920' ' ' GLN . 8.6 m -102.28 155.43 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.456 0.628 . . . . 0.0 110.426 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.4 p -92.2 -4.85 53.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.841 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 12.9 p -133.54 135.89 44.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.281 0.562 . . . . 0.0 111.763 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 919' ' ' VAL . 4.4 mp -111.42 146.68 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.779 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 20.0 m -108.47 116.76 32.58 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.404 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -96.62 125.38 41.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 934' ' ' GLN . 8.8 t -116.3 135.03 54.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.741 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 20.1 m -103.74 144.28 28.35 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.795 171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.84 -7.72 1.76 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 124.127 3.218 . . . . 0.0 114.493 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.03 -16.96 62.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 99.12 28.69 7.56 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 929' ' ' THR . 43.1 tt0 -104.64 110.32 22.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.758 -174.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 929' ' ' THR . 18.2 p -103.54 125.52 50.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.61 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 35.5 m -118.21 134.89 54.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -97.79 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 0.0 110.899 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 944' ' ' LEU . 81.9 m-85 -112.05 134.82 53.37 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.667 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . 0.74 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -153.07 -165.7 13.71 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.968 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.11 -27.28 67.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.791 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -97.69 -0.84 44.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.449 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.74 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 8.7 mm-40 -116.97 109.68 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 943' ' ' LYS . 47.6 mtpt -73.05 138.94 46.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.396 0.617 . . . . 0.0 112.008 -169.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.591 ' CB ' ' HB3' ' A' ' 949' ' ' LYS . 3.3 mm? -94.11 133.82 26.86 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.531 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 25.8 Cg_exo -63.6 -70.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 111.806 177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.29 -77.69 0.1 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -56.8 -32.75 66.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.575 ' HB ' HD12 ' A' ' 944' ' ' LEU . 26.4 mm -70.3 -45.11 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.996 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . 0.591 ' HB3' ' CB ' ' A' ' 944' ' ' LEU . 11.8 pttm -66.66 -36.63 83.0 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.568 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.05 -40.8 90.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.912 0.387 . . . . 0.0 110.501 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -66.89 -43.79 82.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 87.4 mt -65.14 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.002 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -61.65 -33.7 74.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.001 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' A' ' 893' ' ' VAL . 16.7 t -71.47 -24.89 62.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.411 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.14 -16.55 62.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.446 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 50.2 m -58.62 -23.97 60.02 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.043 0.449 . . . . 0.0 111.287 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 5.9 m -59.38 -34.27 72.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.177 0.513 . . . . 0.0 110.339 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.402 HG22 ' CE2' ' A' ' 962' ' ' PHE . 44.5 mm -67.4 -38.22 80.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.63 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.86 -42.45 97.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.536 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.82 -34.82 78.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.887 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 88.3 mtp -64.96 -25.67 67.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.709 0.29 . . . . 0.0 111.043 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 958' ' ' ILE . 40.4 m-85 -86.41 -0.45 55.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 110.929 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 23.1 t -91.96 11.75 24.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 24.8 t-20 -73.51 122.52 87.82 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.971 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 56.2 Cg_endo -90.45 101.81 0.28 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.728 2.285 . . . . 0.0 112.895 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 28.8 m -110.45 101.79 49.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.87 5.66 3.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.983 2.455 . . . . 0.0 113.334 -173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.76 -2.09 57.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.139 0.495 . . . . 0.0 110.281 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.71 132.78 55.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.97 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.608 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 20.3 m -85.69 134.64 33.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.867 0.365 . . . . 0.0 110.675 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -75.13 99.71 4.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.771 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . 0.444 ' HB3' HD13 ' A' ' 888' ' ' LEU . 15.4 mm100 -84.31 112.6 20.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 890' ' ' SER . 37.2 tp -91.93 73.85 5.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.362 0.601 . . . . 0.0 110.562 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 886' ' ' GLN . 8.0 mp -121.34 107.33 12.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.669 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 60.2 mttm 55.89 34.72 24.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.307 0.575 . . . . 0.0 110.79 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.536 ' HB2' HD12 ' A' ' 887' ' ' LEU . 22.9 m -106.8 143.62 34.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.003 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.53 155.38 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.041 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -99.53 130.74 45.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 958' ' ' ILE . 5.9 p -105.39 121.13 57.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.057 0.456 . . . . 0.0 110.27 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.704 ' HB3' HG12 ' A' ' 896' ' ' VAL . 14.4 tmtt? 61.68 -1.44 0.33 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.747 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 893' ' ' VAL . 19.5 t-20 61.3 23.7 13.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.842 0.829 . . . . 0.0 109.409 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.704 HG12 ' HB3' ' A' ' 894' ' ' LYS . 12.4 p -105.84 -27.89 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -136.01 160.6 24.68 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.812 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.619 ' HB2' ' HG3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -121.9 136.77 54.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -117.61 130.38 56.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 32.4 m -115.64 135.83 53.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.981 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -95.03 125.35 39.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.162 0.506 . . . . 0.0 110.118 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.76 146.99 24.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.746 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.4 m -65.13 -20.33 66.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.626 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 0.12 33.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.153 0.502 . . . . 0.0 110.698 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 89.09 8.88 68.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.444 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.24 148.52 22.87 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.584 ' HB ' HG13 ' A' ' 919' ' ' VAL . 47.4 t -110.37 124.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -104.31 114.56 28.87 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.06 120.14 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.457 0.646 . . . . 0.0 110.817 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.803 ' HB3' HE22 ' A' ' 916' ' ' GLN . 1.1 pt20 -104.65 143.26 33.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -119.6 157.93 27.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.092 0.472 . . . . 0.0 111.763 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.3 -17.9 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -77.4 1.44 19.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.635 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.62 8.4 84.73 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 5.8 p -98.23 153.47 18.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.768 0.318 . . . . 0.0 111.198 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.803 HE22 ' HB3' ' A' ' 910' ' ' GLN . 12.5 mm100 -122.78 150.88 42.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.983 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.583 HD12 ' C ' ' A' ' 916' ' ' GLN . 7.1 mp -138.69 133.81 32.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 927' ' ' SER . 3.5 p -116.83 123.94 72.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 168.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 923' ' ' VAL . 2.2 p -117.86 138.27 49.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -93.48 150.62 20.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -49.81 128.38 18.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 923' ' ' VAL . . . 99.48 -8.35 60.22 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.776 -173.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 919' ' ' VAL . 0.8 OUTLIER 58.2 2.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.238 1.415 . . . . 0.0 113.947 172.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 47.4 m -74.76 -5.66 44.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.152 -0.343 . . . . 0.0 111.639 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 1.9 p -142.01 114.79 8.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.962 0.41 . . . . 0.0 111.318 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.567 HG22 ' HB ' ' A' ' 919' ' ' VAL . 0.2 OUTLIER -126.99 145.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.368 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.53 ' HB2' ' CG1' ' A' ' 918' ' ' VAL . 20.1 m -118.24 122.46 43.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -97.34 129.96 44.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.768 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 34.2 m -111.7 121.87 46.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.527 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 25.8 m -97.24 135.47 21.86 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.581 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.03 -13.99 17.33 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 113.205 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.48 -25.79 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 109.667 174.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 106.15 35.53 2.92 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -126.8 116.54 21.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.999 -174.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 36.6 p -105.31 126.46 52.12 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.3 m -117.79 128.66 55.08 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -98.37 126.58 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 110.358 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -112.52 131.12 55.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.44 170.97 16.9 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.62 -20.63 66.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.299 0.55 . . . . 0.0 110.692 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.17 -0.65 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -108.21 147.83 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -99.93 130.97 46.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 111.13 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.1 133.6 72.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.63 -68.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.562 2.174 . . . . 0.0 111.939 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.94 -70.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.751 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -58.62 -29.67 66.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 25.9 mm -67.61 -43.66 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.77 -39.42 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.271 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.08 -43.18 91.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 951' ' ' LYS . 9.7 mmpt? -68.29 -41.58 80.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.54 -34.99 79.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.697 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -62.86 -25.66 68.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.626 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.0 -23.15 65.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.72 -17.59 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.1 m -58.42 -31.55 67.83 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.651 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 893' ' ' VAL . 16.4 m -60.7 -36.5 78.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.449 HD11 ' HB ' ' A' ' 893' ' ' VAL . 50.6 mm -67.95 -39.4 81.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.047 0.451 . . . . 0.0 109.924 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 63.0 tp -60.85 -43.28 98.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.51 -37.23 84.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 25.7 ttt -66.9 -26.33 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 0.0 110.63 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.82 -5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.32 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 964' ' ' ASN . 46.6 t -93.89 6.1 49.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 963' ' ' SER . 5.3 m-20 73.76 148.0 0.12 Allowed Pre-proline 0 N--CA 1.469 0.5 0 O-C-N 123.785 0.678 . . . . 0.0 111.276 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.58 99.11 1.03 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.532 2.155 . . . . 0.0 112.711 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 99.3 m -89.23 114.81 61.8 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.87 69.74 6.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.947 2.431 . . . . 0.0 111.176 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -86.15 0.39 53.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.273 0.559 . . . . 0.0 110.78 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -126.87 148.29 50.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 80.8 m80 . . . . . 0 C--N 1.322 -0.624 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.297 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 21.8 t -86.8 -20.23 27.86 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.752 -0.263 . . . . 0.0 111.061 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -84.24 -13.5 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -108.04 107.57 18.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.534 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 890' ' ' SER . 92.0 mt -98.46 108.34 21.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 112.034 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 889' ' ' LYS . 2.9 mm? -109.59 136.35 49.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.362 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 888' ' ' LEU . 4.8 mptp? 69.77 21.73 6.33 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.709 0.631 . . . . 0.0 110.325 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 887' ' ' LEU . 10.1 m -106.96 147.55 29.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.928 -178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.03 139.97 45.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -98.91 131.34 45.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.72 120.77 64.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 58.09 4.63 0.32 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.112 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 59.8 23.12 12.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.136 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 95.2 t -104.8 -31.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.44 158.53 25.49 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.172 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.492 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.1 OUTLIER -123.27 134.96 54.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.29 130.83 53.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.112 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 22.2 m -115.98 125.73 52.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.39 115.66 21.52 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.3 148.3 25.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.372 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 2.4 p -67.37 -9.58 42.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.74 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 14.3 m -87.54 1.14 54.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 86.92 4.53 82.07 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.146 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.2 152.6 20.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.7 123.71 64.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.511 ' HD1' HG22 ' A' ' 918' ' ' VAL . 38.6 t90 -106.83 112.91 26.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 7.7 p -115.51 118.82 59.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 111.151 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.492 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 46.7 tt0 -102.34 142.47 33.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.931 175.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -112.06 160.05 17.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.694 0.283 . . . . 0.0 110.876 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.38 -17.62 54.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.774 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.82 1.43 12.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.366 0.603 . . . . 0.0 110.654 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.22 4.59 88.06 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.975 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 20.4 t -99.48 155.58 17.49 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 917' ' ' LEU . 15.4 mp0 -130.74 151.7 50.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.92 HD22 ' HD1' ' A' ' 928' ' ' TYR . 1.5 mt -133.62 136.01 44.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.511 HG22 ' HD1' ' A' ' 908' ' ' TRP . 25.2 t -113.6 119.58 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 926' ' ' ILE . 6.7 p -120.14 133.65 66.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 0.0 110.591 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.05 143.98 31.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -50.42 129.69 22.33 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.587 0.554 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 103.12 -8.13 53.09 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.459 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 923' ' ' VAL . 13.7 t 48.49 44.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.953 0.882 . . . . 0.0 111.279 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 5.7 p -82.72 -23.76 33.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.889 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 63.8 m -162.16 130.53 4.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.256 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.619 HG12 HG23 ' A' ' 919' ' ' VAL . 16.3 mt -119.15 145.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.024 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.6 m -118.01 117.35 28.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.92 ' HD1' HD22 ' A' ' 917' ' ' LEU . 41.8 m-85 -99.02 130.05 45.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 916' ' ' GLN . 22.8 p -112.26 122.3 47.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 0.0 110.733 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 931' ' ' PRO . 45.3 m -140.2 109.75 6.97 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.11 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 930' ' ' SER . 20.8 Cg_endo -60.99 -16.74 47.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.243 2.629 . . . . 0.0 112.61 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -74.89 -10.17 59.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.25 -68.1 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . 0.702 ' HG2' ' H ' ' A' ' 935' ' ' THR . 29.8 tt0 169.14 -168.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.702 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 10.0 t -105.33 128.85 53.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.94 0.4 . . . . 0.0 110.279 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 928' ' ' TYR . 10.0 t -117.02 142.11 47.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.71 128.66 54.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.1 0.476 . . . . 0.0 111.204 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 53.2 t80 -109.57 128.06 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.114 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -112.37 162.54 12.36 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.69 -5.7 4.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 117.478 0.639 . . . . 0.0 112.077 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -89.85 4.65 49.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.425 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 943' ' ' LYS . 6.7 tp10 -122.98 162.2 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . 0.819 ' HD3' ' H ' ' A' ' 943' ' ' LYS . 0.0 OUTLIER -99.92 138.81 36.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.023 176.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 948' ' ' ILE . 60.7 mt -97.06 140.6 22.18 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.826 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 22.8 Cg_exo -66.18 165.37 24.52 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.806 2.337 . . . . 0.0 111.254 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 950' ' ' GLN . 58.0 m-20 -53.47 -56.91 12.96 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -61.22 -34.18 74.7 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.662 HG21 HD22 ' A' ' 944' ' ' LEU . 3.2 mp -69.53 -43.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.69 -40.2 96.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.681 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 946' ' ' ASP . 97.0 mt-30 -61.46 -44.47 97.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.991 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -69.31 -39.91 77.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.292 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.66 -36.79 85.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.331 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -64.58 -24.91 67.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 83.3 m -69.31 -22.29 63.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.657 ' HA ' HD13 ' A' ' 958' ' ' ILE . 4.1 mm? -69.89 -15.97 63.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.163 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 9.0 t -58.14 -36.24 72.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.49 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 23.1 t -65.71 -37.63 86.96 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 955' ' ' LEU . 3.4 mp -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.971 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 59.8 tp -66.72 -39.76 88.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.801 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 46.1 tpp -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.503 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -77.91 -5.89 52.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 14.2 t -88.09 4.19 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 8.9 t30 63.65 89.18 0.11 Allowed Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.549 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.45 123.18 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.778 2.319 . . . . 0.0 112.029 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 26.6 m -119.9 89.07 41.51 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.056 0.455 . . . . 0.0 110.33 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.0 49.02 3.05 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.067 2.511 . . . . 0.0 113.014 -176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.98 0.28 57.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 0.0 110.249 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.94 160.46 39.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.53 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 9.2 m -96.83 -45.42 6.65 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -97.46 -21.71 16.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.527 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -83.71 122.4 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.245 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.96 133.64 36.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.07 123.99 44.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.66 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -82.91 -14.85 53.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.748 0.309 . . . . 0.0 110.98 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 39.9 m -91.16 142.89 27.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 34.7 t -125.47 141.41 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -89.1 132.14 34.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.0 121.09 56.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.439 ' HB2' HG12 ' A' ' 896' ' ' VAL . 42.8 mtmt 52.13 11.78 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 59.76 22.47 11.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.438 0.695 . . . . 0.0 110.735 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 894' ' ' LYS . 14.9 p -105.4 -29.06 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.54 162.24 26.16 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.13 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.785 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 1.3 m95 -118.73 136.09 54.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -119.91 130.14 54.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.876 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 18.8 m -117.58 125.31 50.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.253 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -92.0 116.02 28.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 902' ' ' LEU . 3.3 mm? -91.38 152.55 20.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 19.1 p -67.0 -20.06 65.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.538 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 16.2 m -84.88 3.57 37.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 85.2 11.12 76.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.4 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.06 148.91 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.88 122.89 68.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HB2' HD21 ' A' ' 902' ' ' LEU . 4.1 t-105 -108.49 113.64 26.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 39.9 t -115.8 117.75 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 110.768 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.785 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 17.7 mp0 -101.71 148.8 24.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.447 ' HE2' HD22 ' A' ' 917' ' ' LEU . 57.2 m-85 -118.52 159.75 22.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.946 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.1 -17.05 63.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.89 1.53 17.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.651 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 83.97 5.53 87.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.14 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.2 m -97.21 156.87 16.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 929' ' ' THR . 79.4 mt-30 -123.15 152.43 41.17 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.731 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 916' ' ' GLN . 10.6 mp -133.96 136.3 44.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 927' ' ' SER . 36.4 t -112.52 121.15 64.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.93 138.54 49.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -92.58 137.15 32.61 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.73 127.96 33.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.538 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.47 84.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.456 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 925' ' ' SER . 8.4 t -122.53 146.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 117.334 0.567 . . . . 0.0 110.331 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.0 t -86.06 -6.62 58.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.492 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.575 ' H ' HG12 ' A' ' 923' ' ' VAL . 59.6 p -74.1 121.13 20.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 110.287 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 926' ' ' ILE . 0.2 OUTLIER -124.39 146.91 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.825 -177.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 918' ' ' VAL . 31.7 m -107.86 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.99 128.32 42.77 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 916' ' ' GLN . 27.3 m -113.0 122.05 46.47 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.387 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 20.2 m -102.93 124.04 40.03 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.352 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 31.6 Cg_exo -60.59 -10.99 15.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.568 2.845 . . . . 0.0 113.426 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -67.91 -15.45 63.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.26 0.553 . . . . 0.0 110.164 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 111.25 44.29 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.866 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -140.58 111.78 7.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.549 0.214 . . . . 0.0 111.098 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 20.8 m -104.59 123.57 47.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 26.5 m -121.75 128.31 51.61 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 0.1 OUTLIER -104.65 128.87 52.83 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.274 176.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -107.86 127.14 53.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.745 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -94.26 167.54 27.72 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.806 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.27 -27.48 67.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.219 0.533 . . . . 0.0 110.609 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.21 1.92 48.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.518 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.24 -173.62 2.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -99.14 119.11 37.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 945' ' ' PRO . 13.3 tp -101.67 131.77 22.51 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 944' ' ' LEU . 19.2 Cg_exo -68.55 153.53 73.46 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.767 2.312 . . . . 0.0 111.993 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.91 -46.44 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.487 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.14 -32.2 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.774 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 47.4 mm -69.32 -44.03 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 110.013 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -64.69 -44.18 91.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.16 -43.65 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -38.61 83.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.546 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 83.1 mt -64.01 -36.39 83.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 110.569 175.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -63.13 -23.08 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.867 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.94 -25.27 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 958' ' ' ILE . 3.8 mm? -71.83 -30.38 65.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 16.4 m -59.22 -24.32 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.943 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 16.4 m -64.78 -39.4 93.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 955' ' ' LEU . 10.9 tp -69.63 -36.46 70.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.242 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 51.4 tp -62.34 -41.66 98.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.056 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.09 -39.92 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.232 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 23.9 ttt -67.25 -24.34 65.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 110.476 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -89.58 0.23 57.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 7.7 t -78.79 13.88 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.122 0.487 . . . . 0.0 110.712 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.22 77.67 0.33 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.502 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -95.69 19.3 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.244 2.63 . . . . 0.0 111.425 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 26.8 m -106.78 134.77 19.69 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.798 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.18 115.21 2.37 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.593 2.195 . . . . 0.0 111.126 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -78.51 -0.05 27.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.742 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -75.44 -13.27 60.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.101 0.96 . . . . 0.0 112.281 177.684 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 6.5 m -70.06 -38.94 75.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 0.0 111.218 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' A' ' 888' ' ' LEU . . . -139.46 108.78 6.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 111.583 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.07 -83.94 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.199 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.97 -16.55 15.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.563 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' A' ' 885' ' ' ALA . 2.6 pt? -75.33 -19.74 59.45 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.016 -0.273 . . . . 0.0 110.545 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 47.48 67.58 0.79 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.887 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 899' ' ' ALA . 66.8 m -106.96 144.4 33.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 111.474 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.83 140.0 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.43 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -100.88 124.43 46.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.042 0.449 . . . . 0.0 110.944 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.0 p -117.07 123.93 72.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.299 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 67.63 -7.86 0.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.09 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 60.51 22.29 12.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.015 0.926 . . . . 0.0 110.089 -168.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.69 -28.65 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.881 171.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . 0.551 ' HA3' ' NZ ' ' A' ' 951' ' ' LYS . . . -138.93 158.68 25.27 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.105 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.844 ' HD1' ' HG3' ' A' ' 910' ' ' GLN . 0.8 OUTLIER -122.65 136.2 54.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 890' ' ' SER . . . -114.2 130.89 56.62 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.969 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 89.9 m -109.93 124.61 51.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -97.27 115.44 27.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.0 111.224 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 906' ' ' ALA . 98.0 mt -90.22 130.37 36.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 16.9 m -67.06 -9.29 37.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.088 0.471 . . . . 0.0 111.064 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 17.4 m -80.68 -0.24 37.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.1 60.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.59 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 902' ' ' LEU . . . -91.94 138.71 31.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.66 122.27 69.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.126 0.488 . . . . 0.0 109.844 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -108.4 113.38 26.4 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 955' ' ' LEU . 38.3 t -115.11 118.2 58.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.844 ' HG3' ' HD1' ' A' ' 898' ' ' TRP . 11.8 pt20 -103.43 171.32 7.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.798 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -118.44 169.66 9.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -66.19 -17.33 64.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.807 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.66 -0.76 48.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.565 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.2 90.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.017 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 157.6 18.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 910' ' ' GLN . 4.2 pt20 -132.27 154.71 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.59 ' HB3' ' HD1' ' A' ' 928' ' ' TYR . 4.6 pp -137.05 137.38 39.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 169.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.16 121.76 65.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.966 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 926' ' ' ILE . 20.5 t -120.73 134.55 63.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.366 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -92.76 139.68 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -58.06 127.12 30.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.93 0.395 . . . . 0.0 111.34 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.48 -6.25 83.35 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.986 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.802 HG12 ' H ' ' A' ' 925' ' ' SER . 46.4 t -99.86 139.56 21.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.996 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 14.5 p -91.19 -8.37 48.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.404 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.802 ' H ' HG12 ' A' ' 923' ' ' VAL . 14.1 m -93.34 124.84 37.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.472 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 919' ' ' VAL . 55.1 mt -114.48 145.8 19.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.675 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 11.0 p -117.67 116.41 26.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.59 ' HD1' ' HB3' ' A' ' 917' ' ' LEU . 79.7 t80 -110.96 127.02 55.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.031 0.443 . . . . 0.0 110.17 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.505 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 14.2 m -114.5 121.97 45.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.534 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 928' ' ' TYR . 32.5 t -115.91 123.72 30.72 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.59 -0.97 5.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.349 2.7 . . . . 0.0 112.489 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.62 -6.63 45.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.717 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.05 31.45 4.73 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.122 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -143.69 118.99 10.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.931 0.395 . . . . 0.0 111.828 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 5.5 t -104.57 127.19 52.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 31.8 m -118.59 128.79 54.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 111.393 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -100.55 127.65 46.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.567 ' CE1' ' HG ' ' A' ' 944' ' ' LEU . 60.1 t80 -109.1 126.27 53.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.388 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -106.31 161.11 14.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.78 -4.78 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.986 0.422 . . . . 0.0 112.046 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.76 2.98 56.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.036 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.64 176.03 8.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.05 143.76 29.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.545 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 948' ' ' ILE . 51.6 mt -97.37 147.1 32.48 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.224 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.583 ' HB2' HD13 ' A' ' 948' ' ' ILE . 31.9 Cg_exo -59.23 154.96 42.81 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.454 2.103 . . . . 0.0 110.447 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -57.32 -43.25 83.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.947 -170.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 951' ' ' LYS . 85.4 m-85 -68.31 -35.3 77.6 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.324 -176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 944' ' ' LEU . 2.5 mp -70.92 -43.36 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 944' ' ' LEU . 18.0 tppt? -63.7 -39.61 94.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -44.55 97.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.777 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 947' ' ' TYR . 13.5 mmmm -65.29 -42.92 92.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.05 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 919' ' ' VAL . 3.7 mm? -63.04 -35.71 81.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -69.48 -34.88 74.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.12 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 85.0 m -70.53 -24.72 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 909' ' ' VAL . 85.9 mt -70.96 -14.74 62.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 18.0 t -56.85 -38.9 73.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.606 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 17.8 p -66.54 -39.94 88.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.122 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.66 -40.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 109.853 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.03 -40.72 96.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.341 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.11 -40.95 95.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.558 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 15.6 tpt -70.54 -26.56 63.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.136 0.493 . . . . 0.0 110.399 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -85.37 -5.91 59.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 18.0 t -93.34 8.58 39.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.149 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 39.9 m-80 72.64 136.48 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.249 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 17.1 Cg_exo -67.08 125.11 13.08 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.668 2.245 . . . . 0.0 112.012 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 3.1 m -94.05 118.65 67.23 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.243 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.83 145.57 40.96 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.427 2.084 . . . . 0.0 112.388 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.22 20.73 9.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -130.19 125.37 34.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 -179.236 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 16.3 m -89.92 126.51 35.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -69.35 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.145 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -165.34 127.28 2.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 110.517 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -122.99 135.62 54.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.409 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 9.3 mp -99.87 148.11 24.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? 63.23 25.33 14.73 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.431 0.457 . . . . 0.0 111.678 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 57.9 p -106.75 141.57 37.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.511 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.7 140.15 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.59 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -106.53 130.51 54.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.962 0.411 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.17 117.94 46.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 45.55 17.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.96 1.412 . . . . 0.0 112.749 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.74 24.38 12.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 53.4 t -102.09 -30.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.13 157.55 24.95 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.643 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -124.89 136.55 53.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 909' ' ' VAL . . . -124.65 131.78 53.45 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.197 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 17.1 m -105.01 125.54 51.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -85.76 116.66 24.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.23 158.43 23.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.885 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 4.3 m -66.79 -22.04 66.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.733 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 7.8 t -83.38 0.63 45.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.976 0.417 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.33 4.88 67.94 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.341 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -90.07 140.69 29.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.476 HG11 HD12 ' A' ' 955' ' ' LEU . 36.4 t -106.06 123.55 60.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.405 ' HE1' ' HB3' ' A' ' 916' ' ' GLN . 3.0 t90 -102.24 111.96 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.611 HG13 ' HG ' ' A' ' 917' ' ' LEU . 3.2 p -114.51 118.29 58.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.601 0.715 . . . . 0.0 111.119 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 1.033 ' HB3' ' HG2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -106.88 148.02 29.07 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.229 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 951' ' ' LYS . 36.5 m-85 -91.47 175.05 7.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.185 0.517 . . . . 0.0 110.956 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -65.23 -17.39 64.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.698 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.62 -2.44 50.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.37 0.605 . . . . 0.0 111.201 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.01 90.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 63.5 m -95.68 152.29 18.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 1.033 ' HG2' ' HB3' ' A' ' 910' ' ' GLN . 32.0 mt-30 -132.05 154.86 48.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.726 0.298 . . . . 0.0 111.269 -170.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.611 ' HG ' HG13 ' A' ' 909' ' ' VAL . 0.8 OUTLIER -137.83 137.98 38.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.927 0.394 . . . . 0.0 110.003 169.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 15.7 t -104.27 123.39 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.008 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 926' ' ' ILE . 42.5 t -118.21 129.9 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.788 176.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -94.59 139.6 30.98 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.32 127.61 32.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.874 0.369 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.74 83.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.61 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 925' ' ' SER . 30.7 t -115.78 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 122.792 -0.24 . . . . 0.0 110.508 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 35.0 t -91.06 -10.35 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 923' ' ' VAL . 12.5 m -82.61 111.52 18.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.732 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 952' ' ' LEU . 40.4 pt -113.3 155.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 0.0 110.918 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 14.4 m -117.49 116.34 26.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 911' ' ' PHE . 39.7 t80 -101.0 124.68 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.0 t -116.31 128.37 55.5 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.065 0.46 . . . . 0.0 110.046 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 32.2 t -132.88 120.71 16.58 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.43 -12.96 30.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.076 2.518 . . . . 0.0 111.732 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -76.72 -15.87 59.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.097 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 934' ' ' GLN . . . -144.09 -68.38 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . 0.723 ' HG3' ' H ' ' A' ' 935' ' ' THR . 4.0 tp-100 166.1 -164.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.723 ' H ' ' HG3' ' A' ' 934' ' ' GLN . 18.9 m -103.42 127.11 50.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.001 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 7.6 t -119.06 143.34 47.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.255 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 937' ' ' ARG . 8.1 ptt180 -97.78 135.18 39.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.214 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.515 ' HB3' HD21 ' A' ' 944' ' ' LEU . 76.9 m-85 -110.78 126.88 55.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 170.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . 0.669 ' H ' ' HB2' ' A' ' 942' ' ' GLU . . . -146.21 -170.74 15.05 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.231 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.89 -27.41 68.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.828 0.347 . . . . 0.0 110.832 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.89 1.38 57.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.113 0.483 . . . . 0.0 110.669 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.669 ' HB2' ' H ' ' A' ' 939' ' ' GLY . 1.3 mp0 -108.07 174.47 5.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.679 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -99.17 124.19 44.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 938' ' ' TYR . 62.5 mt -97.01 131.04 28.47 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.984 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 15.7 Cg_exo -72.03 154.67 57.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.903 2.402 . . . . 0.0 111.033 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.26 -48.08 82.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.12 -176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . 0.728 ' O ' ' HD3' ' A' ' 951' ' ' LYS . 44.9 m-85 -66.82 -30.67 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.6 -40.81 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.821 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -63.34 -37.63 88.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.004 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -61.08 -44.63 97.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.047 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.728 ' HD3' ' O ' ' A' ' 947' ' ' TYR . 2.3 mptp? -68.61 -42.96 77.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.313 0.578 . . . . 0.0 109.483 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.527 HD13 HG21 ' A' ' 926' ' ' ILE . 62.1 tp -59.38 -38.34 80.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.605 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.19 -25.59 63.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 71.3 m -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.932 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.476 HD12 HG11 ' A' ' 907' ' ' VAL . 2.8 mm? -70.6 -20.27 62.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.602 0.239 . . . . 0.0 111.435 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 7.3 m -58.53 -39.73 81.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.623 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 46.5 p -65.67 -37.67 87.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.64 -40.51 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.789 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.71 -43.24 98.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.12 -38.58 91.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.154 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 17.1 tpt -66.67 -27.15 67.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 110.611 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -87.27 -5.41 58.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.599 . . . . 0.0 110.245 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 965' ' ' PRO . 56.8 m -86.08 14.43 6.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.814 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -98.16 102.16 13.19 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.736 0.779 . . . . 0.0 109.247 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 963' ' ' SER . 74.8 Cg_endo -104.91 -178.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.367 2.712 . . . . 0.0 113.685 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 9.1 t -114.89 143.47 30.15 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.83 92.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.356 2.038 . . . . 0.0 112.098 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -97.65 3.25 50.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.759 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.95 -47.46 77.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 109.351 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.122 175.954 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 23.2 p -87.11 39.0 0.84 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.984 0.421 . . . . 0.0 111.292 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -145.12 139.9 27.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.055 0.455 . . . . 0.0 111.275 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.34 152.41 39.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.63 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 891' ' ' VAL . 0.2 OUTLIER -123.01 129.82 52.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 -175.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 888' ' ' LEU . 2.5 mm? -98.8 -161.74 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.658 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -70.57 -25.79 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.384 0.611 . . . . 0.0 109.598 172.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 14.5 m -107.52 148.36 29.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.629 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . 1.001 HG22 HD11 ' A' ' 887' ' ' LEU . 19.8 t -112.93 138.48 42.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -108.58 126.15 52.63 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.02 118.6 59.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.38 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.641 ' HB2' HG12 ' A' ' 896' ' ' VAL . 94.0 mttt 53.49 7.97 0.12 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.31 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.3 23.49 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.627 0.771 . . . . 0.0 109.854 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 894' ' ' LYS . 12.5 p -105.2 -28.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -138.65 158.14 24.92 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.876 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.447 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 2.9 m95 -122.97 136.53 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 891' ' ' VAL . . . -110.87 130.07 55.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.026 0.441 . . . . 0.0 110.124 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 908' ' ' TRP . 10.1 m -116.99 125.37 51.28 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.758 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.92 117.08 29.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.228 0.537 . . . . 0.0 110.112 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HE3' ' A' ' 908' ' ' TRP . 3.6 mm? -95.56 137.05 35.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.807 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 7.7 t -63.34 -17.82 62.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 22.7 t -81.81 1.04 36.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 91.07 11.31 61.55 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.029 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -91.43 140.63 29.58 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.823 -0.222 . . . . 0.0 110.443 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.735 HG11 HD11 ' A' ' 955' ' ' LEU . 46.7 t -107.59 122.83 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.77 ' HB3' ' HB ' ' A' ' 900' ' ' THR . 1.5 t90 -110.23 115.74 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.452 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 57.5 t -112.41 119.39 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.436 0.636 . . . . 0.0 110.245 173.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.665 ' HG3' ' HG2' ' A' ' 916' ' ' GLN . 8.1 tt0 -104.4 143.33 33.14 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.478 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.52 171.06 9.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.56 -21.04 66.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.25 1.87 49.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.642 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.0 5.35 87.78 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.085 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 15.5 m -94.63 152.07 18.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.665 ' HG2' ' HG3' ' A' ' 910' ' ' GLN . 51.6 mt-30 -134.5 159.15 42.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 926' ' ' ILE . 1.3 pt? -137.91 136.07 36.7 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 169.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 907' ' ' VAL . 7.0 m -114.3 128.08 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.43 . . . . 0.0 111.545 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.93 136.69 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -92.3 140.86 29.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -59.21 128.5 37.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 89.32 -6.14 83.6 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 925' ' ' SER . 41.6 t -111.61 134.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.109 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 18.8 m -91.0 -5.34 55.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.743 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.745 ' H ' HG12 ' A' ' 923' ' ' VAL . 15.0 m -95.43 131.58 41.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.475 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 917' ' ' LEU . 3.7 mp -113.15 146.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 15.2 m -115.34 117.1 29.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.632 ' HB2' ' HE1' ' A' ' 938' ' ' TYR . 43.8 t80 -96.24 127.18 42.01 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 8.9 t -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.333 0.587 . . . . 0.0 110.918 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 22.8 t -118.01 111.18 39.1 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.01 144.83 93.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.246 2.631 . . . . 0.0 111.609 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.0 12.62 8.05 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.577 0.548 . . . . 0.0 110.396 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 934' ' ' GLN . . . -131.39 -91.46 0.54 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 933' ' ' GLY . 30.0 mt-30 178.01 168.1 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.621 0.768 . . . . 0.0 109.9 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 50.3 m -105.24 126.2 51.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.663 0.268 . . . . 0.0 110.359 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 24.7 m -118.96 128.84 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.414 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 13.7 ptm180 -99.67 127.4 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.369 0.604 . . . . 0.0 111.278 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 928' ' ' TYR . 26.0 p90 -110.06 138.53 46.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.011 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -90.94 -179.71 43.0 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.615 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.45 -13.01 60.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.813 0.34 . . . . 0.0 111.152 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.83 -0.16 57.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -92.67 141.07 28.88 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.94 -0.475 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 943' ' ' LYS . 23.5 mtmm -92.99 123.5 36.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.32 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -96.51 135.53 22.34 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 33.9 Cg_exo -61.62 -73.43 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.909 2.406 . . . . 0.0 113.148 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -145.61 -71.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -64.1 -32.77 74.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.667 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 952' ' ' LEU . 32.5 mm -68.53 -43.06 83.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -64.01 -39.68 94.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.807 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.56 -43.7 96.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 951' ' ' LYS . 2.8 mptp? -67.95 -38.69 83.11 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.208 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 948' ' ' ILE . 89.2 mt -62.97 -31.74 72.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.159 0.504 . . . . 0.0 110.494 175.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -69.27 -36.42 77.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.5 -11.71 60.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.588 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.735 HD11 HG11 ' A' ' 907' ' ' VAL . 3.1 mm? -64.28 -19.55 65.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.821 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 48.2 t -58.9 -35.84 73.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.005 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 14.7 m -65.42 -39.86 92.64 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 955' ' ' LEU . 10.5 tp -69.67 -36.41 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 46.5 tp -61.64 -41.36 97.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.202 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 956' ' ' SER . 96.8 mt -66.18 -36.58 83.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 54.3 tpp -65.51 -26.23 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.791 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -86.63 -0.01 55.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.297 0.57 . . . . 0.0 110.364 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 15.2 m -89.29 9.41 26.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.068 0.461 . . . . 0.0 110.337 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -64.2 135.71 96.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.307 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' A' ' 967' ' ' PRO . 3.8 Cg_endo -46.35 -38.95 21.3 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.032 3.155 . . . . 0.0 113.745 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 2.8 p -104.49 100.02 20.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.95 0.405 . . . . 0.0 110.776 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 965' ' ' PRO . 4.9 Cg_exo -80.95 43.41 1.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.368 2.712 . . . . 0.0 112.25 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -80.48 24.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.632 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -67.91 -24.42 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.374 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 38.1 t -142.48 125.3 16.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -90.13 174.82 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.671 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -71.19 93.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.233 175.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 61.7 tp -88.9 110.27 20.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.48 -85.47 0.26 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 125.99 26.38 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 11.1 p -106.64 143.92 34.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.944 0.402 . . . . 0.0 110.823 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.17 142.63 41.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.001 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -106.76 129.16 54.68 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.25 121.03 54.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.62 ' HB3' HG12 ' A' ' 896' ' ' VAL . 58.9 tttm 57.8 4.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.136 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.66 24.42 14.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.779 0.799 . . . . 0.0 109.178 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.62 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.9 p -103.71 -28.94 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.21 158.47 25.34 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.849 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.701 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 0.7 OUTLIER -121.6 135.43 54.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 908' ' ' TRP . . . -121.4 130.18 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.067 0.46 . . . . 0.0 110.865 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 28.8 m -115.66 132.85 56.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.047 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -94.82 115.79 27.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.33 153.67 19.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -19.11 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.239 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 15.3 m -85.2 1.03 49.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.715 0.293 . . . . 0.0 111.262 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.73 69.11 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.943 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 920' ' ' GLN . . . -90.35 141.76 28.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.6 122.31 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 899' ' ' ALA . 2.0 t-105 -104.01 114.62 29.0 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 898' ' ' TRP . 48.7 t -112.41 117.29 54.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.265 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.701 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 42.7 mt-30 -103.62 143.51 32.66 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.907 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 152.41 20.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.418 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 896' ' ' VAL . 26.7 p30 -65.09 -16.24 63.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.35 2.34 50.63 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.289 -0.257 . . . . 0.0 111.555 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 95.53 5.81 60.04 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.602 -0.808 . . . . 0.0 114.202 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 14.0 m -96.53 157.93 15.67 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.756 ' HG2' ' HB ' ' A' ' 929' ' ' THR . 0.8 OUTLIER -133.2 154.68 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.02 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 917' ' ' LEU . 5.6 mp -123.07 134.85 54.24 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.495 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.67 118.66 59.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.25 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 955' ' ' LEU . 12.5 p -123.22 144.61 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 906' ' ' ALA . 61.8 tt0 -93.17 139.55 30.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.146 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.99 128.93 38.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 99.24 -4.01 58.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.981 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 925' ' ' SER . 9.9 p -139.69 151.38 22.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 117.257 0.529 . . . . 0.0 110.521 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 940' ' ' GLU . 5.1 p -91.45 -6.74 52.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.499 ' H ' HG22 ' A' ' 923' ' ' VAL . 16.4 p -68.49 108.85 3.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.25 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.05 145.28 25.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.343 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 937' ' ' ARG . 6.2 p -117.61 122.41 43.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.795 0.331 . . . . 0.0 110.292 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -96.1 127.89 42.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.756 ' HB ' ' HG2' ' A' ' 916' ' ' GLN . 20.9 m -113.96 123.39 49.61 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.323 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 931' ' ' PRO . 48.0 t -107.35 115.06 60.24 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 930' ' ' SER . 23.3 Cg_exo -65.59 2.48 1.57 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.673 2.915 . . . . 0.0 112.861 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.33 -3.48 57.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.55 . . . . 0.0 109.563 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . 104.45 44.28 1.59 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.373 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.29 102.57 2.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . . . . . . . . . 11.9 t -105.43 129.67 53.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.042 0.448 . . . . 0.0 110.57 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 14.8 p -116.93 128.64 55.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.033 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 927' ' ' SER . 7.2 ptp85 -107.8 126.89 53.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.552 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.46 139.65 46.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.574 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 942' ' ' GLU . . . -109.39 173.1 16.75 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.033 174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 924' ' ' SER . 30.5 tt0 -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.83 0.347 . . . . 0.0 111.569 -176.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -95.34 2.22 54.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.322 0.582 . . . . 0.0 110.688 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 939' ' ' GLY . 33.4 mm-40 -91.48 172.32 8.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 130.77 46.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.952 0.406 . . . . 0.0 110.111 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 945' ' ' PRO . 2.9 mm? -94.84 133.2 26.9 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.866 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 944' ' ' LEU . 31.4 Cg_exo -59.82 -65.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 0.0 111.683 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -165.68 -64.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.46 -33.59 72.79 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.57 -172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.24 -42.72 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.2 -44.27 92.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.452 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.6 -43.98 96.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.682 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 951' ' ' LYS . 35.4 mmtm -71.15 -38.02 72.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 955' ' ' LEU . 28.0 tp -57.98 -36.56 72.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.858 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.51 -35.09 79.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.885 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . . . . . . . . . 27.8 t -72.1 -25.26 61.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.256 0.55 . . . . 0.0 110.602 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.628 ' O ' HG13 ' A' ' 958' ' ' ILE . 96.5 mt -71.33 -25.67 62.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.061 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 960' ' ' LEU . 16.7 m -58.2 -25.82 62.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.446 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 19.8 m -62.67 -37.87 88.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 955' ' ' LEU . 2.4 pp -69.68 -34.78 62.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.078 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.14 -42.53 99.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 956' ' ' SER . 92.7 mt -66.03 -35.95 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.682 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . 0.401 ' O ' ' HD3' ' A' ' 965' ' ' PRO . 14.4 tmm? -68.59 -27.18 65.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 110.095 176.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.41 0.624 . . . . 0.0 109.844 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 7.6 t -92.05 17.61 9.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.497 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 9.6 t30 66.61 94.06 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.032 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 961' ' ' MET . 93.3 Cg_endo -85.33 -179.26 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.744 2.296 . . . . 0.0 111.175 173.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 967' ' ' PRO . 35.5 m -117.68 98.04 51.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.63 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 966' ' ' THR . 37.0 Cg_endo -67.82 100.54 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.479 2.12 . . . . 0.0 111.175 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.24 19.8 12.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.75 -171.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.73 114.62 8.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.772 176.782 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . 0.47 ' HA2' ' OE1' ' A' ' 910' ' ' GLN . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 38.6 m 72.62 133.25 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.505 0.669 . . . . 0.0 112.111 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -133.0 148.94 52.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.189 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -87.51 151.6 22.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 887' ' ' LEU . 0.5 OUTLIER -81.17 126.08 31.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 110.832 -177.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . . . . . . . . . 31.9 tp -169.54 -74.98 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.776 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -124.56 0.81 8.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.995 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.2 t -107.36 143.42 35.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.754 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 35.0 t -126.42 140.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.272 . . . . 0.0 110.565 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -92.07 130.68 37.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 954' ' ' CYS . 14.4 m -111.2 122.26 65.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.972 0.415 . . . . 0.0 111.597 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . 0.726 ' HB3' HG12 ' A' ' 896' ' ' VAL . 39.8 ttmt 60.91 1.98 0.5 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.932 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.08 22.52 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.074 -170.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' ' 894' ' ' LYS . 13.3 p -104.22 -29.19 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.9 160.32 26.17 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.327 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.537 ' HD1' ' HB3' ' A' ' 910' ' ' GLN . 0.6 OUTLIER -120.68 133.79 55.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -125.14 130.66 52.63 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.243 -0.583 . . . . 0.0 112.188 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 52.0 m -115.52 125.65 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.296 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -86.59 124.13 32.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.14 141.7 28.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 3.6 m -66.65 -8.4 27.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 3.0 m -85.49 0.5 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 90.32 4.21 71.38 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.68 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -92.02 142.67 27.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.2 123.18 68.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -107.71 112.55 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 917' ' ' LEU . 6.0 p -116.85 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.748 0.785 . . . . 0.0 110.767 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.537 ' HB3' ' HD1' ' A' ' 898' ' ' TRP . 7.6 tt0 -91.91 143.14 26.8 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.857 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 913' ' ' ASP . 19.7 t80 -92.66 150.0 20.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.8 -19.72 60.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . 0.809 ' H ' ' HD1' ' A' ' 911' ' ' PHE . 37.9 t70 -79.97 1.1 28.74 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.188 0.518 . . . . 0.0 111.264 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 91.94 5.71 65.93 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.94 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.7 p -96.05 153.3 17.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -121.83 155.48 35.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.549 0.214 . . . . 0.0 110.555 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.624 ' HB3' HG13 ' A' ' 909' ' ' VAL . 7.9 tt -137.75 131.0 30.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.54 120.8 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.33 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.22 145.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.74 139.33 30.66 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -61.42 128.68 37.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.811 0.338 . . . . 0.0 111.691 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 97.02 -6.63 64.19 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.09 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.07 156.36 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 122.511 -0.405 . . . . 0.0 111.1 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 944' ' ' LEU . 42.0 m -90.32 -5.68 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . . . . . . . . . 15.3 t -69.2 112.35 5.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.218 0.532 . . . . 0.0 109.839 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 948' ' ' ILE . 0.0 OUTLIER -120.64 146.61 25.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.897 -174.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 5.8 m -116.15 117.63 30.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -108.02 129.37 55.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.155 0.502 . . . . 0.0 110.397 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . . . . . . . . . 23.6 m -100.44 121.94 42.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 44.6 t -123.02 125.03 26.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.29 -11.92 32.42 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.348 2.032 . . . . 0.0 111.422 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -105.06 -14.5 15.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.916 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -149.33 22.3 1.22 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.76 -1.21 . . . . 0.0 114.458 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . 0.803 ' HG2' ' H ' ' A' ' 935' ' ' THR . 39.3 tt0 68.3 -161.26 0.2 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.051 0.426 . . . . 0.0 109.906 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.803 ' H ' ' HG2' ' A' ' 934' ' ' GLN . 3.3 p -97.29 126.0 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.439 . . . . 0.0 110.972 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 19.9 p -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.851 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -98.95 128.99 45.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.855 0.36 . . . . 0.0 110.369 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 926' ' ' ILE . 58.4 m-85 -101.84 127.85 48.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -93.41 141.74 15.67 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.676 -167.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.35 -21.88 66.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.533 0.682 . . . . 0.0 109.802 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.18 2.04 37.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.862 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -142.02 -140.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.838 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -100.01 136.26 40.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.706 -169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 924' ' ' SER . 24.6 mt -99.96 132.74 22.35 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.836 169.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.54 155.29 70.84 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.677 2.251 . . . . 0.0 111.42 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 950' ' ' GLN . 24.8 t70 -60.21 -46.74 88.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.376 -176.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -61.69 -31.81 71.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 111.348 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 926' ' ' ILE . 45.3 mm -69.35 -42.56 81.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.44 . . . . 0.0 109.966 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -63.01 -37.24 86.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.104 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 946' ' ' ASP . 81.1 mm-40 -61.11 -44.14 97.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.609 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -67.63 -43.64 79.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.4 -36.24 83.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.855 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -59.4 -34.18 72.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.261 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 893' ' ' VAL . 61.2 m -69.9 -25.41 63.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.651 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . . . . . . . . . 11.0 mp -71.29 -31.55 67.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 15.7 m -59.61 -32.53 70.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.414 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 15.0 m -60.1 -36.22 76.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.544 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.46 -40.81 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.336 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.3 -41.23 98.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.107 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 97.5 mt -66.78 -35.08 79.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.007 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 27.7 ttt -69.54 -26.21 64.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.81 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -84.34 -5.81 59.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.161 0.505 . . . . 0.0 110.245 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 22.9 t -91.2 11.29 23.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 0.0 109.811 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.16 144.78 99.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.022 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.07 -35.38 3.21 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.671 2.914 . . . . 0.0 114.381 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 10.9 t -140.36 114.87 7.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.345 0.593 . . . . 0.0 110.895 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 966' ' ' THR . 6.1 Cg_endo -87.23 150.1 7.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.139 2.56 . . . . 0.0 111.804 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -97.44 -0.73 45.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 109.743 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -71.9 -29.85 64.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.197 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.743 -178.049 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 883' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 884' ' ' SER . . . . . . . . . . . . . 19.9 p -78.79 -63.91 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.023 0.439 . . . . 0.0 110.847 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 885' ' ' ALA . . . . . . . . . . . . . . . -94.76 113.57 25.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.404 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 886' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -81.22 65.94 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.156 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 887' ' ' LEU . . . . . . . . . . . . . 95.3 mt -101.52 106.63 17.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.257 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 888' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 890' ' ' SER . 2.1 pt? -154.56 164.84 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 889' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -85.16 -15.08 44.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.056 0.455 . . . . 0.0 110.791 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.537 ' O ' ' HG ' ' A' ' 888' ' ' LEU . 3.8 p -107.08 154.0 21.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.804 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 891' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.63 139.01 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 892' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -97.08 130.13 44.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 893' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 954' ' ' CYS . 44.7 t -116.51 119.46 62.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.629 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 894' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 56.37 4.96 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.622 1.201 . . . . 0.0 112.316 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 895' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 59.07 23.58 11.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.333 0.653 . . . . 0.0 109.944 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 896' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.57 -29.05 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 897' ' ' GLY . . . . . . . . . . . . . . . -139.78 158.77 25.76 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.448 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 898' ' ' TRP . . . . . 0.463 ' HD1' ' HB2' ' A' ' 910' ' ' GLN . 3.6 m95 -121.03 136.0 55.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 899' ' ' ALA . . . . . . . . . . . . . . . -122.49 130.16 52.76 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.104 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 900' ' ' THR . . . . . . . . . . . . . 23.9 m -116.62 127.07 54.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.483 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 901' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -88.63 117.55 27.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.887 0.375 . . . . 0.0 110.427 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 902' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 908' ' ' TRP . 3.1 mm? -80.21 149.42 30.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.975 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 903' ' ' THR . . . . . . . . . . . . . 8.4 t -65.88 -20.28 66.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.446 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 904' ' ' SER . . . . . . . . . . . . . 39.9 t -83.95 0.77 46.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 111.041 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 905' ' ' GLY . . . . . . . . . . . . . . . 92.62 6.5 63.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.912 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 906' ' ' ALA . . . . . . . . . . . . . . . -85.24 152.34 23.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 907' ' ' VAL . . . . . 0.536 ' HB ' ' CG1' ' A' ' 919' ' ' VAL . 45.2 t -112.08 122.92 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.252 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 908' ' ' TRP . . . . . 0.699 ' HB2' HD21 ' A' ' 902' ' ' LEU . 22.6 t90 -110.08 113.68 26.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 909' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 917' ' ' LEU . 45.7 t -115.2 129.01 72.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 -175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 910' ' ' GLN . . . . . 0.463 ' HB2' ' HD1' ' A' ' 898' ' ' TRP . 35.1 mt-30 -98.61 150.05 22.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -108.5 162.25 14.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.475 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.9 -27.77 61.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.347 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.71 1.53 42.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.489 0.662 . . . . 0.0 111.103 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 84.76 8.19 83.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.065 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.68 165.38 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -0.627 . . . . 0.0 109.519 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -130.8 151.99 50.63 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.2 -177.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 909' ' ' VAL . 0.4 OUTLIER -137.67 134.82 35.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.013 0.435 . . . . 0.0 110.018 173.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' VAL . . . . . 0.619 HG22 ' HD1' ' A' ' 908' ' ' TRP . 42.4 t -114.2 124.3 70.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.157 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 907' ' ' VAL . 14.6 p -118.8 132.55 68.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 110.331 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.04 141.66 28.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.162 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.19 40.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' GLY . . . . . . . . . . . . . . . 101.33 6.48 50.89 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.647 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 925' ' ' SER . 8.1 p -149.78 141.14 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 940' ' ' GLU . 35.1 t -87.1 -5.57 58.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.874 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 925' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 923' ' ' VAL . 19.6 m -82.31 131.16 35.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.3 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.773 HD11 HD13 ' A' ' 952' ' ' LEU . 3.6 mt -120.0 146.43 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.252 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 917' ' ' LEU . 23.3 t -104.35 115.41 30.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 928' ' ' TYR . . . . . 0.574 ' CZ ' HD13 ' A' ' 917' ' ' LEU . 19.7 m-85 -102.12 125.81 48.91 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 929' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 935' ' ' THR . 14.5 t -114.99 123.52 49.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.57 0.7 . . . . 0.0 110.661 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 930' ' ' SER . . . . . . . . . . . . . 43.2 t -105.07 106.61 56.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.697 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 931' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.66 -39.0 93.6 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.346 2.697 . . . . 0.0 112.932 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -97.0 16.18 20.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.785 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 933' ' ' GLY . . . . . . . . . . . . . . . -137.63 -75.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.532 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 934' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 175.54 169.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 935' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 929' ' ' THR . 29.1 m -104.43 124.51 49.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 11.1 m -121.54 130.0 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 937' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 937' ' ' ARG . 0.0 OUTLIER -97.62 128.96 44.73 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.145 174.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 938' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.56 127.44 53.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.803 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 939' ' ' GLY . . . . . . . . . . . . . . . -99.15 169.55 22.89 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.332 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 940' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 924' ' ' SER . 11.7 pt-20 -64.68 -15.93 62.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.449 0.299 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 941' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.45 1.61 55.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 942' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -100.93 146.43 27.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.339 . . . . 0.0 110.684 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 943' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.38 123.38 31.56 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 944' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 948' ' ' ILE . 2.2 mm? -91.43 133.57 31.12 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.407 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 945' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -71.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.271 2.647 . . . . 0.0 113.334 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 946' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -147.26 -75.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.754 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 948' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 948' ' ' ILE . 4.0 mp -67.72 -42.66 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 949' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -63.31 -44.05 96.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.781 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -62.25 -42.63 99.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.854 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 951' ' ' LYS . . . . . 0.508 ' O ' HD13 ' A' ' 955' ' ' LEU . 25.5 mmmt -68.81 -40.58 79.49 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.149 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 926' ' ' ILE . 56.5 tp -62.15 -39.65 93.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.847 175.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 953' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -73.2 -35.45 66.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.38 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 954' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 951' ' ' LYS . 31.8 p -71.53 -20.68 62.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.031 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 955' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 951' ' ' LYS . 4.4 mp -70.71 -17.49 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 956' ' ' SER . . . . . . . . . . . . . 40.5 m -58.89 -28.49 66.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.817 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' SER . . . . . . . . . . . . . 32.2 t -65.43 -37.92 88.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.258 0.551 . . . . 0.0 109.952 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' ILE . . . . . . . . . . . . . 58.2 mt -68.2 -40.29 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.441 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.65 -37.66 82.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.276 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.43 -39.9 94.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.456 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' MET . . . . . . . . . . . . . 15.6 tpt -70.26 -27.09 64.16 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.847 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -81.73 -5.35 58.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.281 0.562 . . . . 0.0 110.785 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' SER . . . . . . . . . . . . . 46.5 m -92.2 4.49 53.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.502 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 965' ' ' PRO . 91.9 m-20 70.71 151.23 0.14 Allowed Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.907 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 964' ' ' ASN . 23.6 Cg_exo -65.29 170.6 10.48 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.901 2.401 . . . . 0.0 112.054 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.02 122.03 63.11 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.211 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.75 29.66 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.468 2.778 . . . . 0.0 114.143 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.07 12.76 18.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 0.0 110.481 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -72.65 -17.68 61.64 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' HIS . . . . . . . . . . . . . 36.1 t60 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.102 . . . . . . . . 0 0 . 1 stop_ save_